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“In life there is nothing to fear, but to understand.” 
(Marie Curie)  
 
 
“What we know is a drop; What we do not know is an ocean.” 
(Isaac Newton) 
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Sumário 
O acufeno é um sintoma referente à perceção de um som nos ouvidos ou na 
cabeça, sem que exista um estímulo acústico externo correspondente. Está presente em 
diferentes patologias (otológicas ou não) e tem um impacto importante na qualidade de 
vida da pessoa afetada. Atualmente, o seu diagnóstico e monitorização são baseados 
em medidas subjetivas audiométricas e psicométricas, sendo que não existem métodos 
objetivos para a identificação do acufeno. Além disso, os mecanismos fisiopatológicos 
subjacentes ao acufeno subjectivo permanecem desconhecidos.  
O objetivo da presente tese é estudar os mecanismos subjacentes ao acufeno 
subjectivo e a sua relação com a surdez, visto que a surdez é a co-morbilidade mais 
frequentemente associada ao acufeno. Pretende-se também avaliar a contribuição dos 
fatores genéticos, audiológicos e imunológicos na etiologia do acufeno.   
Para isso, foram realizadas revisões sistemáticas (RS) sobre esta temática de 
forma a conhecer o estado de arte, primeiramente em relação à forma como os 
pacientes e os familiares percecionam o acufeno e também sobre os ensaios clínicos 
existentes acerca da eficácia do tratamento do acufeno. Ambas as RS contribuíram para 
a identificação de um conjunto de domínios relacionados com o acufeno, usado pelo 
COMIT’ID (Core outcome measures in tinnitus international Delphi), num método de 
consensos Delphi, baseado na Internet, com o objetivo de identificar um ‘Core Outcome 
Set’ (ou seja definir quais as queixas relacionadas com o acufeno que são imprescindíveis 
para a sua avaliação) recomendado para ensaios clínicos de eficácia terapêutica para o 
acufeno assim como para o seu diagnóstico. Estas recomendações são específicas para 
as três modalidades terapêuticas principais: sonora, psicológica e farmacológica uma 
vez que cada modalidade tem fundamentos específicos e por isso visam avaliar 
diferentes aspetos do acufeno.   
Com o objetivo de contribuir para a padronização da avaliação e do tratamento 
clínico do acufeno, foi constituída a TINNET, uma rede europeia para a investigação 
científica do acufeno. Considerando o objetivo do presente estudo e a hipótese de 
integrar esta rede europeia, foram desenvolvidas um conjunto de atividades que em 
muito contribuíram para o conhecimento sobre o acufenos. Entre as diferentes 
atividades realizadas com o apoio da TINNET destaca-se a realização de uma revisão 
sistemática sobre as ‘guidelines’ clínicas existentes para o diagnóstico e tratamento do 
acufeno. Esta revisão foi uma das bases que conduziu ao desenvolvimento das 
‘guidelines’ europeias multidisciplinares para o acufeno: diagnóstico, avaliação e 
tratamento. Estas ‘guidelines’ foram apresentadas na conferência final do TINNET e 
estão atualmente em fase de disseminação.  
Outro foco de interesse da presente tese foi a realização de trabalhos de revisão 
sobre o acufeno somatosensorial (nomeadamente sobre a fisiopatologia, diagnóstico e 
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tratamento), bem como a participação num grupo de consenso internacional sobre o 
diagnóstico deste subtipo do acufeno, de forma a contribuir para uma melhor 
compreensão deste subtipo do acufeno. Também estas atividades contribuíram para o 
desenvolvimento de competências cientificas essenciais ao desenvolvimento do 
presente estudo, dado que permitiram uma melhor compreensão deste subtipo do 
acufeno, demonstrando-se a heterogeneidade e diversidade do acufeno. 
De forma a alcançar os objetivos deste estudo de doutoramento, recrutaram-se 
114 voluntários da população portuguesa com idade dos 55 aos 75 anos. Os indivíduos 
desta amostra permitiam a realização de diferentes estudos nomeadamente os 
laboratoriais, tendo a analise dos resultados envolvido a amostra dividida em quatro 
grupos consoante a presença/ausência do acufeno e de surdez. Dos resultados desta 
tese fazem parte quatro artigos originais que e incluem uma caracterização 
demográfica, aspetos relevantes a nível psicológico e de qualidade de vida, marcadores 
audiológicos do acufeno, perfil imunológico da população e biomarcadores da 
presbiacusia e do acufeno.   
Os resultados obtidos sugerem a perda auditiva como fator de risco para o 
desenvolvimento do acufeno e as queixas a nível psicológico como fator de risco para o 
acufeno mais grave e consequentemente associado a menor qualidade de vida nos 
pacientes com este sintoma. 
A nível da caracterização dos marcadores audiológicos, verificou-se que a 
presença de antecedentes de exposição ao ruído e a perda auditiva aumentam a 
probabilidade de desenvolver acufeno. Também, os participantes com um início abrupto 
do acufeno e que apresentam um efeito negativo ou ‘rebound’ na inibição residual têm 
maior probabilidade de desenvolver acufeno grave ou catastrófico. Encontrou-se nos 
Potenciais Evocados Auditivos, uma redução da amplitude na onda I em pacientes com 
acufeno, bem como valores maiores no ‘Ratio de amplitude das ondas V e I de ambos 
ouvidos’ estando associados a maiores probabilidades de desenvolver acufeno severo 
ou catastrófico.   
O perfil inflamatório da nossa população mostra diferenças significativas entre o 
grupo com e sem acufeno quando comparados para a IL10. Quanto à relação entre os 
parâmetros imunológicos e a acufenometria, verificou-se uma correlação entre o 
aumento da IL1α e acufeno tonal, bem como entre o aumento da IL2 e a inibição residual 
do acufeno. Foi também encontrada uma correlação negativa para a IL10 e a duração 
do acufeno e para o HSP70 e a intensidade do acufeno. Estes resultados são muito 
originais e suscitam a necessidade de estudos futuros que permitam esclarecer os 
mecanismos subjacentes às correlações encontradas. 
Em relação aos biomarcadores, foi efetuada uma revisão sistemática com a 
finalidade de sintetizar evidências para a existência e utilidade clínica dos 
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biomarcadores para o desenvolvimento ou gravidade do acufeno. Foi também realizado 
um estudo acerca do papel do GRM7 e do NAT2 na nossa amostra. Os resultados 
apontam para uma maior prevalência do alelo T no gene GRM7 (60,3% T/T e 33,3% A/T). 
Os participantes com um genótipo T/T parecem ter um maior risco para o 
desenvolvimento de ARHL e 33% apresentam menor risco para o desenvolvimento do 
acufeno, em comparação com indivíduos com A/A e genótipo A/T. Em relação ao 
fenótipo NAT2, o acetilador lento (53%) foi o mais comum seguido pelo intermediário 
acetilador (35,9%). Os nossos resultados sugerem que o genótipo A/T de GRM7 e o 
fenótipo acetilador lento de NAT2 como potenciais biomarcadores da severidade do 
acufeno. 
Os resultados obtidos são originais e no seu conjunto são muito interessantes, 
apontando para a necessidade de estudos futuros em larga escala de forma a 
aprofundar as conclusões aqui obtidas. Por outro lado, os estudos translacionais 
poderão ser a chave para esclarecer os dilemas da fisiopatologia do acufeno.   
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Summary 
Tinnitus is a symptom involving the perception of sound in the ears or head, 
without a corresponding external acoustic stimulus. It is related to many different 
conditions and has a major impact on quality of life of the affected person. Currently, its 
diagnosis and monitoring are based on subjective audiometric and psychometric 
measures. There are no objective methods for tinnitus identification. In addition, the 
pathophysiological mechanisms underlying tinnitus remains unknown. 
The purpose of this thesis was to study the mechanisms underlying tinnitus and 
their relationship to hearing loss, being that hearing loss is the comorbidity most 
frequently associated with tinnitus. It also aimed to evaluate the contribution of genetic, 
audiological and immunological factors to the etiology of tinnitus. 
For this purpose, systematic reviews (SR) were performed, in order to account 
the state of art, the perspectives of the patient and their relatives, and previous clinical 
trials of tinnitus treatments. SRs contributed to the identification of a pool of tinnitus-
related complaint domains used by COMIT’ID (Core outcome measures in tinnitus 
international Delphi) in a 3-round internet-based Delphi survey to identifying core 
outcome sets (COS), i.e., which complaints related to tinnitus are essential for evaluation 
in clinical trials. These recommendations are specific to the three main therapeutic 
modalities: sound, psychological, and pharmacological. 
In order to contribute to the standardization of tinnitus clinical evaluation and 
treatment, TINNET, a European network for scientific tinnitus research, was created. 
Among the different activities carried out in were a systematic review of existing 
national clinical practice guidelines for the diagnosis and treatment of tinnitus. This 
review contributed to the development of a multidisciplinary European guideline for 
tinnitus: diagnosis, evaluation and treatment. This guideline was presented at TINNET 
final meeting and it is being disseminated widely. 
Another aim of the present thesis was to review work on somatosensory tinnitus 
(pathophysiology, diagnosis, treatment and the participation in an international Delphi 
consensus group on the diagnosis of this subtype of tinnitus), to contribute to a better 
understanding of this subtype of tinnitus. 
In order to achieve the objectives of this PhD study, 114 participants aged 55 to 
75 years were recruited from the Portuguese population. Participants were divided into 
four groups according to the presence/absence of tinnitus and hearing loss. The 
completion of the study protocol gave rise to four original research articles, including a 
demographic characterization, relevant psychological and quality of life aspects 
comparing the studied population and the published literature, audiologic markers of 
 ix 
 
tinnitus, and immunological profile of population and biomarkers of presbycusis and 
tinnitus.  
The results point to hearing loss as a risk factor for the development of tinnitus 
and psychological complaints as a risk factor for more severe tinnitus and consequently 
less quality of life in patients with this symptom.  
In characterizing audiological markers, the presence of previous noise exposure 
and the hearing loss increased the probability of developing tinnitus. Also, participants 
with an abrupt onset of tinnitus and who had a negative effect or rebound on residual 
inhibition were more likely to develop severe or catastrophic tinnitus. For the population 
with tinnitus, a reduction in amplitude of auditory evoked potentials wave I and a higher 
values in the 'Ratio of Waves V/I for both ears' were associated with a greater probability 
of developing severe or catastrophic tinnitus. 
The inflammatory profile of the study population showed significant differences 
in IL10 levels between the group with and without tinnitus. IL1α was significantly higher 
in patients with tonal tinnitus, while IL2 was higher in participants who reported 
negative or rebound effect on residual inhibition of tinnitus. A negative correlation was 
also found between IL10 and tinnitus duration, and between HSP70 and tinnitus 
intensity. 
Biomarkers were explored in this thesis. A systematic review was performed to 
synthesize evidence for the existence and clinical usefulness of biomarkers. GRM7 and 
NAT2 were evaluated in the thesis population. The results indicate a higher prevalence 
of the T allele in the GRM7 gene (60.3% T/T and 33.3% A/T). Participants with a T/T 
genotype appeared to be at a higher risk for ARHL development, and 33% have a lower 
risk of developing tinnitus compared to participants with A/A and A/T genotype. 
Regarding the NAT2 phenotype, the slow acetylator (53%) was most common, followed 
by the intermediate acetylator (35.9%). These results suggest that the AT allele of GRM7 
and the slow acetylating phenotype of Nat2 are potential biomarkers of tinnitus 
severity. 
The results in this thesis are very interesting and original, showing us the need 
for future research in larger samples, and employing rigorous methodological design in 
order to control for confounding variables. On the other hand, translational studies may 
be the key to clarifying the pathophysiologic dilemmas of tinnitus.   
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1. Introduction 
Tinnitus derives from the latin word tinnire (to ring). Subjective tinnitus is a 
symptom involving the perception of a sound without an external source, which is only 
heard by the affected person. Since ancient times, we can find records reporting the 
condition and its treatment. For example, an Egyptian medical document originated in 
2500 BC called the Ebers Papyrus refers to the ‘bewitched ear’ and recommends intra-
aural infusions as a treatment (Heller, 2003; Sandlin & Olsson, 2000).  
Tinnitus can be a symptom of various diseases, is described in a variety of ways 
(e.g., buzzing, ringing, roaring) and can be a single sound or combination of different 
sounds (Coles, Vernon, & Moller, 1995; Stouffer & Tyler, 1990). It can also be perceived 
in one ear, both ears, or in the head, as a constant sound or fluctuating in intensity 
(loudness) or pitch. The sound level can vary from barely noticeable to very disturbing, 
and this perception also varies among individuals and within an individual over time. 
Tinnitus most commonly occurs bilaterally (Andersson et al., 2005).  
Due to our progressively aging population it is estimated that in 2050 there will 
be 2 billion people older than 65. Results from the most recent World Health 
Organization (WHO) Global Burden of Diseases (2015) reports hearing loss as the fourth 
leading cause of years lived with disability. Given the strong link between hearing loss 
and tinnitus, we can assume that tinnitus follows this growing trend. It is estimated that 
one in ten people has tinnitus, and so the global burden of tinnitus is very high (Bhatt, 
Lin & Bhattacharyya, 2016).  
Tinnitus has a variety of etiological factors and may be associated with other 
diseases. It often accompanies hearing loss or hyperacusis, but neither is necessary for 
its presence (Eggermont, 2013, 2015; Eggermont & Roberts, 2004). There are two broad 
categories of tinnitus; objective and subjective. Tinnitus can be objective when it is 
audible by others, but these account for less than 1% of all cases. In the majority of cases 
tinnitus is subjective and only heard by the affected person. The prevalence of tinnitus 
in adult population is around 10% to 15% (Henry, Dennis & Schechter, 2005) and rises 
to 59 to 86% whenever there is associated hearing loss (Spoendlin, 1987). In 20% of 
people tinnitus has a significant impact on their quality of life, with repercussions for 
sleep, concentration, emotional stability, and social activities (Davis & Refaie, 2000).  
The majority of tinnitus cases are associated to hearing loss (Roberts 2010), 
which is considered to be the major risk factor for the development of tinnitus (Chung, 
Gannom, &Mason, 1984; Sindhusake et al., 2003, 2004). Some previous studies with 
audiological markers, such as the high frequency thresholds, allow us to perceive 
differences when tinnitus is accompanied by hearing loss, and when it is not. Also, 
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tinnitus psychoacoustic assessment allows us to draw a different picture from 
individuals with hearing loss and individuals without hearing loss. For example, it was 
found that tinnitus pitch is higher among individuals without hearing loss, whereas the 
opposite is true for regarding to loudness (Prestes & Gil, 2009).  
The heterogeneity of tinnitus causes a substantial problem in its classification, 
which has hampered both basic and clinical research. A major challenge for the field is 
to identify the underlying causes of tinnitus for developing specific treatments that 
address the distinct manifestations (Noreña, 2015). Although much research is 
underway, the precise pathophysiology of tinnitus remains unclear. 
For this purpose, TINNET a pan-European multidisciplinary network (COST 
action) has been gathering efforts to standardize the methodology for assessment, 
diagnosis and treatment of tinnitus. This initiative comprised five working groups with 
different objectives in order to facilitate the standards for clinical assessment and 
outcome measurement, by large-scale multi centric data assessment and by data 
management in a quality-controlled database. Moreover, it has the main goal of better 
understanding the underlying tinnitus mechanisms in order to achieve better 
treatments. 
Although there are multiple management options for tinnitus, the majority lack 
high quality scientific evidence to support claims of benefit. Perhaps of all therapeutic 
options, Cognitive Behavioral Therapy (CBT) delivered by a qualified clinical psychologist 
has the most support for its effectiveness in reducing tinnitus symptom severity (Cima 
et al., 2012; Hesser, Weise, Westin & Andersson, 2011; Martinez Devesa, Waddell, 
Perera & Theodoulou, 2007). 
The present thesis aims to contribute with systematic reviews of the literature in 
order to increase knowledge regarding clinically relevant tinnitus subtyping, the tinnitus 
management standardization, the patient’s perspective and the underlying 
pathophysiological tinnitus mechanisms, as well exploring the contribution of 
audiological, immunological and genetic factors to tinnitus etiology in an older 
population. This study has revealed new and extremely interesting results regarding 
tinnitus etiology and factors associated with more severe grades of tinnitus, also 
pointing us to future research studies. 
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2. State of art 
 
2.1. Ear Anatomy 
2.1.1. Summary of ear anatomy and physiology of hearing 
The ear is a mechano-receptor organ that acts as a link between the outer 
environment and the nervous system, referring to complex auditory functions. Humans 
can hear frquencies from 20 to 20.000Hz. The ear is composed by three primary parts: 
the outer ear, middle ear and inner ear. Each section is comprised of structures that play 
distinct roles in the process of converting sound waves into electric signals that go into 
the brain. The external ear collects sound waves from the external environment and 
funnels them toward the tympanic membrane. The middle ear ossicles transmit the 
sound waves to the inner ear (Figure 2.1-1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1-1 - Schematic view of the structures of the ear. 
(Illustration provided by Fernando Vilhena de Mendonça, MD) 
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The outer ear and middle ear collect, amplify, and conduct sound waves to the 
inner ear, where the auditory receptors are to be stimulated. 
The outer ear consists of the pinna and the external auditory canal and has the 
function of collecting and transmitting the sound to the tympanic membrane (Figure 
2.1-2). It also protects from parasitic sounds.  
 
 
 
 
 
Figure 2.1-2 - Schematic view of the structure of the outer ear. 
Legend: EAC, External Auditory Canal. (Illustration provided by Fernando Vilhena de Mendonça, 
MD) 
The pinna, which part protrudes from the side of the skull, attached to the 
temporal bone, captures sound and channels to the ear canal. The pinna is shaped like 
a cone that allows amplifying the sound, differently depending on its origin (Figure 2.1-
3) (Geisler, 1988).  
The most amplified sounds come from about 45 ° (forwards and backwards) of 
the ear in the horizontal plane and about 60 ° above the plane of the ear. Less-amplified 
sounds originate on the opposite side of the head through the mascara effect (Rosowski, 
2012). Anatomically the auricle or pinna is constructed as an organ for "catch" incoming 
sound waves and then funnel them down the external auditory canal. The main 
structures are the tragus and anti-tragus, helix and anthelix (Figure 2.1-3) (Weber, 
Deschler, & Sokol, 2006). 
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Figure 2.1-3 - Schematic view of the anatomy of the pinna. 
(Illustration provided by Fernando Vilhena de Mendonça, MD) 
 
The shape of outer the ear allows a gain of approximately 20dB for sounds from 
2kHz to 4kHz. The tympanic membrane separates the outer and middle ear (Alberti, 
2001) (Figure 2.1-4). It is a thin (0.1 mm), cone-shaped membrane that has three layers. 
The external layer derived from the ectoderm is a stratified squamous epithelium. The 
internal layer comes from endoderm and is a cuboidal mucosal epithelium. The 
intermediate layer comes from mesenchyme and, is the fibrous layer (Figure 2.1-5). It is 
divided into the pars flaccida and the pars tensa. The pars tensa has a central fibrous 
layer (lamina propria), while the pars flaccida is slightly thinner (without the 
intermediate layer). The three layers are important in maintaining the strength of the 
tympanic membrane as well as in aiding the proper vibration with different frequency 
sounds (Lalwani, 2007). The tympanic membrane acts as a mirror of the interior of the 
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middle ear, and knowledge of this structure is fundamental to understand the multiple 
dysfunctions that affect the middle ear (Paço, 2003). According to Paço (2003), the 
tympanic membrane can be divided topographically into six quadrants, of which four 
are referred to as the pars tensa (postero-superior, postero-inferior, antero-superior 
and antero-inferior) and two are referred to as the pars flaccida (Figure 2.1.4). 
 
 
Figure 2.1-4  Anatomy of the tympanic membrane. 
(Illustration provided by Fernando Vilhena de Mendonça, MD) 
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Figure 2.1-5 - The layers of tympanic membrane.  
Legend: CAE external auditory canal, OM middle ear. (Lalwani, 2007) 
 
The middle ear comprises the tympanic cavity, mastoid air cells, and Eustachian 
(auditory) tube. The air filled space, also known as the tympanic cavity, is slightly 
concave and suspended by a bony ring. Posteriorly this includes the mastoid cells that 
communicate to tympanic cavity through the aditus ad antrum. It is connected to the 
back of the nose by a 35-45 mm long thin tube called the auditory tube (necessary for 
equalization of pressure between exterior and middle ear and drainage of mucous 
produced in the middle ear) (Moller, 2006). The auditory tube has an osseous portion 
(posterior 1/3) that opens into the tympanic cavity and a fibro-cartilaginous portion that 
opens into the nasopharynx. There are three important muscles for its function - tensor 
veli palatini, levator veli palatini and salpingopharyngeus (Correa & Gómez, 2007).  
Sound is conducted from the tympanic membrane to the inner ear by three 
bones that constitutes the ossicular chain – the malleus, incus and stapes (Figure 2.1-6). 
The ossicular chain is attached to one side of the tympanic membrane by the malleus, 
which inserts into the vestibular window of the inner ear by the footplate of the stapes. 
When a sound wave hits the tympanic membrane, it propagates through the ossicular 
chain and into the vestibular window of the inner ear. There are two muscles in the 
middle ear, namely the stapedius and tensor tympani, which insert into the stapes and 
malleus, respectively. The middle ear amplifies sound via two mechanisms: The 
proportion of tympanic membrane and stapes platinum surface is 14:1 and the lever 
effect (malleus and incus assured by the malleus and incus ligaments respectively 
anterior and posterior) is 18.3:1 which provides a gain of 20-35dB. The ossicular chain 
maximizes transference of sounds from 1-10kHz (Erminy, Skanavi, Van Den Abbeele, 
Avan, & Bonfils, 1995). The stapes arch reflex causes contraction of stapedius when the 
ear is exposed to sounds louder than 70dB, raising rigidity to ossicular chain and 
protecting the inner hear from noise induced damage.  
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Figure 2.1-6 - Schematic view of the structures of the middle ear ossicles.  
(Illustration provided by Fernando Vilhena de Mendonça, MD) 
 
The inner ear contains a group of interconnected, fluid-filled chambers. The 
snail-shaped chamber, called the cochlea, is an approximately 30-mm-long coiled tube, 
of 2 and 3/4 turns along an osseous axis called modiolus, located within the petrous 
bone and divided by membranes into three chambers (Figure 2.1-7). 
Figure 2.1-7 - Schematic view of the structures of Inner Ear. 
(Illustration provided by Fernando Vilhena de Mendonça, MD) 
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The cochlea is one of the smallest organs of the human body (Figure 2.1-8). Its 
small size is important because if it was larger the necessary mechanical force to vibrate 
its structures would have to be higher and humans would only be able to hear very loud 
sounds. The cochlea acts as active and passive sound filter. 
 
 
 
 
 
 
 
 
 
Figure 2.1-8 - Cochlea. a) Structures of cochlear channel; b) Cross-section of a single cochlear 
turn. 
Legend:  a) 1 – the scala media; 2 – the scala vestibuli; 3 – the scala tympani; 4 – the spiral 
ganglion neurons; 5 – Auditory nerve VIII; b) 1 – Reticular Lamina; 2 –scala vestibule ; 3 – Lateral 
wall (stria vascularis). (Illustration provided by Fernando Vilhena de Mendonça, MD). 
 
The three fluid-filled chambers of the innear ear are: the scala vestibuli, the scala 
tympani, and the scala media (Figure 2.1-8). The scala media or cochlear, located in the 
center, is separated from the scala vestibuli (superiorly) by vestibular membrane and 
from the scala tympani (inferiorly) by the basilar membrane (Moller, 2006). Sound 
vibrations from the bones of the middle ear are transferred to the fluids of the cochlea 
through the vestibular window to the scala vestibuli. Near the apical termination of the 
bony labyrinth there is an opening called the helicotrema. This allows communication 
between the scala vestibuli and scala tympani that are filled by a fluid rich in Sodium 
(Na+) called perilymph, which is similar to cephaloraquidian fluid. The Scala tympani 
ends at the round (tympanic) window, and serves as an escapement of the sound wave. 
The scala vestibuli receives the sound wave from the vestibular window (connection to 
ossicular chain). The scala media narrows towards the apex of the cochlea ending just 
short of the apical termination of the bony labyrinth. It is filled with a fluid rich in 
Potassium (K+) called endolymph, similar to intracellular fluid, possesses a potential of 
+80mV. The basilar membrane has the ability to separated sounds according to their 
frequency (tonotopy spectrum). It becomes larger and less tense near the apex and so, 
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more sensitive to higher frequencies at the basal area where the cochlea has lower mass 
and higher rigidity. It has higher mass and lower rigidity at the apex where it is more 
sensitive to lower frequencies- This process is called passive tonotopy (Figure 2.1-9). The 
sound vibration propagates through cochlear scala and is maximal in the area 
corresponding to the sound frequency.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1-9 - Travelling wave.  
(Illustration provided by Fernando Vilhena de Mendonça, MD). 
 
 
The spiral organ (of Corti), located along the basilar membrane, contains the 
sensory cells (hair cells) (Moller, 2006) (Figure 2.1-10). These tiny sensors (hair cells) are 
mechanoreceptors that convert the sound vibrations of the basilar membrane into 
electrical impulses that are transmitted along the auditory nerve to the brain through 
the auditory pathway – this mechanism is called transduction. The Inner Hair Cells (IHC) 
are the principal auditory receptors. They constitute the most internal row along the 
spiral organ (of Corti) (approximately 3500 cells). Their function is to transform the 
mechanical sound stimulus transmitted from the outer and middle ear into and 
electrical message to be send to auditory nervous centers (in temporal lobe) through 
the auditory pathway (Abbas & Miller, 1993). 
IHCs are sensory cells that transform the hydromechanical, vibratory energy of 
cochlear liquids into bioelectric energy. About 80% of the time the transducer channels 
are closed and only open in the excitatory phase of the stimulus. The process of 
transduction begins when the energy is sufficiently intense, and the stimulation leads to 
the depolarization of IHCs, which leads to the release of neurotransmitters, causing one 
or more afferent fibers of the auditory nerve to fire (Monteiro & Trigueiros, 2018).  
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Figure 2.1-10 - Schematic of the organ of Corti.  
Legend: 1-Inner hair cell (IHC); 2-Outer hair cells (OHC); 3-Tunnel of Corti; 4-Basilar membrane; 
5-Habenula perforate; 6-Tectorial membrane; 7-Deiters' cells; 8-Nuel’s space; 9-Hensen's cells; 
10-Inner spiral sulcus. (Illustration provided by Fernando Vilhena de Mendonça, MD). 
  
The three outer rows along the spiral organ (of Corti) corresponds to the Outer 
Hair Cells (OHC), nearly 12000 cells (Figure 2.1-10). Surrounded by supporting cells – 
Hensen and Claudius cells also have a role in the cycle of K+ and Glutamate (Monteiro & 
Trigueiros, 2018).  
OHCs are pressurized and have a central core without a cytoskeleton which gives 
them strength, flexibility and electromotility according to the stimulus, providing a 
refinement in frequential sensitivity and selectivity. Hence OHC are called the cochlea 
amplifiers. OHCs length can vary from 12µm in the basal region to more than 90µm in 
the apex of the cochlea (Brownell, Spector, Raphael, & Popel, 2001). 
Because only the apical part of ciliated cells are in contact with endolymph 
cochlea found a process to transport K+ from or to cells without ATP consumption, this 
electrochemical gradient is achieved through the stria vascularis, located at external 
wall of scala media and lying in the basilar membrane. It is a highly vascularized and 
metabolically active organ (Figure 2.1-8b).  
Within the cochlea, vibratory energy results in an interaction called the traveling 
wave, which is a wave of fluid vibration along the basilar membrane along the cochlear 
coil. Wave energy is placed at a particular site of the basilar membrane, depending on 
the frequency of vibration. Through the depolarization of cells, the action of mechanical 
vibratory energy is used more effectively in the transduction of bioelectric energy. This 
gradient acts like a battery whose energy permits hearing. Ciliated cells have synapses 
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at their basal pole. The delivery of neurotransmitters to the synaptic cleft (transforming 
electrical energy in chemical) is regulated by alterations in cellular membrane 
Differentiated vibration of the basilar membrane and tectorial membrane causes 
stereocilia flection. The OHCs respond to stimulation when their stereocilia are flexed in 
an external direction. When the stereocilia are flexed in the excitatory direction 
(towards the top), the links between tops are stretched, which increases the likelihood 
of calcium channel opening. Calcium plays a determinant role in the intracellular 
balance, being that it maintains cellular homeostasis through the mechanotransducing 
channels (Figure 2.1-11). The energy of acoustic stimulus induces the movement of the 
basilar membrane synchronized with the deflection of the stereocilia that triggers 
transducer currents. This allows the entrance of K+ into the OHCs and leads to their 
depolarization. The resulting action potentials produce a motor response caused by the 
properties of the prestin protein. This vibratory energy is returned to the basilar 
membrane (Monteiro & Trigueiros, 2018). 
Figure 2.1-9 - Transduction channels: opening and adaptation to potassium levels.  
(http://www.cochlea.eu/po/) 
 
The middle portion of OHCs is where electrical energy is converted into 
mechanical – electromotility. If electrical energy resulting from sound vibration 
coincides with the natural frequency of that cochlear portion then the magnitude of 
vibration augments. Otherwise it decreases. Accordingly, there is a release of 
neurotransmissor in the inferior pole of the cell. 
The OHCs produce a sound that can be detected through a microphone in the 
outer ear – Otoacoustic emissions (OAE).  This is the demonstration of the active cochlea 
mechanisms that are exclusive of OHCs. No other cells in the human body have this 
electromotility, a biological form of piezoelectricity.  
Tinnitus, biomarkers and quality of life in an older population 
 
13 
 
  
Hearing occurs by air conduction or bone conduction. In air conduction sound 
reaches the inner ear by propagating in the air reaching tympanic membrane through 
the external auditory channel. Movement of the tympanic membrane is transmitted to 
the ossicular chain that propagates to the cochlea through the oval window connected 
to stapes footplate. The structures of middle ear serves as an impedance-matching 
mechanism, improving the efficiency of energy transfer from the air to the fluid-filled 
inner ear. Hearing by bone conduction happens when the sound source is in physical 
contact with the head, causing vibration of the bones of the skull that generate a travel 
wave in the cochlea’s basilar membrane (Brownell et al., 2001; Dallos & Fakler, 2002).  
The nervous fibers that come from IHCs converge to form the spiral ganglion. 
From here originates the cochlear part of VIII cranial nerve, the anterior portion of which 
goes to the internal auditory channel (IAC). 
2.1.2. Central Auditory Nervous System (CANS) 
The cochlear nerve contains a total of 30,000 afferent nerve fibers (Spoendlin, 
1987). The cell bodies of these fibers are found in the spiral ganglion, the cochlear part 
(auditory) of VIII cranial nerve. The anterior portion goes to the IAC and enters the brain 
at the spinal bulb (Bonaldi, Lago, Crema, Fukuda, & Smith, 2004; Ruah, 2002) 
At low frequencies individual auditory nerve fibers can respond more or less 
synchronously with the stimulating tone. At higher frequencies phase-locking occurs so 
that neurons can alternate in response to particular phases of the sound wave cycle. 
Three aspects encode the intensity of the sound wave cycle: 1) the amount of neural 
activity in individual neurons, 2) the number of neurons that are active, and 3) the 
specific neurons that are activated. 
The central auditory pathways are composed of various structures, beginning in 
the auditory nerve, followed by the cochlear nuclei, the superior olivary complex, the 
lateral lemniscus, the lower colliculus, the middle geniculate body, terminating in the 
auditory cortex (Figure 2.1-12 and 2.1-13). The auditory nerve divides in two pathways. 
The ascending/afferent auditory pathway (afferent fibers (myelinated bipolar type I 
neurons)  carries sound information to the brain mostly come from IHCs,  and the 
descending/efferent auditory pathway (efferent fibers, non-myelinated bipolar type II 
neurons) carries information back from the brain to the OHCs (Malmierca & Hackett, 
2010). 
 Ascending or afferent auditory pathway, is a fast pathway, which begins in the 
cochlear nucleus – first integrator centre, are composed by three subnucleus: 
Dorsal Cochlear Nucleus (DCN), the postero-ventral Cochlear Nucleus (PVCN) 
and the antero-ventral Cochlear Nucleus (AVCN) (Malmierca & Hackett, 2010; 
Marinho, 2011; Moller, 2006; Phillips, 2007), where the central auditory system 
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begins its course to the auditory cortex (Aquino, Chandra, Haines, & Micco, 2002; 
Ruah, 2002) located at spinal bulb, the fibers keep the cochlear frequencial 
selectivity. From here some projections go to ascendant reticular pathway – non- 
primary auditory pathway, the main function of these pathways, also connected 
to wake and motivation centers as well as to vegetative and hormonal systems, 
is to select the type of sensory message to be treated first. This pathway is 
inactive during sleep (Cochlea, 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1-10 - Primary auditory pathways.  
(Illustration provided by Fernando Vilhena de Mendonça, MD). 
 
 Second integrator centre is Superior Olivary Complex (SOC) also located at spinal 
bulb, majority of fibers cross to the opposite side, SOC is divided in three 
nucleuses: the Complex Superior Olivary lateral (CSOL), the Complex Superior 
Olivary medium (CSOM) and the medial nucleus of do trapezoid body (Martínez 
& Nieto, 2003; Musiek & Baran, 1986; Neijenhuis, 2003). 
 The third integrator centre is Inferior Colliculus, located at midbrain. Together 
with SOC have important role in the localization of sound and integration of 
sounds with a complex temporal pattern, also receives fibers from the Cochlear 
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Nucleus. 
 The fourth integrator centre before cortex is medial geniculated body located in 
thalamus, here starts the integration of information. Can be subdivided in three 
regions: the ventral projects to the primary auditory region of temporal lobe, the 
middle projects to the other temporal lobe regions and the dorsal projects 
afferent to cerebellar associative areas (Seikel, King, & Drumright, 2009). 
 
Primary auditory cortex is located in the temporal lobe, hidden by the lateral 
sulcus incisures. Auditory message arrives here largely decoded by the previous nucleus, 
is memorized, and possibly integrated in a motor response like vocalization. The primary 
auditory cortex has an important role in phoneme discrimination, and is also involved in 
temporal and spectral discrimination (Bellis, 2003). Posteriorly, angular girus, represents 
the Wernicke region, responsible for linguistic stimuli recognition and speech 
understanding (Specht, 2014). 
The descending or efferent auditory pathway extends from the auditory cortex 
to the hair cells. The majority of the bodies of the efferent fibers are located in the SOC 
of the brainstem.   
The anatomical description and role of this pathway is still a matter of debate, 
however it is agreed that it begins at the auditory cortex and associative areas. It is 
divided in two segments. The rostral segment, involves auditory cortex, associative 
secondary areas, medial geniculated body, inferior colliculus and the lateral lemniscus. 
It is possible that this segment has a regulator role of afferent pathway, namely cochlea, 
the auditory nerve, and the inferior nucleus of the brainstem (Baran, Brooke Shinn, & 
Musiek, 2006). The caudal segment comprises the SOC (lateral and middle), cochlear 
nucleus, and ends at the cochlea (IHCs and mainly at OHCs). This segment is also called 
medial olivo-cochlear bundle. In the efferent pathway the main neurotransmitter is 
acetylcholine but dopamine, dynorphins and encephalin are also present. It is 
considered that the physic-acoustic model closest to reality should be based on 
oscillators tuned in frequencies (OHCs) that would be regulated through the medial 
olivo-cochlear bundle. 
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Figure 2.1-11 - Main nuclei involved in binaural hearing.  
(Porter, 2012) 
  
2.1.3.  The close correlation between hearing and cognition 
As far as hearing is concerned we do not hear using a single part of our brain. 
Instead hearing stimuli ‘switch on’ several brain areas. Even a simple word has the 
capacity to activate not only the auditory cortex, but also several other areas where it is 
‘understood’ or semantically or cognitively connected. Evidence demonstrates a very 
close association between hearing and cognition. Recent studies on people aged 50 to 
79 included tests to evaluate hearing capacity, central auditory processing and cognitive 
skills. The most predictive factor of speech discrimination in noisy environment was 
central processing of sound, followed by cognitive skills (such as working memory and 
short-term memory), and by life experience such as socio-economic status. Hearing 
sensitivity evaluated by tonal audiometry was the ‘weakest’ contributor to performance 
of this task (Figure 2.1-14). 
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Figure 2.1-12 - Relationship between cognition, life experience and economic state with hearing. 
(Anderson et al., 2013) 
 
An auditory stimulus activates the entire cerebral cortex and the cognitive 
processes influence ‘how’ we hear (Anderson, White-Schwoch, Parbery-Clark, & Kraus, 
2013). In a complex situation for hearing, the central processing of sound information is 
the most predictive factor for a better speech comprehension, followed by cognitive 
skills – short-term memory and auditory memory – and by life experience such as 
education (Figure 2.1-14). This demonstrates a complex interaction of factors 
influencing hearing in noise and the importance of cognitive skills, lifestyle and central 
auditory processing in the diagnosis and treatment of patients with difficulties hearing 
in noise (Anderson et al., 2013). 
Studies using magnetic resonance imaging showed that hearing loss is correlated 
with reduced volume of the primary auditory cortex (Chang et al., 2004; Eckert et al., 
2013). Furthermore, a longitudinal study revealed that hearing deficiency is 
accompanied by overall cerebral atrophy most evident in the superior, median and 
inferior gyri critical areas for auditory and cognitive processing (Lin et al., 2014). Along 
with diminished volume there is also a reduced neuronal activity in those areas and 
other sub-cortical regions. Moreover, there is also evidence that the brain tries to 
compensate by activating collateral circuits, requiring greater expenditure of mental 
resources (Peelle, Troiani, Grossman, & Wingfield, 2011). The deviation of attention-
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related resources to listening tasks explains the residual attention for the remaining 
cognitive activities. For example, people with hearing impairment that prevents them 
from having a conversation, present a 24% higher probability of declined cognitive skills 
such as concentration, memory and planning capacity (Lin et al., 2013). 
At the same time the brain will change and experience distress. One of the 
reasons for these alterations is social isolation that is associated with diminished 
psychological well-being and impaired self-esteem that results in a poorer lifestyle and 
a diminished quality life. This takes a bi-directional vicious circle, in which on the one 
hand, hearing loss involves structural and functional changes to the brain and on the 
other hand cognition declines correlated with ageing facilitates the onset of hearing loss. 
There are common mechanisms, e. g. atherosclerosis, that contribute both for hearing 
loss and cognitive decline (Figure 2.1-15). 
 
Figure 2.1-13 - Vicious circle between hearing loss and cognitive decline. 
(Lin et al., 2013) 
2.1.4. Hearing Loss 
Hearing loss is extremely common and the degrees of hearing loss can vary from 
a nearly undetectable degree of disability to a profound loss of ability to function in 
society. Although it is a prevalent condition, it is most evident in older adults, many of 
whom require hearing rehabilitation (e.g. hearing aids, bone integrated hearing aids, 
middle ear hearing implantable devices or cochlear implants). Hearing loss can result 
from disorders of the auricle, external auditory canal, middle ear, inner ear, or central 
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auditory pathways. In general, lesions in the auricle, external auditory canal, or middle 
ear cause conductive hearing loss. 
In mammals, ciliated cells do not regenerate if are destroyed after birth (Ruben, 
1967). Therefore, the loss of ciliated cells results in irreversible hearing loss (Abbas & 
Miller, 1993; Riva, Donadieu, Magnan, & Laville, 2007). 
In terms of audiometry findings, there is a general guideline for interpreting 
degrees of hearing loss. Levels should be categorized somewhat more stringently for 
children (Table 2.1-1). 
 
Table 2.1-1 - Guidelines for interpreting hearing loss according to Bureau International 
d’Audiophonologie (BIAP). 
 
 
2.1.4.1. Type and classification of Hearing Loss 
There are three types of hearing loss according to the tonal audiometry pattern: 
Conductive hearing loss, Sensorineural hearing loss (SNHL), and mixed hearing loss due 
to a combination of conductive and SNHL (Figure 2.1-16). 
 
Hearing Threshold Interpretation 
The average tone loss is below 20 dB. 
Normal or subnormal hearing. Mild tone disorder 
with no social consequences. 
Average tone loss between 21 and 40 dB. 
Mild hearing loss. Speech is perceived if the voice 
is normal, difficulties arise if the voice is low-
pitched or distant from the subject. Most of the 
daily life noises are perceived. 
- 1st degree: average tone loss between 41 and 
55 dB. - 2nd degree: average tone loss between 
56 and 70 dB. 
Moderate hearing loss. Speech is perceived if the 
voice is loud. The subject understands better 
what is being said if he can see his/her 
interlocutor. Some daily life noises are still 
perceived. 
- 1st degree: average tone loss between 71 and 
80 dB. - 2nd degree: average tone loss between 
81 and 90 dB. 
Severe hearing loss. Speech is perceived if the 
voice is loud and close to the ear. Loud noises are 
perceived. 
- 1st degree: average tone loss between 91 and 
100 dB. - 2nd degree: average tone loss between 
101 and 110 dB. - 3rd degree: average tone loss 
between 111 and 119 dB. 
Very severe hearing loss. Speech is not 
perceived. Only very loud noises are perceived. 
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Figure 2.1-14 - The three different types of hearing loss. 
(Illustration provided by Fernando Vilhena de Mendonça, MD). 
 
 Conductive hearing loss is usually due to a disease or condition that occurs in the 
ear canal or the middle ear. The signal transmission from the outer ear/middle ear to 
the inner ear decreases independently of the sound pressure level of the stimulus. 
Conductive hearing loss is diagnosed by audiometry, when there is an air-bone gap 
above 10 dB, indicating that the transmission of sound between the outer ear/middle 
ear to inner ear does not function optimally over the entire frequency range (Gelfand, 
2009). This may be due to problems such as outer ear obstruction due to wax, or outer 
or middle ear infection. 
 Mixed hearing loss invovles air-bone gaps with the bone conduction thresholds 
outside of the normal range. For example, impairment of ossicular chain transmission 
such as in otosclerosis, usually begins with stapedo-vestibular fixation causing a 
conductive hearing loss, with a later progression of disease and cochlear involvement 
leading to a mixed or sensorineural hearing loss. Other causes are transverse or 
longitudinal temporal bone fractures, head trauma, chronic otitis media, and middle ear 
tumors. Some inner ear malformations such as large vestibular aqueduct, lateral 
semicircular canal dysplasia and a bulbous lateral end of internal auditory canal can also 
be the cause of mixed hearing loss. 
 SNHL appears as an increase in both bone and airway conduction threshold, 
determined by an audiometry reading that indicates no gap between the air and bone 
thresholds, i.e., the air-bone conduction is equal to the bone conduction. This result 
means that the signal transmission from the outer ear/middle ear to the inner ear 
functions well, but some other obstacle prevents the sounds from being perceived by 
the brain.  Usually the lesions involve the cochlea and/or auditory nerve and may affect 
sensory receptor (hair) cells, auditory neurons, and/or any of the many structures and 
processes that enable them to be activated and to function properly. The resulting 
impairment of auditory functioning is called a SNHL (Gelfand, 2009). After any 
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aggression first damaged cells of the cochlea are supporting (Deiters) cells, next are 
OHCs to be damaged, and posteriorly the other cochlear structures start degenerating: 
IHCs and cells of auditory nerve (Ling et al., 2005). Once hair cells die they do not 
regenerate resulting in irreversible hearing loss. Damage of OHCs blocks the amplifier 
mechanism but the passive tonotopic mechanism persists. Damage of the IHCs reduces 
global cochlear function because they are responsible for the detection of acoustic 
signal and transmission to the brain through VIII cranial nerve. 
Diseases or damage to hair cells cause a reduction in the sensory function.  SNHL 
is the most common type of hearing impairment, and can sometimes be due to damage 
to the central pathways, termed central hearing loss. 
Tinnitus patients frequently have hearing loss but not every patient with hearing 
loss has tinnitus, furthermore some tinnitus patients do not have hearing loss. 
2.1.4.2. More frequent causes of SNHL 
Broadly speaking there are two categories of SNHL, genetics and non-genetic 
(Table 2.1-2). Among non-genetic causes are the damage to the hair cells caused by 
intense noise, viral infections, fractures of the temporal bone, meningitis, and ageing. 
Also, certain types of medication – such as ototoxic drugs (eg, salicylates, quinine, and 
the synthetic analogs of quinine), aminoglycoside antibiotics, loop diuretics (eg, 
furosemide and ethacrynic acid), and cancer chemotherapeutic agents (eg, cisplatin) – 
can produce SMHL. Medical advances in vaccines and antibiotic therapy led to a 
significantly decline in the infectious and teratogenic intrauterine causes. Nowadays 
genetic causes are responsible for more than half of childhood hearing impairments. 
Nearly one-third are syndromic (hearing loss is associated with anomalies in other organ 
systems) and two-thirds are non-syndromic (when hearing loss is the only clinical 
abnormality). Between 70 to 80% of non-syndromic NSHL is inherited in an autosomal 
recessive manner, the remaining 15-20% is autosomal dominant. Less than 5% is X-
linked or maternally inherited via the mitochondria. Much progress has been made in 
the identification of responsible genes. In general, hearing loss associated with 
dominant genes has its onset in adolescence or adulthood and varies in severity, while 
the hearing loss associated with recessive inheritance is congenital and profound and 
almost always related to cochlear defects (Petit, 1996). 
Noise-induced hearing loss (NIHL) is currently a growing problem worldwide. 
Intense noise exposure (due to military service, some professions or leisure activities) 
sometimes leads to a temporary threshold shift in the cochlea but can also lead to 
permanent hearing loss that may be accompanied by other auditory disorders, such as 
tinnitus and hyperacusis (Axelsson & Sandh, 1985). Exposure to sounds greater than 85 
dB for prolonged periods of time can result in high-frequency, symmetric, hearing loss 
Tinnitus, biomarkers and quality of life in an older population 
 
22 
 
  
that is typically maximal at 4kHz. Continued acoustic trauma may lead to irreversible 
hearing loss including at lower frequencies. Noise exposure can cause changes 
throughout the entire auditory pathway and an imbalance of the excitatory and 
inhibitory transmitter systems (Dong et al., 2009; Milbrandt et al., 2000). Hyperacusis is 
a generalized reduced sound tolerance. People with hyperacusis report an unusual 
intolerance to ordinary environment sounds that are not bothersome to other people 
(Baguely, 2003; Vernon, 1987). 
 
Table 2.1-2 - Etiology of SNHL. 
Category Example 
Development and hereditary 
Syndromic 
Non-syndromic 
 
Alport syndrome, Usher syndrome 
Larger vestibular aqueduct syndrome 
Infectious Otitis media, viral, syphilis 
Pharmacologic toxicity Aminoglycosides, loop diuretics, anti-neoplastics 
Trauma Head injury, noise-induced, barotrauma 
Neurologic disorders Multiple sclerosis 
Vascular and hematologic disorders Migraine, cryoglobulinemia, sickle cell 
Immune disorders Polyarteritis nodosa, HIV, Coghan sind  
Bone disorders Paget’s disease 
Neoplasms Vestibular schwannoma 
Unknown etiology Presbycusis, Ménière’s disease 
 
Hearing loss induced by ototoxic drugs can be temporary or permanent. Drugs 
such as aminoglycosides (amikacin, streptomycin, gentamicin, kanamycin, neomycin, 
tobramycin), macrolides (azithromycin, clarithromycin, erythromycin), 
chloramphenicol, tetracyclines (minocycline), metronidazole, vancomycin, 
tuberculostatics (capreomycin), anti-phungals (amphotericin B),  anti-virals (didanosyne, 
ribavirin, zidovudine), non-steroidal anti-inflammatories (acetylsalicylic acid - Especially 
doses > 2.7 g per day; mefenamic acid, indomethacin, naproxen, piroxicam), quinine and 
derivates, anticonceptional drugs, loop diuretics (sulfonamides), analgesic 
(hydromorphone), anesthesic (nitric oxide), antidepressants (mianserina), 
antipsychotics (chlorpromazine), anti-epileptics (valproic acid, carbamazepine, 
gabapentin), anti-neoplastics and others: deferoxamine, methadone, sildenafil (Rybak & 
Whitworth, 2005) are associated with a risk of high-frequency hearing loss and loss of 
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outer hair cells in the cochlea.  It is interesting to note that some of this drugs such as 
quinine has a long period of wash-out from the inner ear that can last until one year. 
Sudden hearing loss can be defined as the loss of 30 dB in three consecutive 
frequencies with less than 72 hours of evolution (Fetterman, Saunders, & Luxford, 1996; 
Wilson, Byl, & Laird, 1980).   
Idiopathic Sensorineural Sudden Hearing Loss (ISSNHL) is described as a 
symptom rather than a disease (Hallberg, 1956) and can be accompanied by tinnitus 
and/or vertigo. There are different theories regarding ISSNHL; some researchers state 
that it can be a result of local autoimmune processes that affect the cochlea (Campbell 
& Klemens, 2000), while others claim that this disease may be a consequence of 
infection or a vascular disorder (Hultcrantz et al., 1994; Kellerhals, 1972; Wilson, Veltri, 
Laird, & Sprinkle, 1983). There are different types of treatments, including 
corticosteroids, hyperbaric oxygen that are based on the immune theory (Kanzaki, Taiji, 
& Ogawa, 1988; Nosrati-Zarenoe & Hultcrantz, 2012; Russolo & Bianchi, 1997).  
Cochlear otosclerosis is an uncommon disease and usually presents in young 
patients. This disease often occurs between 30 and 50 years of age and is known to 
worsen during pregnancy. The stiffening of osseous bone causes a mixed hearing loss 
(sensorineural and conductive hearing loss) that is occasionally combined with tinnitus 
(Hayashi et al., 2006; Youssef, Chandrasekhar, Rosen, & Lee, 1998).  
Retrocochlear lesions are located beyond the cochlea on the vestibulocochlear 
nerve or in one of the auditory areas of the Central Nervous System (CNS). Retrocochlear 
hearing loss, or neural hearing loss, is the result of damage to structures beyond the 
cochlea or neural systems occurring at the level of the auditory nerve or the auditory 
pathway, which causes degeneration of the hearing nerves. Alternatively, retrocochlear 
hearing loss can result from the inability of the hearing nerves themselves to convey 
neurochemical information through the central auditory pathways (Moore, 2008). A 
rather common cause of retrocochlear hearing loss is the growth of a benign tumor 
(vestibular schwannoma) that presses on the auditory nerve. The types of retrocochlear 
hearing loss are divided into two groups: central and vestibular nerve diseases (Moore, 
2008). Auditory diseases (central) are the disorders of hearing or auditory perception 
resulting from diseases of the central auditory pathways or auditory associated cortical 
areas, such as cortical deafness. Above the level of the pons, bilateral lesions are usually 
required to produce auditory dysfunction. Vestibulocochlear nerve diseases are the 
diseases that damage the vestibular and/or cochlea nerves (vestibular schwannoma). 
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By far presbycusis or age-related hearing loss (ARHL) is the leading global cause 
of hearing loss in adults. It is most commonly characterized by symmetric, high-
frequency hearing loss, and difficulties understanding conversation in loud 
environments (Figure 2.1-17). It is a complex process, not entirely clarified, involving 
oxidative stress, cellular apoptosis, and mitochondrial DNA deletions that conduct to a 
deficient protein synthesis and/or accumulation insoluble pigments. Other relevant 
contributive factors are genetic predisposition, smoking, diet, noise exposure and socio-
economic factors (Nelson & Hinojosa, 2006; Seidman et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1-15 – Age related hearing loss alterations. 
Legend: A) Hearing level as a function of age. Pure-tone hearing level increases with age, and 
higher frequencies are affected more than the lower frequencies. (B) Speech discrimination as 
a function of age. For a given pure-tone hearing loss, the speech discrimination as a function of 
age. For a given pure-tone hearing loss, the speech discrimination decreases with aging. (C) Total 
ganglion cell population versus age. There is progressive loss of cochlear neurons as a function 
of aging. (Lalwani, 2007). 
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ARHL classification (initially proposed by Schucknecht, later modified by Nelson 
and Hinojosa, 2003) are based on audiometric and histopathologic findings (Nelson & 
Hinojosa, 2006) (Figure 2.1-18): 
Sensory presbycusis – is the most common, the symmetrical abrupt downward 
slope of the audiogram begins above the speech frequencies (4kHz), therefore speech 
discrimination is often preserved. At histology there is a progressive epithelial atrophy 
with loss of sensory hair cells and corresponding neurons. 
Neural presbycusis – audiometry corresponds to a gentler downward slope, 
usually speech discrimination is severely affected. Histopathology shows 1st neuron 
degeneracy that begins at the basilar region of the cochlea.  
Strial presbycusis (metabolic) – begins early in life, slow progression, it has a 
hereditary component, and is more common in women. Audiometry has a flat pattern, 
with a preserved speech discrimination. Histopathology corresponds to atrophy of the 
stria vascularis (with big intracellular vacuoles, cystic structures and/or basophilic 
deposits). 
Cochlear presbycusis (conductive / mechanical) – Audiometry is pan-tonal or in 
a gradual downward slope with poor speech discrimination.  Histopathology reveals 
thickening and secondary stiffening of the basilar membrane of the cochlea with 
changes in the spiral ligament, in particular a loss of type IV fibrocytes adjacent to the 
basilar membrane. The mechano-electric mechanism is compromised. 
In 25% of the cases: 
Mixed presbycusis – Mixture of the above. 
Indeterminate - None of the above. 
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Figure 2.1-16 - Different structures involved in the types of presbycusis. 
Legend: Red circle – sensory presbycusis; Orange circle – Neural presbycusis; Green circle – Strial 
presbycusis; Blue circle – Mechanical presbycusis. 
(https://www.sobiologia.com.br/conteudos/FisiologiaAnimal/sentido6.php)  
 
It is generally accepted that one of the contributors for the mechanisms leading 
to ARHL is the natural ageing of the organism where occurs a progressive state of 
hypoperfusion of cochlear tissues leading to ischemia, and the production of free 
radicals which are very toxic and harmful to auditory epithelium. This process induces 
mitochondrial mutations and a state of bioenergetic inefficiency (Terao et al., 2018). 
A genetic predisposition of ARHL has the implication that this entity may be 
treatable or preventable. There are studies describing an association between ARHL and 
genes involved in hereditary hearing loss (e. g. GJB2 e KCNQ4); or genes related to 
oxidative metabolism (e. g. NAT2, GSTM1, GSTT1); other studies involve GRHL2 and 
GRM7 and also concerning mitochondrial DNA, the 4977bp deletion and the U and K 
haplogroups. 
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Ageing involves a progressive loss of sensorial epithelium in the inner ear. This 
process begins at the age of forty (Seidman et al., 2004). Seidman and colleagues found 
an average loss of 2000 cochlear neurons for each decade of life (Seidman et al., 2004). 
There are also losses at central auditory pathways, with a 50% reduction of the total 
number of cochlear dorsal and ventral nucleus neurons at the age of 80.  
There has been recent research concerning Heat shock proteins (HSP).HSP-70.  is 
phylogenetically very ancient and present in bacteria, and in humans is genetically 
codified in at least 17 variants. In the nervous and immune systems HSP-70 has both 
intra and extracellular roles with many paracrine effects (Giffard, Macario & Macario, 
2013). It works like an alarm signaling activating cytokine chains such as 
MYK88/IRAK/NFkß. HSPs are present in many tissues: liver, muscles, neurons etc, (Pujol 
& Puel, 1999). In the immune system HSP-70 can have an immunosuppressive or 
immune stimulating effect depending on the cell type involved (Giffard et al., 2013; Pujol 
& Puel, 1999).   
Several studies have shown that in response to an insult the Shock transcription 
factor (HSF1) is activated, which induces several HSPs. This activation is reduced in the 
process of ageing and consequently the cellular protection is also reduced (Lobo, García-
Berrocal, Trinidad, Verdaguer, & Ramírez-Camacho, 2013; May, 2013).   
2.1.4.3. Relationship with tinnitus 
Hearing loss is considered a risk factor for tinnitus development (Chung et al., 
1984; Sindhusake et al., 2003, 2004). Although tinnitus can be triggered by a variety of 
causes, the majority of cases are associated with hearing loss (Roberts et al., 2010). 
Usually, tinnitus patients with normal standard audiograms have some hearing loss at 
frequencies above 8 kHz (Roberts, Moffat, & Bosnyak, 2006). However, not all patients 
with hearing loss develop tinnitus, as demonstrated by the higher prevalence of hearing 
loss compared to tinnitus (Lockwood, Salvi, & Burkard 2002). Although it is unclear 
which factors of hearing loss contribute to the occurrence of tinnitus it is hypothesized 
that interventions that prevent hearing loss may also prevent tinnitus (Roberts et al., 
2010). 
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2.2. Pathophysiology of subjective tinnitus: triggers and maintenance 
Submitted to Frontiers in Neuroscience 
Haúla Faruk Haider, Tijana Bojić, Sara F. Ribeiro, João C. Paço, Deborah A. Hall, 
Agnieszka J Szczepek 
 
 
Abstract 
Tinnitus is the conscious perception of a sound without a corresponding external 
acoustic stimulus, usually described as a phantom perception. One of the major 
challenges for tinnitus research is to understand the pathophysiological mechanisms 
triggering and maintaining the symptoms. Our objective was to synthesize the published 
literature in order to provide a comprehensive update on theoretical and experimental 
advances and to identify further research and clinical directions. We performed 
literature searches in three electronic databases, complemented by scanning reference 
lists from relevant reviews in our included records, citation searching of the included 
articles using Web of Science, and manual searching of the last six months of principal 
otology journals. One-hundred and thirty-two records were included in the review and 
the information related to peripheral and central mechanisms of tinnitus 
pathophysiology was collected in order to update on theories and models. A narrative 
synthesis examined the main themes arising from this information. Tinnitus 
pathophysiology is complex and multifactorial, involving the auditory and non-auditory 
systems. Recent theories assume the necessary involvement of extra-auditory brain 
regions for tinnitus to reach consciousness. Tinnitus engages multiple active dynamic 
and overlapping networks. We conclude that advancing knowledge concerning the 
origin and maintenance of specific tinnitus subtypes origin and maintenance 
mechanisms is of paramount importance for identifying adequate treatment. 
 
Keywords: Tinnitus; Auditory system; Tinnitus pathophysiology; Central tinnitus; 
Peripheral tinnitus; Causes of tinnitus; Tinnitus maintenance 
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Introduction 
Tinnitus is a prevalent symptom associated with various conditions and diseases; 
both otological and non-otological (Baguley et al., 2013). It affects over 70 million people 
in Europe and more than 50 million people in the United States (Heller, 2003; Henry et 
al., 2005; Baguley et al., 2013). The heterogeneity of tinnitus causes a substantial 
problem in its classification, which has hampered both basic and clinical research. A 
major challenge for the field is to identify the underlying causes of tinnitus for 
developing specific treatments that address the  distinct manifestations of tinnitus  
(Noreña, 2015). Although much research is underway, the precise pathophysiology of 
tinnitus remains unclear. 
Tinnitus can be classified according to various criteria including causes, 
comorbidities, symptoms characteristics, and psychological burden. The most common 
form of tinnitus is described as the conscious perception of a phantom sound or noise 
perceived in the ear(s) or head in absence of a known external or internal stimulus 
(Schlee et al., 2014) and this is often associated with a hearing loss.  Tinnitus has been 
further classified according to its initial triggers as a primary tinnitus, which is either 
associated with sensorineural hearing loss (SNHL) or is idiopathic (or unknown cause), 
and a secondary tinnitus, which is related to other causes such as an organic origin 
(Tunkel et al., 2014). Somatic or somatosensory tinnitus is a subtype of subjective 
tinnitus, and the patients's tinnitus perception its cause by the alteration in 
somatosensory afference from the cervical spine or temporomandibular area (Michiels 
et al., 2018). Another causal classification strategy is based on the origin of tinnitus in 
relation to the site of impairment in the auditory pathway, and splits tinnitus into 
peripheral and central types (Henry et al., 2014). Tinnitus duration is also a common 
symptom classification since this can distinguish patients where tinnitus is maintained 
over the longer term after its initial onset. Acute tinnitus has been defined as an onset 
within the past 6 months, whereas chronic tinnitus refers to symptoms lasting 6 months 
or longer (Tunkel et al., 2014). However, the precise temporal boundary from acute to 
chronic is not standardized, since other authors report the transition from acute to 
chronic tinnitus anywhere between 3 and 12 months (Hall et al., 2011; Rabau et al., 
2015). Another symptom classification is based on a description of the tinnitus sound 
such as whether it is continuous or intermittent, pulsatile or non-pulsatile. Questions 
about duration and symptom characteristics are often asked in case history 
questionnaires (e.g. Tinnitus Sample Case History Questionnaire, Schecklmann et al., 
2015).  
Another classification system takes account of the functional and psychological 
impacts caused by tinnitus, and this is particularly important for those with chronic 
bothersome tinnitus. A number of questionnaires have been designed to assess self-
reported impacts and examples include the Tinnitus Handicap Inventory (THI, Newman 
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et al., 1996), Tinnitus Questionnaire (TQ, Hallam et al., 1988),  Tinnitus Functional Index 
(TFI, Meikle et al., 2012), and Tinnitus Primary Function Questionnaire (TPFQ, Tyler et 
al., 2014). The correlation between total scores of THI and TQ is 0.641 (P<0.0001), 
indicating that they assess a similar tinnitus-related construct. Of note, the German 
version of the TQ (Hiller and Goebel, 1992), frequently used in the German-speaking 
countries, is a modified version of the original TQ developed in the UK. Burden can be 
represented by a score on a continuous scale, by narrative description on a categorical 
scale, or by a dichotomous distinction such as between “compensated” or 
“decompensated” tinnitus as measured by the German version of the TQ.  
Whether or not any of these classification strategies are informative with respect 
to the pathophysiology of tinnitus remains controversial. Concerning its origin, there is 
a minimum consensus that tinnitus is related to aberrant neural activity at certain levels 
of the auditory system (Jastreboff, 1990). “Peripheral tinnitus” refers to the auditory 
perception that results from aberrant neural activity at the cochlear level and 
transmitted through the auditory pathways (Jastreboff, 1990; Guitton et al., 2003; Puel 
and Guitton, 2007). “Central tinnitus” refers to the auditory perception that is generated 
in auditory brain centers by the aberrant neural activity and is sustained by that aberrant 
neural activity (Eggermont, 2005; Kaltenbach, 2006; Eggermont, 2007; Kaltenbach, 
2007; Mulders and Robertson, 2009). The auditory centers perform an important role 
because they are involved in the generation of the tinnitus-related activity (Liberman 
and Dodds, 1984b;a; Heinz and Young, 2004; Noreña, 2015). Despite this distinction, 
“peripheral tinnitus” and “central tinnitus” are not completely independent forms 
(Noreña, 2011). This article uses systematic review methodology to identify the latest 
knowledge regarding the different pathophysiological mechanisms that trigger and 
maintain tinnitus symptoms. 
Identifying and selecting appropriate literature sources 
Eligible information sources were review articles and original research articles 
reporting basic science, exploratory and investigational studies. We included animal and 
human studies investigating tinnitus pathophysiology, but we did not include studies 
where the primary focus was an associated condition (such as Ménière’s disease, 
otosclerosis, vestibular schwannoma, chronic otitis media, tumor, autoimmune 
diseases, neurodegenerative or demyelinating disease, or cases of ototoxicity) with 
tinnitus as an incidental observation. Other exclusion criteria were articles not written 
in English language, and records relating solely to objective or somatosensory tinnitus. 
Initial literature searches were conducted in October 2017 using three literature 
search platforms: PubMed, Medline and Web of Science and the search terms 
“pathophysiology” and “subjective chronic tinnitus”. The initial search was 
complemented by scanning reference lists from relevant reviews in our included 
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records, citation searching of the included primary scientific articles using Web of 
Science. Additionally, in May 2018, we performed an update by manually searching key 
otology journals.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2-1 - Flowchart of the literature search and selection process. 
The initial search retrieved 373 records. After duplicates had been removed, 168 
records remained for abstract screening. From those, 47 were excluded as not related 
to the topic of the review or not meeting the inclusion criteria. The remaining 121 full 
texts were screened again for eligibility (Figure 2.2-1). Fifty additional records were 
identified from the manual searching to give a total of 171 records. At least two authors 
independently, from review team, reviewed all records, and in case of disagreement, a 
third opinion was obtained. Information extraction and synthesis focused on tinnitus 
pathophysiology.  
Population characteristics indicating pathophysiology 
A study in Italy performed by Martines and collaborators estimated that in 30% 
of cases, tinnitus had an undetermined etiology (Martines et al., 2010a;Martines et al., 
2010b;c). It is well established that tinnitus often accompanies noise-induced hearing 
loss and presbycusis. According to Davis and Rafaie, approximately 90% of people with 
tinnitus in the UK have some form of hearing loss (Davis and Rafaie, 2000). Large-scale 
population studies have identified other risk factors such as vascular disease, 
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hypertension, diabetes, autoimmune disorders, head injury, and degenerative neural 
disorders (Rojas et al., 2003;Sindhusake et al., 2004). 
Comparing animal and human neurophysiological studies 
Some of the major advantages of the animal model as a way to investigate the 
pathophysiology of tinnitus are the ability to i) control the etiology via controlled 
experimental manipulation of the noise environment or ototoxic drug exposure, ii) to 
randomly assign animals to experimental or control groups, increasing the power of 
statistical testing, and iii) to apply a wide range of experimental tools (from molecular 
to behavioral). Nevertheless, some disadvantages of using animals for tinnitus research 
exist, the main one being the lack of a standardized animal model of tinnitus. These 
fundamental challenges give rise to concerns about the reliability and interpretation of 
results (Lobarinas et al., 2013; Brozoski and Bauer, 2016). Noise exposure in the animal 
model is often traumatic and acute, unlike the more common human experience of 
moderate and prolonged noise exposure, while exposure to highly concentrated 
ototoxic agents such as salicylate are rare in humans. An unresolved issue is the 
distinction between acute and chronic tinnitus in animal models, mainly due to different 
experimental paradigms and different species used. An agreed classification of what 
constitutes acute versus chronic tinnitus in the animal model is of special importance 
for future studies regarding the progression from acute to chronic forms, especially since 
this could provide the basis for seeking objective markers of its natural history. The 
majority of research done with help of animal models points to noise-induced hearing 
loss and tinnitus as an adequate model for the development of chronic tinnitus (Bauer 
and Brozoski, 2001;Turner and Larsen, 2016). The report of Pace and collaborators 
focuses on a novel experimental paradigm and makes distinction between the salicylate-
induced tinnitus (tinnitus duration 5 days) and noise-induced tinnitus (tinnitus duration 
7 weeks) (Pace et al., 2016). An attempt to define such criteria has already been made 
using clinical studies (Leaver et al., 2016a). Based on the obtained findings, species-
specific criteria could be expected to emerge in animal models of tinnitus.  
The pioneering and widely applied salicylate model (Jastreboff et al., 1988) 
induces tinnitus both by direct central effects on the auditory system and by induction 
of peripheral hearing loss (Eggermont, 2015). For a detailed review on animal models of 
tinnitus, the reader could refer to Brozoski and Bauer (2016). Questions about altered 
neural spontaneous firing rates in the auditory pathway, abnormal neural synchrony and 
changes in tonotopic representation have been obtained from animal studies at the 
level of individual neurons and neuronal assemblies, and in human studies at a much 
more macroscopic population level (Adjamian et al., 2009; Eggermont, 2015). The main 
problem here is the translation of research from subcellular neuronal events found in 
animal models to the brain activity patterns observed in people with tinnitus. The 
differences in measurement technique bring important caveats for drawing analogies 
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between animal and human findings. For example, the assumption that the 
interpretation of coupling between local neural activity and the responses monitored 
using blood oxygenation level-dependent functional magnetic resonance imaging 
(BOLD-fMRI) are still unclear (Adjamian et al., 2009). 
One of the overall impressions about the neurophysiological results obtained 
from animal models of tinnitus is that they typically consider tinnitus as the 
consequence of an acute peripheral lesion associated with severe hearing loss. In 
contrast, human neuroimaging studies tend to emphasize the role of auditory thalamus 
and auditory cortex in the chronification and maintenance of tinnitus (Eggermont, 
2015;Brozoski and Bauer, 2016). 
Sites of tinnitus generation 
A fundamental question in tinnitus pathophysiology concerns the neural 
component that generates tinnitus (Henry et al., 2005). Zenner initially postulated that 
tinnitus could originate in any relevant anatomical structure; from the ear throughout 
the central auditory pathways (Zenner, 1998). Initial speculations favored a cochlear 
origin since tinnitus can be perceived in the ears and also due to the fact that there is a 
strong association between the frequency of psychoacoustic identified tinnitus and the 
audiometric profile of hearing thresholds (Sereda et al., 2011). These opinions were 
contradicted by the fact surgical section of the auditory nerve does not eliminate 
tinnitus in every case, which favors the hypothesis about the central rather than 
peripheral origin of tinnitus (House and Brackmann, 1981). 
Nowadays, it is well established that many forms of tinnitus reflect a complex 
interaction between peripheral and central mechanisms within the auditory pathway  
(Noreña and Farley, 2013). Usually two or more triggers (e.g. noise exposure, hearing 
loss, emotional distress, and somatosensory factors) are necessary to elicit a noticeable 
tinnitus (Shore et al., 2007). Tinnitus can be seen as a pathology of neural plasticity with 
a molecular and a systemic component. The molecular component has a cochlear 
component related to the initiation phase of tinnitus; while the systemic component has 
a central aspect associated to the long-term maintenance of tinnitus (Satar et al., 2003; 
Guitton, 2012; Noreña and Farley, 2013; Noreña, 2015; Sedley et al., 2015). It has been 
suggested that peripheral tinnitus may originate from the dysfunction of cochlear outer 
hair cells and the consequent changes in endocochlear potential, leading to increased 
spontaneous cochlear activity. This suggestion provides a possible explanation of 
different causes behind cochlear tinnitus, including tinnitus induced by an acute noise 
exposure (Noreña, 2015). Meanwhile, central tinnitus is mediated by the neuronal 
activity in the auditory centers. A good illustration is the chronic tinnitus induced by a 
noise trauma in the absence of changes in cochlear activity following the trauma 
(Liberman and Dodds, 1984b;a; Heinz and Young, 2004; Noreña, 2015). Although central 
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mechanisms are important for explaining the generation of tinnitus-related activity, 
much of these mechanisms appear to be triggered by a reduction of cochlear activity. 
However, damage to cochlear tissues is not necessary to produce central changes 
related to tinnitus, since a conductive hearing loss can also induce tinnitus (Ayache et 
al., 2003; Midani et al., 2006; Schaette et al., 2012).  
Based on the above assumptions, Noreña proposed three distinct subtypes of 
tinnitus: cochlear tinnitus, peripheral-dependent central tinnitus and peripheral-
independent central tinnitus (Noreña, 2015). Cochlear tinnitus refers to a tinnitus 
generated by aberrant activity in the inner ear, which is propagated through the 
cochlear nerve and the central auditory pathway. This activity may lead to an auditory 
perception, depending on the firing neuronal rates and top-down modulation, (Noreña 
and Farley, 2013;McKenna et al., 2014; Noreña, 2015). Peripheral-dependent central 
tinnitus refers to a tinnitus associated with cochlear spontaneous activity, while 
peripheral independent central tinnitus refers to a tinnitus that is independent from 
cochlear spontaneous activity (Noreña, 2011;2015).  
Cellular mechanisms 
Cochlear damage may include loss of Outer Hair Cell (OHC) electromotility, loss 
of synapses between Inner Hair Cells (IHCs) and spiral ganglion neurons (synaptopathy), 
damage to the stereociliar bundle, death of OHCs or IHCs, or rupture of the basilar 
membrane. All of these processes can be seen in rodents by means of histology, but are 
not easily measureable in humans due to difficulty in access to tissue. These mechanisms 
lead to a decrease in neuronal output from the cochlea to the brain and they could 
account for the potential generation of compensation mechanisms in the brain (Chen 
and Fechter, 2003). 
Position of the tectorial membrane 
Change in the position of the tectorial membrane may be a pathophysiological 
trigger for acute tinnitus following an intense noise exposure. It is well established that 
after noise trauma, the rootlets of stereocilia are altered leading to stiffness and 
contributing to acute increase in cochlear spontaneous activity (Liberman and Dodds, 
1984b;a;1987). The prolonged depolarization of IHCs can occur through any condition 
that changes the relative position of the tectorial membrane. This may originate after 
an increased pressure in the scala media, tectorial membrane detachment, 
degeneration of OHCs or stereocilia (LePage, 1989). In some cases, there might exist 
areas of damaged OHCs but intact IHCs, and so the tectorial membrane can touch the 
IHCs stereocilia, consequently causing their depolarization (Baguley, 2002). 
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Outer Hair Cells (OHC) 
Another pathophysiological trigger for acute tinnitus concerns damage to the 
stereocilia of OHCs, again often following an intense noise exposure. High noise levels 
damage first the OHCs and then the IHCs (Nicolas-Puel et al., 2006). The initiation of 
pathological process starts at the stereocilia of OHCs, with two fundamental processes 
damaged by the noise: intracellular calcium levels and biochemical changes of their 
structural proteins. Eggermont suggested that increased intracellular calcium could be 
the pathological substrate of peripheral tinnitus, by increasing the neurotransmitter 
release of the cells and subsequent activity of afferent fibers (Eggermont, 2000). 
Inner Hair Cells (IHC) and the cochlearNMDA receptors 
The N-methyl-D-aspartate (NMDA) receptor has been found to play an essential 
role in noise-induced tinnitus. In a behavioral animal model, pharmacological 
interventions that antagonize the NMDA receptors prevent tinnitus (Guitton et al., 
2003). These NMDA receptors appear to predominate on the modiolar side of IHCs 
(Pujol et al., 1992), with  a higher percentage of lateral olivocochlear efferent fibers that 
seem to terminate on low-SR high threshold fibers (Liberman, 1980). It seems that an 
increase in glutamate levels derived from IHCs, activates the NMDA receptors that 
release excessive Ca2+ in the dendrites of the spiral ganglion neurons.  This causes an 
over-excitation of NMDA-receptors and consequently a calcium influx during the 
damage. This process may contribute to hearing loss, neural presbycusis and tinnitus  via 
the aberrant excitation of the auditory nerve (Sanchez et al., 2015). Underlying the over-
excitation, there is an increase in adenosine triphosphate (ATP) which consequently 
increases the reactive oxygen species in the synapses between IHCs and spiral ganglion 
neurons (Sahley et al., 2013). An increase in levels of Ca2+ in the NMDA receptors can 
trigger a successive metabolic events such as production of reactive oxygen or hydrogen 
species or even death of spiral ganglion neurons (Parsons and Raymond, 2014). It is likely 
that the blockade of NMDA-receptor activation prevents the loss of IHC ribbons after 
noise damage (Bing et al., 2015). Therefore, concerning the lower auditory pathway, the 
NMDA receptor plays a role in numerous functions such as neuronal plasticity, synapse 
modifications, temporal processing and onset of disease (Sanchez et al., 2015). 
Increase of the endocochlear potential 
The endocochlear potential is a prerequisite for auditory signal transduction. It 
is maintained by keeping high concentrations of K+ in the endolymph and is strongly 
associated with cochlear spontaneous activity (Sewell, 1984; Mittal et al., 2017). An 
increase in the endocochlear potential can depolarize IHCs, which triggers a sequence 
of events that includes opening the voltage-gated Ca2+ channels, an intracellular influx 
of Ca2+ and fusion of the synaptic ribbon to plasmatic membrane. This culminates in 
glutamate release and depolarization of cochlear fibers (Hudspeth, 1985;Moser et al., 
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2006). OHCs can regulate the endocochlear potential, through their mechano-electrical 
transduction channels. In other words, the opening of these channels depends on 
steriociliar bundle deflection. This process seems to be induced by acute noise trauma 
that reduces the opening probability of this channels, consequently increasing the 
endocochlear potential (Patuzzi, 2002). 
Biochemical changes seem to be most relevant to the acute phase of tinnitus. 
The heat-shock protein group (stress proteins), interacts with structural proteins of hair 
cells, giving them support and protecting them from further damage. Any disturbance 
that causes a deficient heat-shock protein system response can lead to incurring tinnitus 
to the person exposed to loud noise (Dechesne et al., 1992). 
Cochlear synaptopathy 
Although the majority of people with tinnitus have a clinically measurable 
hearing loss, a good number do not. According to different series more than 60% of 
people with normal hearing (based on tonal audiometry) have tinnitus (Tucker DA et al., 
2005; Heller & Bergman, 1953). Animal data suggest that the permanent loss of 
synapses between the IHCs and the cochlear nerve fibers occurs because external 
factors such as noise exposure or aging (Kujawa and Liberman, 2009;Sergeyenko et al., 
2013;Kujawa and Liberman, 2015). This condition is popularly called ‘hidden hearing 
loss’ (HHL) (Schaette and McAlpine, 2011), since it is not possible to diagnose through 
conventional tonal audiometry using quiet sounds. In the ear, noise overexposure 
causes a rapid excessive release of the neurotransmitter glutamate from electron-dense 
ribbon synapses in the IHC. This excitotoxic insult induces the swelling of the dendrites, 
which causes an important level of hearing loss at a particular frequency due to a partial 
disconnection among the IHCs and the afferent neurons (Pujol et al., 1993). The ear 
possesses a remarkable healing capacity that allows these neuronal terminals to regrow 
towards the sensory cells and reestablish functional connections restoring hearing (Pujol 
and Puel, 1999), as people experience after noise exposure (e.g., concerts) and have 
their hearing thresholds recovering and their tinnitus disappearing after some time. 
However, in some cases, even if the terminals have grown back, the reconnection can 
be incomplete and synaptic coupling remains incomplete due to either a decrease in the 
number of ribbons (Ruttiger et al., 2013) or a decrease in the number of paired pre-and 
post-synaptic entities (Kujawa and Liberman, 2009). The damage seems to selectively 
affect low spontaneous rate of the cochlear neurons responsible for high thresholds and 
coding moderate-to-high sound intensities (Furman et al., 2013). Recently, Wan and 
Corfas (2017) reported another mechanism underlying HHL. The authors found that 
transient Schwann cells loss results in permanent disruption of the cochlear heminodal 
and consequently in permanent auditory deficits characteristic of HHL. Interestingly, 
these auditory deficits are not related to the synaptic loss, but with the affection of the 
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first heminodes at the auditory nerve peripheral terminal. This study provides new 
insights on the mechanisms, causes and long-term consequences underlying HHL. 
 The extent to which cochlear synaptopathy contributes to tinnitus in animals and 
in humans is still uncertain. Schaette and McAlpine first demonstrated the reduced 
amplitude of wave 1 in the auditory brainstem response (ABR) in the subjects with 
tinnitus but with normal audiogram, when compared to controls (Schaette and 
McAlpine, 2011). An appealing interpretation of these findings is that they are evidence 
for reduced cochlear nerve output as a direct result of cochlear synaptopathy. However, 
there are some important caveats to data interpretation. First, the match between 
tinnitus and control groups  was not 100% regarding the high frequency sensitivity, yet 
wave 1 ABR amplitude is known to be predominantly raised by responses to high-
frequency tones (Don and Eggermont, 1978). Second, this finding has not withstood 
replication (Gilles et al., 2016;Guest et al., 2017). Methodological differences might 
underlie the lack of replication, but another plausible explanation is that tinnitus in 
young audiometrically normal adults is not related to cochlear synaptopathy but may 
reflect other effects of the exposure to noise (Guest et al., 2017). Clear directions for 
further research are to improve the sensitivity of non-invasive electrophysiological 
measures of cochlear synaptopathy in humans, and to examine the broader 
neurophysiological impacts of noise exposure. 
Mechanisms involved in maintenence of tinnitus 
The link between hearing loss and tinnitus is well substantiated. For example, 
patients with conductive hearing loss (e.g. otosclerosis) frequently report having tinnitus 
and these symptoms are usually abolished after surgery (Gersdorff et al., 2000; Ayache 
et al., 2003; Sobrinho et al., 2004). Ear plugging is a way to induce a temporary hearing 
loss in otherwise normally hearing people. Participants who wear a silicone earplug for 
7 days develop tinnitus symptoms, which disappear after removing the earplug 
(Schaette et al., 2012). Implantable and non-implantable hearing devices improve 
tinnitus in 50% of treated patients and eliminating it in 20% of cases (Schaette, 2013), 
likely by partially restoring cochlear output. More specifically, published data confirm a 
strong association between high-pitched tinnitus and high-frequency SNHL, suggesting 
again that hearing loss is a main cause of tinnitus (Noreña et al., 2002; Martines et al., 
2010a; Martines et al., 2010b;c; Sereda et al., 2011). Many theories  suggest that  the 
underlying cause of tinnitus may be associated with damage to the sensory cochlear 
epithelium  (Henry et al., 2005), and if acute then this can be assessed in the patient by 
asking about the temporal association between noise exposure events, abrupt changes 
in hearing and tinnitus onset or exacerbation. In a review, Zhao and collaborators found 
that specific insults to the peripheral auditory system (e.g. cochlear ablation, selective 
IHC or OHC loss, and mixed or incomplete IHC and OHC injuries) can all reduce cochlear 
output (Zhao et al., 2016). The edge theory of tinnitus proposes having cochlear 
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disturbance inducing tinnitus and caused by  the shift of OHCs in the organ of Corti from 
the apical side  towards the lesion in a high-frequency basal side (Nuttal AL, 2004). In 
almost all types of peripheral insults, OHCs are more damaged than IHCs. Combined with 
the edge theory, this provides the foundation of the Discordant Theory, which predicts 
that tinnitus is associated with a disinhibition of neurons in the dorsal cochlear nucleus 
(DCN), due for example to DCN receiving excitation from IHC and not from damaged 
OHC and consequently leading to increasing spontaneous activity in the central auditory 
system (Levine, 1999;Jastreboff and Hazell, 2004). 
Reduced cochlear output through hearing loss likely triggers a cascade of 
neuromodulatory events ultimately causing hyperactivity in central auditory circuits 
(central gain). This process has been proposed to contribute to tinnitus. It seems to be 
associated with neuronal hyperactivity and could likely be a common consequence of 
various kinds of cochlear damage (Parra and Pearlmutter, 2007). It could also explain 
individual cases of tinnitus without hearing loss, since there can be up to 30% damage 
to the OHCs before hearing loss is detectable using pure tone audiometry (Chen and 
Fechter, 2003). 
Hearing loss decreases the input to the central auditory system. This may in turn 
modify the gain of central neurons, resulting in increased spontaneous activity. The 
functional aberrations resulting from either model (tonotopic over-representation, 
enhanced synchronicity, or elevated spontaneous firing rates) may underlie the 
induction of tinnitus (Adjamian et al., 2014) (Figure 2.2-2). 
The sensation of pain and phantom limb perception is often used as an analogy 
to the pathophysiology of tinnitus. Damage in the cochlea (e.g. hair cell loss or synaptic 
damages) leads to a frequency-specific decrease in output from the cochlear nerve. An 
upregulation of activity in the central auditory pathway is a compensatory effort to 
counteract the lack of signals in the particular frequency area. This effort increases the 
gain, falsely leading to the perception of a non-existing sound and possibly 
accompanying hyperacusis (Auerbach et al., 2014). In addition to the auditory pathway, 
tinnitus shares non-auditory networks, similar to these know in chronic pain 
(perception, salience, distress, memory). Such networks, may maintain, in absence of 
the initial “tinnitus-initiator” (De Ridder et al., 2011a;De Ridder et al., 2014;Rauschecker 
et al., 2015). De Ridder and others consider phantom pain and phantom sound to share 
basic underlying mechanisms. The model assumes sensory differentiation resulting in 
cortical activity within the primary and secondary auditory cortices. This activity 
becomes a conscious percept upon connection to a larger brain networks located in the 
frontal and parietal areas of cortex, such as “self-awareness” and “salience network”. 
The latter network intersects with the central autonomic control system and affects the 
limbic-auditory and somatosensory interaction indispensable for consciously 
maintaining the phantom perception (Figure 2.2-2 and 2.2-3). This perception may 
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associate with distress, simultaneously co-activating non-specific distress networks 
located in the anterior cingulate cortex, anterior insula and amygdala. At the same time, 
it is proposed that memory mechanisms may reinforce and maintain the awareness of 
the phantom percept (De Ridder et al., 2011a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2-2 - Potential mechanisms involved in tinnitus pathophysiology. 
Legend: GPNs – global perceptual networks; vl/vmPFC – ventrolateral/ventromedial prefrontal 
cortex; dACC – dorsal anterior cingulate cortex; Prec. – precuneus; IPC – inferior parietal cortex; 
PHC – parahippocampal cortex; HG – Heschl's gyrus; STG – superior temporal gyrus; SG/G/IG, 
supragranular/granular/infragranular neuronal layers; BF – basal forebrain; OFM – orofacial 
movements; S – specific (lemniscal) auditory thalamus; TRN – thalamic reticular nucleus; NS – 
non-specific auditory thalamus; ; DCN – dorsal cochlear nucleus; IC – inferior colliculus.  
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Figure 2.2-3 - Some extra auditory regions involved in tinnitus pathophysiology. 
Central mechanisms 
The compensation mechanism occurring in the central nervous system during 
tinnitus is called “homeostatic plasticity”. This is a phenomenon whereby auditory 
neurons in the brain adapt their synaptic connections in attempt to maintain a neuronal 
network similar to the one before the peripheral damage occurred. Neuronal correlates 
of tinnitus have been proposed as neuronal hyperactivity in the posteroventral cochlear 
nucleus (PVCN), the inferior colliculus (IC), DCN, and the paraflocculus lobe of the 
cerebellum (PFL) (Cacace et al., 2014). Specifically, it has been suggested the presence 
of elevated responses to sound in subcortical areas, in particular in the IC, as a common 
effect among individuals with tinnitus and normal thresholds (Melcher et al., 2009).  A 
large body of data supports the view that DCN is the induction site of tinnitus, which 
then spreads to higher areas (Brozoski et al., 2012;Dehmel et al., 2012;Wu et al., 2015). 
Animal studies show an increased activity in fusiform neurons of the dorsal cochlear 
nucleus during noise-induced tinnitus (Brozoski et al., 2002). Being the site of 
convergence of different somatosensory pathways (trigeminal nucleus and dorsal 
somatosensory pathway), cholinergic and serotonergic systems, it has been proposed 
that the DCN is an important site of maladaptive auditory-somatosensory plasticity (Wu 
et al., 2015). Supporting the importance of the DCN in tinnitus generation is the 
identification of a role of the Kv7.2/3 channel, which shows decreased activity in the 
DCN after noise-induced tinnitus. However, a specific drug compound that modulates 
Kv channels (Kv3.1) has been found not to alleviate subjective tinnitus in humans 
(https://clinicaltrials.gov/ct2/show/NCT02315508?term=QUIET-1&rank=1).  
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Another hypothesis views tinnitus as a product of neuronal hyperactivity in 
particular regions of the central auditory system  such as  cochlear nucleus, IC  and 
thalamus (see (Dong et al., 2010;Middleton et al., 2011;Vogler et al., 2011;Manzoor et 
al., 2013;Kalappa et al., 2014). There is no consensus about cannabinoids, which activate 
the CB1 receptors and which may have an effect on exacerbation or worsening tinnitus. 
However, there seems to be an effect of cannabinoids and their receptors that exist in 
the cochlear nucleus, where they are functional and may have an effect in tinnitus. The 
function of CB1 receptors in the circuitry of the DCN suggests that could increase rather 
than inhibit it, neuronal excitation which if causing  tinnitus might exacerbate rather 
than relief it (Smith and Zheng, 2016). 
There are two main, partially compatible theories on the role of medial 
olivocochlear bundle in tinnitus onset. The first theory emphasizes the role of decreased 
neural efferent input to the cochlear amplifier which, in this way, increases its 
spontaneous activity and induces a chain reaction of neuroplastic changes in the 
afferent auditory relays up to the auditory cortex. The second theory focuses on the 
brainstem as the place of integration of efferent neuronal drive and afferent tinnitus-
related stimuli (Riga et al., 2015). Considering that some studies could not confirm the 
role of medial olivocochlear bundle in tinnitus, this finding is still controversial (Riga et 
al., 2015). 
The auditory cortex also shows evidence of frequency-dependent 
reorganization, although in people with tinnitus but without measurable hearing loss, 
tonotopic map reorganization is not essential (Langers et al., 2012). Comparing cortical 
hubs that involve multiple brain regions in people with tinnitus and in the healthy 
controls through electrophysiological measurement demonstrates fundamental 
differences between the groups (Muhlnickel et al., 1998;Schlee et al., 2009). Mapping 
the cortical hubs has demonstrated essential  differences in the global networks, mainly 
hyperactivity in the gamma frequency range within the temporal cortex associated with 
tinnitus (Schlee et al., 2009). According to this view, the global network may influence 
the auditory cortex in a top-down process and regulate the degree of tinnitus-related 
distress. Those alterations seem to be associated with conscious tinnitus perception  
(Schlee et al., 2008). In particular, the activity and connectivity patterns detected in the 
posterior cingulate cortex and the precuneus region, associate with a distressing tinnitus 
(Maudoux et al., 2012). When cochlear damage causes a reduction of electric signals at 
a given frequency, neurons within the primary auditory cortex responsive to these 
frequencies start responding to adjacent frequencies, as exemplified by the broadening 
of the frequency tuning in this region (Engineer et al., 2011;Yang et al., 2011). Aberrant 
neuronal oscillations have also been observed in the alpha and gamma frequency range 
within the frontal cortex (Muller et al., 2013). These results are in agreement with the 
work of Weisz and collaborators, who were the first group to use the EEG oscillation to 
study tinnitus (Weisz et al., 2005). That first study revealed the dissimilarities of power 
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spectra between a group of people with tinnitus and hearing loss and a matched group 
of control subjects. Over the years, other results provided mixed support for this finding 
(Weisz et al., 2007;Moazami-Goudarzi et al., 2010;De Ridder et al., 2011b;Adamchic et 
al., 2012;Adjamian et al., 2012;Adamchic et al., 2014), and there is not yet any clear 
agreement in the field. For example, recently, Pierzycki and collaborators (Pierzycki et 
al., 2016) found no evidence that resting state whole-scalp EEG reflects any tinnitus-
related percept or symptom severity and so should not be assumed as a biomarker for 
tinnitus. Moreover, the correlation between perception of tinnitus and the frequency 
band power in EEG and magnetoencephalography (MEG) remains unclear.  
Overall, it is now rather well established that most of the nuclei in the auditory 
pathway can be affected during tinnitus. These compensatory mechanisms seem to be 
related to the loss of GABAergic inhibition and decreased activity of specific potassium 
channels (Kv7.2/3) (Yang et al., 2011;Li et al., 2013). However, whether the changes seen 
in central gain are directly related to tinnitus or instead more related to hyperacusis is 
still a matter of discussion (Knipper et al., 2013;Auerbach et al., 2014).  
Non-auditory neuronal networks involved in tinnitus 
Recent work in rodents (with fMRI) and humans (intracranial recordings) strongly 
support the involvement of emotional/cognitive relays of the brain such as temporal, 
parietal, sensorimotor, and limbic cortex in the pathophysiology of tinnitus (Frank et 
al.,2011; Vanneste and De Ridder, 2011).  Neuronal emotional networks which influence 
peripheral and central circuits during tinnitus, involve most likely central regions 
implicated in a normal emotional behavior and in mood altered disorders. Such regions 
comprise the medial prefrontal cortex and ventro-medial parts of the basal ganglia (also 
known as limbic frontostriatal network) (Lowry et al., 2004;Cheung and Larson, 2010). 
In addition, they include dorsal prefrontal regions, the medial and caudolateral orbital 
cortex (medial prefrontal network), insula, posterior thalamus, anterior cingulate, 
posterior cingulate, amygdala (Shulman, 1995;Mirz et al., 2000), parahippocampus, 
hippocampus (Lockwood et al., 1998;Landgrebe et al., 2009), and the subcallosal region 
(Muhlau et al., 2006;Leaver et al., 2011) including the nucleus accumbens (Jastreboff, 
1990;Drevets et al., 2008). The precise functional role of the numerous extra-auditory 
structures is difficult to establish because some of them participate in the generation or 
in the chronification of tinnitus, some in psychological reactions to the tinnitus, some 
are associated with hearing loss and others with hyperacusis (Leaver et al., 2016a;Leaver 
et al., 2016b) (Figures 2.2-2 and 2.2-3). It is highly plausible that there is no coherent 
model for the involvement of extra-auditory structures in chronic tinnitus but rather 
that the patterns are highly dependent on the individual tinnitus profile. A tight 
interaction between limbic non-auditory and auditory pathways and the presence of 
both anatomical and functional abnormalities has been confirmed by different 
neuroimaging techniques (stimulus evoked BOLD fMRI, diffusion MRI, resting-state fMRI 
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and PET) (Leaver et al., 2016b). On the other hand, other groups have not been able to 
determine  significant differences in the connectivity of auditory network between 
control and tinnitus groups (Davies et al., 2014). One of the important observations is 
that the involvement of the extra-auditory brain areas traces the evolution of acute 
tinnitus to its chronic form (Leaver et al., 2016b). Because a relationship between the 
psychoacoustic tinnitus characteristic, the degree of tinnitus distress and underlying 
neural patterns of activity is not scientifically confirmed, there is an urgent need for 
systematic studies to address these questions further (Leaver et al., 2016b). 
The frontostratial circuits appear to have a central role in the development and 
maintenance of both tinnitus and chronic pain (Rauschecker et al., 2015).  Two 
structures are essential in this process: the ventromedial prefrontal cortex and the 
nucleus accumbens. Both of them play a role in evaluating the relevance and emotional 
significance of sensory stimuli and in managing of the information flow via descending 
pathways. The damage in frontostratial areas could explain tinnitus pathophysiology 
and provide new insights for the therapeutic design or prevention of tinnitus and chronic 
pain (Rauschecker et al., 2015). The tinnitus percept seems to be mediated by a 
somatotopic map and the corresponding somatic memory. Furthermore, somatic 
memories depend on somatotopic maps and their active use in the specialized cortical 
areas (Eggermont and Kral, 2016). The genetically defined somatic memories and the 
somatotopic maps are shaped by experience during early development, and are 
independent of auditory input (Bonham et al., 2004;Pienkowski and Harrison, 
2005;Eggermont and Moore, 2012). Corroborating this observation, it was noted that 
the individuals born without limb(s) are free of phantom limb and phantom limb pain 
phenomena. These observations reinforce the relationship between tinnitus and the 
phantom limb that occurs as references to sensory surface maps (Eggermont and Kral, 
2016).  
The medial geniculate body (MGB) within the thalamus has been suggested to 
gate the perception of sound on its way to the auditory cortex and to limbic system 
(Caspary and Llano, 2017). The key component in the pathology of the tinnitus network 
strongly implicates MGB and its ascending inputs from the brainstem, thalamic reticular 
nucleus and, limbic structures, as well as descending inputs from the auditory and 
nonauditory cortices (Shinonaga et al., 1994;Bajo et al., 1995;Lee and Winer, 
2008a;c;b;Rauschecker et al., 2010;Leaver et al., 2011). In addition, a functional model 
of tinnitus suggests that in the affected individuals, tinnitus-related distress correlates 
with abnormal functions in limbic and thalamocortical circuits (Winer et al., 
1999;Rauschecker et al., 2010;Leaver et al., 2011). Concerning the role of MGB, 
opposing hypotheses offered GABA-related explanations. The first one assumes 
tinnitus-related up regulation of GABAergic inhibition whereas the second one assumes 
tinnitus-related suppression of GABAergic inhibition. GABA mediates fast synaptic 
inhibition and a persistent tonic inhibition (Caspary and Llano, 2017).  
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One study has evaluated the cortical benzodiazepine receptor distribution in 
patients with tinnitus, using venous blood samples after radiolabeling with 123I-
iomazenil, radiochemical purity, single-photon emission computed tomography (SPECT) 
and MRI. A comparison of participants with severe chronic tinnitus and controls revealed 
a significant trend toward bilaterally reduced benzodiazepine receptor density in the 
frontal lobes (p < .001) and a reduction in the cerebellum (p = .045) (Daftary et al., 2004).  
An MRI study, involving people with hearing loss affected or not by tinnitus, 
demonstrated increased gray matter in the temporal and limbic areas, and decreased 
gray matter in frontal and occipital areas when compared to a control group. In detail, 
analyses of all cortical areas of the tinnitus participants demonstrated an increase of 
gray matter in cerebellum and subcortical auditory nuclei with the most significant 
effect in the left primary auditory cortex when compared to controls and those with 
hearing loss only. On the other hand, people with hearing loss had decreased gray 
matter in frontal areas and increases in limbic areas, compared to controls. These 
findings imply a particular role for the left primary auditory cortex and other non-
auditory brain structures in tinnitus development (Boyen et al., 2013). Another study, 
with a similar design, using diffusion tensor imaging and voxel-based morphometry 
(VBM), found both gray and white matter changes in the auditory cortex of people with 
hearing loss but without tinnitus, compared to people with tinnitus and controls. Thus, 
the authors concluded that hearing loss rather than tinnitus was associated with the 
observed changes (Husain et al., 2011). A large-scale study examining VBM and surface-
based morphometry changes in brain anatomy from 128 participants with tinnitus and 
hearing loss, tinnitus with clinically normal hearing, and non-tinnitus controls with 
clinically normal hearing managed to replicate some of the morphological differences 
that had been reported in previous studies, but found other differences that 
contradicted previous results (Allan et al., 2016). The variability of morphometry results 
obtained by different teams and by different analysis methods is confusing. It perhaps 
indicates the need for greater standardization in study design, and in analysis 
techniques, as well as more precise subtyping of the condition. 
Theories and models of tinnitus pathophysiology 
A recent report supports the notion that tinnitus is not associated with increased 
metabolic activity in localized auditory regions (Geven et al., 2014), but rather with 
neural synchrony between different cortical networks (Noreña and Farley, 2013;Sedley 
et al., 2015), including the thalamus (Eggermont, 2013;Husain and Schmidt, 2014). 
Oscillatory activity within large neuronal ensembles is one method for measuring neural 
synchrony in the human brain. The power of the oscillatory activity can be separated 
into different frequency bands, the premise being that these reflect different functional 
processes. A steep audiometric edge between regions of normal and impaired hearing 
may be sufficient to disrupt the normal pattern of neural synchrony in tonotopically 
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organized regions of the central auditory system. De Ridder et al. (2015) have observed 
that oscillatory activity in the gamma frequency band usually appears bilaterally in 
tinnitus patients and they have proposed this to be the substrate of tinnitus. However, 
the evidence only partially supports this model because there are a number of 
methodological issues that complicate the attribution of findings to the tinnitus versus 
the hearing loss (Adjamian et al., 2012). With respect to this edge region, some studies 
have found tinnitus-related changes in the magnitude of the oscillatory power in 
delta/theta frequency bands (1-4/4-8 Hz), as well as in alpha (8-12 Hz) and gamma 
(>30Hz) frequency bands (Eggermont and Tass, 2015). These authors observed tinnitus-
related low-frequency delta oscillation that are hypothesized to originate from the 
thalamus low frequency bursting (Sedley et al., 2015). The delta activity extended 
beyond auditory cortex to the temporal, parietal, sensorimotor and limbic cortices. The 
diffuse distribution of activity was too extensive to be consistent with the putative "edge 
effect" theory. Rather, delta frequency band activity has been found to interact with 
alpha, beta and gamma frequency band activities in specialized brain regions such as 
parahippocampal and inferior parietal regions. And this has been proposed as a 
neurophysiological correlate of the network-based interactions between tinnitus 
perception and memory processes. In line with further development of the 
synchronicity model, Schlee and others investigated the correlation between chronic 
tinnitus and cortical activity in the alpha frequency range (Schlee et al., 2014). The 
authors confirmed the reduction of alpha power and auditory alpha variability in the 
tinnitus brain. According to their conclusions, changes in alpha power reflect the 
enhanced and reduced excitability of engaged neuronal networks (Schlee et al., 2014).  
Overall, these results suggest a role for neural synchrony both for establishing 
pathological activity within the auditory cortex and for recruiting extra-auditory 
networks in tinnitus. However, the precise details of these mechanisms warrant further 
attention. 
De Ridder and collaborators proposed a pathophysiological framework that 
involves deafferentation and the concept of dysfunctional noise-canceling tinnitus can 
be defined as a result of activity of and connectivity between multiple, parallel 
subnetworks, (De Ridder et al., 2014) (Figure 2.2-2). Such subnetworks could be 
responsible for encoding specific tinnitus characteristics. The model includes the brain 
areas directly associated with the perception of tinnitus and the areas that are essential 
for the affected person to perceive tinnitus as an external sound source. The inferior 
parietal-ventrolateral prefrontal cortex-auditory cortex participate in retrieving a sound 
from memory and in the auditory awareness. The core tinnitus subnetwork can be 
defined as simultaneously activated brain areas necessary to perceive tinnitus, devoid 
of its affective components. Because of communication within the core tinnitus 
subnetwork, the affected brain areas undergo adaptation process, possibly mediated by 
neuronal synchrony (De Ridder et al., 2014).  
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Recently, Sedley and collaborators proposed another framework to explain 
tinnitus pathophysiology from the ear to the cortex (Sedley et al., 2016). That model 
assumes a so-called predictive coding model, in which spontaneous activity of the 
auditory subcortex involves ‘tinnitus precursor’, which is normally ignored against the 
prevailing percept of ‘silence’ (Figure 2.2-2). This model explains the simple and unitary 
content of tinnitus. The sensory precision tinnitus model comprises causes of 
spontaneous sensory input and their graded processing in a predictive coding 
framework.  
The broader framework is equally applicable to other conditions similar to 
tinnitus, such as chronic nociceptive pain. Nevertheless, some types of  pain such as 
central post-stroke pain,  cannot be  explained by this framework (Klit et al., 2009). 
There are a number of psychological models of tinnitus. The neurophysiological 
model (Jastreboff, 1990) proposes that fear is a conditioned responses that is 
responsible for generating a bothersome tinnitus (Jastreboff and Hazell, 1993). The 
neurophysiological model draws on behavioral psychology and has the following stages: 
(1) generation of the tinnitus-initiating signal in the peripheric auditory system; (2) 
detection of the neuronal activity induced by tinnitus; (3) perceptional evaluation of 
tinnitus. Husain proposed a neuropsychological model that includes the regions and 
connections involved in mediating chronic tinnitus (Husain, 2016). The brain regions 
identified incorporate the neuropsychological (Jastreboff, 1990; Kaltenbach, 2006; 
Eggermont and Roberts, 2012) and psychological (e.g. Sweetow, 1986; Hallam et al., 
1988) components of tinnitus. This model differs from those already existing in that it 
uses MRI evidence to explain habituation to tinnitus. The model predicts a key role of 
the amygdala in a severe, non-habituated tinnitus. The frontal cortex becomes more 
engaged in subjects with mild, habituated tinnitus, and this may facilitate bypassing the 
emotional processing from the amygdala and the use of alternate limbic pathways 
involving the insula and parahippocampus gyrus (Husain, 2016).  
Tinnitus models that are influenced by the cognitive psychology movement 
include the cognitive behavioral model (McKenna et al., 2014) and fear-avoidance model 
(Cima, 2018). Both of these seek to explain the causes and chronicity of tinnitus-related 
distress from a cognitive perspective, and both offer an integrative approach that could 
shed insights on higher-order pathological processes of tinnitus-related distress.  
Conclusions 
Significant advances in understanding the molecular, cellular and system-level 
mechanisms of tinnitus have been made in the last decade. Although tinnitus may be 
induced by a peripheral insult, the tinnitus generators are found mainly centrally, in and 
around the primary auditory cortex as well as in many non-auditory higher-order 
processing centers.  Reduced input to the auditory nerve shifts the balance of central 
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excitation and inhibition, and this may lead to hyperactivity, increased bursting activity 
and increased synchrony. This view is consistent with the multifactorial nature of 
tinnitus, which involves  auditory, attentional, memory and emotional systems 
(Kaltenbach, 2011).  
The current view on tinnitus therefore is that it is a symptom encompassing a 
distributed network across the peripheral and central auditory system. Many studies 
would indicate that the restoration of cochlear output to the brain should also abolish 
tinnitus. Preliminary evidence reporting benefit from hearing aids and cochlear implants 
for tinnitus support this view. 
Recent novel findings may open perspectives for new therapeutic approaches on 
molecular level (e.g. intracochlear application of NMDA antagonists, modulation of 
microtubule associated proteins molecular pathway, GABA modulation); on a systemic 
level (behavioral strategies, transcranial magnetic stimulation); “hybrid” solutions that 
would involve synergistic action of pharmacotherapy and Vagal Nerve Stimulation (Bojic 
et al., 2017) and lastly the intracochlear pharmacological interventions supported by a 
nonspecific, mostly anxiolytic pharmacotherapy (Guitton, 2012). Factors that determine 
the phase of tinnitus pathophysiological evolution (initiation or maintenance), the level 
(molecular or systemic), the mechanism (neurotransmission or neuromodulation) 
(Guitton, 2012) will in the future determine the therapeutic approach. The therapy of 
tinnitus will have to be strictly individualized, with an assessment protocol that would 
define tinnitus in the sense of the phase (chronicity), level of lesion (peripheral or 
central) and whenever possible – the mechanism of tinnitus maintenance. This approach 
in tinnitus evaluation will engage specific multidisciplinary teams whose collaboration 
will have as a center the subjective wellness and improvement of tinnitus patients.  
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2.3. Tinnitus in adults, a health problem, implications for the patients 
and clinicians 
2.3.1.  Symptoms, causes and global burden 
Tinnitus is a symptom that comprises the perception of a sound in the ears or 
head, without a corresponding external acoustic stimulus. The percept can be a simple 
sound like hissing, sizzling, or ringing, or a complex composite of sounds, or multiple 
separate sounds (Baguley, McFerran, & Hall, 2013).  
Tinnitus can cause significant emotional reactions to it and negatively impact the 
quality of life of the affected person. Clinicians talk about habituation to tinnitus so that 
over time symptom severity tends to diminish (Cima, Crombez, & Vlaeyen, 2011a). 
Indeed, a systematic review that pooled outcomes for ‘no-intervention’ controls across 
a number of randomized controlled trials also confirmed a small but consistent 
reduction in symptom severity (Phillips, McFerran, Hall, & Hoare, 2018). Those 
individuals who do remain disturbed by their tinnitus over the longer term may be those 
with some additional comorbidity such as generalized anxiety, depression, hyperacusis, 
headache, and vertigo, which may make the individual more prone to focus attention 
on their tinnitus symptoms (Cima, Vlaeyen, Maes, Joore, & Anteunis, 2011b; Dobie, 
2003; Holgers, Zöger, & Svedlund, 2005; Kennedy, Wilson, & Stephens, 2004; Møller, 
2003).  
Tinnitus can also be categorized according to its duration as acute (duration 
inferior to 6 months) or chronic (if tinnitus lasts longer than six months) (Tunkel et al., 
2014). It is believed that chronic tinnitus may be related to somatosensory 
manifestations (Kennedy et al., 2004) and related to a decrease in alfa neuronal activity 
in the temporal areas of the brain (Schlee, Herrmann, Pryss, Reichert, & Langguth, 2014).  
There are two broad categories of tinnitus; objective and subjective (can not be 
heard by others). Objective tinnitus can be audible by others and, account for less than 
1% of all cases, mainly originates from vascular or muscular problems in the vicinity of 
the ear or in the head and neck (Folmer, Martin, & Shi, 2004; Sismanis, 2003). Tinnitus 
can be pulsatile and if it is synchronous with the heart beat then a vascular pathology 
might be suspected. In particular, when there is a unilateral pulsatile tinnitus that is 
synchronous with the heart beat then there is an 80% higher probability that the origin 
is a vascular loop adjacent to the VIIIth cranial nerve (Chadha & Weiner, 2008).  
In the majority of cases, tinnitus is subjective because it is audible only by the 
person affected. Subjective tinnitus can be associated with a variety of medical 
conditions, both otological and non-otological (Martines et al., 2010a; Martines, 
Bentivegna, Martines, Sciacca, & Martinciglio, 2010b, 2010c). For example, a low 
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frequency tinnitus is most typical of Ménière’s disease (Havia, Kentala, & Pyykkö, 2002). 
However, nearly 30% of all tinnitus cases are considered to be idiopathic (Martines et 
al., 2010a,b,c). Tinnitus etiology can be multifactorial and complex, and given it is often 
of gradual onset, even careful medical history taking cannot always identify a cause. 
Epidemiological case control studies confirm hearing loss and ageing (Hoffman & 
Reed, 2004), noise exposure (Nondahl et al., 2002; Shargorodsky, Curhan, & Farwell, 
2010; Sindhusake et al., 2003) exposure to ototoxic medication (Cianfrone et al., 2011; 
Seligmann, Podoshin, Ben-David, Fradis, & Goldsher, 1996) and depression (Zeman, 
Koller, Langguth, & Landgrebe, 2004) as some of the most common risk factors. Nearly 
40% of people with tinnitus also report some degree of sound intolerance (hyperacusis) 
(Anari, Axelsson, Eliasson, & Magnusson, 1999), but whether there is a 
pathophysiological link between these two conditions remains unknown. Other known 
associations include sleeping problems (Alster, Shemesh, Ornan, & Attias, 1993; 
Crönlein, Langguth, Geisler, & Hajak, 2007; Fioretti, Fusetti, & Eibenstein, 2013), head 
or neck injury (Kreuzer, Landgrebe, Schecklmann, Staudinger, & Langguth, 2012), 
emotional exhaustion (Hébert, Canlon, & Hasson, 2012), anxiety, irritation and 
frustration (Zeman et al., 2014). For some authors tinnitus is regarded as the result of 
chronic stress and related immune response (Szczepek & Mazurek, 2017). 
With respect to hearing loss, associations are more than simply having both 
conditions. When a hearing loss is present, the tinnitus frequency usually matches the 
region of greatest threshold losses, especially in the case of down-sloping SNHLprofiles 
(Schecklmann et al., 2012). Nevertheless, not everyone with a hearing loss has tinnitus, 
and some people with tinnitus have a normal clinical audiometric profile. 
It is widely posited that if prognostic indicators and clinically meaningful 
subtypes or profiles of tinnitus could be identified then this would be an effective 
approach to reducing the variable responsiveness to the different management options 
currently available. However, pathophysiological mechanisms underlying tinnitus are so 
far elusive and so, without this basic biological understanding and the identification of 
tinnitus biomarkers, these goals have not yet been achieved. 
It is estimated that one in ten people have tinnitus, and so the global burden of 
tinnitus is very high (Bhatt, Lin, & Bhattacharyya, 2016). Information about the 
prevalence of tinnitus is rather patchy. A recent systematic review of adults (aged 18 
years or more) found that global prevalence ranged from 1.5 to 42.7% (McCormack, 
Edmondson-Jones, Somerset, & Hall, 2016). But many of these studies defined tinnitus 
in slightly different ways and so this may explain the wide range. For those population-
based studies which used the same tinnitus definition, prevalence rate was somewhat 
narrower (11.9 to 30.3%). Examining the study information indicated that prevalence 
increased with age, and was also slightly higher for men than for women, but this may 
be explained by occupational rather than biological differences between the sexes.  
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A large American cross-sectional study found that 21.4 million people have 
tinnitus, and of those 36% experience constant tinnitus, 15% experienced tinnitus at 
least once every day and 49% at least once a week (Bhatt et al., 2016). Concerning 
tinnitus symptom severity, 7.2% described their condition as a ‘big or very big problem’, 
20.2% as a ‘moderate problem’, and 72.6% as ‘not a bothersome problem’ (Bhatt et al., 
2016). The Tinnitus Functional Index (Meikle et al., 2012) is an instrument that can be 
used as a diagnostic tool to grade overall symptom severity and this has five category 
levels from ‘very big problem’ to ‘not a problem’. 
The majority of individuals with tinnitus do not report major discomfort, and 
learn or finding strategies quickly to live with their tinnitus, ignore it or become 
habituated to it (Cima et al., 2011a). When tinnitus becomes uncomfortable this is 
mainly due because the presence of other factors or comorbidities interfering with the 
daily life of the patient, directing excessive attention to the tinnitus, interfering with 
sleep, disturbing concentration and work (Cima et al., 2011b; Dobie, 2003). The 
characteristics of the personality of the person, as well as the effectiveness of their 
coping strategies, allow us to understand how they will react to the presence of tinnitus, 
and how they will deal with the emotional aspects that underlie them (Vallianatou, 
Christodoulou, Nestoros, & Helidonis, 2001). The particularity of the psychological 
aspects related to the presence of tinnitus may contribute to the variability of the 
reactions described by individuals with tinnitus (Cima et al., 2011b). This is reflected in 
a higher prevalence of somatic disorders, depression, anxiety, phobias, psychoticism 
and hostility in people who report tinnitus (Oliveira & Trigueiros, 2002). 
Results from the most recent World Health Organization (WHO) Global Burden 
of Diseases (2015) reports hearing loss as the fourth leading cause of years lived with 
disability. Given the strong links between hearing loss and tinnitus, then tinnitus surely 
follows this trend. It has been recognized that the economic burden to society is high 
compared to some other chronic conditions. For example, a large prospective Swedish 
cohort study found that sickness absence at work due to tinnitus and hearing loss 
increased the risk of future claims for disability pension by three times compared to non-
audiological diagnoses (Friberg, Jansson, Mittendorfer-Rutz, Rosenhall, & Alexanderson, 
2012). Furthermore, tinnitus is the most common complaint in modern warfare. For 
example, the annual disability compensation paid by US department of Veteran’s Affairs 
for tinnitus and hearing loss exceeds $2 billion USD (Yankaskas, 2011). 
2.3.2. Diagnosis 
Several studies compare tinnitus to chronic pain, some common complaints are 
present in both of them, such as sleep disturbances, depression and/or anxiety, high 
levels of hypochondria and obsessive-compulsive disturbances, coping strategies poorly 
adjusted, reflecting difficulties in controlling the tinnitus percept and daily life activities. 
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Among patients suffering from chronic pain tinnitus is a prevalent complaint, although 
usually not disturbing (Cima et al., 2011b). 
 Tinnitus can be a symptom of many diseases, the generalized lack of knowledge 
regarding those impairs standardization of diagnosis assessment (Figure 2.3-1). It is 
important to highlight that the sooner a diagnosis is reached the better the prognosis 
for treatment effectiveness (Herraiz, 2008). Nevertheless, the advised therapy should 
be chosen according to the tinnitus impact on patient’s life (Grewal, Spielmann, Jones, 
& Hussain, 2014). To inform a patient that there is “nothing can be done” regarding his 
problem or that they have to “learn to live with it”, is inappropriate and risks making 
tinnitus an even greater problem for the patient (Newman et al., 2011). 
Figure 2.3-1 - Diagnosis and treatment of tinnitus. 
(TRI Tinnitus Clinic Network (2009) – “TRI Flowchart for Patient Management". Tinnitus Research 
Initiative).  
2.3.2.1. Clinical history and Questionnaires 
Because there is not an objective and strict method for tinnitus evaluation we 
have to rely on patient’s collaboration, their description and information (Baguley et al., 
2013).The methodology applied to tinnitus diagnosis involves a detailed anamnesis 
enquiring about associated or triggering factors and comorbidities. It is important to ask 
questions about the patient’s lifestyle regarding noise exposure, at work or for leisure. 
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It is also important to evaluate other symptoms that may be related to tinnitus such as 
hearing loss, difficulties in speech discrimination, dizziness, hyperacusis, headaches, 
sleeping disturbances, etc.  Paying attention to the patient, trying to better understand 
their problem, is not only important for an accurate diagnosis, but may also facilitate 
counselling (Langguth, Kreuzer, Kleinjung, & De Ridder, 2013). A complete ENT 
observation and head and neck auscultation should always be performed in cases of 
pulsatile tinnitus. Tinnitus intensity modulation according to certain neck or 
temporomandibular joint movements should also be evaluated. To evaluate the impact 
of tinnitus on patient’s life it is recommended to use questionnaires (e.g. Tinnitus 
Handicap Inventory, Tinnitus Functional Index), although they may retain some bias 
inherent to the formulation of the questions (Møller, 2016). There are no studies 
establishing correlations between these questionnaires and tinnitus intensity or 
discomfort (Hiller & Goebel, 2006), so there is a strong emotional component to the 
clinical evaluation (Jastreboff, 1990; Li, Gu, & Zeng, 2015). 
2.3.2.2. Audiological evaluation 
In addition to standard tonal audiometry, high frequencies audiometry, and 
speech audiometry, audiological evaluation includes the tympanogram. Tympanometry 
is important to discard tympanic membrane or ossicular chain alterations, or auditory 
tube dysfunctions, that may originate be responsible for tinnitus (Ambrosetti & Del Bo, 
2011). Stapedius reflex evaluation, in cases of intermittent or pulsatile tinnitus, may be 
indicative of dysfunctions, particularly of the stapedius muscle (Levine, 2013). 
Psychoacoustic measurements inform us about the tinnitus type of sound, 
duration, loudness, pitch, minimum masking level (Van de Heyning, Gilles, Rabau, & Van 
Rompaey, 2015) and residual inhibition (Ambrosetti & Del Bo, 2011). This allows the 
patient to identify among the offered sounds, which corresponds to their tinnitus 
(Langguth et al., 2013). However, this type of measurement lacks objectivity and 
consistency, especially in cases where tinnitus involves complex sounds, is changeable 
in time, or is fluctuating (Ambrosetti & Del Bo, 2011; Baguley et al., 2013). It is also 
important to evaluate the presence of hyperacusis, or generalized oversensitivity for 
sounds, characterized by loudness discomfort levels below normal (Ambrosetti & Del 
Bo, 2011). 
2.3.2.3. Otoneurolgic and neurophisiologic assessment  
Other exams that are usually included in tinnitus diagnosis include auditory 
brainstem evoked response (ABR) and OAE. Through the evaluation of the latencies and 
peaks of several waves, ABR verifys the integrity of central auditory pathways, providing 
information about the location of pathology in the cochlea or retro cochlear. If the result 
is normal it is possible to assure the patient that there no tumors of the auditory 
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pathways. This is useful both for diagnosis and therapy because it is common that 
tinnitus patients, at the initial phase of the complaints, are worried about the possibility 
of having a tumor. Reassuring the patient regarding this fear will reduce levels of anxiety 
(Vallianatou et al., 2001). The distortion products of OAE evaluate the functioning of the 
ciliated OHC, and understand determines if are there any lesions at specific cochlear 
areas This evaluation is particularly important for patients without hearing loss detected 
by tonal audiometry, according to the theory of cochlea’s ciliated cells discordant 
functioning (Ambrosetti & Del Bo, 2011). 
Imaging techniques are useful in some clinical cases such as tumoral, 
inflammatory or infectious pathology. These can be essential for certain specific 
therapies in identification of underlying cause. Human imaging studies have given 
important contributions for the identification of brain centres involved in tinnitus 
pathogenesis (Adjamian, Sereda, & Hall, 2009) (figure 2.3-2). 
 
 
 
 
 
 
 
 
 
 
Figure 2.3-2 - Principal structures of the limbic system involved in the pathophysiology of 
tinnitus, identified through imaging.  
(Adjamian, Sereda, & Hall, 2009).  
 
2.3.2.4. Difficulties in tinnitus diagnosis  
There are several strategies for tinnitus management among multidisciplinary 
teams of health professionals (Hall, Szczepek, Kennedy, & Haider, 2015). For this reason, 
there is often a lack of communication between and within the health professional 
teams. The inexistence of standardization has hampered the development of large scale 
randomized clinical trials and scientific evidence (Møller, 2007). In fact, the absence of 
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standardized methodologies for tinnitus diagnosis and treatment prevents meta-
analysis that are necessary for the interpretation of large databases (Ward, Vella, Hoare, 
& Hall, 2015), and would be very helpful in the realization of more effective tinnitus 
clinical interventions. The COMiT (Core Outcome Measures in Tinnitus) initiative (a 
subgroup of experts from TINNET WG5 dedicated to the definition of Core Outcomes 
Set (COS) for tinnitus) published two systematic reviews for the identification of clinical 
outcomes domains, one from the patient perspective (Hall et al., 2016) and the other 
from existing randomized clinical trials on treatment effectiveness for tinnitus (DOI 
10.1186/s13063-016-1399-9). Furthermore, and in accordance to COMET (Core 
Outcome Measures in Effectiveness Trials) Initiative recommendations (Kirkham et al., 
2016), three internet-based Delphi rounds for the definition of core outcome sets (COS), 
the minimum reporting standard for outcomes to be assessed and reported in all clinical 
trials, in accordance to at final face-to-face meetings for sound-, psychology-, and 
pharmacology-based interventions to manage chronic subjective tinnitus in adults, were 
conducted (Hall et al., 2015). Fuller, Haider et al. (2017) published a systematic review 
of existing tinnitus guidelines. Reviewing five guidelines for the management and 
treatment of subjective tinnitus they discriminate fundamental parameters: clinical 
history, patient’s observation, audiological evaluation, evaluation of how bothersome is 
tinnitus using a validated questionnaire or visual analogue scale, referral to mental 
health in cases of elevated tinnitus-related distress, and performance of imaging studies 
in selected cases.  
2.3.3. Treatment 
The shortage of scientific knowledge regarding tinnitus pathophysiology is one 
of the main obstacles for the achievement of more effective tinnitus therapies (Lee et 
al., 2014). There is no cure for subjective tinnitus and most of the existing therapeutic 
options are focused on the management of tinnitus collateral effects without truly 
reducing tinnitus perception (Cima, Andersson, Schmidt, & Henry, 2014; Hall et al., 2011; 
Tyler, 2012). Example of treatment include therapies for temporomandibular joint 
pathology, miofascial trigger points, dental treatments, chiropractors, muscle  
relaxation, electric stimulation, some pharmacotherapies for anxiety or depression, 
surgery and CBT (train, habituation and counselling). Nevertheless, and besides the 
apparently high diversity of therapeutic options, there is scarce scientific evidence of 
their effectiveness, which may exacerbate symptoms of distress and depression in 
tinnitus patients (Tyler, 2012). At the same time, 2110 dollars per chronic tinnitus 
patient is spente annually in healthcare management, unfortunately in most of the cases 
without therapeutic success (Goldstein et al., 2015). 
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2.3.3.1. Drugs therapy 
There are no drugs approved by any regulatory agency of medical drugs as 
specific for tinnitus, which would probably be the patient’s first and ‘easy’ choice. 
Nevertheless, it is predictable that such drugs under research would be based on 
antagonists of NMDA receptors (e. g. dopamine, GABA and encephalines) applied in the 
tympanic cavity (through the tympanic window) in order to stabilize synaptic activity 
and reduce excitotoxicity at primary auditory neurons (Puel, 1995; Ruel et al., 2001). 
Notably, some medical drugs can alleviate some symptoms associated to tinnitus 
such as dizziness, depression, anxiety and sleep disturbances (Hall et al., 2011). 
2.3.3.2. Acoustic therapy e Auditory stimulation 
Acoustic therapy, initially proposed by Vernon in 1976, allows the patient to have 
tinnitus control, promotes habituation and distraction, neutralizes the threat and fear 
related to the presence of an unknown sound, and may contribute to reorganization of 
CANS through neural plasticity (Newman et al., 2011). Equipment includes 
electroacoustic hearing aids (amplification of environmental sounds masks the tinnitus), 
noise generators (initially white noise and more recently noise bands in frequencies that 
promote a more effective masking, adjusted by audiologists using some filters), or 
systems combining hearing aids to noise generator (when it is necessary to have both 
hearing rehabilitation and tinnitus treatment). The option is defined by the existence of 
and type of hearing loss (Del-Bo, Baracca, Forti, & Norena, 2011). Electroacoustic 
hearing aids have the advantage of improving speech recognition that may be disturbed 
by tinnitus percept. The most recent option includes the open-fit systems that are more 
comfortable and reduce the sense of ear occlusion. This allows better amplification of 
the more highe pitched sounds than other types of electroacoustic hearing aids (Del-Bo 
et al., 2011). Moreover, bilateral equipment fitting represents a significant improvement 
compared to unilateral fitting, and electroacoustic hearing aids using frequential 
transposition systems present better results (Levine, 2013). 
As part of a more recent therapy, the Neuromonics Tinnitus Therapy invovles 
acoustic stimulation is obtained through an instrument similar to MP3, using soft music 
(baroque type or new age) adapted to individual tinnitus frequency spectra, in order to 
compensate for hearing loss in those frequencies areas and reduce the emotional 
component. In preliminary studies better results were reported for Neuromonics than 
stimulation with narrow band sounds (Baguley et al., 2013; Langguth et al., 2013; 
Newman et al., 2011). 
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2.3.3.3. Tinnitus Retraining Therapy 
Tinnitus retraining therapy (TRT) is based in the neurophysiological model of 
tinnitus. Treatment is based on the process of tinnitus habituation, through CNS 
plasticity, and aims to reduce the impact of tinnitus on daily life, and promote 
habituation through reduction of tinnitus intrusiveness (Jastreboff & Jastreboff, 2000; 
Sáez-Jiménez & Herráiz-Puchol, 2006). Treatment involves a series of counselling 
sessions (directive counseling) after patients initial evaluation. The aim of these 
counselling sessions is to eliminate or reduce anxiety or fear reactions. Sound 
generators, hearing aids or background noise are also used to provide the auditory 
systems with constant neutral signs to decrease the strength of tinnitus signal and 
decreases the gain within the auditory pathways (Jastreboff, 2011; Langguth, 2015; 
Hesse, 2016; Shin & Lee, 2016).  Based on a medical evaluation of tinnitus, patients are 
placed into one of five general categories that guide the treatment recommended (Table 
2.3-1) (Jastreboff & Jastreboff, 2000).  
Table 2.3-1 - TRT-Categories of Tinnitus and Hyperacusis patients. 
Category 
Impact 
on life 
Tinnitus 
Subjective 
hearing 
loss 
Hyperacusis 
Prolonged 
sound induced 
exacerbation 
Treatment 
0 Low Present 
Not 
present 
Not present Not present 
Abbreviated version 
of counselling. 
1 High Present 
Not 
relevant 
Not present Not present 
Full counselling and 
sound therapy with 
sound generators 
2 High Present 
Significant 
presence 
Not present Not present 
Full counselling (with 
the stressing matters) 
and sound therapy 
with combination 
instruments 
3 High 
Not 
relevant 
Not 
relevant 
Present Not present 
Full counselling with 
stress issues related 
to hyperacusis and 
sound therapy using 
sounds generators 
and hearing aids 
4 High 
Not 
relevant 
Not 
relevant 
Present Present 
Full counselling, 
sound therapy with 
sound generators set 
at the threshold. 
 
There is direct involvement of the patient in these sessions, explaining and 
demystifying the tinnitus, often using illustrative support material (Jastreboff & Hazell, 
2004; Sáez-Jiménez & Herráiz-Puchol, 2006). However, this therapy shows better long-
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term results and is poorly studied (Grewal et al., 2014). A randomized controlled trial 
comparing TRT to Standard Care (SC) for chronic tinnitus concluded that adults with 
moderate to severe tinnitus and hearing loss amenable to amplification, benefited from 
either TRT or SC treatment when combined with hearing aid use. TRT benefit may 
exceed that of SC. The global improvement in tinnitus severity that accrued over an 18-
month period appeared to be robust and clinically significant (Bauer, Berry, & Brozoski, 
2017). TRT is also used to treat hyperacusis, through sound desensitization (Jastreboff 
and Jastreboff, 2000; Vernon and Press, 1998). Hyperacusis is a common symptom 
accompanying tinnitus, and results from enhanced functional gain at auditory pathway 
(Bartnik & Skarżyńsky, 2005). 
 
2.3.3.4. Surgical treatment 
There may also be surgical options for tinnitus. An example of this is the case of 
stapedectomy or stapedotomy in patients with otosclerosis which may improve 
moderate or severe subjective tinnitus (Chang & Cheung, 2014). In cases of vascular-
nervous compression, microvascular decompression in the initial stages of tinnitus up 
to the fourth year may be beneficial (De Ridder et al., 2010). Gritsenko, Caldwell, 
Shaparin, Vydyanathan, & Kosharskyy, (2014) describe a clinical case of a 65-year-old 
patient with left cervical pain and homolateral tinnitus who referred with ablation of the 
medial (C2-C3) branches of the dorsal branch on the side where the patient felt tinnitus. 
Cochlear implants may be indicated for tinnitus with severe or profound SNHL, 
especially for older patients (Kim et al., 2013). Brainstem auditory implants, especially 
for individuals who have had both VIII cranial nerves destroyed by trauma or bilateral 
schwannomas, have also been showed to reduce the intensity of tinnitus (Kaltenbach, 
2006). However, the use of these devices is not free of drawbacks, inherent to their 
economic value, surgical risk and possible loss of any residual function in the affected 
ear (Kim et al., 2013). Because tinnitus is often associated with hearing loss at high 
frequencies, middle ear implants can also be an alternative as they achieve greater 
acoustic gains directly in the cochlea in this frequency region, promoting relief in the 
perception of tinnitus (Biesinger & Mazzoli, 2011). In cases of unilateral hearing loss 
bone-anchored-hearing-aids can be a useful solution. On the other hand, Zenner and 
colleagues (2016) reviewed the literature on these devices, and found poor evidence of 
their success in the treatment of chronic tinnitus due to inconsistent methodologies of 
studies and sample sizes. 
The use of low-intensity laser therapy, with commercially available equipment, 
which has one hundredth the power of lasers used in surgery, has been used to 
accelerate the recovery of peripheral nerve lesions, soft tissue lesions and to reduce 
inflammatory processes and pain (Baguley et al., 2013; Kleinjung, 2011). However, so far 
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the results of the clinical investigation does support the use of laser therapy, although 
this therapy has been used for about 20 years in patients with tinnitus (Kleinjung, 2011). 
2.3.3.5. Physiotherapy Treatments 
In this therapeutic modality we can consider therapies for the treatment of 
diseases of the temporo-mandibular joint, myofascial trigger points, dental treatments, 
chiropractic and muscle relaxation of the head and neck chains. Many of these options 
may be effective in controlling somatosensory tinnitus, especially if it is of mild-
moderate intensity. 
There is intense debate about the efficacy of cervical spine therapy, which is 
defined by Michiels and colleagues (2015) but contested by Bhatt and colleagues (2015). 
It is expected that new scientific studies can deepen the relevance of this form of 
treatment for chronic subjective tinnitus. 
Functional dental therapy was also recommended for the treatment of chronic 
tinnitus by Buergers and colleagues (2014). 
 
2.3.3.6. Psychological treatment and Cognitive Behavioral Therapy 
More recently, the first tests were designed to treat tinnitus through virtual 
reality immersion (3D auditory and visual environments), with a success rate equivalent 
to cognitive therapies. In this case, virtual reality seems to regulate neural plasticity 
(Malinvaud et al., 2016) 
Patients with decompensated chronic tinnitus, particularly subjective tinnitus, 
present a high discomfort and very high comorbidities with psychological or psychiatric 
alterations. Hence their evaluation and immediate interventional response should be 
considered, including by a mental health professional (D'Amelio, Archonti, Falkai, 
Plinkert, & Delb, 2004).  
The main purpose of psychological therapy in tinnitus is to reduce the negative 
impact on the individual's life by acting on the negative thoughts or cognitive distortions 
associated with to tinnitus (Searchfield, Magnusson, Shakes, Biesinger, & Kong, 2011). 
The therapist and patient work together in a way to identify these cognitive distortions 
for the patient to construct a more logical and rational meaning, reducing the 
occurrence and level of discomfort associated with them, in a counseling process. 
CBT based on methods of psychology, are defended as therapeutic options 
referred to by several authors and recently, strong scientific evidence (Cima et al., 2014). 
The CBT approach intends to reduce patient’s emotions regarding his tinnitus, improving 
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daily life. Because this therapy does not focus on tinnitus pathophysiology it does not 
reduce the intensity of tinnitus (Grewal et al., 2014), but it is highly recommended to 
control tinnitus related distress and anxiety (Cima et al., 2014). This effect persists long 
term (Goebel, Kahl, Arnold, & Fichter, 2006). CBT is based in cognitive restructuring and 
behavioral modification, including mechanisms of physichopsycho-education, 
relaxation, mindfulness training and control of attention techniques (Langguth et al., 
2013). Because this modality has many dropouts, an internet-based model of self-help 
CBT was created. It is known that many tinnitus patients perform internet searches in 
attempts to get information. It has been found a significant improvement at 3 months 
follow-up of this self-help modality (Andersson & Kaldo, 2005). 
Although reported since the 1980’s, ‘mindfulness-based therapies’ have only 
recently been actively applied to tinnitus treatment, especially for chronic tinnitus 
(Ludwig & Kabat-Zinn, 2008). It is one of the sub-categories of behavioral therapies that 
intends to manage negative feelings, stress and anxiety in tinnitus patients. In parallel, 
acceptance and commitment therapy has already given the first steps, always in 
connection with other behavioral therapies. Both reveal a strong potential in chronic 
tinnitus treatment (Cima et al., 2014), nevertheless there are still no comparative studies 
and standardized methodologies for a systematic evaluation of these therapies. In fact, 
there are still no systematic comparative studies among several therapies of 
psychological counselling (Zenner et al., 2016). There is an urgent need for 
standardization of assessment methodology to allow progression of studies (Grewal et 
al., 2014). The same is said for acoustic therapies (with sound or music) (Zenner et al., 
2016). 
2.3.3.7. Transcranial Magnetic Stimulation  
One of the oldest tinnitus therapies is based on electrical stimulation. Besides 
the persisting droughts regarding its efficiency it has been used regularly for tinnitus 
suppression since the 1960’s (Lee et al., 2014). This method seems to present higher 
success rate for low frequency type of tinnitus and when there is moderate hearing loss 
(Lee et al., 2014). Repetitive transcranianal magnetic stimulation has been a 
therapeutically option for chronic tinnitus (Figure 2.3-3), regardless of tinnitus location 
or psychological patient’s status (Rossi et al., 2007). This is less painful than electrical 
transcranianal stimulation (Kleinjung, Steffens, Londero, & Langguth, 2007). However, 
the information regarding long-term results is scarce (Lehner et al., 2015). The placebo 
effect of this therapy still confuses the researchers (Rossi et al., 2007). On the other 
hand, recent studies failed to present benefic results for subjective chronic tinnitus 
patients. Hence most recent tinnitus guidelines recommend against this treatment 
modality (Tunkel et al., 2014). 
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Figure 2.3-3 - Transcranial Magnetic Stimulation in a patient with chronic tinnitus compared to 
a control group.  
(Schecklmann et al., 2015) 
 
 
Final Considerations 
 
It is common to use distraction strategies and techniques of attention control in 
these patients, as well as relaxation training, in order to reduce the excessive attention 
that patient pays to tinnitus and help him to focus and concentrate in other activities. 
This includes strategies of sound enrichment complemented by other therapeutic 
procedures (Greimel & Kröner-Herwig, 2011). 
Fuller and collaborators presented in their systematic review, six proposals of 
shared therapies from the analyzed tinnitus guidelines (Fuller, Haider et al., 2017). 
Overall, patients should have access to the information regarding available therapeutic 
options; the use of hearing aids can improve tinnitus in patients with hearing loss and 
cognitive behavioral therapies are useful. Moreover, there is still controversy regarding 
the efficacy of TRT. It is agreed that drugs are ineffective for tinnitus, except for the 
treatment of accompanying comorbidities such as anxiety or depression. In summary, 
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treatment goals should be realistic in order to prevent feelings of disappointment and 
depression in patients, whose own coping skills regarding tinnitus certainly influence the 
treatment outcome (Møller, 2016). 
Due to the huge diversity of tinnitus etiologies it is important to appropriately 
perform clinical meaningful tinnitus subtyping, in order to identify potential treatable 
causes and obtain the appropriate tinnitus management for each patient. In order to 
perform this task multidisciplinary guidelines for tinnitus diagnosis and treatment are 
essential. 
The assessment of the individual with tinnitus and therapy strategies should be 
multidisciplinary to ensure coverage of all dimensions of the patient. Moreover, 
therapeutic strategies should be tailored to the individual, after proper information and 
with respect for patient choice and individual needs. 
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3. Objectives 
3.1. General Objective  
This study aims to evaluate the contribution of inflammatory, immunological or 
genetic factors in the etiology of tinnitus in patients with or without hearing loss. 
3.2. Specific Objective    
 
 To evaluate the existence of differences in the tonal and vocal audiogram 
in the four subgroups (according to having or not tinnitus and hearing 
loss).  
 To determine by auditory brainstem responses distinctive factors in the 
subgroups. 
 To determine by distortion product otoacoustic emissions distinctive 
factors in the subgroups. 
 To evaluate the quality of life of these subgroups (using MOS SF-36, and 
in tinnitus groups THI). 
 To assess the susceptibility to anxiety and/or depression (BSI). 
 To evaluate in the peripheral blood parameters of inflammation and 
immunity (HSP-70, IL1-alfa, IL1-beta, IL2, IL-6, IL10, TNFalfa, IFNgamma e 
TGFbeta) in the subgroups. 
 To determine the correlation between phenotype and genotype (NAT2 
and GRM7). 
 
4. Methods 
4.1. Ethic Commission and National Committee for Personal Data 
Protection 
The study was drafted in accordance with the Declaration of Helsinki for the 
Protection of Human Subjects, one of the principles of medical research and on the 
evolution of Europe, the World Health Organization and the Community Involves beings, 
as well as the constant DL 43/04 of 19 August, DR I Series. 
The study protocol was approved by the Ethics Committees of the Hospital Cuf 
Infante Santo and Faculty of Medical Sciences of the New University of Lisbon (number: 
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65/2014/CEFCM) (Appendix I and II). All participants signed the Informed Consent 
(Appendix III). 
The study protocol was approved by the National Committee for Personal Data 
Protection (number: CNPP 1637/2016) (Apendix IV). 
4.2. Study methodology 
Transversal cohort study to analyze the etiological factors of tinnitus in a 
population aged between 55 and 75 years, with or without hearing loss. 
4.2.1. Study population and sample size calculation  
The population was composed of individuals between the ages of 55 and 75 
years. Participants were recruited at the ENT consultation of the Hospital Infante Santo 
CUF in the period defined for data collection. 
Due to the complexity of sample size calculation in the presence of several 
primary variables and scarce information regarding the variables (genetic and 
inflammatory parameters) it was decided to perform the calculation using a pilot sample  
involved in the study. Therefore,  the sample size calculation was based on information 
about IL1-alfa, IL1-beta, IL2, IL-6, IL10, TNFalfa, IFNgamma regarding 40 participants, to 
compare groups with tinnitus (n=20) and without tinnitus (n=20). For a power of 80% 
and a significance level of 95% where obtained very high sample sizes (58 to 1240 in 
each group) not being possible to reach it because of time and financial restrictions 
related to the present PhD study. 
The organization of subjects in the sample (n = 114 individuals) was performed 
according to the audiological data being integrated in four separated groups: 
 Subgroup I – composed by individuals without hearing loss and without 
tinnitus (control group); 
 Subgroup II – composed by individuals without hearing loss and with 
tinnitus; 
 Subgroup III – composed by individuals with hearing loss and without 
tinnitus; 
 Subgroup IV – composed by individuals with hearing loss and with 
tinnitus. 
These subgroups allowed the comparison of the presence of tinnitus (subgroup 
II + subgroup IV) with its absence (subgroup I + subgroup III), as well the presence of 
hearing loss (subgroup III + subgroup IV) with its absence (subgroup I + subgroup II).  
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4.2.2.  Inclusion/Exclusion criteria 
We considered in the present study all individuals between the ages of 55 and 
75 years, from Hospital Cuf Infante Santo ENT consultation, where it is expected a 
proportional distribution between sexes. Included volunteers agreed to participate, 
gave written informed consent, and performed all the required tests. Individuals with or 
without hearing loss, with or without tinnitus, who did not have any of the exclusion 
factors were included. For the purposes of inclusion hearing loss was defined as bilateral 
sensorineural deafness in down slope audiometric pattern, above 1000 Hz with poor 
speech discrimination (Speech Recognition Threshold (SRT) > 40 dB SPL and 100% 
discrimination to 60 dB or worse). 
The primary evaluation variable was tinnitus, and the tinnitus participants were 
evaluated by psychoacoustic measurements with an expected tinnitus frequency 
between 2kHz and 16kHz and at any level of sound intensity. 
Exclusion factors included inability to understand and sign the informed consent 
due to a significant cognitive impairment, or uncompensated medical disorder or a 
serious psychiatric disorder that requires urgent medical evaluation. Also, individuals 
over 55 years of age who presented possible factors that may overlap with the study 
variables were excluded, i.e. Ménière’s disease, chronic otitis media, otosclerosis, 
tinnitus from diseases of the outer ear (e. g. occlusive exostosis, outer otitis), history of 
massive ototoxic drugs use, massive noise exposure, a history of previous malignancy 
with chemotherapy, history of autoimmune disorders and neurodegenerative and 
demyelinating diseases. Individuals who did not attend all clinical evaluation visits were 
be excluded from the sample. 
4.2.3. Outcomes variables  
The primary outcome evaluation variable was tinnitus. This study aimed to 
evaluate the contribution of audiological, inflammatory, or genetic factors (secondary 
outcome variables) to the etiology of tinnitus in patients with or without hearing loss 
4.2.4. Study planning and Institutions involved  
The participants were recruited at ENT consultations at the Hospital Cuf Infante 
Santo. 
In the first visit – Screening (S), eligibility was assessed. Before being included in 
the study all participants were given explanation about what the study involved and the 
purpose of the study before signing the Informed Consent. 
Baseline (V0) – this visit took place a few days after screening according to 
participant availability. It involved a detailed clinical history, and characterization of 
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hearing loss and tinnitus (if present: date of beginning of the complaint, if was sudden, 
insidious or gradual) tinnitus characterization (confirm the type (pitch) and number of 
sound perceptions – tonal, noise, pulsatile or other; if loudness is steady or has 
fluctuations; if the location is in one ear, both ears or in the head; if the timing is 
intermittent or continuous), associated factors, and trigger factors. Previous intake of 
ototoxic drugs was recorded (Appendix V). In this visit a complete ENT observation 
(microscopic otoscopy, anterior rhinoscopy, oropharynx and head and neck inspection, 
with stethoscope auscultation in cases of pulsatile tinnitus was performed). 
Also, in this visit participants were asked to complete the Tinnitus Handicap 
Inventory (THI) – Portuguese validate version (only the tinnitus subgroups) (Oliveira & 
Meneses, 2008) (Appendix VI), the Brief Symptom Inventory (BSY) - Portuguese validate 
version (CANAVARRO, 1999) (Appendix VII), and the Portuguese validated version 
Medical Outcomes Study Short Form Health Survey (MOS SF-36) (Ferreira, 2000), 
(Appendix VIII).  
In the same visit tonal audiometry standard and high frequency, speech 
audiometry, auditory brainstem responses and distortion product otoacoustic emissions 
(all subgroups) and psychoacoustic measurements (only the tinnitus subgrups) were 
performed. 
On the same day all participants had peripheral blood sample collection to 
evaluate parameters of inflammation and immunity (HSP-70, IL1-alfa, IL1-beta, IL2, IL-6, 
IL10, TNFalfa, IFNgamma e TGFbeta) and genetic analysis. 
Participants attended a final visit, at the end of the study, in which they were 
informed about the obtained results, and given final recommendations regarding their 
complaints and preventive measures. 
 
This study was realized at Hospital Cuf Infante Santo, in the ENT departament, 
in collaboration with the Immunology and Biostatistics departments of Nova Medical 
School and also BioISI – Biosystems & Integrative Sciences Institute Deafness group from 
Science Faculty of Lisbon University. The genetic parameters were obtained from the 
collaboration with their study ‘Age-related hearing loss: genetic susceptibility and social 
impact’. 
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5. Tinnitus as a health problem 
5.1. Tinnitus in the patient’s perspective  
In our study we have tried to increase knowledge concerning tinnitus while a 
health problem and from the patient’s perspective and their significant others (Haider, 
Fackrell, Kennedy, & Hall, 2016). With this purpose we have performed a systematic 
review that was also included as the initial phase roadmap of the TINNET outcomes 
measures group of TINNET. This work allowed to detail more insights regarding the 
different dimensions of tinnitus symptom and its repercussions on the patient’s daily 
life. With a similar objective another study performed a retrospective qualitative 
analysis anonymized clinical data from patients who attended a UK tinnitus treatment 
centre between 1989 and 2014.  Content analysis was used to code and collate the 
responses of 678 patients to the clinical interview question ‘Why is tinnitus a problem?’ 
into categories of problems (domains). 
The obtained results allowed to define a pool of domains that was the basis for 
developing COS for early-phase clinical trials of sound-, psychology-, and pharmacology-
based interventions to manage chronic subjective tinnitus in adults: the COMIT'ID study 
using a Delphi process and face-to-face meetings to establish consensus (Hall, Smith, 
Heffernan & Fackrell, 2018b; Smith et al., 2018).  
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5.1.1.  Why is Tinnitus a Problem? A Qualitative Analysis of Problems Reported 
by Tinnitus Patients 
Submitted to Trends in Hearing 
 
Emily J. Watts, Kathryn Fackrell, Sandra Smith, Jacqueline Sheldrake, Haúla Haider, 
Derek J. Hoare 
 
Abstract 
 
Objectives 
Tinnitus is a prevalent complaint and people with bothersome tinnitus can report 
any number of associated problems. Yet to date only a few studies, with different 
populations and relatively modest sample sizes, have qualitatively evaluated what those 
problems are. Our primary objective was to determine domains of tinnitus problem 
according to a large clinical dataset.  
Design 
This was a retrospective analysis of anonymised clinical data from patients who 
attended a UK tinnitus treatment centre between 1989 and 2014.  Content analysis was 
used to code and collate the responses of 678 patients to the clinical interview question 
‘Why is tinnitus a problem?’ into categories of problems (domains).  
Results 
We identified 18 distinct domains of tinnitus-associated problems. Reduced 
quality of life, tinnitus-related fear, and constant awareness were notably common 
problems.  
Conclusion 
Clinicians need to be mindful of the numerous problem domains that might 
affect their tinnitus patients. Current questionnaires, as well as being measures of 
severity, are useful clinical tools for identifying problem domains that need further 
discussion, and possibly measurement with additional questionnaires. The domains 
identified in this work should inform clinical assessment and the development of future 
clinical tinnitus questionnaire. 
 
Keywords: Psycho-social/Emotional; Behavioral Measures; Adult or General 
Hearing Screening 
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Introduction 
 
Often described as a ringing, whistling or buzzing sound, tinnitus is a complex 
and diverse symptom, defined as the perception of a sound that has no external source 
(McFadden, 1982). For some, the experience of tinnitus goes beyond the ‘phantom’ 
sensation of sound. It can cause problems such as insomnia, difficulty concentrating, and 
poor psychological well-being, ultimately decreasing symptom-specific health-related 
quality of life (Langguth & Landgrebe, 2011; Nondahl et al., 2011; Pierce et al., 2012; 
Stevens, Walker, Boyer, & Gallagher, 2007; R. S. Tyler & Baker, 1983; Hall et al., 2018). 
The impact of tinnitus on a person can range from mildly problematic to completely 
debilitating with significant social and economic consequences (Andersson, 2002; 
Stockdale et al., 2017). Of the 10% of the general population who experience chronic 
tinnitus (Landgrebe et al., 2012; McFerran & Phillips, 2007) 20% experience ‘clinically 
significant tinnitus’ and seek relief from their symptoms (Henry, Jastreboff, Jastreboff, 
Schechter, & Fausti, 2003). However, management of tinnitus can be complex, requiring 
an individualised and often multifaceted approach to reduce symptoms and associated 
co-morbidities (Decot, 2005; Department of Health, 2009; Hoare, Gander, Collins, Smith, 
& Hall, 2012).  
Psychoacoustic estimates of tinnitus provide little information on its impact and 
the associated problem symptoms (Andersson, 2002; Jakes, Hallam, Chambers, & 
Hinchcliffe, 1985). Typically, clinicians and researchers alike rely on multi-attribute self-
report questionnaires to measure tinnitus severity and identify appropriate 
management pathways. For example, tinnitus questionnaire items can ask about 
particular difficulties with concentration, sleep, coping, and emotional wellbeing.  
Negative consequences or limitations of tinnitus can be categorised into 
‘domains’ that are theoretically similar or contribute to a specific aspect of tinnitus 
distress or annoyance, and many tinnitus questionnaires provide measures, to varying 
degrees, of different problem domains associated with tinnitus. Patient interviews, to 
assess the effects of treatment for example, can be structured around what are 
considered important domains (Andersson & Edvinsson, 2008). To belong to the same 
domain, consequences or limitations would have to produce a sufficiently similar effect 
on the patient such that questionnaire items could logically be combined to measure a 
specific problem caused by tinnitus. There is however, no universal agreement on what 
these domains are, how many domains of tinnitus problem there are, or how these 
domains should be assessed (Baguley & Andersson, 2003; Hall et al., 2018). For example, 
the Tinnitus Handicap Questionnaire (THQ; Kuk, Tyler, Russell, & Jordan ,1990) assesses 
handicap in relation to psychological and auditory problems, whilst the Tinnitus 
Handicap Inventory (THI; Newman, Jacobson, & Spitzer, 1996) probes problems with 
function, emotion, and catastrophizing. One of the more recent multi-attribute 
questionnaires to be developed is the Tinnitus Functional Index, (TFI, Meikle et al., 
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2012). The TFI was specifically developed to cover multiple distinct problem domains 
(intrusiveness, sense of control, cognition, sleep, auditory, relaxation, quality of life and 
emotional impact of tinnitus), to measure tinnitus severity, and to be a responsive 
outcome measure (Meikle et al., 2012). More recent still, the Tinnitus Primary Function 
Questionnaire (TPFQ, Tyler et al., 2014) was developed to measure “the primary ways 
tinnitus impacts on a person’s life” (p.261) with domains covering problems with sleep, 
hearing, concentration, and emotions.  
Whilst many of questionnaires drew heavily on previous questionnaires when 
selecting items or potential domains to include, the true starting point to developing any 
questionnaire is to identify and understand what the problems that need to be 
measured are. This is something that can only be answered by people who experience 
tinnitus and might include not only problems that arise because of tinnitus, but also 
problems that patients confuse with or ascribe to their tinnitus (e.g. consider hearing 
difficulties or cognitive problems as tinnitus problems when they are more likely due to 
an unacknowledged hearing loss). Tyler & Baker (1983) surveyed 72 members of a 
Nottingham-based tinnitus self-help association asking why tinnitus was a problem to 
them. Respondents had an average age of 61 years (SD = 13.1), 66% were women, 34% 
were men, and the mean age at onset of tinnitus was 51.9 years (range = 9-73). On 
average, respondents reported 4.6 difficulties due to tinnitus (range = 1-13) with fewer 
difficulties being reported by those who had experienced tinnitus for a longer time. The 
31 problems reported were grouped into four main domains: (1) ‘Effects on hearing’ 
including problems understanding speech and television, listening to the radio, 
appreciation of music, use of the telephone, localisation of sounds, and listening to 
environmental sounds; (2) ‘Effects on lifestyle’  including problems getting to sleep, 
persistence of tinnitus, worsening upon waking, requiring/avoiding noisy situations, and 
conversely requiring/avoiding quiet situations, withdrawing from/avoiding friends, 
family problems, interference with work, difficulty learning to drive, and explaining 
tinnitus to others; (3) ‘Effects on general health’ including dependence on drugs, pain 
and headaches, giddiness/imbalance, general ill health, ineffectiveness of drugs, 
tiredness, and ineffectiveness of tinnitus masker; (4) ‘Emotional problems’ including 
despair, frustration and depression, annoyance, irritation and inability to relax, difficulty 
concentrating, confusion, insecurity, fear and worry, and consideration of suicide. The 
most commonly reported problems in that study were ‘getting to sleep’, and the 
‘persistence of tinnitus’. Tyler & Baker acknowledge that there may have been some 
bias in their dataset towards patients who suffer more severely as all respondents were 
members of a tinnitus self-help group. The same survey was subsequently used by 
Sanchez & Stephens (1997, 2000) to assess why tinnitus was a problem amongst a 
population of 436 tinnitus clinic patients (mean age of 57 years, range 14-92 years, 51% 
women, 49% men), at baseline and at follow-up (1.5 to 5 years later). In this study, all 
respondents were patients attending a tinnitus clinic for the first time. Duration of 
tinnitus ranged from 1 month to 70 years, and 394 (90.1%) had some degree of hearing 
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loss. They reported, on average, 3.78 distinct problems (range = 1-12). Younger patients 
(those under 50 years) reported more problems. Thirty distinct problems were reported, 
many of which were common to Tyler & Baker (1983), but Sanchez & Stephens (1997, 
2000) determined there were five problem domains; sleep, auditory, health, situational, 
and psychological problems. The most common problems were ‘hearing difficulties’ and 
‘sleep difficulties’. More recently, Manchaiah et al. (2018) took a deductive approach to 
quantify tinnitus-related problems in a population of 240 tinnitus research volunteers 
(Mean age of 57 years, 57% men, 43% women), using the International Classification of 
Functioning, Disability and Health (ICF) framework (World Health Organization, 2001). 
Most but not all reported problems could be classified according to the framework. The 
most commonly reported problems were coded as ‘emotional functions’ and ‘sleep 
functions’.   
Therefore, to date there have been three studies evaluating problem domains 
associated with tinnitus, in different populations, and with relatively modest sample 
sizes. Here we performed a retrospective analysis of anonymised clinical data from 678 
patients who attended a tinnitus treatment centre in the UK. The primary aim was to 
identify the domains of tinnitus problem according to this large patient population.  
 
Materials and Methods  
 
This study was a retrospective analysis of anonymised data that had been 
routinely collected from patients attending the Tinnitus and Hyperacusis Centre 
(London, UK) between 1989 and 2014. Data use and analysis complies with the 
governance procedures of the data controller (JS). 
 
Data collection  
The Tinnitus and Hyperacusis Initial Interview Form (Jastreboff & Jastreboff, 
1999) was completed by an audiologist (JS) during the first consultation to assess each 
patient’s suitability for Tinnitus Retraining Therapy (TRT). The interview includes 
questions on tinnitus laterality, constancy, percentage awareness and annoyance, and 
the degree of severity, annoyance and effect on life experienced over the last month 
(using a 0-10 rating scales) and a single question asking patients to say “Why is Tinnitus 
a Problem?” in one sentence. For this question, the audiologist recorded the exact 
wording of patients’ responses. For example one patient responded with “sleep 
disturbance is a problem, apprehension and waking sleeping”. The same questions were 
asked about sound tolerance and hearing loss, if indicated. A further question used a 0-
10 rating scales to determine the degree to which each complaint (tinnitus, sound level 
tolerance, and hearing loss) is a life problem. For the present study, we were primarily 
interested in the patients’ recorded responses (free-text) to the single question: “Why 
is Tinnitus a Problem?”  
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Participants  
The responses from 678 patients to the question “Why is Tinnitus a problem?’ 
were analysed. 
 
Content analysis of free-text data from responses to “Why is Tinnitus a 
Problem?”  
Free text responses were analysed using a conventional content analysis 
approach, i.e. information was collated directly from patients’ responses without 
imposing pre-existing categories or theories (Hsieh & Shannon, 2005). Hence the goal of 
content analysis here was to provide knowledge and understanding of the phenomenon 
under study, i.e. why tinnitus is a problem, through the subjective interpretation of text 
data using a systematic process of coding and identifying themes in the data. Patient 
responses given to the question “Why is tinnitus a problem?” were in general short, such 
as “can’t control it” or “cannot work”. To avoid any misinterpretation of meaning that 
could occur due to a lack of context, we coded responses using only what was written 
rather than what was implied (Elo & Kyngäs, 2008).  
Content analysis was conducted by EW (all data), KF, SS, and DH (each analysed 
one third of responses, allocated using a random number generator: 
https://www.random.org/) First, authors independently analysed their assigned 
dataset. This involved data familiarisation (reading and rereading) and the extraction of 
any meaningful initial units (problem codes) from each response. Meaningful units 
constituted parts of a sentence, a whole sentence, or a passage of text that pertains to 
the same topic, and had to contain enough information to allow meaningful 
interpretation with respect to the research question. Two authors assessing the same 
dataset met to examine and discuss their independently extracted problem codes. Each 
author presented their interpretations of the data, rotating who presented first in each 
meeting to ensure that no one author led the identification of problem codes. Any 
disagreements regarding these codes were discussed until consensus was reached or 
the other authors were consulted to reach a majority decision. To ensure consistency of 
coding across all pairs of authors, one author (EW) was involved in coding the entire 
dataset.  Finally, the extracted 994 problem codes were reviewed and categorised by 
four authors (EW, KF, SS, DH) into domains that were considered representative of the 
themes emerging from the problem codes. This was an iterative process involving (i) 
data familiarisation of all problem codes involved all authors reading all codes; (ii) 
identification of potential conceptual labels (domains) based on data familiarisation. 
Any of the four authors could suggest a domain that they believed was representative 
of the data, but the domain was only included if all four authors agreed that it reflected 
the content of the problem codes; (iii) allocation of each problem code to a relevant 
domain, continuing until all codes were allocated to a domain (Elo & Kyngäs, 2008; 
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Graneheim & Lundman, 2004). These initial domains were then refined by all authors, 
checking for commonality or overlap between the content of the codes that were 
allocated to different domains, whether codes should be reallocated to a different 
domain, whether domains should be merged together, or whether there was more than 
one domain emerging from the group of problem codes allocated to the same domain. 
For example, the problem codes grouped under initial domains described as 
‘Distraction’ and ‘Concentration’, were sufficiently similar to combine and form a single 
domain, subsequently described as ‘Inability to Concentrate’. Initial domains described 
as ‘Anger’, ‘Frustration’ and ‘Stress’ were combined to form an ‘Emotional Reaction to 
Tinnitus’ domain. This iterative process continued until every problem code and domain 
was deemed valid, with each code only being allocated to one domain (Elo & Kyngäs, 
2008).  
In a final validation step, audiologist members of the British Society of Audiology 
tinnitus and hyperacusis special interest group (who were not authors or otherwise 
involved in the project) checked that the 994 extracted problem codes and domain 
grouping captured the essence of the raw data and represented the core themes from 
the data. The original raw data responses, the extracted problems codes and associated 
domains, and codes (25) removed for being ambiguous were examined and discussed. 
Each domain was discussed in turn with further refinements made through an iterative 
process and the domains were finalised. One major revision to the domains involved 
codes initially associated with the domains ‘inability to relax’, ‘effect on social life’, and 
‘effect on work’ being combined under a new domain named ‘reduced quality of life’.  
Clinicians in the focus group felt that the codes associated with these initial domains 
were all simply different ways in which patients express tinnitus as having a general 
consequence for their quality of life. They considered the initial domain were not 
clinically meaningful and were all meaningfully captured as ‘reduced quality of life’.    
 
Secondary analyses 
Because many patients reported more than one tinnitus-related problem we 
examined the degree to which problem codes related to different domains co-occurred 
within individual responses. Hierarchical cluster analysis was conducted in PAST version 
3.06 (Hammer, Harper, & Ryan, 2001). In this analysis the likelihood of reporting 
different set of tinnitus related problems were estimated as Euclidean distances 
between problems when plotted per patient in an 18-dimensional space (representing 
the 18 domains in our data). We were interested in whether any of the domains 
identified more consistently grouped together, i.e. patients with problem x also 
generally report problem y.  This would indicate tinnitus problems likely to co-occur, or 
potentially that there is redundancy of a domain, i.e. domain x and y are the same thing.   
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Results 
 
Subjects 
Of the 678 patients reporting reasons why tinnitus was a problem, the mean age 
was 57.2 years (SD = 14.0), 64% (432) were male and 36% (245) were female. Two-
hundred and eighteen patients reported unilateral tinnitus, 302 reported bilateral 
tinnitus, and a further 90 reported hearing their tinnitus in their head (n=610, missing = 
68). Over 70% of patients (n=503, missing = 83) reported fluctuations in their tinnitus, 
and 56% (n=382, missing =40) report sudden onset of tinnitus.  
Percentage of time aware of tinnitus over the last month ranged from 0-100% 
(mean = 56%, SD = 30, n= 652). Percentage of time annoyed by tinnitus over the last 
month also varied from 0-100% of the time (mean = 39%, SD = 27, n=580). Two-hundred 
and sixty-five patients reported previously trying treatments for tinnitus, with the 
average number tried being two. However many patients had tried none (n=413), and 
some had tried as many as five.  
Of the 678 patients reporting problems, 252 patients reported hearing problems 
(missing = 20), yet only 54 used hearing aids. When asked to rate severity, annoyance, 
and effect of tinnitus on life over the last month on 0-10 point scales, patients averaged 
4.4 (SD = 2.3), 6.4 (SD = 2.5), 5.2 (SD = 2.8) respectively (n=669). When asked to rate how 
problematic tinnitus, sound tolerance, and hearing loss were on a 0-10 point scale, 
patients averaged 5.6 (SD = 2.8, n=649), 4.5 (SD = 3.0, n=353), and 3.0 (SD = 2.9, n=387) 
respectively. 
 
Data Analysis 
Four hundred and forty patients reported only one problem, 207 reported two 
problems, 30 patients reported three problems, and one patients reported four 
problems. The 994 problem codes were grouped, refined and finalised into 18 domains 
of tinnitus-related problem (Table 5.5-1).  
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Table 5.1-1 - The 18 domains of tinnitus handicap, the number of and examples of 
relevant codes 
 
The domains ‘Reduced quality of life’ and ‘Fear’ included the highest numbers of 
problem codes, (125 and 107 respectively), whilst ‘Need for knowledge’ and ‘Loss of 
peace’ had the fewest (17 and 14 codes respectively) (Table 5.1-1). Cluster analysis 
revealed an apparent independence of the problem domains we defined (Figure 5.1-1). 
the smaller the ‘distance’ between domains the more common it was for these domains 
to be reported together by the same patient. Hence, ‘Loss of peace’ and ‘Need for 
knowledge’ were most commonly reported together, whereas ‘Quality of life’ and 
‘Constant awareness’ were least often reported together.  
Domain 
number 
Domain name 
n codes in 
sample 
Example codes 
1 Reduced quality of life 125 
Spoiling life; Interferes with everything, 
functional through emotional 
2 Fear 107 
Scares the life out of me; Fear of it always 
being there in future;  I perceive it as a threat 
3 Constant awareness 99 
The focus of my life; Always there; constant 
sound 
4 Annoyance 87 
Annoying; Constant irritation; irritability; 
noise is really bothering me 
5 Inability to concentrate 81 Wants all my attention; Cannot concentrate 
6 Loss of quiet 72 
Feel it will never be quiet again; Impacts my 
quiet time 
7 
Feeling deficient due to 
tinnitus 
63 
Wants to be perfect; Feels damaged. Based 
on own measure of before and after. 
8 Loss of control 53 
No choice; Can’t do anything about it; don’t 
have control over it; a problem I cannot solve 
9 
Effect on sleep and 
alertness 
50 Difficult to sleep; Wake up tired 
10 
Emotional consequences of 
tinnitus 
49 
Very distressing; Makes me feel as if I'm 
falling apart 
11 Effect on listening 44 
Affects hearing of what’s around; Noise gives 
me less opportunity to hear 
12 
Emotional reaction to 
tinnitus 
39 Stresses me out; Driving me mad 
13 Loss of sense of self 31 
There and it wasn't before; Changing my 
personality 
14 Physical Effects of Tinnitus 22 Makes me feel unwell; Tiring 
15 Unpleasantness of Percept 22 Too loud to handle; Sharp frequency 
16 Intrusiveness 19 Constantly invasive; Intrusion in my head 
17 Need for Knowledge 17 Why do I have it?; Will it always be there? 
18 Loss of Peace 14 Shattered my peace; Stops me finding peace 
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Figure 5.1-1 - Cluster analysis indicating relatedness of tinnitus problems within the responses 
from individual patients. Distances are Euclidean distances in an 18 dimensional space. 
 
Discussion 
In this largest study of its kind to date, we examined why tinnitus is reported as 
a problem in a clinical population. A retrospective analysis of data from 678 patients 
attending a tinnitus and hyperacusis clinic, whom identified one or more reasons why 
tinnitus was a problem, led us to identify 18 distinct problem domains.  
Strengths and Limitations 
Due to the subjective nature of qualitative research the involvement of four 
analysts, and our stepped process of identifying and verifying domains, supports there 
being rigour in the analytical process. The sample in this study is representative of a 
typical tinnitus patient population in terms of age and gender. However, patients were 
attending a private clinic, which would indicate at least some patients are from a more 
affluent socio-economic group than may have been represented if this study had been 
completed through a National Health Service clinic for example, where care is free at 
point of access. Variables such as tinnitus severity may differ between our sample and 
that in other populations and influence what is reported as a problem. If for example, 
our sample had more severe tinnitus then they would more likely have co-morbid 
anxiety or depression and potentially ascribe additional problems to their tinnitus 
(Bhatt, Bhattacharyya, & Harris 2017). Furthermore, the sample includes patients 
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attending the clinical over a 25-year period. It may be that some problems domains are 
much less an issue now than in previous decades.    
A limitation of the Tinnitus and Hyperacusis Initial Interview Form may be that it 
is not a self-report questionnaire. It was completed by the clinician during initial 
consultation, whom recorded the exact wording of the patients’ responses. However, 
the consultations are not audio recorded and as consequence the free-text responses 
cannot be verified. That being said, all forms were completed by the same clinician, so 
there is no discrepancy in user completion. There was also a small amount of 
demographic data missing.   
It is acknowledged that reporting a reason why tinnitus is a problem does not 
imply causation or any relation between tinnitus and the problem reported at all. It may 
simply be that the problem is ascribed or confused with tinnitus. A full clinical evaluation 
is therefore indicated to disambiguate, for example, hearing problems due to hearing 
loss and those incorrectly ascribed by the patient to their tinnitus (Henry et al., 2015). 
That may be well be an issue in the current dataset given only a minority of those who 
reported hearing problems also reported using hearing aids.  
 
Why tinnitus is a problem? 
Of the 18 problem domains identified, the most common, collectively accounting 
for 53% of the total codes, were ‘Reduced quality of life’, ‘Fear’, ‘Constant Awareness’ 
‘Annoyance’ and Inability to Concentrate’. Here we discuss evidence of those domains 
in the literature. 
 
Reduced quality of life, emerged here as the commonest problem domain. This 
is in part due to its breadth; based on the clinician focus group it came to include a 
number of initial smaller domains relating to the effects of tinnitus on work, social life, 
and relaxation. It refers therefore to a general degradation or ‘spoiling’ of the quality of 
daily activities and experiences, relating most closely to the ‘Effects on lifestyle’  domain 
described by Tyler & Baker (1983). As a construct, quality of life is widely discussed in 
the tinnitus literature (Erlandsson & Hallberg, 2000; Nondahl et al., 2007; Härter, 
Maurischat, Weske, Laszig, & Berger, 2004). As a term it is broad ranging, from use to 
mean general wellbeing of individuals and society, to health specific, where for tinnitus 
it is used to describe tinnitus questionnaires quite generally (i.e. as measures of tinnitus-
specific health-related quality of life). However, it also appears as a distinct construct of 
tinnitus problem as a subscale in the TFI, which has been shown to measure a different 
construct to general quality of life (Fackrell, Hall, Barry, & Hoare, 2016). In a similar 
fashion to how this domain emerged in the current study, in developing the TFI quality 
of life subscale, domains initially considered distinct termed ‘Social Distress’, ‘Leisure’, 
and ‘Work’ domains were grouped to form a single broad subscale (Meikle et al., 2012).  
As a domain therefore quality of life provides a subscale but not one that in itself is, for 
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example, indicative of the need for a particular intervention. Rather it is only useful as 
general marker of tinnitus problem level.   
 
Fear, is a domain that has previously been underrepresented in analyses, 
questionnaires, and therapies. It includes, for example, a fear of the tinnitus itself, or a 
fear for a future with tinnitus, or fears of activities or sounds somehow making the 
tinnitus worse. Fears of the unknown are more specifically considered anxieties given 
they relate to imprecise or unknown threats (Öhman 2008). However, here we need to 
distinguish fear as a tinnitus domain from the construct of anxiety. Although reported 
as an issue by 12 of the 72 respondents (16.6%), fear is not featured as an individual 
problem within Tyler & Baker (1983). It is included within their ‘Emotional Problems’ 
domain, as part of the problem: ‘Insecurity, Fear and Worry’. Sanchez & Stephens (1997, 
2000), who build on Tyler & Baker's work, do not report fear as a specific problem 
domain. None of the tinnitus questionnaires mentioned previously explicitly use 
questions that would measure tinnitus-related fear. These questionnaires were 
developed prior to this study, and are based on the domains established by earlier 
works, which similarly do not single out problems related to fear. More recently 
developed tinnitus questionnaires either provide a composite measure of tinnitus-
related fear, the Fear of Tinnitus Questionnaire (FTQ; Cima, Crombez, & Vlaeyen, 2011), 
and the Tinnitus Fear-Avoidance Cognitions and Behaviors Scale (T-FAS; Kleinstäuber et 
al., 2013), or include a number of relevant items, e.g. the Self-efficacy for Tinnitus 
Management Questionnaire (STMQ; Smith & Fagelson, 2011). 
Fear is proposed to be a key factor in the maintenance of chronic tinnitus distress 
by Cima et al. (2011), as measured by a self-devised ‘Fear of Tinnitus Questionnaire’, 
developed for their study and yet to be validated. Cima et al. (2011) propose a fear-
avoidance model for tinnitus, based on a model originally proposed for pain (Vlaeyen & 
Linton, 2000). This model predicts that the less tinnitus is experienced as a threat, the 
more accepted it becomes. Based on this concept, Cima et al. (2011) developed a 
Cognitive Behavioural Therapy (CBT) based treatment that includes elements of Tinnitus 
Retraining Therapy (TRT), with the aims of decreasing patients’ fear of tinnitus and 
correcting their “dysfunctional beliefs” (p.1958) about tinnitus. Whilst their treatment 
has shown some benefit for patients in terms of reduced handicap even though the 
tinnitus percept might not have changed, the precise mechanism of benefit, e.g. 
extinction of fear, cognitive restructuring, requires evaluation using valid and specific 
questionnaire measures.  
 
Constant awareness of tinnitus as a problem is not explicitly featured in previous 
studies, perhaps because awareness is considered to be an implicit problem. However, 
the codes in our study demonstrated that being aware of their tinnitus was, for many 
patients, their main issue. Reflective of this, there has been a growing recent interest in 
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mindfulness and acceptance based interventions for tinnitus management (Hesser, 
Westin, Hayes, & Andersson, 2009). 
Awareness is captured to more or less a degree by different tinnitus 
questionnaires.  For example, the THI asks “Do you feel as though you cannot escape 
your tinnitus?”, whereas the TFI includes an explicit question about percentage 
awareness over the last week within its ‘Intrusiveness’ subscale. In clinical studies, 
awareness is sometimes captured through a tinnitus diary over a specified time period 
(Kröner-Herwig, Frenzel, Fritsche, Schilkowsky, & Esser, 2003; Zachriat & Kröner-Herwig, 
2004), or more simply on a percentage of awake time awareness rating (e.g. Molini et 
al., 2010). Patient reports of awareness in our study were more related to the constancy 
of awareness; that it was inescapable, or permanent, although there were responses 
that simply stated tinnitus was a problem because “I’m aware of it”. Interestingly in the 
study by Molini et al. (2010) there was an improvement in their primary measure for 
most patients after treatment yet percentage awareness did not change. There may be 
a disparity therefore between ‘awareness’ and what might make tinnitus clinically 
bothersome for an individual. Consequently, in terms of awareness, it would seem best 
to include a measure of it in the context of a multi-attribute questionnaire rather than 
relying on it alone as a measure of handicap or benefit.  
 
Annoyance in the current study was determined from codes ranging from 
tinnitus being “a little annoying” to being a “constant irritation”. It was included with 
‘Emotional Problems’, as part of ‘Annoyance, irritation and inability to relax’ by Tyler & 
Baker (1983). Interestingly, Sanchez & Stephens (1997, 2000) did not report annoyance 
as one of their problem domains. Yet it does feature in a number of clinical 
questionnaires. One of the questions of the THQ asks (to what degree) “Tinnitus makes 
me feel annoyed” (Kuk et al., 1990).Item 3 in the TFI asks “What percentage of your time 
awake were you annoyed by your tinnitus?” This item is pooled with items related to 
awareness and tinnitus loudness in the ‘Intrusiveness’ subscale (Meikle et al., 2012). The 
THI (Newman et al., 1996) does not mention annoyance specifically but does question 
‘irritability’ and ‘upset’ due to tinnitus.  
In the literature, annoyance is acknowledged as an important issue. Hiller & 
Goebel (2006) comment that tinnitus annoyance contributes heavily to the level of 
tinnitus severity. Andersson (2002) suggests both psychological and educational aspects 
to a treatment plan to tackle annoyance. In the present study annoyance was quite 
consistently coded as tinnitus being annoying or initiating, suggesting it is an important 
construct to measure routinely and specifically in clinical practice and research.  
 
‘Inability to concentrate’ was, as with other domains, reported across a spectrum 
from “mildly distracting” to “permanent distraction” and “can’t think about anything 
else”.  Problems of concentration and confusion are grouped under ‘Emotional 
Problems’ by Tyler & Baker (1983). Concentration problems ranked as the most common 
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problem in both studies by Sanchez & Stephens (1997, 2000). A number of 
questionnaires provide a measure of concentration problem. Conrad et al. (2015) 
reports the recently developed Tinnitus Cognitions Scale (T-Cog) which they found to 
provide subscale measures of tinnitus-related catastrophic thinking” and “tinnitus-
related avoidance cognitions”. The THQ asks (to what degree): “I cannot concentrate 
because of tinnitus”. The THI asks “Because of your tinnitus, is it difficult for you to 
concentrate?”, and “Because of your tinnitus, is it difficult for you to read?” which could 
be used as further insight into concentration issues. The TFI ‘Cognitive subscale’ provides 
a multi-item measure of this seemingly important domain (Meikle et al., 2012). More 
recently, Bankstahl & Görtelmeyer (2013) published a self-report tinnitus questionnaire 
specifically to measure the degree of cognitive ‘failures and mishaps’ that are relevant 
to performing adequately in daily life. This questionnaire is yet to be widely used.  
A number of studies have also explored associations between tinnitus and 
performance on behavioural measures of memory (Hallam, McKenna, & Shurlock, 2004; 
Rossiter, Stevens, & Walker, 2006; Stevens et al., 2007) or attention (Hallam et al., 2004; 
McKenna & Hallam, 1999; McKenna, Hallam, & Shurlock, 1995; Stevens et al., 2007). 
These studies provide mixed evidence of any association and have particular 
methodological limitations that make further research warranted (Mohamad, Hoare, & 
Hall, 2016). As a result, a reliable link between performance-based and questionnaire-
based measures is yet to be determined. 
 
Conclusions 
The current study points to 18 distinct domains of tinnitus problem that need to 
be considered in tinnitus assessment, and in the development of assessment tools or 
questionnaire measures of the impact of tinnitus. A single questionnaire of 18 domains 
would require at least 54 items (Meikle et al., 2012), however this would not be practical 
for use in every clinical or research situation. Furthermore, patients will not report 
problems in all 18 domains at pre-intervention assessment for example, making the 
same questions redundant in a post-intervention assessment. One possible action is to 
remove any domains considered irrelevant to an individual at pre-intervention, so they 
are not measured at post-treatment assessment (Tyler et al., 2014). An effective 
assessment needs to allow patients to express exactly what problems they are having, 
then more domain-specific questionnaires such as the Fear of Tinnitus Questionnaire 
(Cima et al., 2011) can be selected. 
Current tinnitus questionnaires provide measures of various combinations of the 
domains identified here, but no single questionnaire covers all domains. A 
comprehensive measurement of all possible domains identified herein would require a 
combination of tinnitus questionnaires to be used.  
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5.1.2. A narrative synthesis of research evidence for tinnitus-related complaints 
as reported by patients and their significant others 
The data presented has been published by Hall, D. A., Fackrell, K., Li, A. B., 
Thavayogan, R., Smith, S., Kennedy, V., Tinoco, C., Rodrigues, E. D., Campelo, P., Martins, 
T. D., Lourenço, C. M., Ribeiro, D., & Haider, H. F. (2018) as is possible to see at 
 
Hall, D. A.*, Fackrell, K., Li, A. B.*, Thavayogan, R., Smith, S., Kennedy, V., Tinoco, C., 
Rodrigues, E. D., Campelo, P., Martins, T. D., Lourenço, C. M., Ribeiro, D., & 
Haider, H. F.* (2018). A narrative synthesis of research evidence for tinnitus-
related complaints as reported by patients and their significant others. Health 
and quality of life outcomes, 16(1), 61. 
 
 *Equal contribution  
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A narrative synthesis of research 
evidence for tinnitus-related 
complaints as reported by 
patients and their significant 
others 
Deborah Ann Hall1,2*† , Kathryn Fackrell1,2†, Anne Beatrice Li3, Rachel Thavayogan3, Sandra 
Smith1,2, Veronica Kennedy4, Catarina Tinoco5, Evelina D. Rodrigues6, Paula Campelo5, 
Tânia D. Martins5, Vera Martins Lourenço5, Diogo Ribeiro5 and Haúla F. Haider5† 
 
Abstract 
Background: There are a large number of assessment tools for tinnitus, with little 
consensus on what it is important to measure and no preference for a minimum reporting 
standard. The item content of tinnitus assessment tools should seek to capture relevant 
impacts of tinnitus on everyday life, but no-one has yet synthesised information about the 
range of tinnitus complaints. This review is thus the first comprehensive and authoritative 
collection and synthesis of what adults with tinnitus and their significant others report as 
problems in their everyday lives caused by tinnitus. 
Methods: Electronic searches were conducted in PubMed, Embase, CINAHL, as well as grey 
literature sources to identify publications from January 1980 to June 2015 in which participants 
were enrolled because tinnitus was their primary complaint. A manual search of seven relevant 
journals updated the search to December 2017. Of the 3699 titles identified overall, 84 records 
(reporting 86 studies) met our inclusion criteria and were taken through to data collection. 
Coders collated generic and tinnitus-specific complaints reported by people with tinnitus. All 
relevant data items were then analyzed using an iterative approach to narrative synthesis to 
form domain groupings representing complaints of tinnitus, which were compared patients 
and significant others. 
Results: From the 86 studies analyzed using data collected from 16,381 patients, 42 discrete 
complaints were identified spanning physical and psychological health, quality of life and 
negative attributes of the tinnitus sound. This diversity was not captured by any individual study 
alone. There was good convergence between complaints collected using open- and closed-
format questions, with the exception of general moods and perceptual attributes of tinnitus 
(location, loudness, pitch and unpleasantness); reported only using closed questions. Just two 
studies addressed data from the perspective of significant others (n = 79), but there was 
substantial correspondence with the patient framework, especially regarding relationships 
and social life. 
Conclusions: Our findings contribute fundamental new knowledge and a unique 
resource that enables investigators to appreciate the broad impacts of tinnitus on an 
individual. Our findings can also be used to guide questions during diagnostic assessment, to 
evaluate existing tinnitus-specific HR-QoL questionnaires and develop new ones, where 
necessary. 
(Continued on next page) 
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Background 
Tinnitus is a common condition which is usually de- 
scribed as a buzzing, ringing or hissing sound in the ears 
or in the head. Prevalence estimates vary from 11.9–30. 
3% of the population depending on the question asked 
and the age of the population enrolled [1]. Davis and 
Rafaie [2] reported that tinnitus is “clinically significant” 
in about 20% of those who experience it. Data from UK 
clinical records concerning tinnitus that requires profes- 
sional healthcare assistance indicates  an  incidence  rate 
of 5.4 new cases for every 10,000 person-years (95% con- 
fidence interval: 5.3 to 5.5) [3]. 
In the case of tinnitus, both diagnostic assessment and 
evaluation of treatment-related outcomes rely on self- 
reports by patients because there are no observable clin- 
ical signs or objective tests of tinnitus. However, the range 
of potential tinnitus-related complaints is poten- tially 
extremely broad in scope and, because the tinnitus 
experience is very individualised and personal, those 
complaints tend to differ between individuals. To effect- 
ively discriminate problems experienced by different pa- 
tients therefore, it is desirable to  ask  a comprehensive 
set of questions that are able to capture  this  diverse 
range of possible complaints [4]. This ensures that no 
important effects of tinnitus which  might be  important 
for personalizing individual patient management are 
missed. There has been no comprehensive collection 
about what all the possible complaints might be. The 
commonest problems have been proposed as aspects of 
quality of life such as psychological or emotional effects, 
impact on lifestyle, sleep disturbance, auditory  and 
health effects [5], but this is by no means exhaustive. 
These five examples each describe a discrete dimension 
or aspect of tinnitus; which we call a “domain”. 
For the purposes of assessment, multi-item question- 
naires have been developed and these ask questions rele- 
vant to numerous tinnitus domains. For the individual 
who seeks help, all the domains in which they experi- 
ence problems, not just a limited subset, should to be 
explored to optimize diagnosis and rehabilitation  [4]. 
Yet, since there has been no comprehensive collection 
about what all the possible complaints might be, there is 
little consensus among clinicians and researchers as to 
preference for a “standard” assessment [6]. Kennedy and 
colleagues [5] analyzed the item content of five common 
tinnitus-specific HR-QoL questionnaire  instruments  
used for this purpose (Tinnitus Handicap Inventory 
THI, Tinnitus Severity Index TSI, Tinnitus Reaction 
Questionnaire TRQ, Tinnitus Handicap Questionnaire 
THQ, and the Tinnitus Questionnaire/Tinnitus Effects 
Questionnaire TQ/TEQ). For each questionnaire item, 
they classified what domain of tinnitus complaint it con- 
sidered (see Table 1), using category labels that had pre- 
viously been reported by three patient-centred studies 
[7–9]. The authors noted that there was a wide variation 
across the five questionnaires in the domains of tinnitus 
complaint that were assessed and in the proportion of 
items within each domain. These findings raise questions 
about whether these assessment tools are well-suited to 
effectively discriminate problems experienced by differ- 
ent patients. Certainly those assessing a limited number 
of domains could miss important aspects of an individ- 
ual patient’s difficulties. It is interesting to note that 
questionnaire developers draw on clinical experience, 
but tend not to provide adequate information on 
whether and how they established that the included 
items and subscales are important to patients (Table 1). 
In this article, we therefore fill an important know- 
ledge gap by conducting a comprehensive literature 
search and narrative synthesis to draw together an in- 
depth list of patient-reported domains describing dif- 
ferent tinnitus-related problems.  To  date,  no-one  has 
yet conducted such a synthesis of the available data, 
despite the fact that this information is important for 
understanding the impact of tinnitus  on  an  individual, 
for guiding  patient  assessment  and  for  developing 
new and evaluating existing tinnitus-specific HR-QoL 
questionnaires. 
None of the questionnaire developers listed in Table 1 
formally acknowledged a conceptual framework guiding 
their development work, but it appears to us that tinnitus-
specific HR-QoL questionnaire items tend to span the 
multi-dimensional categories of health captured by the 
conceptual framework for the World Health Organization 
(WHO) health-related Quality of Life-100 instrument; 
namely physical health, psychological state, level of 
independence, social relations, personal beliefs and their 
relationship to salient features of their environ- ment [10]. 
We therefore use this conceptual  framework to organize 
and present the  patient-reported  domains that we 
identified from the literature. 
Tinnitus affects not only the patient, but also those  
close to them (typically partners). The experiences of 
close relatives and friends therefore can provide 
(Continued from previous page) 
Trial Registration: PROSPERO registration number: CRD42015020629. Protocol published in BMJ Open. 2016; 
6e009171. 
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Table 1 Stakeholder input and data considerations during development of tinnitus-specific patient-reported questionnaire 
instruments. This table reported the top six most frequently used in clinical trials of tinnitus interventions; all developed in 
the English language [see 9] 
Questionnaire instrument Patient 
input 
Professional 
input 
Tinnitus constructs (domains or subscales) 
 
 
Tinnitus Handicap Inventory [39] Unclear  Yes Tinnitus handicap (functional; emotional; catastrophic) 
Tinnitus Functional Index [21] No Yes Functional impact of tinnitus (intrusiveness; cognition; emotional; sleep; auditory; 
relaxation; sense of control; quality of life) 
Tinnitus Severity Index [67] Unclear  Unclear Negative impact of tinnitus 
Tinnitus Reaction Questionnaire [55] Unclear  Yes Psychological aspects of tinnitus 
Tinnitus Handicap Questionnaire [43] Yes Yes Tinnitus handicap (behavioural, emotional and social; auditory; outlook on 
tinnitus) 
Tinnitus Questionnaire/ Tinnitus Effects 
Questionnaire [24, 22] 
Unclear  Yes Psychological aspects of tinnitus (intrusiveness; emotional and cognitive distress; 
sleep; auditory; somatic complaints) 
 
 
 
important insight into the wider impact of tinnitus on 
everyday life and can be used as an “external barometer” 
for the needs of the patient. In the  case of couples, it    
can even serve to identify therapeutic needs, to be di- 
rected towards either the couple or the  spouse  alone 
[11]. While there is a growing body of literature on the 
impact of tinnitus in those living with the condition; it is 
unclear what is known about the perspective of signifi- 
cant others. 
This review answers the research question concerning 
what dimensions of tinnitus-related complaints patients 
and their significant others are reported as being a prob- 
lem. The main objective of the present review is to col- 
lect and synthesise complaints in everyday life that have 
been reported by people with tinnitus, and also by their 
significant others. This process generates two perspec- 
tives about living with tinnitus: (i) the personal impact    
of tinnitus from the perspective of the person with tin- 
nitus, and (ii) the personal impact of tinnitus from the 
perspective of the significant other. Clarifying what com- 
plaints are reported by individuals with tinnitus and by 
significant others would make it easier to identify any 
potentially important gaps in the content validity of 
current tinnitus-specific HR-QoL questionnaire instru- 
ments. Secondary objectives addressed whether people 
with tinnitus and their significant others have similar or 
different perspectives, and whether subtypes of tinnitus 
and health-related comorbidities influence the nature of 
the tinnitus complaints that are reported and which 
countries contributed data to our study findings. 
 
Methods 
We followed the search strategy, data collection and syn- 
thesis methods and the quality assessment  as laid out in 
a predefined protocol [12]. Moreover, to aid later data 
synthesis, we separately recorded domains identified by 
open questions from those identified by closed questions 
(such as Numerical Rating Scales and  questionnaires), 
and we recorded the evidence from closed questions 
such as if scores were elevated due to tinnitus, compared 
to controls. It is important to make distinctions between 
data gathering methods, since open questions best  en- 
able patients to have a voice about what is important to 
them, and not all closed questions necessarily reflect the 
tinnitus experience as seen from the patient perspective. 
 
Eligibility criteria 
Records were  eligible  for  studies  in  which  adults  
(≥18 years old) reported tinnitus as a primary complaint, 
irrespective of whether or not they were attending  a 
clinic for treatment of those complaints, and those 
reporting data gathered from the significant others of 
adults with tinnitus. Studies reporting tinnitus as a sec- 
ondary complaint were excluded. In the context of this 
review, we used the term “patient” to refer  to  anyone who 
has the lived experience of tinnitus. The review in- cluded 
studies reporting data gathered from the signifi- cant 
others of adults with tinnitus. 
Records were eligible if tinnitus-related  complaints 
had been collected as part of the screening or baseline 
assessments, prior to any tinnitus-specific  intervention. 
To be eligible, specific complaints (such as “getting to 
sleep” and “waking up early”) had to have been collected 
by the authors and sorted into domains (e.g. “Sleep diffi- 
culties”) for reporting, or those complaints constituted 
items in a subscale or global questionnaire measure. In 
our review, a domain was defined as a discrete dimen- 
sion or aspect of tinnitus that can encompass individual 
complaints with a similar conceptual theme which could 
be measured by a questionnaire subscale or single- 
construct questionnaire, but this was not a prerequisite. 
Collecting and synthesizing data corresponding to indi- 
vidual complaints was not the primary objective of this 
review and was deemed too great a task for the re- 
sources and time available. 
Eligible study types were cross-sectional, non- 
intervention ‘observational’ designs, using techniques 
such as population surveys, questionnaires, interviews,  
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focus groups and case series. Records were excluded for 
studies reporting regression modelling predicting tin- 
nitus severity, expert opinions, manufacturers’ articles, 
practice guidelines, case reports, web-based patient dis- 
cussion forums and any reviews. If systematic reviews 
were identified then all included records would be indi- 
vidually assessed for eligibility. 
Eligible records were studies published on or after 
January 1980 conforming to our protocol [12]. To avoid 
language bias, articles that were not published in English 
were screened at full text or extracted by native speakers 
of the written language, using professional colleagues 
known to the authors. 
 
Information sources 
Information sources were published records which in- 
cluded grey literature, such as conference papers and 
postgraduate dissertations that had been archived on ei- 
ther Open Grey, PsycEXTRA, DART, ProQuest Disserta- 
tions and Theses, Networked Digital Library of Theses 
and Dissertations, Cos Conference Papers Index (Pro- 
Quest) and Web of Science (Thomson Reuters). Grey lit- 
erature also included website content, searched using 
Google with the keywords page-by-page up to the point 
at which a page contains no eligible records. For peer- 
reviewed articles, electronic databases were searched: 
PubMed (National Center for Biotechnology Informa- 
tion), Embase (OVID), and Cumulative Index to Nursing 
and Allied Health Literature (CINAHL, EBSCO). Elec- 
tronic searches identified publications  from  January 
1980 to June 2015 and were conducted between 12 and 
17 June 2015. 
Four manual search methods were implemented to in- 
crease our confidence in a comprehensive  coverage  of 
the available literature and to ensure that all potentially 
eligible records had been identified. First, on 12 January 
2016, we contacted 25 patient associations from across 
Europe, North America, and Oceania (see Box 2 [12]) to 
enquire about commissioned reports and unpublished 
reports relevant to the primary objective. Second, man- 
ual searches of reference lists of all articles identified as 
using open questions (14 March 2016) was conducted. 
Third, the bibliography of the 71 eligible records was cir- 
culated by email (8 July 2016) to 24 tinnitus experts who 
had previously developed patient-reported instruments 
(see Box 1 [12]) to identify any candidate records that 
were missing from our list. Finally, to ensure that the re- 
view was up-to-date, manual searches of the top five 
journals in which eligible records had been sourced (i.e. 
Ear and Hearing, International Journal of Audiology, 
Audiology, European Archives of Oto-Rhino- 
Laryngology and the Journal of Psychosomatic  Research) 
, and three additional journals in which eligible records 
using  open  questions had  been sourced  (International 
 
Tinnitus Journal, Journal of Speech and Hearing Disor- 
ders, and Hearing, Balance and Communication which 
was formerly the Journal of Audiological Medicine). The 
final manual search identified publications from June 
2015 to December 2017 and was conducted on 20 Janu- 
ary 2018. 
 
Search strategy 
The electronic database search strategy required ´tin- 
nitus´ as a title or keyword, in conjunction with add- 
itional relevant search terms defined as relevant medical 
subject headings (MeSH) or text words, wherever pos- 
sible. The search terms for PubMed and Embase used a 
combination of terms appearing in the title, keyword or 
subject, with terms as follows: ´(tinnitus) AND (problem 
OR complain* OR symptom)´ OR ´(tinnitus) AND (pa- 
tient OR significant other OR partner OR family)´. For 
CINAHL and grey literature searches, “tinnitus” was de- 
fined as a keyword only. The only exception was Pro- 
Quest Dissertations and Theses in which keywords 
related specifically to co-morbidities, treatments, neural 
mechanisms and structures were excluded. 
 
Study selection 
Eligibility assessment was independently performed by 
two co-authors at each key step (i.e. title, abstract, and 
full-text screening). Discrepancies in title screening were 
resolved by DAH and HFH, while discrepancies at ab- 
stract and full-text stages were resolved by DAH and KF. 
Those discrepancies in eligibility assessment were pre- 
dominantly concerned with evaluating the two criteria 
‘patient complaints not reported at the domain level’ and 
‘factors predicting tinnitus severity’. 
 
Data collection process 
Two coders independently performed duplicate data col- 
lection for every study. Overall 13 coders shared  the  
task, predominantly during a 5-day workshop. The num- 
ber of studies per coder ranged from 5 to 66 (median 9). 
To minimize observer bias, the workshop included hands-
on training with pre-prepared guidance material and 
electronic data collection form. To promote further data 
consistency, DAH and KF completed a post-hoc in- 
spection of all 86 studies, collating one data record for 
each study. This eliminated minor discrepancies in data 
collection, in particular participant characteristics  from 
the eligibility criteria (Methods) rather than from the 
reporting of findings (Results). We contacted the corre- 
sponding author by email (without reminder) to seek 
clarification of information, where required. 
 
Data items 
The electronic data collection form included a list of  
fields relating to eligibility criteria, characteristics of the 
Tinnitus, biomarkers and quality of life in an older population 
 
85 
   
Hall et al. Health and Quality of Life Outcomes (2018) 16:61 Page 5 of 15 
 
 
study population, relevant study findings and other de- 
tails predefined in the protocol [12]. When information 
was not reported, the data field recorded ‘not stated’. 
Tinnitus-related complaints were obtained from the 
measurement tools used for collecting individual com- 
plaints (transcribing the exact interview questions or 
scales, where relevant, and the responses or  scores 
given). Tinnitus dimensions that included several do- 
mains describing patients and significant others’ com- 
plaints, were labelled according to descriptions given by 
the original authors. For studies using closed  questions 
to assess the impact of tinnitus, we did not simply ex- 
tract data indiscriminately on all subscales or items  of  
the questionnaire. Instead, we extracted data only for 
those subscales or items that had  been  highlighted  by 
the study findings or conclusions as reflecting experi- 
enced complaints (i.e. those showing elevated scores in 
people with compared to controls, or demonstrating a 
substantive treatment-related change over time). 
 
Synthesis of results 
All included records were subjected to a qualitative syn- 
thesis that interpreted the data such that new conceptual 
understanding could emerge [13]. A variety of different 
terms were used to describe the same underlying theor- 
etical construct, and so we needed to make grouping de- 
cisions across the data between studies to cluster 
together common domain-level concepts across studies. 
Before domain-level grouping of tinnitus-related com- 
plaints, three corresponding authors responded to our 
query by confirming that ‘tinnitus intensity’ was concep- 
tually equivalent to the loudness of the tinnitus percept 
[14–16]. 
Three coders used an iterative approach carefully con- 
sidering the examples and explanations given by the 
study authors for each domain of tinnitus-related com- 
plaint. The first step required searching for and grouping 
the domain-level data reported by tinnitus patients 
under descriptive labels (“codes”) that contained recur- 
ring keywords, such as “sleep” and “emotion”. Prelimin- 
ary domain groupings emerged from the given data 
taken directly from the full texts (without any abstrac- 
tion). For the second step, the examples or quotes corre- 
sponding to these codes were considered too, and 
domain-level concepts were reviewed by the same three 
coders, and re-grouped, where necessary. The same cod- 
ing scheme was then applied to the domain-level data 
and examples reported by significant others, in a third 
step, with new descriptive labels (“codes”) added as re- 
quired. Steps 2 and 3 involved constantly moving back 
and forth within the data to identify any overlap or dif- 
ferences in the emerging codes and domain-level group- 
ings. Two new coders then reviewed the classification 
and made suggestions for revisions based on the domain 
 
keywords. Suggestions were shared among the coders, 
leading to a harmonization of the domain classification 
[17]. Considering the subjective nature of qualitative 
analysis, it was agreed that the coding and grouping 
process was complete once consensus was reached be- 
tween all coders. The final set of domain labels were 
carefully reviewed with two lay representatives (native 
English speakers with tinnitus) to ensure they were 
understandable by the non-expert. 
 
Results 
Study selection 
Figure 1 illustrates the flow diagram of all study records 
(see Additional file 1). Of the 3508 titles identified by 
electronic searches, 3201 were excluded (‘out of scope’). 
This left 308 potentially relevant records for the next  
stage of abstract screening, including a small number of 
full-texts for those grey literature records. Fourteen re- 
cords were translated for full-text screening and data 
collection (see Additional file 2) by trained native 
speakers. Overall, 212 records were excluded at abstract 
screening, and 52 records were excluded at the full-text 
screening and data collection stage with reasons for ex- 
clusion given in Fig. 1. Records were excluded for ex- 
ample because references were incomplete, abstracts 
were not accessible, or full texts were not accessible (see 
Additional file 3). Records classified as ‘complaints not 
reported’ all used standard questionnaires and closed 
questions, or objective quantitative measures; none used 
qualitative research methods asking open questions. 
Manual search methods included contacting patient 
associations, searching reference lists, asking tinnitus ex- 
perts for a bibliography list and searching selected jour- 
nals. Only two associations responded (British Tinnitus 
Association and Belgian Tinnitus Association) and nei- 
ther identified any commissioned reports relevant to the 
primary objective. For the reference list search, four arti- 
cles were selected from the 96 full-texts assessed for eli- 
gibility specifically because they included open questions 
(see Fig. 1). One was based on authors’ own single open 
question (Tinnitus Problem Questionnaire) [7], one was 
based on the authors’ own structured interview [18], and 
two were based on the Structured Clinical Interview for 
Personality [19, 20]. From these, 38 potentially relevant 
records were identified. Three tinnitus experts sent ref- 
erences for potential records, and from these, ten poten- 
tially relevant records were identified. The  manual 
search of the seven selected journals identified 13 add- 
itional eligible full texts. 
The electronic and manual searches created a final list 
of 84 full-text articles that were included for data collec- 
tion and data synthesis. References for all of these arti- 
cles can be found in Additional file 4 and our complete 
dataset can be found in Additional file 5. Two articles 
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[21, 22] each reported two separate studies, and so this 
contributed two independent datasets to the synthesis (i. 
e. 86 studies in total). 
 
Study characteristics 
All 86 included studies assessed the patient experience, 
whilst two additionally questioned significant others. In 
total, our review considered data collected from 16,381 
patients and from 79 significant others. El Refaie [23] 
confirmed by email that the number of participating sig- 
nificant others in his study was 57. 
The majority of studies used closed questions (e.g. 
questionnaires, numerical rating scales) as the primary 
method of collecting individual complaints. Only eight 
studies asked open questions (885 patients). Open ques- 
tions were used in the context of structured interviews. 
Two were based on the American Diagnostic and Statis- 
tical Manual of Mental Disorders [24, 25], one on the 
Psychological Impact of Tinnitus Interview [26], one on 
the authors’ own structured interview [27], and one on 
the authors’ own semi-structured interview [28]. The 
remaining three studies all asked the question from the 
Tinnitus Problem Questionnaire “Please make a list of 
the difficulties which you have as a result of your tin- 
nitus. List them in order of importance, starting with the 
biggest difficulties. Write down as many of them as you 
Fig. 1 Flow diagram of study records. Eighty-four records yielded 86 independent datasets for synthesis. Note that none of the review articles 
were systematic reviews 
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can” [7, 8, 29]. None of the included studies collected 
data using focus groups. Just two  studies  investigated  
the perspective of family members; one using a ques- 
tionnaire about the quality of family life [23] and one 
using the author’s own questionnaire [30]. Hence, all the 
data for significant others was collected using closed 
questions. 
 
Synthesis of results 
Complaints relevant to people with tinnitus 
Overall 42 discrete unidimensional patient-reported do- 
mains were identified by the process of the data synthe- 
sis (highlighted by closed bullet points in Fig. 2), with 
nine multi-dimensional supra-level domains (highlighted 
in bold font in Fig. 2). A number of descriptors could    
not be fit into this domain framework because they were 
broad (e.g. Tinnitus handicap; Tinnitus problem; Tin- 
nitus severity), described multiple theoretical constructs 
which do not group together (e.g. Effects of tinnitus on 
the patients social, emotional and physical behaviour), or 
described external modulators of the tinnitus (e.g. 
Stressors associated with onset or exacerbation of tin- 
nitus). All of those descriptors that we were unable to al- 
locate to one of the 51  domains  are  given  in  
Additional file 6. 
We have classified the domains into categories in- 
spired by the conceptual framework of quality of life as 
 
measured by the WHOQOL-100 [10]. All domains are 
presented in Fig. 2, ordered according to the frequency 
reported across all 86 studies. About two-thirds of do- 
mains were identified from both open- (□) and closed- 
(⊠) question formats. Any notable exceptions are 
discussed below. For transparency of reporting, Add- 
itional file 6 gives the domain grouping table that lead to 
the list of domains reported in Fig. 2. This table contains 
full details of our chosen domain label and all of the ori- 
ginal domain-level terminology used by authors  across 
the source information. 
 
 
Negative attributes of the tinnitus sound 
Data synthesis revealed numerous negative attributes of 
the tinnitus sound. Open-question formats elicited pa- 
tient reports of ‘Tinnitus awareness’ and ‘Tinnitus intru- 
siveness’, also supported by the closed-question data. 
‘Tinnitus loudness’ was a recurring  negative  attribute, 
but this always arose from a closed  question  asked by  
the investigator (Fig. 2). Occasionally authors’ reporting 
of loudness was intermixed with annoyance. For ex- 
ample, “subjects tended to report tinnitus that was per- 
ceived as moderately loud and annoying” [31]. ‘Tinnitus 
pitch’, ‘Tinnitus location’, and ‘Tinnitus unpleasantness’ 
were also identified solely by closed questions (Fig. 2), 
but these rarely occurred across the 86 studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 Domain-level grouping created from the responses gathered from patients and significant others. Our domain-level groupings are mapped 
into the category headings given by the World Health Organization (see headings in capital letters in the top row). Domain-level grouping in the 
bottom row could not easily be fitted into the WHO nomenclature. Multi-attribute categories are given in bold font; with any denoted with an 
open bullet point (o) indicating additional multi-attribute domains that have been grouped within the same category. Closed bullet points (●) 
indicate discrete unidimensional patient-reported domains arising from the data collected. The superscript numbers indicate how many studies in 
total identified that domain (e.g. n11). An open square (□) denotes that the domain was identified using an open-question format. A crossed 
square (⊠) denotes that the domain was identified using a closed-question format 
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Physical health problems 
Patients often associated their tinnitus with their phys- 
ical health. ‘Sleep difficulties’ were the most common 
physical health difficulty in our dataset; identified using 
both open- and closed-question formats. Examples indi- 
cated difficulties in getting to sleep, in maintaining sleep 
and in the overall quality of sleep, for example “prob- 
lems in getting to sleep, waking in the night, waking 
early” [22], and “tired during the  day  because  tinnitus 
has disrupted sleep, lie awake at night because of tin- 
nitus, difficult to get back to sleep after waking up at 
night” [32]. Complaints about physical health included 
pain, headaches, pressure in ears/head, nausea, dizziness 
and generally feeling unwell. These were collected and 
reported as a high-level multi-dimensional construct 
coded as ‘Physical health problems’ [7, 8, 21, 33]. How- 
ever, some studies separated out ear/head pain, head- 
aches and muscle tension as symptoms of somatic 
complaints [34, 35]. We have therefore coded these as a 
single domain in its own right; coded as ‘Bodily com- 
plaints’. A few studies identified an individual physical 
symptom such as ‘Feeling tired’ [16], ‘Pain’ [16, 36], and 
‘Loss of appetite’ [30]. 
 
Functional difficulties due to the tinnitus 
Five studies clustered a broad range of functional diffi- 
culties into a high-level, supra-domain that we have 
called ‘Functional difficulties due to tinnitus’ [37–41]. 
This label came from the reporting of the functional 
subscale of the Tinnitus Handicap Inventory; a closed- 
question format. Different functional aspects were also 
coded as separate domains across studies. Most common 
in this category was ‘Negative effects on hearing’. This 
domain included any hearing problem that was  attrib- 
uted by patients to their tinnitus, over and above hearing 
loss per se. Examples were “difficulties in speech under- 
standing” [42] our translated from Polish, interference 
with “ability to tell where sounds are coming from” [43], 
and “distortion of sounds” [28]. Patients also often at- 
tributed ‘Concentration difficulties’ to their tinnitus, “be- 
ing distracted by tinnitus” [44]. Related to the dimension 
of concentration difficulties was the domain that  we  
have coded as ‘Ability to ignore’ tinnitus, e.g. “Less able 
to divert their attention from their tinnitus” [27]. 
A number of studies using closed-question formats also 
reported ‘Cognitive difficulties’ which encompassed prob- 
lems with memory and/or attention, such as “Can’t ex- 
press/tip of tongue, Sudden forgetfulness;  Difficulty 
thinking clearly or remembering” [21, 45]. Five studies 
grouped a broad range of functional difficulties into a high- 
level, supra-domain that we have called ‘Functional difficul- 
ties due to tinnitus’ [37–41]. This label came from the 
reporting of the functional subscale of the Tinnitus Handi- 
cap Inventory; again a closed-question format. 
 
Emotional complaints associated with tinnitus-related distress 
Data synthesis revealed many different emotions experi- 
enced by patients, but the commonality was that they were 
all directly attributed to the tinnitus, or some other relevant 
sensation. Most commonly reported was a high-level con- 
struct that we have called ‘Tinnitus-related distress’. Distress 
is multi-dimensional in nature and encompasses a constel- 
lation of different emotions that other studies had coded as 
separate domains, such as “Inability to concentrate, Dis- 
tress/upset, Stress/tension/inability to relax, Irritability, Iso- 
lation, Helplessness/frustration” [8] and “[…][…] depression 
[…], anxiety […]” [18], and “loudness, unpleasantness of the 
noises; […] worries about the persistence of the noises; […] 
emotional effects (irritability, anger, sadness)” [22]. Annoy- 
ance was the most common specific emotion in our data-  
set. Again these codes predominantly arose from closed 
questions, but the authors of one of the open question  
studies [7] pooled “irritation” and “inability  to  relax”  into 
the same domain as “annoyance” giving some insight into 
what this construct might mean to patients. A small num- 
ber of studies did specifically capture, as a separate domain, 
the sense that tinnitus made them feel ‘Irritable’. For ex- 
ample, “Tinnitus causes me to feel irritated and angry” [42] 
translated from Polish. And perhaps related to this con-  
struct was also the feeling of ‘Frustration’: “So ...everyone 
says ‘you can’t keep on focusing on tinnitus, you must do 
something nice instead, like travelling’ [...] but I say ‘Yes, 
but I cannot fly any more” [28]. ‘Worries/concerns’ was an- 
other emotion directly associated with the tinnitus experi- 
ence. The content of the worry appeared to differ from one 
patient to another, for example “I worry that there is some- 
thing seriously wrong  with my body” [22] and “It becomes  
a general feeling of worry in me that I did not have before 
when I did not know so much. It gets back at me, perhaps  
in many areas. It is how it feels, it sort of spreads in a way” 
[28]. Two studies reported ‘Fear,’ and so we coded this as a 
separate emotion because it seemed to capture a stronger 
sense of emotion. For example, “I’m afraid that the tinnitus 
will become more disturbing and impairing in the  long  
term” [38]. 
Finally, our data synthesis identified one negative emo- 
tion that was associated with bodily sensations (not with 
tinnitus per se), which we have termed ‘Distress from bod- 
ily sensations’. This domain was identified by four studies 
all using a closed-question format. It tended to be pre- 
sented as a sign of a somatization or somatoform disorder, 
such as measured by the Tinnitus Questionnaire [14, 44]. 
 
Negative thoughts about tinnitus 
A number of studies identified  a construct  associated  with 
a ‘Change in sense of self ’. Examples include “self-blame” 
and a negative “self-image”; “I am retired now, 54 years old 
and retired, it is not really fun is it, to think that thought?” 
[28]. Most of these examples arose in response to an open  
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question asked by the investigator. Open questions also 
identified ‘Loss of peace,’ for example “Peace of mind” [46]. 
‘Suicidal thoughts’ was identified from both  open  and 
closed questions pertaining to suicide risk [26, 35]. Five 
studies captured high-level,  supra-domain  ‘Negative 
thoughts about tinnitus,’ by asking closed questions. The 
sense of being unable to “escape tinnitus” and no longer 
coping with the tinnitus [37, 39], both questions that form 
part of the Catastrophic subscale of the Tinnitus Handicap 
Inventory. Similarly, the construct termed ‘Loss of control’ 
forms a distinct domain of the Tinnitus Functional Index e. 
g. [21]. ‘Irrational beliefs’ were also identified by a closed 
question in one study [47]. 
 
General mood states 
In contrast to emotions, we have classified moods as 
general feelings that are not triggered by tinnitus, nor by 
any other sensation. Mood states tended not to be re- 
ported by patients using open questions, but rather in 
response to specific questionnaire items. A small num- ber 
of studies used ‘Mood states’ as a high-level ‘supra- 
domain’ term, often measured using a generic mood 
questionnaire [26, 28, 30, 48]. Others used the term 
‘General distress’, a construct that is synonymous with 
‘stress’ and was typically measured using a generic stress 
questionnaire e.g. [48–50]. From our dataset, a recurring 
specific mood state was ‘Anxiety’. ‘Depressive symptoms’ 
was another. Typically, anxiety and depression were 
measured using a relevant (sub)scale of a closed-item 
questionnaire, such as the State Trait Anxiety Inventory 
[15, 51], Beck Depression Inventory e.g. [15, 52], or the 
Hospital Anxiety and Depression Scale e.g. [16]. Two 
other mood states relating to feelings not necessarily di- 
rected towards the tinnitus were ‘Lack of joy’ (e.g. “fre- 
quency of loss of joy”, 44) and ‘Anger’ [48]. 
 
Health-related quality of life 
Many study findings attributed a reduction in quality of life 
specifically to the tinnitus (i.e. ‘Quality of Life associated 
with tinnitus’) [43]. This domain was identified using ques- 
tionnaire items or subscales [Tinnitus Handicap Question- 
naire, 21; Tinnitus Functional Index, 27], and also in 
response to an open question asked by the investigator [27, 
e.g. “Impairments in quality of life, reduced stress tolerance, 
psychosocial withdrawal”). A number of studies defined 
‘health-related Quality of Life’ as a generic domain relevant 
to people with tinnitus but not specifically attributed to the 
tinnitus. This was most commonly measured using a single-
item Numerical Rating Scale e.g. [44, 53]. 
‘Negative impact on activities’ was another multi- 
dimensional domain that emerged from the data synthe- 
sis of both open- and closed-question formats. The type 
of activities were either unspecified “avoided otherwise 
enjoyable activities, more restricted in their activities” 
 
[27], or encompassed several different types of activity in 
the same author code, such as “interfered with work, less 
interested in going out” [54]. Within this supra-domain 
there were three unidimensional  domains  associated 
with specific categories of activity; namely social, work, 
and individual. ‘Negative impact on social activities’ was 
illustrated by examples such as “General interference with 
leisure; Less interested in going out; Social life was 
limited” [21, 28]. ‘Negative impact on work activities’ was 
exemplified by this description “Work as a situation in 
which tinnitus had a severe negative impact. Some had 
stopped working altogether, and others  had  reduced 
their working hours or changed workplace/work assign- 
ments” [28]. With respect to ‘Negative impact on indi- 
vidual activities’, an illustrative example was “ability to 
concentrate, listen to music or read newspapers” [55]. 
Patients also reported issues relating  to  relationships 
with family and friends, for example “I become, yes,  
some kind of obstacle for, for some things my wife and I 
might have planned to do together” [28], and these were 
classified by the category ‘Negative impact on 
relationships’. 
While some studies mentioned the use of coping strat- 
egies without giving examples, our data synthesis did in- 
dicate a diversity of cognitive and behavioural 
approaches to coping in use by patients, and which we 
have labelled as the domain ‘Difficulties coping’. Exam- 
ples spanned avoidance (“I avoid noise due to tinnitus; I 
avoid silence due to tinnitus; Due to my tinnitus I avoid 
sporting activities” [38, 46]), using hearing protection 
(“Due to my tinnitus  I try to protect my ears whenever     
it is possible” [38]), and what the authors called ‘saving 
face’ (“what is shown to other people” [28]). None 
seemed specific enough to separate into distinct domains 
with the exception of ‘Lack of support from family and 
friends’ (e.g. “I notice people have a hard time trying to 
understand” [28] and “Family gets aggravated with me” 
[56]). A final domain in this category was ‘Sexual diffi- 
culties’. There was just one instance of this, and it was 
assessed in a study using the Chronic Illness Problem 
Inventory [24]. 
 
 
Miscellaneous domains 
A small number of other domains were recorded, but 
could not easily be classified according to the above cat- 
egories. Of note, a few studies included an assessment 
that indicated a clinical diagnosis of depression (e.g. 
Harrop-Griffiths [24] assessed patients against the 
American Diagnostic and Statistical Manual (DSM III) 
criteria). No studies reported on a formal clinical diag- 
nosis of anxiety. Other domains were ‘Need for know- 
ledge’ which was exemplified by: “Explaining tinnitus to 
others” [7], and ‘Acceptance of tinnitus’ which included 
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the example “Tolerance” [57]. These two domains were 
identified by few studies. 
Also not easily classified in the WHOQOL-100 con- 
ceptual framework were two studies reporting a reduced 
sound tolerance, possibly associated with hyperacusis 
[28, 58]. 
 
Secondary analyses 
Secondary objectives addressed whether people with tin- 
nitus and their significant others have similar or differ- 
ent perspectives, whether subtypes of tinnitus and 
health-related comorbidities influence the nature of the 
tinnitus complaints that are reported, and which coun- 
tries contributed data to our study findings. 
 
Complaints reported by significant others 
Only two studies addressed domains of tinnitus-related 
complaints reported by 79 significant others in terms of 
their own personal experience [23, 30]. These question- 
naire studies identified ten domains which were all con- 
tained within the classification for people with tinnitus 
(see Additional file 7): ‘Sleep difficulties’, ‘Negative effects 
on hearing’, ‘Mood states’, and ‘General distress’, ‘Negative 
impact on relationships’, ‘Negative impact on activities’, 
‘Negative impact on social life’, and ‘Difficulties coping’, 
‘Physical health problems’, and ‘Need for knowledge’. 
‘Negative impact on relationships’ was the only domain 
to be identified in both studies. 
In addition to comparing the domains identified by pa- 
tients and significant others, we had planned to conduct 
two further secondary analyses. The first was to explore 
whether different tinnitus subtypes might influence dif- 
ferent patterns of reported domains. Pre-specified classi- 
fications were tinnitus duration (acute versus chronic), 
tinnitus presence (intermittent versus constant), tinnitus 
pulsatility (non-pulsatile versus pulsatile), tinnitus sever- 
ity (mild versus moderate versus severe), co-morbid anx- 
iety, depression and severity of hearing loss. Adequate 
analysis of each research required a sufficient number of 
studies either to have enrolled only participants accord- 
ing to individual subtypes, or to have separately charac- 
terized and reported complaints according to subtype. 
Unfortunately, none of the included studies did this for 
any of the pre-specified classifications. The second was 
to explore whether a health-related comorbidity might 
influence different patterns of reported domains. Seventy-
one of the studies reported no co-morbidity re- lated 
inclusion criteria, 10 reported hearing loss, one in- 
somnia, and one hyperacusis. Although this is  
insufficient to draw any strong conclusions, the form of 
the co-morbidity was associated with the  reporting  of  
the associated complaint. Notably, the study recruiting 
people with tinnitus and insomnia was one of the studies 
identifying the ‘Sleep difficulties’ domain [59], and the 
 
study recruiting people with tinnitus  and  hyperacusis 
was one of the studies identifying the ‘Reduced sound 
tolerance’ domain [58] (Fig. 2). In addition, three of the 
10 studies actively recruiting people with hearing loss 
identified ‘Negative effects on hearing’. [47, 50, 60]. 
The final secondary analysis explored which countries 
contributed data to our findings. The complete dataset 
included the data item for the country where the study 
was conducted. Overall, the data predominantly came 
from UK, USA, Germany and Sweden (shown in Fig. 3), 
including the two studies investigating significant others 
(UK) and the four qualitative research studies reported 
below in Table 2 (UK, Sweden). This observed geograph- 
ical bias was unlikely to be explained by our study de- 
sign since we translated all eligible records. 
 
Quality assessment 
The protocol described three assessments of the  quality  
of collecting, defining and reporting the domains of 
tinnitus-related complaints. We evaluated the extent to 
which investigators used an open questioning  format, 
and then assessed quality for those studies using a quali- 
tative research design. Qualitative research is valuable 
because it can illuminate the personal meaning of tin- 
nitus without constraining findings by any investigators ’ 
preconceptions and can enable  an  in-depth  exploration 
or relevant issues. Eight articles used open question 
interviewing, but four either used a closed format re- 
sponse scale [26, 27] or used patient responses only to 
make a psychiatric diagnosis [24, 25]. Only four 
remaining records [7, 8, 28, 29] met the Critical Ap- 
praisal Skills Programme (CASP) [61] checklist screen- 
ing questions confirming that they were qualitative 
research studies (610 patients in  total).  Two  authors 
(KH and DAH) then subjected these records to a quality 
assessment using the remaining eight CASP checklist 
questions and agreed ratings are given in Table 2. While 
reporting of findings was adequately detailed, there was 
no confirmation of ethical approval, no consideration 
about whether or how data collection might have been 
affected by the investigator-patient relationship and in- 
complete reporting of how the text-based data had been 
analyzed to identify tinnitus domains. 
The remaining 80 records (82 independent studies) 
were subjected to the quality assessment  described  in  
the protocol [12], relevant to the degree to which re- 
ported findings reflected the heterogeneity of a ‘typical’ 
tinnitus population. Records were assessed for: (i) justifi- 
cation of sample size, ii) reporting a wide variety of ages 
(mean and SD), (iii) gender balance (men and women), 
and (iv) no eligibility criteria that would exclude particu- 
lar tinnitus subgroups. Each criterion was scored 0, 1 or   
2 to give a composite score out of 8. The mean quality 
score was 5.24 (SD = 1.37). Most poorly handled was the 
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justification for sample size, with 69 studies not given 
any explanation for why the numbers recruited were suf- 
ficient to address the primary question. 
 
 
Discussion 
The effects of tinnitus on the person with the condition 
and on their significant others are pervasive  and affect 
the quality of life for all involved. This comprehensive 
review is important because it has collated and synthe- 
sized, for the first time, everyday life tinnitus-related 
complaints that have been reported by people who have 
the lived experience of tinnitus and their significant 
others. 
 
Comparison with other studies 
To our knowledge, no other study has achieved a com- 
prehensive qualitative synthesis of patient-reported com- 
plaints associated with tinnitus. Perhaps two of the 
closest are a systematic review of clinical trials of tin- 
nitus in adults [6], and a qualitative content analysis of 
tinnitus problems and effects on everyday life according 
to the International Classification of Functioning, Dis- 
ability and Health [62]. The findings of these two studies 
 
Table 2 CASP checklist for records that passed the first two screening questions. ✓  = checklist criterion was met, ✗  = not met, and? 
= can’t tell 
 Research 
design 
Recruitment 
strategy 
Data 
collection 
Relationship/ 
bias 
Ethical 
issues 
Data 
analysis 
Statement of 
findings 
Value of the 
research 
Tyler & Baker 1983 [7] ? ? ✓  ✗  ✗  ✗  ✓  ✓  
Sanchez & Stephens 1997 
[8] 
✓  ✓  ? ✗  ✗  ✗  ✓  ✓  
Sanchez & Stephens 2000 
[29] 
✓  ? ? ✗  ✗  ✗  ✓  ? 
Andersson & Edvinsson 
2008 [28] 
? ✓  ✓  ? ✗  ✗  ✓  ✓  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 World map illustrating the distribution of study sites for all included studies, inspired by the World Health Organization (WHO) regional 
classification, but with Region of the Americas separated into North and South and with Australia and separated from Western Pacific region, 
because of cultural and language differences. Regions are colour coded in different shades of blue and the values denote the number of studies 
contributing to the review from that country 
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are consistent because they map very well onto concepts 
that are equivalent to the domains that  have  emerged 
from our qualitative data synthesis, albeit  sometimes 
with a slightly different choice of wording (e.g. ‘Tinnitus- 
related cognitions’ [6] became ‘Negative thoughts about 
tinnitus’ and ‘Sustaining attention’ [62] became ‘Concen- 
tration difficulties’). The main reason for these differ- 
ences in wording can be attributed  to  the  novel 
influence of involving lay people with  tinnitus  whose 
role has been to challenge us to find domain labels that 
were as jargon free as possible. Members of the public 
were not explicitly involved in our review team, but did 
influence our choice of domain labels at the  reporting 
stage because of their involvement in an ongoing study 
as part of the next step in our research programme [63]. 
Despite our rather strict definition of a domain, our 
synthesis identified a large number of discrete unidimen- 
sional constructs associated with tinnitus  complaints. 
This lengthy classification list differs markedly from all 
previous studies, but perhaps surprisingly even for those 
published studies which surveyed tinnitus patients using 
an open question and then analyzed the resulting patient 
narratives. For example, Tyler and Baker’s landmark 
study [7] of 72 patients reported only four domains 
(hearing, lifestyle, general health, emotional problems). 
The examples that they gave  for  the hearing  domain 
map well onto our domain ‘Negative effects on hearing’, 
and so do those for health (see ‘Physical health prob- 
lems’). However, lifestyle and emotional problems  do 
not, perhaps because Tyler and Baker [7] intermingled a 
range of different concepts. For example, the examples 
that they gave for lifestyle we have coded under numer- 
ous discrete domains (Sleep difficulties; Tinnitus aware- 
ness; Difficulties coping; Negative impact on social life; 
Negative impact on relationships; Negative impact on 
work activities; Negative impact on individual activities; 
Need for knowledge). Indeed, Sanchez and Stephens [8, 
29] seem to have also recognized a difficulty with multi- 
dimensional constructs because in their analysis of data 
collected  using  the  same  procedure  as Tyler  and Baker 
[7] they created the additional domain ‘Sleep’. We con- 
sider there to be scientific value in reporting patient- 
related complaints at the level of individual, discrete 
health-related constructs, not high-level broad categor- 
ies. In our experience, both patients and healthcare pro- 
fessionals find these both understandable and highly 
relevant to their own personal experiences [63]. 
 
Limitations of the study 
We acknowledge a potentially limiting factor is that our 
search identified only four qualitative research studies 
assessing 610 patients [7, 8, 28, 29], and no new qualita- 
tive studies were identified in the manual search update 
but see [62]. Geographical bias was avoided since no 
 
records were excluded because of an inability to ad- 
equately translate into English. 
Given the relative paucity of qualitative methodology 
to understand tinnitus complaints, as experienced by the 
patient and their significant others, it is possible that 
additional complaints might emerge from new research. 
For example, we are aware of one unpublished study, 
presented at a recent conference [64], in which the au- 
thors collected tinnitus-related complaints from 988 pa- 
tients using a single open question: “Why is tinnitus a 
problem?”. However, this new study does not add any 
new information to the domain-level grouping repre- 
sented in Fig. 2. 
 
Future directions 
Our findings highlight a number of knowledge gaps each 
of which be a promising future direction for research. 
First, the tinnitus-related complaints spanned aspects of 
physical health, psychological health (i.e. functional, cog- 
nitive and emotional), independent activities, social rela- 
tions, and leisure activities. For the majority of these, we 
found converging evidence for their relevance to people 
with tinnitus, through responses to open-format ques- 
tions as well as group differences in scores on closed- 
format questionnaires. Although patients typically attrib- 
uted direct causality to the tinnitus, we noted that these 
domains are also generic components of well-being that 
are represented within the  WHO conceptual framework 
of quality of life [10]. This raises an important un- 
answered question about whether or not a profile of the 
impact of tinnitus could adequately be measured by a 
standardised, generic quality of life instrument. 
Second, we observed that a small number of patient- 
reported domains were identified only by  directed, 
closed questions asked by the investigator and  were 
never ‘spontaneously’ reported by patients in response to 
an undirected, open question. Notably, these included 
general moods (not triggered by tinnitus) and also  the 
four major perceptual attributes of the tinnitus sound (i. 
e. its location, loudness, pitch and  unpleasantness). 
These domains highlight discrepancies between the per- 
spectives of patients and healthcare professionals; while 
they appear to be valued by clinical practitioners, this is 
not true for patients. This finding also raises a specific 
dilemma because loudness is a common primary out- 
come measure in clinical trials [6], and yet it may not be 
so relevant to patients. Importantly, this review raises 
concerns about whether tinnitus loudness has sufficient 
content validity to be an essential item for inclusion, cer- 
tainly as part of a patient-reported primary outcome in- 
strument when determining the clinical efficacy of an 
intervention. Again, further research is warranted. 
Third, the impact of tinnitus on the patient ’s signifi- 
cant other may provide clues on how a couple or family 
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deal with tinnitus in their daily routine and considering 
such challenges may contribute a more complete clinical 
profile of a patient undergoing clinical assessment and 
management. Our review highlights a gap in our know- 
ledge concerning third-party disability because there is a 
paucity of literature about the effect of tinnitus on sig- 
nificant others. Like hearing loss, many fewer studies are 
directed at investigating the impact of the condition on 
close friends and family than on patients themselves. For 
hearing loss, a recent review identified 24 articles report- 
ing the impact of tinnitus on significant others [65]. 
However, in the case of tinnitus, third-party disability 
does not appear to be a topic of growing research inter- 
est because we identified only two articles, with the most 
recent having been published over 10 years ago  [23]. This 
lack of data means that our findings are unlikely to 
capture all domains relevant to this stakeholder group, 
and so further research is warranted. 
Finally, our findings make a specific  contribution  to 
the ambitious roadmap for developing a Core Outcome 
Set for tinnitus which would set minimum standards for 
collecting and reporting outcomes in all clinical trials of 
tinnitus [63]. This review identifies all those patient- 
reported domains that could be candidates for a Core 
Outcome Set, thus giving credence to the patients ’ 
viewpoint. 
 
Conclusions 
There is a recognition that measurement  instruments 
used for clinical diagnosis and for evaluation of the out- 
come of tinnitus interventions should have good content 
validity (i.e. that their content  is an adequate reflection  
of complaints that are relevant to tinnitus) [66]. The 
findings of this comprehensive review therefore contrib- 
ute fundamental new knowledge and a unique resource 
that will enable investigators to evaluate the relevance to 
patients of any multi-item patient-reported  question- 
naire for tinnitus. Clarifying the types of tinnitus-related 
complaints that are often reported enhances our under- 
standing of the lived experience of patients and high- 
lights important gaps in content validity of current 
tinnitus-specific HR-QoL questionnaire instruments. 
 
Additional files 
 
 
 
Abbreviations 
CINAHL: Cumulative Index to Nursing and Allied Health Literature; HR- 
QoL: Health-related quality of life questionnaire; MeSH: Medical subject 
headings; PICOS: Patient, Intervention, Comparison, Outcome, Setting; 
TEQ: Tinnitus Effects Questionnaire; THI: Tinnitus Handicap Inventory; 
THQ: Tinnitus Handicap Questionnaire; TQ: Tinnitus Questionnaire; 
TRQ: Tinnitus Reaction Questionnaire; TSI: Tinnitus Severity Index; 
WHO: World Health Organization 
 
Acknowledgements 
We thank Agnieszka Szczepek, Birgit Mazurek, and Pia Lau for translating 
articles from German to English, and Anna Pajor and Magdalena Korczyńska 
for translating articles from Polish to English. Lena Wong for translating 
articles from Mandarin Chinese to English. Richard Tyler, Richard Hallam, and 
Soly Erlandsson reviewed the bibliography list and sent potential records for 
screening. Harriet Smith assisted with the data synthesis, while Veronica 
Colley and Brian Thacker contributed a lay perspective to the process of 
domain labelling. Finally, Sarah Michiels, Dean Thompson, Alain Londero and 
Luca Del Bo contributed to the quality assessment. 
   Funding 
Additional file 1: Table summarising the electronic information sources 
used to identify the 3580 records. For a description of the abbreviations, 
see text. (DOCX 17 kb) 
Additional file 2: Fourteen non-English language records that were 
screened and either excluded or included at the full-text stage by native 
language speakers. ‘Complaints not reported’ = authors reported the glo- 
bal tinnitus score calculated from a multi-attribute questionnaire without 
reporting the component domains or subscales. (DOCX 18 kb) 
Additional file 3: Records that were excluded because either the 
abstracts and/or full-texts were not accessible, or there was an 
This work is supported by an independent research program funded under 
the Biomedicine and Molecular Biosciences European Cooperation in Science 
and Technology (COST) Action framework (TINNET BM1306). This supported 
the 5-day “workshop” for data collection and one project management 
meeting. DH and KF are funded by the National Institute for Health Research 
(NIHR). DH is an NIHR Senior Investigator. The views expressed are those of 
the authors and not the funder. 
 
Availability of data and materials 
The dataset used for the qualitative synthesis during the current study are 
   available from the corresponding author, on reasonable request. 
incomplete reference which meant that the article could not be traced. 
(DOCX 35 kb) 
Additional file 4: References for all 84 full-texts included for data collec- 
tion and synthesis. (DOCX 22 kb) 
Additional file 5: Complete dataset, including our domain coding and 
quality assessment. (XLSX 520 kb) 
Additional file 6: Grouping table reporting the different terminology 
used by authors to describe the same theoretical constructs. Grouping 
considered the examples and explanations given by the study authors 
for each domain of tinnitus-related problem (examples not reported 
here). Domains that could not be coded either because they were not 
well-defined, described multiple theoretical constructs which did not 
group together, or described external modulators of the tinnitus were as 
follows: Ability to mask the tinnitus sound; Aggravated by noise; Auditory 
perceptual characteristics of tinnitus; Catastrophic; Changes for loud back- 
ground noise; Changes in perception over time; Effects of tinnitus on health; 
Effects of tinnitus on the patients social, emotional and physical behaviour; 
Emotional; Emotional reaction, social activities and communication, and fo- 
cused attention; Emotions; Factors that aggravate tinnitus; Functional; Func- 
tional handicap caused by tinnitus; Illness focusing; Masking effects; Medical 
interaction; Most problematic situation; Other people; Overall patient stress 
and severity of tinnitus; Psychological; Relax; Relief from tinnitus; Self- 
perceived tinnitus handicap; Sensations in the presence of such sounds; Situ- 
ational difficulties; Situational effects; Stressors associated with onset or ex- 
acerbation of tinnitus; The extent of problems due to tinnitus; Tinnitus 
loudness/strength, annoyance, impact on life and severity; Tinnitus handicap; 
Tinnitus problem; Tinnitus sensation; Tinnitus severity; Tinnitus burden and 
severity. (DOCX 18 kb) 
Additional file 7: Grouping table reporting the different terminology 
used by authors to describe the same theoretical constructs 
describing complaints reported by significant others who are 
members of the family of a person with tinnitus. Each grouping 
considered the examples and/or explanations given by the study 
authors for each problem domain (examples reported in the text). All 
data come from just two studies [23, 31]. (DOCX 14 kb) 
Tinnitus, biomarkers and quality of life in an older population 
 
94 
   
Hall et al. Health and Quality of Life Outcomes (2018) 16:61 Page 14 of 15 
 
 
 
Authors’ contributions 
ABL and DAH conducted the electronic searches, KF conducted the manual 
searches. Screening and eligibility steps were carried out by ABL and RT, 
under guidance from DAH and KF. The workshop (15–20 April 2016, Lisbon) 
was organized by HFH and led by KF and data collection was conducted by 
KF, DAH, ABL, HFH, DER, TDM, SS, PC, VK, RT, CT, DR, and VML. KF and DAH 
led the domain-level grouping step, and DAH and KF conducted the data 
synthesis and CASP quality assessment. DAH and HFH contributed equally to 
all other stages of the protocol development, produced and approved the 
manuscript. All authors read, edited and approved the final manuscript. HFH 
and KF are the data guarantors. 
 
Ethics approval and consent to participate 
Not applicable. 
 
Competing interests 
The authors declare that they have no competing interests. 
 
Publisher’s Note 
Springer Nature remains neutral with regard to jurisdictional claims in 
published maps and institutional affiliations. 
 
Author details 
1Otology and hearing group, Division of Clinical Neuroscience, School of 
Medicine, University of Nottingham, Nottingham NG7 2RD, UK. 2National 
Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, 
Nottingham NG1 5DU, UK. 3School of Medicine, University of Nottingham, 
Nottingham NG7 2RD, UK. 4Department of Audiovestibular Medicine, 
Halliwell Health and Children’s Centre, Bolton NHS Foundation Trust, 
Farnworth, UK. 5ENT Department, Hospital Cuf Infante Santo - Nova Medical 
School, Travessa do Castro, 3, 1350-070 Lisbon, Portugal. 6WJCR - William 
James Center for Research, ISPA-Instituto Universitário, Rua Jardim do 
Tabaco, n°34, 1149-041 Lisbon, Portugal. 
 
Received: 7 May 2017 Accepted: 2 April 2018 
 
 
 
References 
1. McCormack A, Edmondson-Jones M, Somerset S, Hall DA. Systematic review 
of the reporting of tinnitus prevalence and severity. Hear Res. 2016;337:70– 
9. 
2. Davis A, El Rafaie A. Epidemiology of tinnitus. In: Tyler RS, editor. Tinnitus 
handbook. San Diego: singular publishing. Group. 2000:1–23. 
3. Martinez C, Wallenhorst C, McFerran D, Hall DA. Incidence rates of clinically 
significant tinnitus: 10-year trend from a cohort study in England. Ear Hear. 
2015;36(3):e69–75. 
4. Kirshner B, Guyatt G. A methodological framework for assessing health 
indices. J Chronic Dis. 1985;38(1):27–36. 
5. Kennedy V, Wilson C, Stephens D. Quality of life and tinnitus. Audiol Med. 
2009;1:1–12. 
6. Hall DA, Haider H, Szczepek AJ, Lau P, Rabau S, et al. Systematic review of 
outcome domains and instruments used in clinical trials of tinnitus 
treatments in adults. Trials. 2016;17(1):270. 
7. Tyler RS, Baker LJ. Difficulties experienced by tinnitus sufferers. J Speech 
Hear Disord. 1983;48(2):150–4. 
8. Sanchez L, Stephens D. A tinnitus problem questionnaire in a clinic 
population. Ear Hear. 1997;18:210–7. 
9. Sanchez L, Stephens D. Survey of the perceived benefits and shortcomings 
of a specialist tinnitus clinic. Audiology. 2000;39:333–9. 
10. World Health Organization. The WHOQOL Group. Development of the 
WHOQOL: Rationale and current status. Int J Ment Health. 1994;23(3):24–56. 
11. Scarinci N, Worrall L, Hickson L. The effect of hearing impairment in older 
people on the spouse: development and psychometric testing of the 
significant other scale for hearing disability (SOS-HEAR). Int J Audiol. 2009; 
48(10):671–83. 
12. Haider H, Fackrell K, Kennedy V, Hall DA. Dimensions of tinnitus-related 
complaints reported by patients and significant others: protocol for a 
systematic review. BMJ Open 2016;6e009171. 
13. Noblit G, Hare R. Meta-ethnography: Synthesising qualitative studies. 
Qualitative research methods series 11. California: Sage Publications; 1988. 
 
14. Vanneste S, Figueiredo R, De Ridder D. Treatment of tinnitus with 
cyclobenzaprine: an open-label study. Int J Clin Pharmacol Ther. 2012;50(5): 
336–44. 
15. Crocetti A, Forti S, Ambrosetti U, Del BL. Questionnaires to evaluate anxiety 
and depressive levels in tinnitus patients. Otolaryngol - Head Neck Surg. 
2009;140(3):403–5. 
16. Maes IH. Tinnitus: assessment of quality of life and costs: Universiteit 
Maastricht; 2014. 
17. Saldaña J. The coding manual for qualitative researchers: London: sage 
publications ltd; 2009. 
18. Andersson G, Vretblad P, Larsen HC, Lyttkens L. Longitudinal follow-up of 
tinnitus complaints. Arch Otorhinolaryngol - Head Neck Surg. 2001;127:175– 
9. 
19. Reich GE, Johnson RM. Personality characteristics of tinnitus patients. J 
Laryngol Otol. 1984;98(S9):228–32. 
20. Belli S, Belli H, Bahcebasi T, Ozcetin A, Alpay E, Ertem U. Assessment of 
psychopathological aspects and psychiatric comorbidities in patients 
affected by tinnitus. Eur Arch Otorhinolaryngol. 2008;265(3):279–85. 
21. Meikle MB, Henry JA, Griest SE, Stewart BJ, Abrams HB, et al. The tinnitus 
functional index: development of a new clinical measure for chronic, 
intrusive tinnitus. Ear Hear 2012;33. 2:153–76. 
22. Hallam RS, Jakes SC, Hinchcliffe R. Cognitive variables in tinnitus annoyance. 
Br J Clin Psychol. 1988;27:213–22. 
23. El Refaie A, Davis A, Baskill J, Lovell E, Owen V. A questionnaire study of the 
quality of life and quality of family life of individuals complaining of tinnitus 
pre- and post- attendance at a tinnitus clinic. Int J Audiol. 2004;43(7):410–6. 
24. Harrop-Griffiths J, Katon W, Dobie R, Sakai C, Russo J. Chronic tinnitus: 
association with psychiatric diagnoses. J Psychosom Res. 1987;31(5):613–21. 
25. Marciano E, Carrabba L, Giannini P, Sementina C, Verde P, Bruno C, et al. 
Psychiatric comorbidity in a population of outpatients affected by tinnitus. 
Int J Audiol. 2003;42:4–9. 
26. Henry JL, Kangas M, Wilson PH. Development of the psychological impact 
of tinnitus interview: a clinician-administered measure of tinnitus-related 
distress. Int Tinnitus J. 2001;7(1):20–6. 
27. Stobik C, Weber RK, Münte TF, Walter M, Frommer J. Evidence of 
psychosomatic influences in compensated and decompensated tinnitus. Int 
J Audiol. 2005;44(6):370–8. 
28. Andersson G, Edvinsson E. Mixed feelings about living with tinnitus: a 
qualitative study. Audiol Med. 2008;6(1):48–54. 
29. Sanchez L, Stephens SDG. Perceived problems of tinnitus clinic clients at 
long-term follow up. J. Audiol Med. 2000;9(2):94–103. 
30. Toft S. Tinnitus : effects on the patient and partner: University of Leicester; 
2003. 
31. Dineen R, Doyle J, Bench J. Audiological and psychological characteristics of 
a group of tinnitus sufferers, prior to tinnitus management training. Br J 
Audiol. 1997;31(1):27–38. 
32. Tyler R, Ji H, Perreau A, Witt S, Noble W, Coelho C. Development and 
validation of the tinnitus primary function questionnaire. Am J Audiol. 2014; 
23:260–72. 
33. Sourgen PM, Ross E. Perceptions of tinnitus in a group of senior citizens. 
South African. J Commun Disord. 1998;45:61–75. 
34. Hallam RS. Manual of the tinnitus questionnaire (TQ). London: The 
Psychological Corporation; 1996. 
35. Hiller W, Goebel G. A psychometric study of complaints in chronic tinnitus. J 
Psychosom Res. 1992;36(4):337–48. 
36. Hoekstra CEL, Wesdorp FM, van Zanten GA. Socio-demographic, health, and 
tinnitus related variables affecting tinnitus severity. Ear Hear. 2014;35(5):544– 
54. 
37. Alsanosi AA. Impact of tinnitus on quality of life among Saudi patients. 
Saudi Med J. 2011;32(12):1274–8. 
38. Kleinstäuber M, Jasper K, Schweda I, Hiller W, Andersson G, Weise C. The 
role of fear-avoidance cognitions and behaviours in patients with chronic 
tinnitus. Cogn Behav Ther. 2013;42(2):84–99. 
39. Newman CW, Jacobson GP, Spitzer JB. Development of the tinnitus 
handicap inventory. Arch Otolaryngol Head Neck Surg. 1996;122:143–8. 
40. Fetoni AR, Lucidi D, De Corso E, Fiorita A, Conti G, Paludetti G. Relationship 
between subjective tinnitus perception and psychiatric discomfort. Int 
Tinnitus J 2016;20(2):76–82. 
41. Wagenaar OV, Wieringa M, Mantingh L, Kramer SE, Kok R. Preliminary 
longitudinal results of neuropsychological education as first and sole 
intervention for new tinnitus patients. Int Tinnitus J. 2016;22;20(1):11–7. 
Tinnitus, biomarkers and quality of life in an older population 
 
95 
   
Hall et al. Health and Quality of Life Outcomes (2018) 16:61 Page 15 of 15 
 
 
42. Kaluzny W, Durko T, Pajor A. Impact of tinnitus on quality of life in the 
patients’ self-assessment. Polish Otolaryngol. 2005;59(2):271–6. 
43. Kuk FK, Tyler RS, Russell D, Jordan H. The psychometric properties of a 
tinnitus handicap questionnaire. Ear Hear. 1990;11(6):434–45. 
44. Stobik C, Weber RK, Munte TF, Frommer J. Psychosomatic stress factors in 
compensated and decompensated tinnitus. Psychother Psychosom 
Medizinische Psychol. 2003;53(8):344–52. 
45. Bankstahl US, Görtelmeyer R. Measuring subjective complaints of attention 
and performance failures – development and psychometric validation in 
tinnitus of the self-assessment scale APSA. Health Qual Life Outcomes. 2013; 
11:86. 
46. Kennedy V, Chéry-Croze S, Stephens D, Kramer S, Thai-Van H, Collet L. 
Development of the international tinnitus inventory (ITI): a patient-directed 
problem questionnaire. Audiological Medicine. 2005;3(4):228–37. 
47. Rutter DR, Stein MJ. Psychological aspects of tinnitus: a comparison with 
hearing loss and ear, nose and throat disorders. Psychol Health. 1999;14(4): 
711–8. 
48. Zirke N, Seydel C, Szczepek AJ, Olze H, Haupt H, Mazurek B. Psychological 
comorbidity in patients with chronic tinnitus: analysis and comparison with 
chronic pain, asthma or atopic dermatitis patients. Qual Life Res. 2013;22(2): 
263–72. 
49. Gomaa MAM, Elmagd MHA, Elbadry MM, Kader RMA. Depression, anxiety 
and stress scale in patients with tinnitus and hearing loss. Eur Arch Oto- 
Rhino-Laryngology. 2014;271(8):2177–84. 
50. Seydel C, Haupt H, Olze H, Szczepek AJ, Mazurek B. Gender and chronic 
tinnitus: differences in tinnitus-related distress depend on age and duration 
of tinnitus. Ear Hear. 2013;34(5):661–72. 
51. Ooms E, Vanheule S, Meganck R, Vinck B, Watelet JB, Dhooge I. Tinnitus 
severity and its association with cognitive and somatic anxiety: a critical 
study. Eur Arch Oto-Rhino-Laryngology. 2012;269:2327–33. 
52. Karatas E, Deniz M. The comparison of acoustic and psychic parameters of 
subjective tinnitus. Eur Arch Oto-Rhino-Laryngology. 2012;269(2):441–7. 
53. Cho CG, Chi JH, Song JJ, Lee EK, Kim BH. Evaluation of anxiety and 
depressive levels in tinnitus patients. Korean J Audiol. 2013;17:83–9. 
54. Wilson PH, Henry J, Bowen M, Haralambous G. Tinnitus reaction 
questionnaire: psychometric properties of a measure of distress associated 
with tinnitus. J Speech Hear Res. 1991;34(1):197–201. 
55. Jakes SC, Hallam RS, Rachman S, Hinchcliffe R. The effects of reassurance, 
relaxation training and distraction on chronic tinnitus sufferers. Behav Res 
Ther. 1986;24(5):497–507. 
56. Erlandsson SI, Hallberg LRM, Axelsson A. Psychological and audiological 
correlates of perceived tinnitus severity. Audiology. 1992;31:168–79. 
57. Jakes S, Hallam R, Chambers C, Hinchcliffe R. A factor analytical study of 
tinnitus complaint behaviour. Audiology. 1985;24:195–206. 
58. Urnau D, Tochetto TM. Characteristics of the tinnitus and hyperacusis in 
normal hearing individuals [Características do zumbido e da hiperacusia em 
indivíduos normo-ouvintes]. Arq Int Otorrinolaringol. 2011;15(4):468–74. 
59. Miguel GS, Yaremchuk K, Roth T, Peterson E. The effect of insomnia on 
tinnitus. Ann Otol Rhinol Laryngol. 2014;123(10):696–700. 
60. Cabral A, Tonocchi R, Ribas A, Almeida G, Rosa M, Massi G, Berberian AP. 
The efficacy of hearing aids for emotional and auditory tinnitus issues. Int 
Tinnitus J. 2016;20(1):54–8. 
61. Critical Appraisal Skills Programme (2017). CASP Qualitative Research 
Checklist.[online] Available at: http://media.wix.com/ugd/dded87_ 
25658615020e427da194a325e7773d42.pdf. Accessed 9 Apr 2018. 
62. Manchaiah V, Beukes EW, Granberg S, Durisala N, Baguley DM, Allen PM, 
Problems AG. Life effects experienced by tinnitus research study volunteers: 
an exploratory study using the ICF classification. J Am Acad Audiol. 2017; 
[Epub ahead of print] 
63. Fackrell K, Smith H, Colley V, Thacker B, Horobin A, Haider HF, Londero A, 
Mazurek B, Hall DA. Core outcome domains for early phase clinical trials of 
sound-, psychology-, and pharmacology-based interventions to manage 
chronic subjective tinnitus in adults: the COMIT'ID study protocol for using 
a Delphi process and face-to-face meetings to establish consensus. Trials. 
2007;18(1):388. 
64. Watts E, Fackrell K, Smith S, Sheldrake J, Hoare D. Why is tinnitus a problem? 
A qualitative analysis of problems reported by tinnitus patients. 10th 
International Tinnitus Research Initiative Conference. Nottingham, UK. 2016. 
http://www.tinnitusresearch.org/images/files/meetings/files2016/TRI2016_ 
Abstract_Book.pdf. Accessed 9 Apr 2018. 
 
65. Kamil RJ, Lin FR. The effects of hearing impairment in older adults on 
communication partners: a systematic review. J Am Acad Audiol. 2015;26(2): 
155–82. 
66. Prinsen CAC, Vohra S, Rose MR, Boers M, Tugwell P, Clarke M, Williamson PR, 
Terwee CB. How to select outcome measurement instruments for outcomes 
included in a “Core outcome set” – a practical guideline. Trials. 2016;17:449. 
67. Meikle MB, Griest SE, Stewart BJ, Press LS. Measuring the negative impact of 
tinnitus: a brief severity index. In Abstr Assoc Res Otolaryngol. 1995;167. 
Tinnitus, biomarkers and quality of life in an older population 
 
96 
 
  
5.2. Diagnosis and treatment of Tinnitus 
In the present study we intend to contribute to increase knowledge regarding 
tinnitus in order to allow improvements in its diagnosis and treatment. 
We have a subchapter regarding TINNET an European research network with the 
goal of coordinating 235 researchers, mathematicians and clinicians from different 
disciplines out of 30 participating countries in order to establish standards for tinnitus 
diagnosis and improve treatment efficacy. 
We had an international systematic review (SR) of existing tinnitus guidelines 
(Fuller et al., 2017). Another SR of outcome domains and instruments used in clinical 
trials of tinnitus treatment effectiveness in adults, the protocol for this SR was previously 
published (Hall et al., 2015). 
In order to demonstrate the diversity regarding tinnitus symptom also included 
in this subchapter is a scoping review about somatosensorial tinnitus and a study about 
the Delphi methodology used in order to obtain a consensus diagnosis criterion on this 
subtype of tinnitus. 
 
5.2.1. TINNET as an European research network for tinnitus 
TINNET is the acronym that stands for TINnitus research NETwork or TINnitus’s 
NEw Treatments. It was a Cost Action BM1306 - ‘Better understanding the 
Heterogeneity of Tinnitus to Improve and Develop New Treatments’. 
COST (Cooperation in Science and Technology) is a working network whose 
mission is to strengthen joint technical and scientific research in Europe. It is based on 
an intergovernmental cooperation network agreed by the representatives of 19 
European countries during the Ministerial Conference held in Brussels in November 
1971. In order to better manage the resources available in Europe, both in terms of 
scientific and technological knowledge as financial. Cost actions also have the mission of 
supporting young researchers.  
TINNET was a pan-European multidisciplinary network with the aim to identify 
pathophysiologically and clinically meaningful subtypes of tinnitus and their 
neurobiological underpinnings. It was launched on April 2014 and has lasted during four 
years (Figure 5.2-1). Specifically, this action had the major goal to facilitate (1) the 
identification of meaningful criteria for tinnitus subtyping, (2) the neurobiological 
underpinnings of the different tinnitus subtypes and (3) their relevance for response to 
treatment. This will be facilitated by standards for clinical assessment and outcome 
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measurement, by large-scale multicentre data assessment and by data management in 
a quality-controlled database. 
Figure 5.2-1 - Organization and objectives for TINNET Working Groups. 
COST Action BM1306 comprised 5 working groups (WG): WG1 Clinical, WG2 
Database, WG3 Neuroimaging, WG4 Genetics and WG5 Outcomes (Table 5.2-1). 
 
Table 5.2-1 - Five interactive working groups: objectives. 
WG 1 Clinical: Standard for phenotypes; disclosure of guidelines. 
WG 2 
Database 
WG3 
Neuroimaging 
Standard – Neuroimaging studies (EEG, MRI ...); 
Mechanisms of neuro-biological subtypes of tinnitus. 
Management and 
quality control; 
statistical analysis; 
Deployting the 
database on the site. 
WG 4 
Genetics 
Standard – collection, storage, sharing - Biobank; 
Genetic biomarkers. 
WG 5 
Results 
Standard – clinical trials, evaluation results; 
identification of clinical predictors. 
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WG 1 Clinical: Establishment of a standard for patient assessment and characterization 
Experts from different disciplines have joined forces to develop easy and 
meaningful guidelines for detailed clinical and phenotypic characterization of tinnitus 
cases and controls (symptom scoring instruments and specific validated self-report 
questionnaires) (Figure 5.2-3). 
Tinnitus evaluation (e.g. audiologic assessment, loudness, frequency, 
modulatory factors) but also comorbid conditions (e.g. hearing impairment, 
hyperacusis, depression, anxiety) and impact (tinnitus related handicap, quality of life) 
were be assessed.  
Figure 5.2-2 - Network Management and Organization. 
 
WG 2 Database establishment and implementation on the website 
Combining complemented disciplines such as clinicians, clinical trial and data 
documentation specialists, biostatisticians and mathematicians this WG had the goal of 
standardisation of data management (statistical analysis) and quality control, for 
development of strategies for hypothesis driven data analyses and for data driven 
analyses. They planned to extend the database to accommodate longitudinal data and 
develop statistical methods for analysing longitudinal data, to identify clinical, 
neuroimaging or genetic treatment predictors and strategies to advance the database 
in a self-learning expert system to assist clinicians in treatment decisions. 
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WG 3 Neuroimaging 
In this WG have participated clinical researchers and specialists in neuroimaging. 
They have established standard operation procedures (SOPs) for data acquisition, 
analysis development and standardization of innovative data-analysing methods (e.g. 
MRI (magnetic resonance tomography) - connectivity analysis, individual component 
analysis and EEG (electroencephalography), in order to identify the neurobiological 
mechanisms of the different forms of tinnitus (clinically relevant) and test neuroimaging 
as an endophenotypization strategy in tinnitus research. 
WG 4 Genetics 
This WG has joined clinicians, experts from molecular genetics, statistics and 
bioinformatics with the goal of creating a pan-European biobank to study the underlying 
genetic basis of tinnitus. They had the responsibility of establishment of SOPs for sample 
(blood) collection, storage, sharing and genetic analysis of the human genome as well 
for statistical analysis of genotypic data and correlation with clinical and neuroimaging 
data and for gene-gene and gene-environment interaction studies. 
WG 5 Standards for Treatment outcome measurement and central collection of results 
This WG brought together clinicians, experts for clinical research methodology, 
statisticians, and representatives of the health industry and patient organisations (for 
specification of outcome measurements relevant for patients). WG5 has established 
standards for outcome measurements in clinical trials to enable data collection of 
treatment results in the central database. And also defined standards for clinical trials 
in tinnitus and for outcome measurement both in clinical trials and in clinical routine 
(Figure 5.2-3).  
 
 
 
 
 
 
 
Tinnitus, biomarkers and quality of life in an older population 
 
100 
 
  
Figure 5.2-3 - Roadmap of WG5 activities. 
 
This European Concerted Research Action (COST Action) intended a stepwise 
approach which involved identification of (1) meaningful clinical and demographic 
characteristics for tinnitus subtyping, (2) tinnitus related changes of brain activity in the 
different forms of tinnitus, (3) intermediate genetic phenotypes for the identification of 
genetic factors in the pathogenesis of tinnitus and (4) predictors for response to various 
treatments. This approach required a coordinated effort from basic scientists, 
technicians and clinicians of different disciplines working together in ongoing close 
collaboration. Up to now 235 researchers out of 30 participating countries registered for 
being a participant in the TINNET Action. 
Haúla Haider has actively participated since the beginning of the TINNET 
(April/2014) as co-chair of clinical working group and member of the working group 5. 
She has participated in a Short Time Scientific Mission at University of Nottingham (UK), 
NIHR Nottingham Biomedical Research Centre, Hearing Sciences group, Division of 
Clinical Neuroscience, School of Medicine. She has also organized a training school and 
TINNET meetings and was member of WG1 and WG5 steering groups dynamically 
participating at scientific activities of both groups. The principal delivers from WG1 were 
the European survey about tinnitus assessment and treatment, a systematic review 
about existing tinnitus guidelines (Fuller & Haider et al., 2017), the Multidisciplinary 
European Guidelines for Tinnitus: diagnostics, assessment and treatment.  
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WG3 has established a consensus for neuroimaging data acquisition based on 
input from tinnitus experts in neuroimaging from across the world. Recommendations 
for electroencephalography (EEG) and magnetoencephaolography (MEG) are already 
available on the TINNET website. The recommendations for magnetic resonance 
imaging (MRI) are in the final stages of dissemination.  
WG4 have published an updating study exposing that the available evidence for 
genetics in tinnitus is scarce and addressing the ideal design of studies concerning 
tinnitus genetic should use concordance twin studies and optimize patient selection 
according to phenotype and/or etiology to avoid genetic interpretation bias (Lopez-
Escamez et al., 2016).  
From WG5, a systematic review about outcome domains and instruments used 
in clinical trials of tinnitus treatments in adults and a narrative synthesis of research 
evidence for tinnitus-related complaints as reported by patients and their significant 
others, member of Delphi steering group COMiT’ID, participating as key advisor involved 
in activities that conducted to the Delphi process of achievement of a core outcome set 
of recommended outcome that should be evaluated in tinnitus effectiveness treatment 
on sound, psychologic or pharmaceutics therapies. The action had its final meeting in 
March 2018 but there are still ongoing research networking activities. 
Tinnitus, biomarkers and quality of life in an older population 
102 
 
  
5.2.2. Different Teams, Same Conclusions? A Systematic Review of Existing 
Clinical Guidelines for the Assessment and Treatment of Tinnitus in Adults 
The data presented has been published by Fuller, T. E., Haider, H. F., Kikidis, D., 
Lapira, A., Mazurek, B., Norena, A., Rabau S., Lardinois R., Cederroth C.R., Edval, N.K., 
Brueggeman P.G., Rosing, S. N., Kapandais, A., Lungaard, D., Hoare D.J. & Cima, R.F.F. 
(2017) as is possible to see at 
 
Fuller, T. E.*, Haider*, H. F., Kikidis, D., Lapira, A., Mazurek, B., Norena, A., ... & Cima, R. 
F. F. (2017). Different teams, same conclusions? A systematic review of existing 
clinical guidelines for the assessment and treatment of tinnitus in adults. 
Frontiers in psychology, 8, 206. 
*Equal contribution 
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Background: Though clinical guidelines for assessment and treatment of chronic 
subjective tinnitus do exist, a comprehensive review of those guidelines has not been 
performed. The objective of this review was to identify current clinical guidelines, and 
compare their recommendations for the assessment and treatment of subjective tinnitus 
in adults. 
Method: We systematically searched a range of sources for clinical guidelines (as 
defined by the Institute of Medicine, United States) for the assessment and/or treatment 
of subjective tinnitus in adults. No restrictions on language or year of publication were 
applied to guidelines. 
Results: Clinical guidelines from Denmark, Germany, Sweden, The Netherlands, and the 
United States were included in the review. There was a high level of consistency across 
the guidelines with regard to recommendations for audiometric assessment, physical 
examination, use of a validated questionnaire(s) to assess tinnitus related distress, and 
referral to a psychologist when required. Cognitive behavioral treatment for tinnitus 
related distress, use of hearing aids in instances of hearing loss and recommendations 
against the use of medicines were consistent across the included guidelines. 
Differences between the guidelines centered on the use of imaging in assessment 
procedures and sound therapy as a form of treatment for tinnitus distress respectively. 
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Conclusion: Given the level of commonality across tinnitus guidelines from different 
countries the development of a European guideline for the assessment and treatment 
of subjective tinnitus in adults seems feasible. This guideline would have the potential 
to benefit the large number of clinicians in countries where clinical guidelines do not yet 
exist, and would support standardization of treatment for patients across Europe. 
Keywords: tinnitus, clinical guidelines, assessment, treatment, systematic review  
 
INTRODUCTION 
 
Tinnitus is essentially made up of two components, the phantom 
perception of a  sound  in  the  ears  or  head,  and  the  degree  
of emotional reaction to that percept. Tinnitus can  co-occur 
with several medical-otological disorders such as presbycusis, 
though etiology is unknown for the majority of tinnitus patients 
(Baguley et al., 2013b). In rare cases tinnitus indicates  a  
serious underlying pathology such as vascular troubles, vestibular 
schwannoma (VS), or otosclerosis (Baguley et al., 2013a). In 
most cases however subjective tinnitus is a benign symptom. In 
many patients co-morbidities exist such as anxiety, depression, 
insomnia, and concentration problems, all of which severely 
impair quality of life (Langguth et al., 2011). In 1–3% of cases 
tinnitus causes severe health problems, with a wide range of 
effects on daily life functioning (Davis and Refaie, 2000; Fujii 
et al., 2011; Kim et al., 2015). Evidence corroborates that the 
aversive psychological reactions, such as cognitive problems, 
negative emotions, and dysfunctional attentional processes are 
of main importance in leading to a severe tinnitus condition 
(Erlandsson and Hallberg, 2000; Andersson et al., 2006; Cima 
et al., 2011; Kleinstauber et al., 2013; McKenna et al., 2014; 
Handscomb et al., 2017). 
During the last decades, efforts have been made to better 
understand tinnitus pathophysiology and provide specialized 
treatments to patients (Kamalski et al., 2010; Cima  et  al.,  
2012; Langguth et al., 2013; Hoekstra et al., 2014). A large 
number of management strategies including various assessment 
and treatment procedures exist and have evolved but lack 
empirical support. For example, there is no evidenced treatment 
or licensed pharmacological therapy to eliminate the tinnitus 
percept (Langguth and Elgoyhen, 2012). The Cochrane Library 
lists 10 completed systematic reviews on different tinnitus 
treatments, all of which reported small numbers of studies of 
variable quality (e.g., Martinez-Devesa et al., 2010). These facts 
combined makes it difficult for healthcare professionals to decide 
what is best for which tinnitus patient. This is evidenced by the 
discrepancy between scientific and clinical perspectives on the 
management of tinnitus and the actual day-to-day practice in 
European healthcare settings (Hoare et al., 2012); tinnitus patient 
care is fragmented and ad hoc (Hoare and Hall, 2011; Hoare    
et al., 2012). To date there has been no overview of the number 
of existing clinical practice guidelines for tinnitus, the details 
included, their comparability, or their purpose. Clinical practice 
guidelines are defined as systematically developed statements  
to assist practitioner and patient decisions about appropriate 
health care for specific clinical circumstances (Field and Lohr, 
 
1990). They have the benefit of simplifying and standardizing 
assessment and treatment options for clinicians and patients.     
A European Union guideline would extend this benefit to 28 
countries. This systematic review aims to identify, review, and 
examine the clinical guidelines which do exist for tinnitus. The 
tinnitus assessments (diagnostics and measures), processes, and 
treatment options recommended by the respective guidelines will 
be compared and summarized. 
 
METHODS 
The aims, the work plan, and the protocol for this systematic 
review were developed by TINNET Working Group 1, a COST 
Action BM1306 (2014–2018) to create a pan-European tinnitus 
research network (http://tinnet.tinnitusresearch.net/). This 
review was registered with PROSPERO, the international register 
of systematic reviews (protocol number: CRD42016038588) 
prior to commencing the literature search. The review was 
exempt from human ethics procedures as there were no human 
participants and only secondary sources of data (the clinical 
guidelines) were used. 
Eligibility Criteria 
Records were  considered  eligible  for  inclusion  if  they  fit  
the definition of a guideline by describing and making 
recommendations on the assessment, diagnosis, and or treatment 
of subjective tinnitus for adults (i.e., people aged 16 years or 
older). Those records were required to identify or describe 
themselves as guidelines, and be the most recent  guideline  
form the country of origin. No publication date or language 
restrictions were imposed on the eligibility of the guidelines. 
Guidelines were excluded if they were for objective tinnitus, 
pediatrics, referred only to the triage or referral pathways for 
assessing and treating tinnitus, or if they were a guide for only one 
specific type of assessment or treatment procedure for tinnitus. 
Literature Search 
The literature search for clinical guidelines included the Medline, 
PubMed, and the Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), and EMBASE databases. In addition to 
these the National Guideline Clearinghouse (www.guideline. 
gov), National Institute for Health and Clinical Excellence 
(NICE; https://www.nice.org.uk/), Guideline International 
Network (GIN; http://www.g-i-n.net/), Google, and hand-search 
of reference lists of any included guidelines was undertaken. 
International experts were also contacted to ask if they were 
aware of any guidelines that had not already been identified from   
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the search results. The date that the search for guidelines was 
first conducted was 2 May 2016 and was undertaken by TEF and 
HH using “tinnitus” and “guideline” as the two key terms. The 
final search was conducted on 24 June 2016. 
 
Study Selection 
Two reviewers independently screened search results by title and 
abstract, and then by full text if required. The first 20 pages      
of search results from Google, and all search results from GIN, 
NICE, and the National Guideline Clearinghouse were screened. 
In the event of disagreements, a third reviewer (BM) acted as an 
arbiter. As an additional check and in line with other systemic 
review searches using internet search engines, a post-hoc rule of 
stopping searching after three consecutive pages without new 
search results was applied. In this case, no new search results were 
identified after the first eight pages. 
 
Data Extraction 
Data extraction was undertaken using a tailored form that had 
been pilot tested and was  emailed  to  reviewers  in  the  form 
of an Excel spreadsheet. A document with guidance on the 
extraction of information for each of the items was provided to 
each of the reviewers to improve consistency of data extraction. 
Data extraction from each guideline was undertaken  by  at  
least two reviewers who were native speakers of or fluent in   
the language in which the guideline was published. Reviewers 
extracted information from the guidelines regarding items about 
the: country and year of publication, availability, author details, 
sponsor/funder involved, scope, target audience, developers and 
process related to the guideline, recommendations for assessment 
and treatment procedures, the level of evidence and type of rating 
system used (e.g., Oxford) related to the recommendations, and 
items related to the implementation and revision of the guideline. 
 
Data Management 
HH and TEF were responsible for data management and 
maintained editorial rights. All identified records were saved into 
a Microsoft word master file and then saved in pdf-copy. 
 
Quality Assessment and Risk of Bias 
All reviewers of the guidelines also completed the AGREE II tool 
(Brouwers et al., 2010) to assess the quality of the guidelines. 
AGREE II is an international tool to assess the quality and 
reporting of practice guidelines (www.agreetrust.org). It contains 
23 items grouped under six guideline domains. Each item is 
scored on a 1–7 scale where 1 = “Strongly disagree” and 7 = 
“Strongly agree.” Scores are standardized to provide an overall 
percentage score. Previous reviews have used a 60% marker to 
distinguish high and low quality guidelines (Sanclemente et al., 
2014; Ruszczynski et al., 2016). 
Details relating to the sources of funding, professional 
affiliations, and editorial independence of the guideline 
developers were extracted as indicative of risk of bias. 
 
Data Synthesis 
Data extracted by the reviewers were collated and integrated 
into summary tables and a narrative synthesis describing 
the similarities and differences between the clinical practice 
guidelines was completed. 
 
RESULTS 
Five clinical guidelines for tinnitus were ultimately included in 
this review (see Figure 1 for details of the search and selection 
process). They were guidelines from Denmark (Jørgensen et al., 
2007), Germany (The Association of the Scientific Medical 
Societies, 2015), The Netherlands (Dutch Association for Ear 
Nose Throat and Head surgery [Nederlandse Vereniging voor 
Keel – Neus – Oor heel kunde en Heelkunde van het Hoofd – 
Halsgebied], in press), Sweden (Idrizbegovic et al., 2011), and 
United States (Tunkel et al., 2014). Several documents were 
excluded as by definition not providing a guideline. For example, 
the Australian audiology clinical practice standards (Audiology 
Australia, 2013) underwent full-text screening but was not 
included as it only related to audiological management and had 
a brief section on tinnitus assessment. The UK Good Practice 
Guide (Department of Health, 2009) also was excluded as it 
explicitly states: “This Good Practice Guide to the delivery of 
services is not, and does not aim to be, an evidence-based 
guideline for clinical practice with individual patients” (p. 5). 
The Tinnitus Research Initiative (TRI) algorithm (Biesinger et al., 
2010), after some debate within the review team, was also 
excluded because it was judged not to be a “clinical guideline.” 
A list of full text documents considered but excluded is in 
Appendix 1. 
Although there was not a restricting time period for the 
guidelines, no guidelines older than 10 years were identified. 
With exception of the Danish guideline (published in 2007) all 
were developed during the last 5 years. 
 
Details about Development of the Clinical 
Guidelines 
Table 1 provides detailed information about the stakeholder 
involvement, rigor of development, and the editorial 
independence associated with the respective clinical guidelines. 
All the guidelines included information on the professional 
backgrounds of the participants in the respective development 
groups and in three out of the five cases (American, Dutch,    
and German), provided information on how views of funding 
bodies and competing interests were addressed. Although patient 
groups and the public were consulted in the development of three 
guidelines (American, Dutch, and German), the actual expected 
users of the guidelines were health professionals. 
Details were provided in all guidelines (with the exception  
of those from Sweden which did not provide methodological 
information) about how literature was located and used to 
inform the respective recommendations. That is, details of search 
strategies using MeSH and other search terms and databases such 
as Medline and PsychInfo were included. Tools and criteria used 
to assess the evidence included the: Oxford Centre for Evidence 
Based Medicine (U.S. and German guidelines) and American 
Academy of Paediatrics’ (American guideline) evidence criteria 
respectively, the AMSTAR checklist (Dutch guideline), and   
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the GRADE ranking system of trust in conclusions of the 
literature (Dutch guideline). American, Danish, Dutch and 
German guidelines all provided information  and  referred  to 
the research literature associated  with  each  recommendation 
as well as describing their methods for reaching consensus on 
each recommendation. The Dutch, German and U.S. guidelines 
consider the strengths and limitations of the research literature 
and were reviewed externally prior to publication. Similarly, 
those three guidelines also state a year by and/or describe 
conditions under which they would be revised. 
 
Assessment Recommendations in the Clinical 
Guidelines 
Table 2 compares assessment recommendations between the 
respective national tinnitus guidelines. All guidelines, except 
the Danish, recommend a clinical history (anamnesis/targeted 
history/special tinnitus anamnesis) be taken. 
All guidelines describe the need for physical examination   
by an ENT doctor, although physical examination is not 
explicitly referred to in the Swedish guideline. The American 
guideline recommends examination to exclude objective tinnitus, 
cardiovascular disease and vascular lesions, neurologic diseases, 
middle or outer ear infection/disease, vertigo,  head-neck 
masses, or other treatable conditions. The German guideline 
additionally mentions cervical, dental, and temporomandibular 
joint functional exploration in a silent environment to evaluate 
tinnitus modulation. 
Audiological assessment was recommended in all the included 
guidelines. The majority refers to audiometry as a general 
category, but the  German  guideline  provides  most  detail.  
For example, it  specifies  details  relating  to  the  assessment  
of oto-acoustic measurements, brainstem auditory evoked 
responses, caloric tests, determination of tinnitus loudness and 
frequency using narrow-band noise and pure tones, residual 
inhibition, Feldmann masking curves (Feldmann, 1984), and 
loudness discomfort level. None of the other guidelines included 
in this review recommend psychoacoustic measurements of 
tinnitus frequency or intensity. 
The German guideline does not refer to specific psychological 
assessments though the other guidelines do in varying terms. 
For example, when tinnitus is severe or accompanied by 
psychological factors, the Swedish guideline recommends 
psychological assessment while the Danish guideline 
recommends a structured interview. The  American  guideline 
on the other hand recommends that clinicians distinguish 
between patients with or without bothersome tinnitus for 
subsequent referral (when necessary) to a psychologist or 
psychiatrist. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1 | PRISMA flowchart showing the stages of guideline search, screening and inclusion.  
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TABLE 1 | Summary of guideline development by country.  
Country Professionals involved Views of patients considered Target users Views of funding body Competing interests 
 
  
 
Germany Audiologists, psychiatrist, psychologists, 
otolaryngologists, dentists, pediatricians, 
neurologists, and patient representative 
groups 
Patient representative groups were included 
in the guideline development group; 
contributed to external review on draft 
documents, and patient related information 
was also considered from the results of a 
literature review 
Physicians (especially ENT), phoniatry 
and pediatric audiology, psychiatry, 
psychosomatic, neurology, mouth, 
jaw, and facial surgeons and dentists, 
psychologists, general practitioners 
A statement concerning financial 
and other interests and editorial 
independence is included. 
Competing interests are declared 
and when relevant, stakeholders 
with competing interests were 
excluded 
 
 
Denmark Speech Pathologist and hearing therapists  NS Hearing therapists NS NS 
 
Netherlands Details provided. ENT-doctors, 
psychologist, clinical physicist-audiologist 
Dutch Association of the Hearing Impaired 
consulted. A literature review regarding 
patient preferences was also conducted 
ENT doctors, audiology centers, 
GP’s, psychologists, psychiatrists 
A statement of independence 
was signed by professionals 
involved 
Competing interests are declared 
 
 
 
USA Paediatric and adult otolaryngologists, 
otologists/neurotologists, geriatrician, 
behavioral neuroscientist, neurologist, 
audiologist, family physician, radiologist, 
psychiatrist, psycho-acoustician, nurse, 
physician, and consumer advocates 
Yes: also included a draft of the guideline 
being made available for public comment 
Any clinician, health care provider, 
specialty physicians, and 
non-physician providers such as 
audiologists and mental health 
professionals 
Funded by American Academy 
of Otolaryngology—Head and 
Neck Surgery Foundation but no 
statement of independence from 
the process 
Competing interests are declared 
 
 
 
Sweden Partial details provided—included medical 
doctors, and professional representatives 
from the tinnitus teams for diagnostics and 
rehabilitation 
NS Staff at the audiology and balance 
clinic at Karolinska University Hospital 
and professionals that might refer to 
the clinic (GPs, ENTs or audiologist) 
NS NS 
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TABLE 1 | Continued 
 
 
Country Methods used Evidence criteria Category of 
evidence* 
Strengths and 
limitations 
Methods for reaching 
consensus 
Consequences of the 
recommendations 
Link between 
evidence and 
recommendations 
Peer review? Update of the 
guidelines? 
 
 
 
Germany Systematic 
methods used, 
details provided in 
the guideline 
Classified according 
to Oxford Centre of 
Evidence-based 
Medicine criteria 
1a Strengths and limitations 
of the body of evidence 
are clearly described 
Formal consensus 
technique 
The guideline includes 
health benefits, side 
effects and risks 
formulating the 
recommendations 
There is an clear link 
between the 
recommendations 
and the supporting 
evidence 
External review Due in 2020. 
 
 
 
Denmark Systematic 
methods used, 
details provided in 
the guideline 
NS The guidelines are 
based on literature, 
and articles based 
on the consensus of 
leading 
professionals in the 
field of audiology 
(evidence level IV) 
NS Informal consensus. All 
recommendations are 
based on the ICF model 
NS Each 
recommendation is 
provided with an 
argument based on 
relevant literature 
Not peer NS 
reviewed 
 
 
 
Netherlands Systematic 
methods used, 
details provided in 
the guideline 
Based on AMSTAR 
checklist 
1a, 1b, IV The strength of the 
evidence is specified 
according to GRADE. 
Evidence tables describe 
limitations and strengths 
of the included studies 
Recommendations were 
evidence based and the 
importance the 
workgroup gave to them 
conforms to GRADE 
Recommendations were 
made considering the 
scientific value, 
preferences of the 
patient, costs, and 
availability of the 
organization 
There is a clear link 
between the 
recommendations 
and the supporting 
evidence 
External review Update due in 2020 
or sooner if new 
compelling evidence 
warrants earlier 
consideration 
 
 
 
USA Systematic 
methods used, 
details provided in 
the guideline 
Based on criteria 
from the Oxford 
Centre for 
Evidence-Based 
Medicine 
American Academy 
of Pediatrics 
Categories of 
evidence (A, B, C, 
D, and X) updated 
to be in accordance 
with Oxford Centre 
for Evidence-Based 
Medicine 
Strengths and limitations 
of the body of evidence 
are clearly described 
This guideline was 
developed using an 
explicit and transparent a 
priori protocol for 
creating actionable 
statements based on 
supporting evidence and 
the associated balance 
of benefit and harm 
The benefits and harms 
of the recommendations 
have been considered for 
each recommendation. 
There is an clear link 
between the 
recommendations 
and the supporting 
evidence 
External review Update due in 
2018/9 or sooner if 
new compelling 
evidence warrants 
earlier consideration 
 
 
 
Sweden No method reported No evidence criteria No evidence 
provided 
None provided. NS NS NS NS NS 
 
 
*Unless stated, the level of evidence refers to/uses the Oxford Centre for Evidence Based Medicine criteria (GRADE system consists of 4 grades of degree of trust in conclusions of the literature: high, moderate, low, and very low) NS, 
not specified; ENT, Ear Nose Throat; GP, General Practitioner. 
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TABLE 2 | Clinical guideline recommendations regarding assessment of patients with tinnitus. 
 
Guideline Physical examination Hearing and audiology tests Psychological 
assessment 
Assessment 
tools/questionnaires 
recommended 
Other assessment 
procedures 
Procedures not 
recommended 
Germany Orientating neurological • Pure tone audiometry NS • Goebel-Hiller Tinnitus • Special tinnitus anamnesis • Acoustic examination 
 assessment of cervical spine, • discomfort, possibly with  Questionnaire, (see Structured Tinnitus with more than 84 dB 
 vestibular is with examination of categorical loudness scaling  • VAS or other validated Interview (Goebel and Hiller, 1 week after acute 
 denture (including TMJ) in silence • determining of tinnitus loudness  scales 2001) tinnitus or tinnitus 
 to screen modulation of tinnitus and frequency using narrow-band   • X-rays of the cervical spine, if exacerbation 
 • Orientating examination of noise and pure tones   further indicated also  
 functioning of N. facialis • residual inhibition   functional images  
 • ENT examination including • determining the minimum masking     
 tympanic membrane level by white noise and pure     
 microscopy, tones; masking curves according     
 asopharyngoscopy and to Feldmann     
 eustachian respectively • tympanometry and acoustic reflex     
 • stethoscopic examination of including recording possible     
 the ear and of the carotid changes due to breathing or heart     
 artery, particularly in pulsatile rate     
 tinnitus • TEOAE and/or DPOAE     
  • brainstem auditory evoked     
response (BAER) 
• preliminary vestibular examination 
possibly including caloric testing 
• Brainstem audiometry (BERA) 
when medically justified, 
economically viable and likely to be 
 useful in informing counseling 
might be of potential benefit 
 
Denmark NS • Audiometry (performed by ENTs) • Structured interview • THI-DK If necessary also: NS 
  • LDL/UCL  • VAS-scale for hyperacusis • ABR,  
  • If necessary also: ABR  • Tværfaglig Tinnitus • CT/MRI,  
    Screening (Danish tool • blood samples,  
    assessing signs of • other neurological tests  
    anxiety)   
Netherlands • Anamnesis, • Audiometry (Air and bone • Detailed assessment • TQ, mini-TQ • MRI/MRA, • Not to use MRI with 
 • ENT-assessment inclusive conduction) regarding the nature how • THI • CT, every patient with 
 otoscopy and tuning fork • Speech audiometry tinnitus impacts on daily • TFI • DSA (angiography) non-pulsatile, 
 tests,  life and functioning, • THQ  unilateral tinnitus. 
 • Blood pressure measurement,  comorbid symptoms • HADS   
 • Flexible nasofaryngoscopy,      
 • Palpation of neck and area      
 around ear      
      
(Continued) 
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TABLE 2 | Continued 
Guideline Physical examination Hearing and audiology tests Psychological 
assessment 
Assessment 
tools/questionnaires 
recommended 
Other assessment 
procedures 
Procedures not 
recommended 
 
 
 
USA • Targeted history and physical 
examination of the head and 
neck including otoscopy and 
neurologic examination. 
• When pulsatile tinnitus is 
reported, the examination 
should focus on identification 
of cardiovascular disease and 
vascular lesions 
• Prompt, comprehensive 
audiological examination (Tonal and 
Speech audiometry and 
Immittance) in patients with tinnitus 
that is unilateral, persistent (≥6 
months), or associated with hearing 
difficulties (Strong 
recommendation); 
• Initial comprehensive audiological 
examination (including ear specific 
masked air and bone conduction) 
in patients who present with tinnitus 
regardless of laterality, duration, or 
perceived hearing status (Option) 
• Distinction between 
patients with bothersome 
tinnitus from patients with 
non-bothersome tinnitus. 
• Assess degree of tinnitus 
related disability (including 
baseline measurement for 
the purpose to establish 
effects of treatment). 
• Assess if further 
psychological treatment 
required 
• TQ, 
• TEQ, 
• THQ, 
• TRQ, 
• THI, 
• TFI 
NS • Imaging studies 
unless patients have 
one or more of the 
following: tinnitus 
that localises to one 
ear, pulsatile tinnitus, 
focal neurological 
abnormalities, or 
asymmetric hearing 
loss 
 
 
 
Sweden NS • Audiometry (including LDL when 
necessary) 
• Speech and speech in noise test 
and impedance audiometry 
• ABR and MRI when necessary 
• In case of severe tinnitus: 
the first encounter with 
the psychologist/ 
psychiatrist is 
investigative and 
informative. (1) symptoms 
tinnitus, (2) individual’s 
mental status, (3) the 
overall life situation 
• BAS (basic own 
questionnaire), 
• THI 
• HADS (when necessary) 
• Anamnesis focused on tinnitus NS 
onset, laterality, character and 
patients’ problems. 
• Consideration of psychological 
factors and somatosensory 
factors 
 
 
ABR, Auditory brainstem response; BAER, Brainstem auditory evoked response; CT, Computer tomography; DSA, Digital subtraction angiography; DPOAE, Distortion product optoacoustic 
emission; ENT, Ear nose throat; GP, General Practitioner; HADS, Hospital Anxiety and Depression Scale; LDL, Loudness discomfort level; MRA, Magnetic resonance angiography; MRI, Magnetic 
resonance imaging; TEOAE, Transient evoked optoacoustic emission; TEQ, Tinnitus evaluation questionnaire; TFI, Tinnitus functional index; THI, Tinnitus handicap inventory; THQ, Tinnitus 
handicap questionnaire; TMJ, Temporomandibular joint; TQ, Tinnitus questionnaire; TRQ, Tinnitus reaction questionnaire; UCL, Uncomfortable listening level; VAS, Visual analog scale. 
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The Tinnitus Handicap Inventory (THI; Newman et al., 1996, 
1998) is the most frequently referred to assessment questionnaire 
followed by Tinnitus Questionnaire (TQ; Goebel and Hiller, 
1994). Visual Analog Scales (VAS; e.g., Germany, Denmark) and 
the Hospital Anxiety and Depression Scale (HADS; Zigmond 
and Snaith, 1983, e.g., The Netherlands, Sweden) were referred 
to by at least two guidelines. The American guideline referred 
to a large number of questionnaires including the: TQ (Goebel 
and Hiller, 1994), THI (Newman et al., 1996, 1998), Tinnitus 
Effects Questionnaire (TEQ; Hallam et al., 1988), Tinnitus 
Handicap Questionnaire (THQ; Kuk et al., 1990), Tinnitus 
Reaction Questionnaire (TRQ; Wilson et al., 1991), and Tinnitus 
Functional Index (TFI; Meikle et al., 2012). 
Several guidelines make recommendations for or  against  
the use of other assessment related procedures. For example,  
the German guideline refers to X-rays of the cervical spine. 
Although three guidelines recommend magnetic resonance 
imaging (MRI) as an assessment of  tinnitus,  The  American 
and the Dutch guideline recommend against it, unless patients 
have one or more of: tinnitus that localizes to one ear, pulsatile 
tinnitus, focal neurological abnormalities, or asymmetric hearing 
loss. The German guideline also recommends against acoustic 
examination using sound pressure levels more than 84 dB 1 week 
after acute tinnitus or tinnitus exacerbation. 
 
Summary of Recommendations Regarding the 
Assessment of Subjective Tinnitus 
• Conduct a thorough physical examination to exclude possible 
(physical) causes of tinnitus (three of five guidelines; not stated 
in Danish and Swedish). 
• Complete a thorough audiological assessment (all guidelines). 
• Establish the degree to which a patient experiences subjective 
tinnitus as bothersome or distressing using a validated and 
reliable multi-item questionnaire such as the TQ, THI, TFI, 
or HADS (all guidelines). 
• In situations where patients appear to be experiencing a degree 
of distress or difficulties related to living with tinnitus, consider 
making a referral for an assessment by a psychologist or 
psychiatrist (four of five guidelines; not stated in German 
guideline). 
• Variation exist in recommendations regarding the use of 
imaging studies (e.g., MRI). 
 
Treatment Recommendations across the Guidelines 
Table 3 compares therapeutic recommendations for the 
treatment of subjective tinnitus between the respective national 
tinnitus guidelines; note the Danish guideline is not included    
in this table as it provides only recommendations regarding 
assessment procedures. Across the guidelines there is generally 
a high degree of consistency in the recommendations for or 
against: the use of medicines (prescribed drugs and herbal 
supplements); audiological and psychological interventions; and, 
transcranial magnetic stimulation. Greatest variation occurs in 
the recommendations concerning the use of therapies involving 
sound such as Tinnitus Retraining Therapy (TRT). 
There is a consensus that medicines should not be prescribed 
for the treatment of subjective tinnitus, though some variation  
in the level of specificity that each guideline has. For example, 
the German guideline lists specific medicines that should not   
be prescribed for the treatment of tinnitus. The German and 
Swedish do however note that medicines such as antidepressants 
might be prescribed to treat comorbid conditions. Herbal 
supplements such as Gingko biloba are also specifically 
recommended against being used in all guidelines except for 
Sweden which does not make recommendations for or against 
their use. 
The use of hearing aids is recommended by all guidelines but 
only when clinically meaningful hearing loss is also present in 
people suffering from tinnitus. The use of a cochlear implant    
is mentioned in the Dutch and German guidelines and only 
recommended when there is profound hearing loss or deafness 
in addition to tinnitus. The Dutch guideline is the only one       
to provide scores on tinnitus questionnaires  (e.g.,  TQ,  THI) 
for when such interventions should be considered (e.g., it 
recommends referral to specialized stepped-care CBT for tinnitus 
in cases where TQ score is greater than 30, in combination with 
a clinically relevant request for healthcare by the patient, as is 
judged by the referring party). 
Psychological interventions for tinnitus can potentially 
include a wide range of components but there is general 
consensus on the use of two of them. In particular, the provision 
of information and education about tinnitus and treatment 
options is consistently recommended across the guidelines 
although there is some variation in the specificity of the content 
that each provides. Second, specialized CBT for tinnitus is 
specifically recommended by all the guidelines except for Sweden 
which mentions it only in relation to the presence of stress, 
anxiety, or depression. 
Least consistency exists across the guidelines in relation to 
TRT. Specifically, the Dutch guideline recommends that TRT can 
only be contemplated if tinnitus is very mild (TQ < 30) and   
the patients specifically asks for TRT, the American guideline 
indicates that sound therapies “may” be recommended to 
patients with tinnitus, while the Swedish guideline recommends 
that sound stimulation be used as part of TRT for people  
without hearing loss. The German guideline recommends the 
use of notched music therapy, but  recommends  against  the  
use of TRT. 
In relation to other less commonly used treatments (such     
as acupuncture or hyperbaric oxygen), the guidelines mostly 
indicate that there is an insufficient body of evidence to be able 
to make recommendations for or against their use. 
Lastly, three guidelines (Germany, The Netherlands, and 
U.S.) either caution that there is insufficient evidence, or make 
additional recommendations against the use of transcranial 
magnetic stimulation (rTMS), transcranial direct current 
stimulation (tDCS), dietary supplements, neuromodulation 
treatments, and hearing aids for tinnitus patients  without 
hearing loss. 
 
Summary of Therapeutic Recommendations 
regarding the Treatment of Subjective Tinnitus 
• Provide information about tinnitus and treatment options (all 
guidelines). 
• Use hearing aids only when patients also experience hearing 
loss (all guidelines). 
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TABLE 3 | Tinnitus guideline recommendations regarding treatments for tinnitus.  
Country Medicine Audiological Psychological Sound therapies Other Treatments recommended 
against using 
 
Germany • None for tinnitus but 
refers to, for example, 
some for co-morbid 
depression, e.g., 
glutamate-antagonists. 
• Hearing aids for patients with 
hearing loss; Cochlear 
Implants for patients with 
deafness. 
• General counseling (including 
information provision). 
• Tinnitus specific CBT (aimed 
at reducing attention focusing 
toward the ear noise, 
reappraisal of the tinnitus and 
its consequences) individual or 
group-settings, also treatment 
for comorbidities. 
• Hospital treatment for 
decompensated tinnitus 
and/or with severe psychiatric 
comorbidity. 
• An absence of conclusive 
evidence of effectiveness for 
self-help groups. 
• Audio therapy including 
“notched music,” “coordinated 
reset” or music therapy. 
• Absence of evidence of 
effectiveness for: 
acupuncture, cervical 
vertebral spine therapy/ 
physiotherapy, hyperbaric 
oxygen; and, electric 
stimulation (e.g., 
transcutaneous electric 
stimulation, ear and 
cervical spine; vagus 
stimulation); Acoustic 
Coordinated-Reset 
Neuromodulation. 
• Uncertain 
recommendation for 
rTMS. 
• Sound therapy including Noiser 
and TRT. 
• Hearing aids for patients with 
only tinnitus. 
• Medicines (including: steroids, 
melatonin, antidepressants, 
Sulpirid, Apraxolam, Sertraline, 
Botox A, Pramiprexol, 
Nortriptyline, Piribedil, 
Vardenafil, Trazodone, 
Atorvastatin, Gabapentin, 
anticonvulsants, Paroxetine, 
Lamotrigine, Cyclandelat, 
Baclofen, Nicotinamide, 
Tocainid, Misoprostol, 
Egb 761, Amitriptyline, 
Misoprostol, Pramipexole 
Dopamine. 
• Herbal medicines and vitamins 
(including Ginkgo biloba zinc). 
 
 
 
Netherlands   None • Consider a trial of hearing aids. 
• In patients with high TQ (>60) 
or THI (>78) scores, and have 
severe hearing loss or 
deafness and have not 
responded to CBT, consider 
Cochlear Implant. 
• Educational material about 
tinnitus and treatment options 
considered essential. 
• Specialised CBT for patients 
with TQ > 30 or THI >36. 
• TRT can only be contemplated 
in case tinnitus is very mild 
(TQ<30) and the patients 
specifically asks for TRT. 
None • rTMS. 
• TDCS. 
• Gingko biloba. 
• Acupuncture. 
• Auditive perceptual training. 
• Hyperbaric oxygen. 
 
 
 
Sweden • None for tinnitus 
specifically but does 
state that if necessary, 
sleeping pills or 
antidepressants, can be 
used to treat sleep 
disorders or depression 
(no drug types, names, 
or dosage provided). 
• For people with tinnitus and 
hearing loss hearing aids are 
fitted. 
• Individual or group tinnitus 
information meetings. For 
patients without hearing loss, 
this is based on a modified 
version of TRT protocol. 
• There is reference to CBT in 
case of stress/ anxiety/ 
depression, but no clear 
recommendation. 
• Sound stimulation as part of 
TRT for people without hearing 
loss. 
• For middle ear 
dysfunctions such as 
otosclerosis, surgery is 
possible – no clear 
recommendation is 
provided. 
• For tensions or pain in the 
jaw, neck, shoulders or 
back, referral to “bite” 
therapist, or 
physiotherapist. 
None 
 
 
(Continued) 
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• Specialised CBT for tinnitus should be offered to patients 
(three of four guidelines; Sweden refers to use of CBT in 
context of co-morbid anxiety or depression). 
• There is a lack of consensus on the use of TRT for tinnitus. 
• Prescribed medicines and herbal supplements should not be 
used for the treatment of tinnitus (all guidelines). 
• Treatment with TMS is recommended against by Dutch and 
U.S. guidelines, and German guidelines give an “uncertain” 
recommendation. 
 
Quality Assessment of the Guidelines 
The AGREE II tool was used by the authors who undertook  
data extraction of the respective guidelines and the summarized 
results are shown in Table 4. In general the domains of 
“stakeholder involvement” and “clarity of presentation” 
respectively by guideline developers were rated high (good 
quality). Conversely, ratings on the domain of “applicability” 
which refers to how the guidelines might be disseminated, 
implemented and evaluated were low. For the domains 
addressing the scope and purpose of the guidelines, rigor of 
development and editorial independence, a pattern emerged 
whereby the American, Dutch and German guidelines were rated 
considerably higher (AGREE II scores >60% on all domains) 
than the Danish and Swedish guidelines (AGREE II scores <60% 
on all domains). 
 
DISCUSSION 
This systematic review aims to compare existing clinical 
guidelines for the assessment and treatment of subjective tinnitus 
in adults. Five guidelines, developed in the last 10 years within 
Europe, Scandinavia, and North America  were  included  in  
the review. Although there are differences in some specific 
recommendations for assessment and treatment procedures 
across the guidelines, in general, commonalities across guidelines 
were high. The fact that there are differences in some of the 
recommendations is not surprising and appears to reflect the 
relatively young state of the field and the evolving nature of 
assessment and treatments for subjective tinnitus—a symptom 
with a high level of heterogeneity. On the other hand, the level 
of agreement, for example, in the recommendation of specialized 
cognitive behavioral therapy reflects the growing evidence base 
for the effectiveness of this treatment to alleviate patients’ distress 
and impairment, even though significant changes in the tinnitus 
percept itself as a result of CBT have been proposed, though not 
yet assessed across studies. 
When the methods of the development of guidelines were 
reported, it was clear that the respective groups were making 
efforts to be transparent, systematic, and using the best available 
evidence base, and frequently linking recommendations to 
specific research literature. For example, systematic reviews and 
meta-analyses were referred to whenever available to inform 
recommendations. It should be noted though that  there  is  a 
lack of high quality studies or powered randomized trials of 
some treatments either for practical or methodological reasons. 
Regardless, the strengths and limitations of the evidence for 
particular recommendations were included for the majority TA
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TABLE 4 | Summary of AGREE II domain scores (%) by country. 
 
 Scope & Purpose Stakeholder involvement Rigour of development Clarity of presentation Applicability Editorial independence 
Germany 61 94 83 89 71 67 
Denmark 52 44 24 59 2 17 
Netherlands 81 100 97 100 9 100 
USA 86 97 93 100 71 88 
Sweden 42 42 1 33 2 13 
Median 61 94 83 89 9 67 
Average 64 75 60 76 31 57 
 
of the guidelines and thus enable the user/reader to make 
informed decisions about following the recommended actions. 
Furthermore, target users were generally clearly defined and the 
development groups were comprised of a range of the health 
professionals often involved in the assessment and treatment of 
tinnitus. These two factors are important not only for providing 
expert input into the guideline, but also for garnering “buy-in” 
from potential users of the guidelines and focussing the content. 
 
Differences between the Guidelines 
Differences in recommended assessment procedures tend to 
relate to specific techniques (questionnaires, diagnostic tests, 
types of scanning techniques) rather than general principles 
[e.g., trying to establish tinnitus severity, hearing loss, psycho- 
social problem(s)], or the presence or absence of severe physical 
pathology that might be causing the tinnitus. Differences related 
to, for example, the recommended questionnaires for assessing 
tinnitus related interference and distress. While all the guidelines 
referred to the THI (the German guideline indirectly refers to 
this), only the American, Dutch and German guidelines referred 
to the TQ. Recommendations for specific questionnaires to 
measure psychological distress (especially symptoms of anxiety 
and depression) also varied with some guidelines not mentioning 
any (e.g., United States) and others such as the Dutch and 
Swedish guidelines which referred to the HADS. Differences 
also existed between the recommendations to assess loudness 
discomfort levels with the American  and  Dutch  guidelines  
not recommending the use of such tests while the other 
guidelines did. 
With regard to treatments, differences are found primarily 
regarding recommendations for the use of sound  therapies.  
TRT specifically is not recommended by the German guideline, 
conditionally by the Dutch guideline and the American guideline 
indicates that clinicians “may” recommend it; TRT is currently 
being tested in a large multicenter trial in the U.S. (clinical  
trials ID: NCT01177137). A lack of evidences about other 
treatments such as acupuncture, hyperbaric oxygen and some 
herbal supplements leads most groups to recommend against 
them. The American guideline though is more cautious and 
simply states that because there is a lack of evidence they can 
neither recommend for or against the use of such treatments. 
Differences in the recommendations of assessment and 
treatment procedures could be explained by a combination of 
factors including the time of the development of the guideline 
and availability of translated versions of the questionnaires (e.g., 
the TFI was published in 2012 which was after that of the Danish 
and Swedish guidelines), the known psychometric properties of 
the questionnaires themselves [e.g., concerns have been raised 
about the cross-cultural use of the HADS (Maters et al., 2013)], 
and the different methods used to reach consensus by the 
different guideline groups. 
 
Consistencies across the Guidelines 
Across the guidelines consensus appears to exist on a number of 
important general features of assessment relating to subjective 
tinnitus. Specifically, there is consensus about the initial need 
for excluding  a  physical  cause  of  the  tinnitus,  conducting  
an audiometric assessment of the patient, using standardized 
questionnaires to measure degrees of tinnitus related distress, 
and when relevant, making referrals for further psychological 
assessment. 
Regarding the therapeutic recommendations for the treatment 
of subjective tinnitus, all guidelines recommend against the use 
of medicines for the treatment of the tinnitus specifically but note 
that medicines are appropriate for treating co-morbid conditions. 
There is also agreement in the recommendations to use hearing 
aids for patients experiencing hearing loss and CBT to facilitate 
adjustment to the symptom, alleviate distress and tinnitus-related 
interference in daily life. 
As a group of tinnitus researchers and clinicians, we endorse 
the specific principles and practices of assessment and treatment 
that are consistently found across the guidelines. Further, while 
a treatment for removing the tinnitus percept does not exist, we 
reiterate the importance of providing patients with bothersome 
tinnitus, evidence based cost-effective treatment(s) in a way (such 
as stepped care) that is minimally burdensome to the patient. 
That is patients who are assessed as having relatively little tinnitus 
related distress and interference should receive less intensive 
treatment in the first instance, than someone who is assessed as 
having severe levels of distress and interference in activities of 
daily living. 
 
Strengths and Limitations of the Review 
There are two critical factors that affect the conclusions that  
can be drawn from the included guidelines. Firstly,  and  as  
with all systematic reviews, the search strategy and inclusion 
criteria used determine what is located and subsequently 
included. In this review, we used the search terms “tinnitus”  
and “guideline” to conduct the search in a wide range of 
databases, repositories of clinical guidelines, and search engines, 
with the intention of being focussed enough to  identify  the 
most relevant documents within a manageable number of 
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search results. Only including the term “guideline” though 
might have resulted in relevant documents, albeit not called 
“guidelines,” being omitted from search results. Similarly, our use 
of inclusion/exclusion criteria that led to the decision to exclude 
documents such as the TRI flowchart could  be problematic as  
it (the TRI flowchart) is a comprehensive document potentially 
used in many situations to inform assessment and treatment 
decisions. 
To minimize the risk of  omitting  relevant  search  results  
we contacted a range of international experts and members of 
guideline development groups. In addition to this, we conducted 
hand searches of the references lists of included guidelines for 
relevant sources. We also recruited native speakers to extract 
data from the respective guidelines in an effort to ensure that 
data collection was as accurate as possible. It is possible, that 
different search and inclusion criteria might have led to different 
documents being included. However, given the large range of 
assessment and treatment options and the limited evidence base 
around many treatments in particular, it is unlikely that our 
conclusions would differ significantly if further guidelines had 
been identified at this time. Future systematic reviews though will 
be able to use this as a reference point. 
 
IMPLICATIONS AND CONCLUSIONS 
As researchers from around the world are collecting and making 
efforts to better understand the heterogeneity of subjective 
tinnitus in adults and systematically evaluate assessment and 
treatment options, we have, for the first time, described the major 
similarities and differences between existing clinical guidelines 
for subjective tinnitus in adults. The results reveal true guidelines 
from only five countries and thus highlight a need to develop 
guidelines that are endorsed by the range of professionals 
involved in assessing and treating tinnitus.  Although  we  do 
not place a great deal of weight on the quality assessment 
ratings of the guidelines, they do suggest that there is room     
for improvement particularly with regard to implementation 
and evaluation. The absence of guidelines contributes to the 
variations that exist in assessment and treatment of tinnitus 
internationally. 
While it would be tempting to do so, it is beyond the scope  
of this paper to formulate a new or composite guideline based 
on the results that we have obtained. Instead, the results of this 
review in conjunction with those from a survey of European 
tinnitus healthcare providers and researchers (Cima et al., 2016) 
will form the basis of further work on the development of a set 
of European clinical guidelines for the assessment and treatment 
of tinnitus being undertaken by the COST-action TINNET: 
Working Group I “Clinical.” As with existing clinical guidelines, 
attention will need to be given to how the future European 
guideline is disseminated, subsequently evaluated, and the 
implications for resource management considered. We expect   
it to be challenging task but one that will hopefully result in a 
more reliable and equitable assessment and treatment of tinnitus 
patients across Europe. 
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APPENDIX 
Excluded full text documents 
1. UK Good practice guide for adults with tinnitus (Department 
of Health, 2009). 
2. Audiology Australia Professional Practice Standards - Part B 
Clinical Standards (Audiology Australia, 2013). 
3. American Speech language and hearing association Tinnitus 
triage guidelines (American Speach Language Hearing 
Association, 2016). 
4. Ear care, NHS Scotland General practice guide for ear care. 
(NHS Scotland, 2006). 
5. TRI flowchart (Biesinger et al., 2010). 
6. Clinical guide for audiologic tinnitus management: 
Assessment and Clinical guide for audiologic tinnitus 
management: Assessment (Henry et al., 2005a) and Treatment 
(Henry et al., 2005b). 
7. Adult Tinnitus Management Clinical Practice 
Recommendation (Henry et al., 2015). 
8. American Academy of Audiology Audiologic  Guidelines  
for the Diagnosis and Management of Tinnitus Patients 
(American Academy of Audiology, 2000). 
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Abstract 
Background: There is no evidence-based guidance to facilitate design decisions for confirmatory trials or  
systematic reviews investigating treatment efficacy for adults with tinnitus. This systematic review therefore seeks to 
ascertain the current status of trial designs by identifying and evaluating the reporting of outcome domains and 
instruments in the treatment of adults with tinnitus. 
Methods: Records were identified by searching PubMed, EMBASE CINAHL, EBSCO, and CENTRAL clinical trial 
registries (ClinicalTrials.gov, ISRCTN, ICTRP) and the Cochrane Database of Systematic Reviews. Eligible records were 
those published from 1 July 2006 to 12 March 2015. Included studies were those reporting adults  aged  18 years  or 
older who reported tinnitus as a primary complaint, and who  were  enrolled  into  a  randomised  controlled  trial,  a 
before and after study, a non-randomised controlled trial, a case-controlled study or a cohort study, and written in  
English. Studies with fewer than 20 participants were excluded. 
Results: Two hundred and twenty-eight studies were included. Thirty-five different primary outcome domains were 
identified spanning seven categories (tinnitus percept, impact of tinnitus, co-occurring complaints, quality of life,  
body structures and function, treatment-related outcomes and unclear or not specified). Over half the studies 
(55 %) did not clearly define the complaint of interest. Tinnitus loudness was the domain  most often reported  
(14 %), followed by tinnitus distress (7 %). Seventy-eight different primary outcome instruments were identified. 
Instruments assessing multiple attributes of the impact of tinnitus were most common (34 %). Overall, 24 different 
patient-reported tools were used, predominantly the Tinnitus Handicap Inventory (15 %). Loudness was measured 
in diverse ways including a numerical rating scale (8 %), loudness matching (4 %), minimum masking level (1 %) 
and loudness discomfort level (1 %). Ten percent of studies did not clearly report the instrument used. 
Conclusions: Our findings indicate poor appreciation of the basic principles of good trial design, particularly the 
importance of specifying what aspect of therapeutic benefit is the main outcome. No single outcome was reported  
in all studies and there was a broad diversity of outcome instruments. 
(Continued on next page) 
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Background 
Tinnitus is an auditory percept – often described as a 
‘ringing in the ears’– in the absence of a corresponding 
auditory stimulus and is experienced by approximately 
10–20 % of the population [1]. As a symptom there is a 
no consensus on its aetiology [2, 3] and work is ongoing 
to profile tinnitus so that interventions can be more spe- 
cifically targeted [4]. For a subset of individuals, tinnitus 
severely interferes with activities of daily life, but its im- 
pact is wide-ranging and heterogeneous across individuals. 
Patients report problems in getting to sleep, the need to 
avoid noisy situations, hearing difficulties, difficulties with 
concentration, and experience despair, frustration, irrita- 
tion, depression, fear and worry [5]. Currently, no cure ex- 
ists for tinnitus but many interventions are being tested 
[6]. There is reasonable evidence to suggest that cognitive 
behavioural-based psychological treatments are effective 
at improving quality of life [7], negative mood, dysfunc- 
tional beliefs and tinnitus-related fear [8]. 
Despite some optimism for treating tinnitus-related 
distress [9] the field is plagued by a number of funda- 
mental and recurring problems that limit the evidence 
base and ultimately affect patient care and policy-related 
decisions. From a trialists’ perspective there is disagree- 
ment on what tinnitus-related problems constitute dis- 
tinct elements of tinnitus, such as perceived loudness or 
emotional distress, and which are sufficiently important 
to be considered as domains that should be measured in 
all studies [10]. This situation has contributed to the 
high level of diversity in, for example, trial design and 
measurement of outcomes in confirmatory randomised 
controlled trials, which hinders comparison and meta- 
analysis across studies [6]. A recent systematic review ex- 
amined outcomes of randomised controlled trials of inter- 
ventions for adults with tinnitus up to March 2013 [11]. 
However, the review was not concerned with evaluating 
what was measured, nor the choice of outcome instru- 
ments. Rather, it focused on evidence for treatment-related 
benefits and harms, using this information to develop a 
clinical practice guideline [12]. Hence, further investigation 
is warranted to determine more generally what outcomes 
(namely domains and instruments) are being used in trials 
of tinnitus interventions. 
The difficulties in synthesising evidence from tinnitus tri- 
als has negative implications for the provision of effective 
clinical care since clinicians, insurers, healthcare commis- 
sioners,  regulatory  bodies  and  other  policymakers  cannot 
make informed decisions without good evidence. There are 
very few practice guidelines and so in the UK and other 
countries care is not delivered to tinnitus patients in a 
standardised way [13]. Rather it tends to be driven by reim- 
bursement policies and by which clinical  profession  
(general practitioner, ENT specialist, audiologist, clinical 
psychologist, etc.) delivers the care. 
In sum, the variations in research and in clinical meth- 
odologies used to assess, treat, and study tinnitus form a 
problematic circle, where an incomplete evidence base 
means that clinical guidelines are developed with limited 
knowledge, and the lack of standardised clinical practices 
cannot reliably feed back into addressing important 
research questions. This scenario is ultimately likely to 
contribute to an inefficient use of scarce healthcare re- 
sources and unnecessary suffering for patients.  At 
present we attempt to break this circle by  examining  
what outcome domains have been defined, and what 
outcome measures have been used in studies of treat- 
ments for adults with tinnitus, by means of a systematic 
review of publicly available trial protocols. This should 
ultimately lead to a description of a minimum  standard 
for trialists to choose outcome measures for use in clin- 
ical trials that evaluate a tinnitus intervention  [10].  A 
core set would enable results to be more easily  com- 
pared and synthesised and the most effective interven- 
tions to be identified [14]. 
 
 
Objectives 
The primary objective of this systematic review is to 
identify and evaluate the current reported outcome do- 
mains in clinical and experimental studies of adults with 
tinnitus, with a focus on trial designs investigating the 
treatment of tinnitus, and published between the date  of 
an international consensus meeting in July  2006  [15]  
and March 2015. Data collection considered both which 
domain of tinnitus was identified as important for dem- 
onstrating therapeutic benefit and which instrument was 
used to assess that domain. Three secondary objectives 
considered the choice of instruments with respect to 
identifying patterns: (1) across continents to determine 
whether there are geographical preferences for using one 
primary outcome instrument over another, (2) across 
years to determine changes over time in the uptake of 
outcome instruments as a primary outcome, and  (3) 
across interventions to determine whether particular 
(Continued from previous page) 
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classes of intervention favour using one primary out- 
come instrument over another. 
 
Methods 
Details of the study eligibility criteria, information sources, 
search strategy, selection and data collection processes, as 
well as data synthesis methods were published as a protocol 
in advance of completing the data collection [16]. Reporting 
is guided by the Preferred Reporting Items for Systematic 
reviews and Meta-analyses (PRISMA) [17] and are de- 
scribed using the PRISMA checklist (see Additional file 1). 
 
Eligibility criteria 
Study eligibility was defined according to PICOS (Patient, 
Intervention, Comparison, Outcome, Setting)  and  there 
were no modifications to the published protocol [16]. All 
included studies assessed adults (men  and  women)  aged  
18 years or older who reported tinnitus as one of their pri- 
mary complaints, irrespective of whether they were re- 
cruited from clinical or non-clinical populations.  There  
were no restrictions on the type of intervention as long as 
the main motivation was to bring about a therapeutic bene- 
fit for people with tinnitus. Studies in which the impact on 
tinnitus was of secondary relevance (e.g. where reducing 
hearing problems was the primary aim) were excluded. 
Consistent with this approach, only those studies reporting 
tinnitus-related changes as a primary outcome were in- 
cluded, irrespective of how those changes were measured. 
The systematic review included  randomised  controlled 
trials, before and after studies, non-randomised controlled 
trials, case-controlled studies and cohort studies.  There  
were no restrictions on research settings. 
To be included in this report, articles were required to 
be written in English and published in or after July 2006 
[15]. These decisions were motivated by resource limita- 
tions. Furthermore, to improve clinical and scientific 
value, any studies either recruiting fewer than 20 partici- 
pants with tinnitus or having fewer than 20 at the end 
point of the study were excluded. This cut-off was selected 
in advance, following Needleman et al. [18]. We included 
published systematic reviews and meta-analyses that con- 
sidered tinnitus trials meeting the above criteria. These re- 
views and meta-analyses were not subject to the data 
collection process itself, but we did a hand-search and in- 
clude any additional eligible studies reported within them. 
During the data collection process, a small number of 
studies were identified where age-related eligibility or target 
sample size were missing. In cases where neither pieces of 
information were reported, the corresponding author was 
contacted for more details by email, with one reminder. 
 
Information sources 
Studies were identified by searching electronic databases 
of research literature (Table 1). The following list details 
 
Table 1 Table summarising the electronic information sources 
used. For a description of the abbreviations, see text 
Type of electronic search Database Number of items (n) 
Academic databases PubMed 759 
EMBASE 244 
CINAHL 145 
CENTRAL 560 
Clinical trial registers ClinicalTrials.gov          141 
ISRCTN 22 
ICTRP 183 
CDSR 23 
 
 
 
the database, as well as the number of records identified by 
the search strategy (in parentheses): PubMed (National 
Centre for Biotechnology Information) (n = 759), EMBASE 
(Ovid) (n = 244), Cumulative Index to Nursing and Allied 
Health Literature (CINAHL, EBSCO) (n = 145) and the 
Cochrane Central Register of Controlled Trials (CEN- 
TRAL) (n = 560). A number of different electronic trial 
registers were also searched: ClinicalTrials.gov (n = 141), 
the International Standard Randomised Controlled Trial 
Number registry (ISRCTN, BioMed Central) (n = 22), the 
International Clinical Trials Registry Platform (ICTRP, 
World Health Organisation) (n = 183), and the Cochrane 
Database of Systematic Reviews (CDSR) (n = 23). Electronic 
searches were run on 12 and 13 March 2015 by authors 
DAH and AJS, and were not updated. 
In addition, a hand-search was conducted using the 251 
published records that had met eligibility at the abstracts 
and full-text screening stages. Specifically, we hand- 
searched the set of registered clinical trials to identify any 
further registers of the same trial and also to identify any 
published protocols or study findings that were indexed to 
that trial by its unique study identifier. We also manually 
searched the 18 systematic review articles to look for any 
overlooked studies for inclusion. An additional 52 records 
were identified by these approaches. Following this step, 
the systematic review articles themselves were not in- 
cluded for data collection purposes. 
 
Search strategy 
The search strategy used in this systematic review was 
previously published [16]. Search terms for PubMed, 
EMBASE, and CINAHL were informed by the PICOS 
criteria and were: (1) tinnitus AND (2) stud* OR clinical 
trial* OR therap*  OR  treatment*  OR  intervention*.  
Where possible the search was limited to humans (not 
animals), adults (not paediatric), English language and 2006-
date of search.  The  syntax  for  the  subsequent  search of 
the CENTRAL trials registry of the Cochrane Collaboration  
was:  #1  tinnitus;  #2  Paediatric:TI,AB,KY; 
#3  Pediatric:TI,AB,KY;  #4  child*:TI,AB,KY;  #5  #1 NOT  
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#2 NOT #3 NOT #4, #6 english:LA, #7 #5 AND #6, #8 
(2006–2015):PD NOT IN MEDLINE NOT IN EMBASE 
AND 2006 TO 2015:YR, and #9 #5 NOT INMEDLINE 
NOT INEMBASE. Electronic trial registers all used ‘tin- 
nitus’ as the main search term. 
 
Data management 
DAH was responsible for data management and main- 
tained the editorial rights. All identified records were 
saved into a Microsoft Excel master file where records 
were tracked through the screening and data collection 
process by a unique study identification code. A simple 
system of record annotation was implemented to  cap- 
ture reasons for exclusion. At the end of data collection, 
checking and formatting, a pdf copy of the master file 
was created as a ‘locked’ record so that there is a version 
of the data that cannot be edited in error (7 December 
2015). An editable Excel version of this document can    
be downloaded (see Additional file 2). 
 
Selection process 
Endnote was used to remove 141 duplicate records from 
the PubMed, EMBASE and CINAHL searches, while the 
remaining 362 duplicates were manually identified  
within the Excel master file by DAH and HH using au- 
thor names, study title and trial  registration  number. 
This gave a total of 1574 records for eligibility screening. 
Screening steps were carried out DAH, HH and AJS. 
Following the pre-specified protocol, a two-step process 
was implemented to decide eligibility: first  by  reading 
the title, and second by reading the abstract and full text. 
It was possible to exclude 1153 records by title and sum- 
mary information alone (see Fig. 1). Full texts were ob- 
tained for the 421 remaining records  that  potentially  
met the inclusion criteria or for which there was 
 
insufficient summary information to make a clear deci- 
sion. From this step, a further 170 records were ex- 
cluded, leaving 251 for data extraction. It is interesting   
to note that almost one third  of those records excluded   
at this step was due to the small sample size of the study 
(see Fig. 1). Twenty-two records were excluded because 
they recruited participants below 18 years of age. More- 
over, 55 full texts were excluded because the sample size 
was less than 20 participants and 11 full texts were ex- 
cluded because they were not available in English. In- 
stead, these were published in national journals written  
in the native language. So that the reader can scrutinise 
the data for evidence of geographical bias in these three 
full-text exclusion criteria, details are broken down by 
country in Table 2. This information gives some indica- 
tion for a risk of bias excluding tinnitus studies con- 
ducted in the USA  since 21 were removed on the basis  
of small sample size, leaving only 39 records from the 
USA contributing to the systematic  review. There is also 
a risk of bias excluding tinnitus studies conducted in 
China since six were removed because they were pub- 
lished in Chinese, leaving only three records from China 
contributing to the systematic review. Note that lan-  
guage bias was avoided for studies registered  on  
ISRCTN and ICTRP since an English language transla- 
tion is given. Ten trials in Iran, seven in Japan and two    
in China, two in Brazil and one in the Republic of Korea 
were included via this route. 
At least two co-authors performed each key step (i.e. 
title screening, full-text screening, and data collection) in- 
dependently for every record. Due to an error in allocating 
full texts to co-authors, some records had data collection 
by more than two co-authors (31 were completed by three 
co-authors, 11 by four and 9 by five). Discrepancies be- 
tween independent co-authors were rare and were mostly 
 
 
Fig. 1 Flow diagram of study records 
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Table 2 Summary of those records excluded at the full-text screening stage because (1) the sample size was less than 20 participants,  
(2) because the articles were not available in English, or (3) they recruited participants below 18 years of age. Details are broken down by 
country 
Sample size <20 Non- English language Minimum eligibility (age in years) 
 13 14 15 16 17 
Austria    1   1 
Belgium 2     1  
Czech Republic        
Finland 2       
France 3       
Germany 4 1  2  4  
Italy 3      1 
Spain 1       
Sweden 3       
Switzerland 1     1  
The Netherlands 3       
Turkey     1   
Iran  2   1   
Iraq   1     
Israel 1       
Egypt    1    
Brazil 2 1   1   
Uruguay 1       
China  6   1  1 
Japan 3       
Republic of Korea 1 1  1  1  
Australia 2      1 
New Zealand 1     1  
USA/Canada 22       
 
accountable by differences in terminology. These were re- 
solved by DAH who was responsible for data manage- 
ment. As per the protocol [16], inter-rater agreement was 
not calculated, but all co-authors reviewed and approved 
the master file before data lock. 
We pieced together data from multiple reports of the 
same study by manually screening all included records 
using author names, study title and trial registration 
number. This step of consolidating records happened 
throughout the data collection process, and in particular 
during the data formatting check. Where there were 
multiple reports, the data extraction reflects the infor- 
mation provided in the report with the latest publication 
date. Any discrepancies between information reported in 
the different articles were noted under the data item 
heading ‘intention versus reporting’. 
 
Data collection process 
We contacted 29 trialists to request missing information 
about the minimum age for inclusion and two investigators 
to request missing information about sample size. With re- 
spect to age, 20 confirmed that all participants were 18 years 
of age or older, two authors could no longer be contacted, 
two responded but were unable to confirm the minimum 
age, one responded but said he was too busy to provide the 
information, and four did not respond. On the basis of this, 
nine records were excluded. Both investigators who were 
contacted about sample size were able to provide the re- 
quired information and so these records were included. A 
summary of those relevant records are provided in more 
detail in an additional Table (see Additional file 3). After ex- 
clusion, 228 records were included for data collection. A 
further Table provides full references (see Additional file 4). 
Data items gave rise to headings in a data collection 
sheet. Data collection was guided by an electronic form 
(Excel spreadsheet) that was also used to collate all re- 
sponses. Data collection was conducted by a pool of 20 
project team members (number of extracted studies 
ranged from 5 to 228, median 19.5). The primary reason 
for not limiting data collection to a smaller pool was to  
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lessen the resource burden since we received no grant 
funding to conduct the research activity. To mitigate 
against observer bias, a full set of guidance notes was pro- 
duced for the data collection procedure and calibration 
exercises were conducted with new members of the re- 
view team prior to any individual contribution to this re- 
view. Both the sheet and the guidance notes were 
developed and revised across several review authors dur- 
ing a 3-day workshop and through two iterations of pilot- 
ing. Data collection was conducted independently and 
with at least two team members for every included record. 
In an amendment to the pre-specified protocol, DAH veri- 
fied the data collection for all included records to ensure 
consistency in approach and in terminology; the latter be- 
ing necessary for automated data counting. Another step 
to mitigate against observer bias during the data collection 
process was by avoiding any instance where an individual 
extracted data relating to one of their own trials. 
 
Data items 
Data items included all of the fields reported in the pub- 
lished protocol [16]. A majority of data items fall within the 
PICOS framework. Participant data items relating to the 
inclusion criteria for each trial record were: (1) minimum 
age, (2) maximum age (if any), (3) tinnitus duration, (4) 
intermittent or constant tinnitus, (5) pulsatile or non- 
pulsatile tinnitus, (6) tinnitus severity, (7) any other sub- 
types of tinnitus, and (8) any other health-related comor- 
bidities. Participant data items relating to the exclusion 
criteria for each trial record were: (9) any other subtypes of 
tinnitus, and (10) health-related comorbidities. Intervention 
data items recorded the (11) type and (12) duration of 
intervention in each arm of the trial. Data items describing 
the study design (i.e. ‘comparison’) comprised: (1) a pull- 
down list of study design options (randomised controlled 
trials, before and after studies, non-randomised controlled 
trials or case-control studies and cohort studies) and (2) a 
record of the duration of each intervention, separately for 
each arm of the trial. Outcome data items were: (1) the out- 
come domain(s) specified by the investigators, (2) the in- 
struments specified by the investigators,  and  (3)  time 
frame. Information relating to these three data items was 
recorded separately for all primary and secondary out- 
comes. Where authors were not explicit about this distinc- 
tion, we tried to tease this information out of the article by 
reading the Methods and Results sections of each record.  
But if this was not possible, then all information was en- 
tered as a primary data item. A ‘setting’ data item reported 
the country where the study was conducted. Supplementary 
information was also extracted from each included trial on: 
(1)   the   name   and   email   address   of  the corresponding 
author, (2) the date of study start, (3) the aim of the trial, 
(4) sample size calculation, with a full-text extraction of the 
reported details, (5) the sample size, (6) a description of any 
 
modifications to the methods, particularly any discrepancies 
between the trial protocol and the subsequent report of the 
findings, and (7) the date of publication. The protocol was 
amended so that if minimum age of eligibility or sample 
size estimate was not reported, then the data collection re- 
corded the minimum age of the recruited participants or 
the recruited sample size as the ‘next best alternative,’ where 
this information was given. An additional data item not 
planned in the protocol recorded whether the study authors 
specified any minimal clinically important difference, or re- 
lated construct that was used to interpret the clinical sig- 
nificance of the findings. For example, Cima and et al. [8] 
specified a pre- versus post-intervention change of 0.065 
(SD 0.15) in health utility score measured using the 36-item 
short form Health Survey. This information is not reported 
here, but will be presented in a separate manuscript. If any 
information is not reported, then ‘not stated’ was recorded 
in the corresponding field. 
Where a trial record consolidated several pieces of in- 
formation (such as a protocol and the published find- 
ings), the data items reported in the synthesis related to  
the most recent publication. For those records in which 
several pieces of information are consolidated into a sin- 
gle record, we sought to detect any modifications to the 
methods leading to inconsistencies between the protocol 
and the final reported study. Given that the review fo- 
cused on the design of clinical trials, wherever possible 
information relating to each data item  was  taken from 
the study design reported in the most recent publication, 
not from any report of the study results. For example, 
sample size recorded the estimated sample size not the 
number of participants actually enrolled into each inter- 
vention arm. And, the date of publication recorded the 
date of the print copy, not the date of first submission, 
acceptance or the date of 'online first' publication. 
 
Outcomes and prioritisation 
The primary research question in this review concerned 
the outcome domains (and instruments) being used in 
clinical trials of tinnitus treatment. Therefore, the prior-  
ity for data synthesis and reporting of findings was data 
relating to all primary outcomes.  Where  authors  failed 
to distinguish between primary and secondary outcomes, 
we classified them all as primary. Those outcomes expli- 
citly defined as secondary were also examined, but as a 
secondary research question. 
 
Risk of bias in individual studies 
Given that the primary objective of this systematic re- 
view concerns methodology (not therapeutic effects), we 
limited the assessment of risk of bias to the data collec- 
tion methods for consolidated records rather than any 
analysis of those data. In particular, we investigated 
where there were inconsistencies between the outcomes  
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defined in the trial registration and/or protocol and 
those given in the subsequent study report. Of the 228 
studies selected for inclusion, 60 (26 %) had multiple re- 
cords. We examined only those consolidated records with 
a protocol and study report(s) comparing data items 
across records. From this set, 21 were found to have de- 
scriptions of eligibility criteria (inclusion or exclusion), 
primary outcome measures, and/or secondary outcome 
measures that were altered retrospectively in the final re- 
port. An additional Table gives more details about the 
findings from the risk of bias assessment (see Additional 
file 5). None of the studies reported a justification for the 
changes, but insufficient information was given in the 
publications to determine any instances of intentional de- 
ception (i.e. outcome-reporting bias) where outcomes had 
been selected on the basis of the results, for inclusion in 
the publication of trial findings [19–21]. We did not con- 
tact authors to examine reasons for altered reporting. 
 
summary of quality, as per the protocol [16]. Instead, we 
sought to describe the ways in which the authors’ speci- 
fication of each primary outcome domain appeared to be 
inadequate using a narrative approach. Primary outcome 
domains in category 7 were classified into five subheadings 
(Table 3). On 128 occasions (25 %), the investigators did  
not explicitly state which domain their trial intended to as- 
sess and so we refer to these as ‘not specified’. ‘Tinnitus se- 
verity’ was the next most common phrase used  to  define 
the outcome domain of interest (n = 69, 14 %). We  note 
that in our protocol [16], we had stated that this is not an 
adequate domain because it does not explain the dimension 
of complaint on which severity should be considered. The 
same applies to ‘tinnitus handicap’ (n = 14, 3 %). We also 
experienced difficulty in interpreting a further 58 (12 %) 
data entries because the terminology was indeterminate (re- 
ferred to as ‘cannot code’). We are confident that this is not 
a coding issue, as DAH verified that the data collection for 
all included records captured the text as reported by the au- 
Results thors. Examples include ‘improvement,’ ‘treatment re- 
The primary objective was to identify and evaluate the 
current reported outcome domains and instruments in 
designs of intervention studies of adults with tinnitus, 
published since July 2006. 
 
Domains 
For the first part of the analysis, we scrutinised the data 
collected under the data item relating to the primary 
outcome domain(s) specified by each set of investigators. 
There were 505 data entries describing 35 different types 
of primary domain (Table 3). Domain grouping was 
conducted by a subgroup of tinnitus experts (three ENT 
surgeons, one audio-vestibular physician, and two re- 
searchers) and was broadly informed by the Cochrane 
Effective Practice and Organization of Care (EPOC) rec- 
ommendations [22]. Patient outcomes concerned with 
health status, well-being and health behaviours consti- 
tuted the largest category by far and so we expanded this 
into domains relating to (1) the tinnitus percept, (2) the 
impact of tinnitus, (3) other co-occurring complaints, 
(4) health-related quality of life, and (5) body structures 
and functions (Table 3). Remaining EPOC categories 
were (6) adverse events or harms and (7) satisfaction, 
with further categories for (8) treatment-related out- 
comes, and (9) for domains that were unclear or not 
specified by the author. The most popular primary out- 
come domain directly relating to tinnitus was ‘tinnitus 
loudness’ (n = 70, 14 % defined as primary outcome do- 
main in all studies), with ‘tinnitus distress’ (n = 33, 7 %) 
and ‘tinnitus annoyance’ (n = 21, 4 %) following. 
Over half (n = 279, 55 %) of the data entries did not 
clearly describe the complaint of interest. Since this was 
such a large percentage, we chose to examine this  in  
more detail rather than simply report as a quantitative 
sponder,’ ‘change,’ ‘tinnitus impact,’ ‘size of tinnitus problem,’ 
‘tinnitus impairment,’ ‘problems associated with tinnitus,’ ‘dif- 
ficulties due to tinnitus,’ ‘degree of tinnitus,’ ‘sensation of tin- 
nitus,’ and ‘tinnitus characteristics’. Again, none of these 
clearly explain the dimension of complaint on which im- 
provement or problems should be considered. ‘Multi-do- 
main specification’ refers to composite measures describing 
several different complaints such as  ‘tinnitus  annoyance  
and distress’ and ‘internal thoughts, sensations and feelings’ 
(n = 10, 2 %). 
There were 579 data entries describing 60 different types 
of secondary domain. Again, Table 3 indicates similar pat- 
terns, with ‘tinnitus loudness’ (n = 42, 7 %), with ‘tinnitus 
distress’ (n = 18, 3 %) and ‘tinnitus annoyance’ (n = 15, 3 %) 
being the most popular. Safety (n = 43, 7 %), Quality of life 
(n = 20, 3 %), and depression (n = 18, 3 %) were also popu- 
lar as secondary outcome domains. 
 
Instruments 
The second part of the primary objective  was to identify  
and evaluate the  current  reported  outcome  instruments  
and for this we interrogated the data collected  under  the 
data item relating to the primary outcome instrument(s) 
specified by each set of investigators. Overall, there were 
505 data entries describing 78 different types of instrument 
(Table 4). We used a categorisation scheme based  on the 
one for domains. Instruments were grouped according to 
whether the tests relate to: (1a) the tinnitus percept (investi- 
gator-administered), (1b) the tinnitus percept (numerical 
rating scale), (2a) the impact of tinnitus (patient-reported 
questionnaire), (2b) the impact of tinnitus (numerical rating 
scale), (3) other co-occurring complaints, (4a)  health- 
related quality of life (patient-reported questionnaire), (4b) 
health-related quality of life (numerical rating scale), (5)  
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Table 3 Summary of all primary and secondary outcome domains across all 228 clinical trials. Domains have been grouped according 
to eight major topic categories. Categories 1–5 relate to different types of ‘patient outcomes’, categories 6–7 relate to ‘adverse events’ 
and ‘satisfaction’, following the Effective Practice and Organisation of Care classification scheme [22]. Categories 8 and 9 best describe 
the remaining outcomes reported in the included records. Percentages are rounded so, for example, 0 % denotes a value that is <0.5 % 
 Primary domains   Secondary domains  
Number Percentage (%)  Number Percentage (%) 
(1) Domains relating to the tinnitus percept:      
Tinnitus loudness 70 14 %  42 7 % 
Tinnitus pitch 12 2 %  13 2 % 
(2) Domains relating to the impact of tinnitus: 
     
Tinnitus distress 33 7 % 18 3 % 
Tinnitus annoyance 22 4 % 15 3 % 
Tinnitus awareness 10 2 % 2 0 % 
Cognition 2 0 % 4 1 % 
Behaviour 1 0 % 0 - 
Acceptance of tinnitus 0 - 3 1 % 
Catastrophising 0 - 1 0 % 
Concentration 0 - 2 0 % 
Tinnitus intrusiveness 0 - 2 0 % 
Tinnitus-related cognitions 0 - 1 0 % 
Tinnitus-related fear 0 - 1 0 % 
(3) Other co-occurring complaints: 
     
Depression 8 2 % 18 3 % 
General distress 5 1 % 5 1 % 
Anxiety 4 1 % 6 1 % 
Anxiety and depression 4 1 % 13 2 % 
Hearing threshold 4 1 % 11 2 % 
Hearing loss 2 0 % 1 0 % 
Speech perception 2 0 % 0 - 
Hearing handicap 1 0 % 3 1 % 
Hearing loss annoyance 1 0 % 0 - 
Sleep quality 1 0 % 12 2 % 
Somatic sensations 1 0 % 1 0 % 
Fear (anxiety) 0 - 1 0 % 
Hyperacusis 0 - 3 1 % 
Mood 0 - 2 0 % 
Sound tolerance 0 - 1 0 % 
Speech discrimination 0 - 3 1 % 
(4) Health-related quality of life (QoL): 
     
QoL (tinnitus) 16 3 % 13 2 % 
QoL 9 2 % 20 3 % 
Coping 3 1 % 0 - 
Occupational health 0 - 1 0 % 
QoL (hearing) 0 - 1 0 % 
Sense of control 0 - 1 0 %  
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Table 3 Summary of all primary and secondary outcome domains across all 228 clinical trials. Domains have been grouped according 
to eight major topic categories. Categories 1–5 relate to different types of ‘patient outcomes’, categories 6–7 relate to ‘adverse events’ 
and ‘satisfaction’, following the Effective Practice and Organisation of Care classification scheme [22]. Categories 8 and 9 best describe 
the remaining outcomes reported in the included records. Percentages are rounded so, for example, 0 % denotes a value that is <0.5 % 
(Continued) 
(4) Body structures and functions: 
 
Neck mobility 1 0 % 1 0 % 
Neural activity 1 0 % 2 0 % 
Oxidative stress 1 0 % 0 - 
Active myofascial 
trigger points 
0 - 1 0 % 
Blood parameters 0 - 1 0 % 
Gene expression 0 - 1 0 % 
Metabolism 0 - 4 1 % 
Neck pain 0 - 1 0 % 
Neuroendocrine hormones 0 - 1 0 % 
Pharmacokinetics 0 - 1 0 % 
Structural brain change 0 - 1 0 % 
(6) Adverse events or harms:     
Safety and tolerability 6 1 % 4 1 % 
Safety 2 0 % 43 7 % 
Drug safety and tolerability 1 0 % 4 1 % 
Side effects 1 0 % 15 3 % 
Headache 0 - 1 0 % 
Pain frequency 0 - 1 0 % 
Pain intensity 0 - 1 0 % 
(7) Satisfaction:     
Treatment satisfaction 1 0 % 5 1 % 
(8) Treatment-related outcomes: 
    
Withdrawals 1 0 % 0 - 
Adequacy of blinding 0 - 1 0 % 
Credibility (sham) 0 - 1 0 % 
Credibility (treatment) 0 - 2 0 % 
Needling sensation (acupuncture) 0 - 1 0 % 
Therapeutic alliance 0 - 1 0 % 
Tolerability 0 - 5 1 % 
(9) Domain of interest unclear or not specified by the authors: 
Not specified 128 25 % 140 24 % 
Cannot code 58 11 % 76 13 % 
Multi-domain specification 10 2 % 10 2 % 
Tinnitus severity 69 14 % 29 5 % 
Tinnitus handicap 14 3 % 5 1 % 
Total 505 100 % 579 100 % 
 
body structures and functions, (6) adverse events or harms, 
(7) satisfaction, (8) treatment-related outcomes, or (9) were 
unclear or not specified by the authors. Twenty-eight differ- 
ent instruments were used only once as a primary outcome 
and these are listed in an additional Table  (see Additional 
file 6). 
Instruments assessing the impact of tinnitus were 
most common and of these, the Tinnitus Handicap  
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Table 4 Summary of all primary and secondary outcome instruments used across all 228 clinical trials. Instruments have been grouped 
according to the major domain categories reported in Table 3, as well as those instruments that were not clearly specified by the authors. 
Note that the total refers to the number of instruments across all 228 trials. The remainder are reported in Additional file 6. Percentages are 
rounded so, for example, 0 % denotes a value that is <0.5 % 
Primary outcome instruments Secondary outcome instruments 
Number Percentage (%) Number Percentage (%) 
(1a) Investigator-administered tests relating to the tinnitus percept: 
Tinnitus loudness matching 20 4 % 16 3 % 
Tinnitus pitch matching 9 2 % 22 4 % 
Minimum masking level 5 1 % 12 2 % 
Loudness discomfort level 3 1 % 2 0 % 
Tinnitus bandwidth matching 0 - 2 0 % 
(1b) Patient-reported numerical rating scales relating to the tinnitus percept: 
Tinnitus loudness 37 8 % 24 4 % 
Tinnitus pitch 0 - 2 0 % 
(2a) Patient-reported questionnaire instruments relating to the impact of tinnitus: 
Tinnitus Handicap Inventory 77 15 % 31 5 % 
Tinnitus  Questionnaire (German version) 29 6 % 11 2 % 
Tinnitus  Questionnaire (English version) 5 1 % 0 - 
Tinnitus Functional Index 18 4 % 3 1 % 
Tinnitus Beeinträchtigungs Fragebogen 13 3 % 8 1 % 
Tinnitus Severity Index 12 2 % 1 0 % 
Tinnitus Reaction Questionnaire 11 2 % 2 0 % 
Tinnitus Handicap Questionnaire 8 2 % 5 1 % 
Mini-Tinnitus Questionnaire 6 1 % 0 - 
Tinnitus Effects Questionnaire 2 0 % 0 - 
Tinnitus diary 2 0 % 0 - 
Tinnitus  Psychological Impact Questionnaire 2 0 % 0 - 
Tinnitus Severity Scale 0 - 6 1 % 
Tinnitus Acceptance Questionnaire 0 - 6 1 % 
(2b) Patient-reported numerical rating scales relating to the impact of tinnitus: 
Tinnitus distress 7 2 % 8 1 % 
Tinnitus annoyance 21 4 % 14 2 % 
Tinnitus awareness 10 2 % 2 0 % 
(3) Patient-reported questionnaire instruments relating to other co-occurring complaints: 
Beck Depression Inventory 7 1 % 13 2 % 
Hospital Anxiety and  Depression Scale 7 1 % 27 5 % 
Perceived Stress Questionnaire 3 1 % 0 - 
Spielberger State and Trait Anxiety Inventory 3 1 % 3 1 % 
Brief-Coping with Problems Experienced 2 0 % 0 - 
Pittsburgh Sleep Quality Index 2 0 % 2 0 % 
Hearing Handicap Inventory 1 0 % 4 1 % 
Hyperacusis questionnaire (undefined) 1 0 % 2 0 % 
Attention and Performance  Self-assessment Scale 0 - 2 0 % 
Befindlichkeitsskala 0 - 2 0 % 
Cognitive Failures Questionnaire 0 - 2 0 % 
Depression Anxiety and Stress Scale 0 - 3 1 %  
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Table 4 Summary of all primary and secondary outcome instruments used across all 228 clinical trials. Instruments have been grouped 
according to the major  domain categories reported  in Table 3, as well as those  instruments  that were not clearly specified  by the authors.   
Note that the total refers to the number of instruments across all 228 trials. The remainder are reported in Additional file 6. Percentages are 
rounded so, for example, 0 % denotes a value that is <0.5 % (Continued) 
 
Insomnia Severity Index 0 - 7 1 % 
Major Depression Inventory 0 - 5 1 % 
Sleep Questionnaire (undefined) 0 - 3 1 % 
(4a) Patient-reported questionnaire instruments relating to health-related quality of life: 
Clinical Global Impression Scale 4 1 % 14 2 % 
36-item short form Health Survey 2 0 % 6 1 % 
WHOQOL-BREF 0 - 10 2 % 
EuroQoL 0 - 2 0 % 
Quality of Life Inventory 0 - 2 0 % 
(4b) Patient-reported numerical rating scales relating to health-related quality of life: 
Quality of Life (tinnitus) 5 1 % 6 1 % 
Quality of Life 4 1 % 1 0 % 
(5) Technical and laboratory measurements relating to body structures and functions: 
Pure tone audiometry 15 3 % 23 4 % 
Speech audiometry (various types) 6 1 % 11 2 % 
Electroencephalography 4 1 % 5 1 % 
Blood chemistry 2 0 % 10 2 % 
Positron Emission Tomography 2 0 % 0 - 
Electrocardiogram 1 0 % 4 1 % 
Digit symbol test 1 0 % 2 0 % 
Blood drug levels 0 - 4 1 % 
Magnetic Resonance Imaging 0 - 3 1 % 
Otological examination 0 - 4 1 % 
Otoscopy 0 - 2 0 % 
Psychoacoustic assessment (undefined) 0 - 3 1 % 
Tympanometry 0 - 2 0 % 
Urine analysis 0 - 2 0 % 
(6) Measures of adverse events or harms: 
    
Adverse events/Side effects 4 1 % 30 5 % 
(7) Measures of satisfaction: No instruments reported 
(8) Measurement instruments of treatment-related outcomes: 
 
Withdrawal rate 2 0 % 2 0 % 
(9) Measurement of interest unclear or not specified by the authors: 
Cannot code 20 4 % 52 9 % 
Other numerical rating scale (undefined) 18 4 % 29 5 % 
Questionnaire (authors’ own) 15 3 % 13 2 % 
Numerical rating scale of tinnitus severity 12 2 % 1 0 % 
Not specified 8 2 % 18 3 % 
Total 505 87 % 579 85 % 
 
Inventory was the most popular (n = 77, 15 %) [23] and 
was one of the instruments recommended by the 2006 con- 
sensus meeting [15]. Other recommended questionnaires 
were the Tinnitus Questionnaire (n = 34, 7 %), the Tinnitus 
Reaction Questionnaire (n = 11, 2 %), and the Tinnitus 
Handicap Questionnaire (n = 8, 2 %). However, our review  
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indicates that the Tinnitus Functional Index, Tinnitus 
Beeinträchtigungs Fragebogen (a shortened version of the 
Tinnitus Handicap Inventory translated into German) and 
Tinnitus Severity Index were just as widespread. 
Tinnitus loudness matching was a popular tool for asses- 
sing the tinnitus percept (n = 20, 4 %). A numerical rating 
scale of loudness  was  also  a  common  approach  (n = 37, 
8 %), but there was little consistency in the measurement 
scale used (e.g. Table 5). Other domains relating to the 
impact of tinnitus were evaluated using a numerical rating 
scale predominantly annoyance (n = 21, 4 %), awareness 
(n = 10, 2 %), and distress (n = 7, 1 %). Numerical rating 
scales with 0–10 and 0–100 point scales were popular. 
About 16 % (n = 78) of the data entries did not clearly 
report the instrument used. These were classified  into  
five subheadings under Table 4, category 9. On 20 occa- 
sions (4 %), we experienced difficulty in interpreting the 
data entry (referred to as ‘cannot code’). One recurring 
example was where investigators did not state the proven- 
ance of the ‘tinnitus questionnaire’ which could be either 
a published Tinnitus Questionnaire [24, 25], or a transla- 
tion of one of these or to an authors’ own instrument. We 
observed 15 instances (3 %) where investigators reported 
using their own (unpublished) questionnaire, which limits 
reproducibility. 
There were 579 data entries describing 108 different types 
of secondary instrument (Table 4). Of those, 49 instruments 
were used only once as a secondary outcome and these are 
listed separately in a Table (see Additional file 6). Although 
the Tinnitus Handicap Inventory remained a common 
choice as a secondary outcome (n = 31, 5 %), other 
tinnitus-related questionnaires were much less so. Instead, 
adverse events (n = 30, 5 %) and the Hospital Anxiety and 
Depression Scale (n = 27, 5 %), pure tone audiometry (n = 
23, 4 %), tinnitus pitch matching (n = 22, 4 %), the Clinical 
Global Impression Scale (n = 14, 2 %) and the WHOQOL- 
 
BREF (n = 10, 2 %) were some of the more popular choices 
for secondary outcomes. 
The protocol did state that the timing of the primary  
end point would be examined [16], but we did not pursue 
this analysis because the timing of the end point was re- 
ported inconsistently across studies (some relative to the 
start of the treatment and others relative to the end of the 
treatment) and the duration of treatment varied so greatly 
(some were just a few days, some extended up to 1 year, 
and others did not clearly specify). Moreover, the time 
frame of surveillance for adverse events was rarely stated. 
 
Pattern of primary outcome instruments across world regions 
The first secondary analysis assessed how the pattern of 
primary outcome instruments varied across world re- 
gions. Countries recruiting into identified clinical trials 
were categorised into six world regions using the World 
Health Organisation (WHO) as a guide  [26].  Findings 
are summarised in Fig. 2. The ‘European region’ repre- 
sented the greatest research activity with 151 sites 
recruiting across all 228 trials. Most research was con- 
ducted in Germany (n = 48), Belgium (n = 20), and UK 
(n = 12). In the Middle East and Africa region, most tri- 
als were conducted in Iran (n = 17), while in Asia most 
research was conducted in Japan (n = 11) and the Repub- 
lic of Korea (n = 9). 
With respect to patient-reported questionnaires relating 
to the impact of tinnitus, the Tinnitus Handicap Inventory 
was the most common one used as a primary outcome 
across all world regions, except for Oceania where the 
Tinnitus Reaction Questionnaire was preferred. Since few 
clinical trials were conducted in South America or Ocea- 
nia, findings for these world regions should be interpreted 
with caution. The Tinnitus Questionnaire was common in 
Europe, especially in Germany, but not in the rest of the 
world. Even in Europe, it is used in different forms 
Table 5 Summary of the different formats for numerical rating scales used across all 228 cl inical trials. These are used to assess a 
wide range of domains including tinnitus loudness annoyance, awareness, distress and tinnitus-related quality of life 
Primary outcome instruments Secondary outcome instruments 
 Number Percentage (%)  Number Percentage (%) 
Numerical rating scale (0–3) 1 0 %  0 - 
Numerical rating scale (0–10) 49 10 %  18 3 % 
Numerical rating scale (0–100) 18 4 %  13 2 % 
Numerical rating scale (1–9) 0 -  1 0 % 
Numerical rating scale (1–10) 12 2 %  0 - 
Numerical rating scale (1–100) 1 0 %  0 - 
Numerical rating scale (4 points) 3 1 %  2 0 % 
Numerical rating scale (5 points) 2 0 %  2 0 % 
Numerical rating scale (7 points) 3 1 %  0 - 
Numerical rating scale (10 points) 0 -  1 0 % 
Numerical rating scale (10-cm line) 5 1 %  14 2 %  
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because the English and German versions differ from one 
another [28]. The Tinnitus Severity Index was common in 
the Middle East and Africa region, but not in other parts 
of the world. Measures of tinnitus loudness were also 
most common in the Middle East and Africa region (both 
using loudness matching and numerical rating scales), 
with countries in Asia also favouring a loudness numerical 
rating scale. 
 
Pattern of usage of primary outcome instruments across 
years 
We also examined the status of selected primary outcome 
instruments over the time frame of the review (Fig. 3). 
Due to the wide variety of instruments, analysis focused 
on the most frequently used that were highlighted in the 
previous section (Instruments). For meaningful analysis, 
we split the total time frame into three periods, using the 
best available information. The first period was from 1 
January 2011 to 12 March 2015 (i.e. the date of the elec- 
tronic searches) (n = 102). The second period was from 1 
August 2006 to 31 December 2010 (n = 99). The third 
period included any remaining studies in which data was 
collected on or before 31 July 2006 (i.e. before the Tin- 
nitus Research Initiative (TRI) consensus meeting) [15], 
but not published until after this date (n = 27). Here we 
describe the patterns for the first two periods because of 
the comparable sample size and more robust definition, 
but all data are presented in Fig. 3. The Tinnitus Handicap 
Inventory, the Tinnitus Handicap Questionnaire, and the 
Tinnitus Beeinträchtigungs Fragebogen were equally popu- 
lar across both 5-year periods. The Tinnitus Functional 
Index and numerical rating scales of tinnitus loudness in- 
creased in popularity, while the Tinnitus Questionnaire 
(German version), the Tinnitus Reaction Questionnaire, 
the Tinnitus Severity Index and tinnitus loudness match- 
ing all seemed to decrease in popularity. 
 
Pattern of usage of primary outcome instruments across 
interventions 
All records were coded according to eight broad classes of 
procedure either as part of the intervention of interest or 
the control. These were: pharmacology (n = 66), electro- 
physiology (n = 59), sound therapy (n = 56), psychological 
therapy or counselling (referred to as ‘talking’) (n = 47), 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 World map illustrating the distribution of recruiting sites for all included studies, inspired by the World Health Organization (WHO) regional 
classification. Figures within each country indicate only one trial [27] had a recruiting site in South Africa and so this was combined with countries in 
the WHO Eastern Mediterranean region to create the Middle East and Africa region (n = 20). The WHO Region of the Americas was separated into 
North and South America because we anticipated that language differences might influence choice of outcome instruments. Similarly, Australia and 
New Zealand were considered separately from Western Pacific region, as Oceania, while other countries were combined with the WHO Southeast Asia 
region to create a single Asian region 
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complementary therapy (n = 33), surgery (n = 10), manual 
physical therapy (n = 7), and relaxation (n = 3). Where in- 
terventions involved more than one procedure, all proce- 
dures were coded. For example, an intervention involving 
an intra-tympanic injection was coded as both pharmacol- 
ogy and surgery, and Tinnitus Retraining Therapy with a 
Ginkgo biloba supplement was coded as talking, sound 
and pharmacology. 
The domain of tinnitus loudness was least frequently 
assessed in talking therapies (3 %), with the other major 
classes of intervention all assessing this perceptual charac- 
teristic more frequently: pharmacology (17 %), electrophysi- 
ology (16 %), sound therapy (15 %), and complementary 
therapy (14 %). In contrast, talking therapies favoured as- 
sessments of tinnitus distress (13 %) more than the other 
intervention classes: pharmacology (2 %), electrophysiology 
(6 %), sound therapy (7  %),  and  complementary  therapy 
(4 %). Numerical rating scales and the Tinnitus Handicap 
Inventory were commonly used  as  outcome  instruments 
for all types of interventions. 
 
Quality assessments 
Following the protocol, we assessed the quality of defining 
and reporting outcomes in three ways. The first quality as- 
sessment considered the degree to which primary outcome 
instrument(s) in each study were appropriate and consist- 
ent with the authors’ choice of primary outcome domain(s). 
For example, the Tinnitus Severity Index would not be con- 
sidered an ideal measure for quality of life, nor would ‘psy- 
chophysical method’ as a measure of tinnitus loudness. 
Within each study, we counted the number of consistent 
primary outcomes, calculated as a function of the propor- 
tion (%) of primary outcomes in that study. Overall, 31 
(14 %) studies achieved a 100 % score, with 16 of those spe- 
cifying a single primary outcome. In contrast to this, 133 
(58 %) studies scored 0 %, with 52 of those failing to specify 
the primary domain and five not specifying the primary 
instrument. The remaining studies reported only par- 
tially correct outcomes: n =5 scored 1–25 %, n = 31 
scored 26–50 %, n = 21 scored 51–75 % and n =7  
scored 76–99 %. 
The second quality assessment demonstrated that few 
trial designs were informed by a sample size calculation 
based on previous data for the primary outcome instru- 
ment. We excluded from this analysis 91 records  that 
were trial registrations because a sample size calculation 
was not required for reporting. Of the remaining 137 re- 
cords, sample size calculation was reported in only 37 of 
them (27 %). A sample size calculation requires specifi- 
cation of the primary outcome instrument, the expected 
difference between the treated and untreated groups, the 
pooled standard deviation, the desired statistical power, 
whether the hypothesis testing is one- or two-sided and  
the significance level (alpha). Over the 37 studies report- 
ing sample size calculation, 31 (83 %) and 32 (86 %) 
studies reported statistical power and alpha value re- 
spectively, but the primary outcome instrument, the ex- 
pected difference between groups and whether the test 
was  one-  or  two-sided  were mentioned  in  only  17  
(46 %), 19 (51 %) and 14 (38 %) studies respectively. 
From the 17 studies reporting the primary outcome in- 
strument, the Tinnitus Handicap Inventory was the most 
popular choice (n = 8). However, the magnitude of the ex- 
pected change varied from study to study. It ranged from 
6.55 to 20 points, but was also expressed as 50 % of reduc- 
tion. Note that the developers of the Tinnitus Handicap 
Inventory recommend that a 20-point or greater change is 
required to account for test-retest variability [29]. 
The third quality assessment highlighted  that  many  of  
the studies are suboptimal in terms of clearly defining what 
end point is the most important with respect to drawing a 
conclusion about treatment efficacy. For assessing whether 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 Pattern of usage over time for selected primary outcome instruments. Note that the identification of studies categorised as ‘pre-July 2006’ 
may not be representative as many records relating to this period would have been excluded according to our search criteria  
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an intervention has therapeutic benefit to patients,  it  is 
good practice to state a priori  one  outcome  instrument  
[30]. Figure 4 illustrates the number of primary outcome 
instruments administered in each study. Just over half of all 
studies (118/228, 52 %) reported only one primary measure. 
However, the remainder reported multiple measures with- 
out distinguishing primary from secondary outcomes, with 
70 studies (31 %) reporting two or three potential primary 
measures, 29 studies (13 %) reporting four or five and 11 
studies reporting more than this. Two studies reported 12 
measures without distinguishing primary from secondary 
outcomes [31, 32]. 
 
Exploring the pattern of primary outcomes across tinnitus 
subgroups 
A final analysis pre-specified in the published protocol 
was an exploratory one to address the question about 
whether a particular outcome domain (or instrument)  
was preferentially selected in trials enrolling a particular 
tinnitus subtype [16]. Here we considered tinnitus sever- 
ity (as denoted by the authors), hearing loss, depression 
and anxiety because these are most relevant for deter- 
mining choice of a tailored intervention. 
 
Tinnitus severity 
With respect to the primary domains, 96 out of the 505 
came from studies that specified a severe tinnitus as an in- 
clusion criterion. In those studies, an objective criterion 
was defined as some sort of minimum score on a pub- 
lished tinnitus questionnaire. For this subgroup compared 
to all 228 studies, we expected there would be a greater 
proportion of primary domains evaluating the functional 
impact of tinnitus, but this was not the case. The pattern 
was not noticeably different from the full dataset. 
 
Hearing loss 
Forty-seven of the 505 primary domains came from stud- 
ies that specified a hearing loss as an inclusion criterion. 
Again, only studies were considered where an objective 
 
 
 
criterion had been defined and this was typically a mini- 
mum hearing level in dB at particular frequencies. Com- 
pared to the full dataset reported in Table 3, the 
proportion assessing tinnitus distress was slightly  lower 
(4 % compared to 7 %). We also noted that the only study 
to report on a speech-based primary measure was part of 
this hearing loss subgroup [33]. Other audiological do- 
mains such as loudness and pitch had the same pattern of 
usage as the full dataset. 
 
Depression and anxiety 
Only one registered clinical trial actively recruited par- 
ticipants experiencing a comorbid depressive state [34], 
and no studies specified an inclusion criterion for a co- 
morbid generalised anxiety. It is not possible,  therefore, 
to consider any patterns within these subgroups. 
 
Discussion 
There is a growing general recognition that insufficient at- 
tention has been paid to the outcomes measured in clin- 
ical trials [14]. Specifically, for tinnitus these limitations 
have been acknowledged in a number of systematic re- 
views, especially those published by the Cochrane Centre 
[35, 36], and have been highlighted by an international 
working party of the Tinnitus Research Initiative [15]. 
 
Principal findings 
No single outcome was reported in all studies. Instead a 
diverse range of outcomes were measured and reported. 
There are three key messages from our work. 
First, over half of all studies did not adequately describe 
the domain for which they were predicting a predominant 
therapeutic benefit. In these cases, primary (and second- 
ary) outcome domains were either not specified at all or 
were unclear. We believe that non-reporting mainly 
reflected a poor understanding of how important it is for 
individual trials to pre-specify the expected outcome. 
When conducting the review, we observed that the head- 
ings used within trial registries promote the reporting of 
instrument choice, rather than the outcome domain. 
Second, there was extremely broad diversity of out- 
come instruments. Loudness was the most popular per- 
ceptual attribute of tinnitus described at the  domain  
level, but there was no agreement on how to measure it 
and the precise methodology was often under-reported. 
Examples of descriptions for loudness matching included 
‘matching at 1 kHz’, ‘psychoacoustical measure’, and ‘by 
audiometry’. Patient-reported questionnaires relating to 
the impact of tinnitus were the most common primary out- 
come instruments, but again there was no consensus about 
which one should be chosen. The Tinnitus Handicap In- 
ventory remains the most popular questionnaire instrument 
simply because it is translated into the greatest number of 
languages. Certainly, it has limitations for the purpose of 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Number of primary outcome instruments reported across the 
228 studies included in the review 
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outcome measurement [28]. Worthy of note, we advise 
caution if pooling findings from the Tinnitus Handicap In- 
ventory in a meta-analysis since it is unclear whether all 
translations achieve equivalence with the British original 
[37]. In compiling the list of tinnitus-related questionnaires 
(Table 4), it was striking how uninformative are the ques- 
tionnaire names in helping trialists to choose between 
them. All include the word ‘tinnitus’ but rarely qualify that 
with a description of which tinnitus-related domains or 
constructs are assessed by the tool. Generic names and 
terms such as ‘handicap’ and ‘severity’ perpetuate the diffi- 
culty that many trialists experience in understanding what 
construct(s) a particular questionnaire instrument mea- 
sures. For example, the Tinnitus Handicap Inventory [23] 
predominantly measures the construct of tinnitus-related 
distress, while the Tinnitus Handicap Questionnaire [38] 
measures the physical, emotional and social consequences 
of tinnitus, as well as hearing ability. 
Third, treatment-related outcomes were rarely recorded. 
Safety, tolerability, side effects and withdrawals might be 
domains that all inform the measurement of adverse 
events, but these accounted for less than 2 % of primary 
outcome domains and 12 % of secondary outcome do- 
mains. Again, non-reporting mainly reflected a poor un- 
derstanding of how important it is for individual trials to 
investigate and report harms, as well as benefits [39]. 
 
Comparison with other studies 
Our work provides the first detailed set of information on 
the selection and reporting of outcome domains and out- 
come instruments in clinical trials of tinnitus. One previ- 
ous systematic review examined outcomes of randomised 
controlled trials of interventions for adults with tinnitus 
[11], but outcome data collection and reporting was re- 
stricted to ‘use of validated instruments for assessing tin- 
nitus symptoms … any audiometric data … length of 
follow-up, and adverse event reporting.’ pp. 2–3, not the 
full set of outcomes considered in the present review. Re- 
ported findings indicated only that 20 % of studies used a 
validated tinnitus instrument, 79 % of studies used audio- 
metric measurements, 42 % of studies specified adverse 
events, and the median follow-up time was 3 months. No 
further details were given and what constitutes a ‘validated 
instrument’ was not defined, so comparisons are re- 
stricted. Our study findings at least confirm the limited 
use of patient-reported questionnaire instruments relating 
to the impact of tinnitus. While we find little consistency 
across studies in reporting adverse events, our findings 
suggest that adverse event reporting is about 5 %, mark- 
edly less than the 42 % reported by Plein et al. [11]. 
Our review identifies limitations in the range of re- 
ported outcomes in clinical trials that are reflected more 
broadly across the field of audiological research.  Here 
two reviews have been undertaken to identify outcome 
 
measures used in research on adults with hearing loss.     
In the first, Granberg et al. [40] conducted a systematic 
review of published articles, including a range of study 
designs. The authors found 51 different patient-reported 
questionnaire instruments relating to the impact of hear- 
ing loss out of the 122 studies included, with only 16 be- 
ing used twice or more. Our review confirmed similar 
diversity (24 different tinnitus-related questionnaire in- 
struments) and lack of consensus (14 used twice or 
more). In the second, Barker and et al. [41] conducted a 
scoping review to document the range and nature of 
outcome measurement in the context of adult auditory 
rehabilitation. Like us, they included registered trials and 
published studies. The most common outcome domain 
was ‘hearing handicap’ which was measured in 23 out of 
the 37 studies included, using five different patient- 
reported questionnaire instruments. Again, the use of 
generic terms such as ‘handicap’ perpetuate the difficulty 
that many trialists experience in understanding what 
construct(s) are measured by a particular questionnaire 
instrument. The frequency of reporting adverse  events 
was not given by Granberg et al. [40], but Barker et al. 
[41] stated  that no studies  reported  on adverse events. 
Poor reporting of harms-related data is not restricted to 
clinical trials in the hearing sciences [42]. 
 
Strengths and limitations of the study 
The strengths of our study rest on the inclusion of both 
registered (ongoing) clinical trials of tinnitus, as well as 
published study findings and on the broad-ranging and 
comprehensive evaluation of both the outcome domains 
and the outcome instruments used. Several potential 
limitations were unavoidable due to limited resources. 
These were the use of a pre-defined  time  window  and 
the exclusion of non-English language records.  While  
the search strategy excluded trials  that  were  registered 
or published prior to July 2006, it is likely to have in- 
cluded trials designed prior to this date. However, there 
was insufficient information reported to ascertain this  
with any degree of certainty. Whether or not any sys- 
tematic bias was introduced by the use of an English- 
language restriction is also uncertain, and may not affect 
systematic review conclusions [43]. 
Our study adds new insights to an emerging body of 
empirical evidence on outcome reporting within  ENT 
and audiology trials [40, 41]. Our findings should help to 
steer trialists in these disciplines about good reporting 
practice, as well as to inform Cochrane and other sys- 
tematic reviewers on the choice of outcomes for their 
work. Our study leads us to agree with Hoare et al. that 
‘To be useful, future studies should … be consistent in 
their use of outcome measures’ [35]. 
The longer-term intention for this work is to develop a 
core outcome set that identifies by consensus a minimum  
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standard for reporting in clinical trials of tinnitus in adults. 
This review makes a specific contribution to that ambi- 
tious endeavour by identifying which domains have been 
defined in relevant clinical trial designs to date. When de- 
veloping a core outcome set, it is important to capture in 
the long list of potential outcome domains all those that 
need to be considered for inclusion [44]. For that long list 
to be truly comprehensive, it is important to capture rele- 
vant information that is contained within those studies. A 
limitation of the current review concerns those domain def- 
initions that were unclear or not specified by their authors. 
This is especially important where the domains relate to 
patient-reported outcomes of the impact of  tinnitus.  One 
way to address the current gap is to deconstruct the patient-
reported outcome instruments by creating  a list  of  all 
questionnaire items, grouping individual items into simi- lar 
constructs or domains and then cross-checking them against 
the current domain list reported here [44]. 
 
Conclusions 
We are the first group to conduct a systematic review that 
targets the reporting of outcome domains  and instruments  
in clinical trial designs that evaluate interventions for tin- 
nitus. The findings of this review have produced an ex- 
tremely rich dataset that has enabled us to  address  a 
number of different primary and secondary questions con- 
cerning different aspects of good trial design. Our findings 
add important new insights pointing to the lack of aware- 
ness and understanding of good trial design in so far as this 
relates to outcomes. A general lack of consensus regarding 
the choice of outcomes did affect trial design, conduct and 
reporting with particular reference to lack of sample size 
calculation, and lack of robust interpretation of whether the 
intervention was therapeutically beneficial or not. 
Our findings emphasise the need to improve trial de- 
sign and reporting. A small number of the included 
studies in our review acknowledged Consolidated Stan- 
dards of Reporting Trials (CONSORT) guidelines for 
reporting [45], but this is more the exception than the  
rule. Using such guidelines would improve definitions of 
all outcome measures including pre-specifying the time 
point of primary interest as well as detailed reporting of 
any important changes to  methods  or  outcomes  after 
the trial commenced with reasons for such changes. To 
improve reporting, we draw attention to the specialised 
CONSORT guidelines for reporting harms-related issues 
in a randomised controlled trial [39]. 
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Somatosensory tinnitus is a generally agreed subtype of tinnitus that is associated 
with activation of the somatosensory, somatomotor, and visual-motor systems. A key 
characteristic of somatosensory tinnitus is that is modulated by physical contact or 
movement. Although it seems common, its pathophysiology, assessment and treatment 
are not well defined. We present a scoping review on the pathophysiology, diagnosis, and 
treatment of somatosensory tinnitus, and identify priority directions for further research. 
Methods: Literature searches were conducted in Google Scholar, PubMed, and 
EMBASE databases. Additional broad hand searches were conducted with the additional 
terms etiology, diagnose, treatment. 
Results: Most evidence on the pathophysiology of somatosensory tinnitus suggests 
that somatic modulations are the result of altered or cross-modal synaptic activity 
within the dorsal cochlear nucleus or between the auditory nervous system and other 
sensory subsystems of central nervous system (e.g., visual or tactile). Presentations of 
somatosensory tinnitus are varied and evidence for the various approaches to treatment 
promising but limited. 
Discussion and Conclusions: Despite the apparent prevalence of somatosensory 
tinnitus its underlying neural processes are still not well understood. Necessary 
involvement of multidisciplinary teams in its diagnosis and treatment has led to a large 
heterogeneity of approaches whereby tinnitus improvement is often only a secondary 
effect. Hence there are no evidence-based clinical guidelines, and patient care is 
empirical rather than research-evidence-based. Somatic testing should receive further 
attention considering the breath of evidence on the ability of patients to modulate 
their tinnitus through manouvers. Specific questions for further research and review are 
indicated. 
Keywords: somatosensation, somatosensory, tinnitus, physical therapy, physiotherapy, cross modal 
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INTRODUCTION 
 
Tinnitus is defined as the conscious perception and reaction to  
a sound in the absence of a matching external acoustic stimulus, 
commonly described as a phantom perception. It is considered  
a symptom rather than a disease per se (Jastreboff and Hazell, 
1993; Bürgers et al., 2013). Tinnitus is present in more than 10% 
(11.9–30.3%) of the adult population (McCormack et al., 2016), 
although only 0.5–3% refers to it as a problem that decreases 
quality of life (Coles, 1984; Swain et al., 2016). 
Although tinnitus has been the subject of much research, its 
pathophysiology remains poorly understood. It is well-accepted 
that many social factors, such as poor education, lower income, or 
occupational and recreational activity associated with high noise 
exposure, influences the prevalence and risk of tinnitus (Hoffman 
and Reed, 2004). Moreover, it is regularly associated with hearing 
loss, trauma, or ototoxic medication triggering cochlear damage, 
with sustained neural changes in the central auditory system  
that succeeds such lesions (Møller, 2011a; Langguth et al., 2013). 
Tinnitus prevalence is believed to increase with age up to 65 years, 
where after it decreases (Hoffman and Reed, 2004; Shargorodsky 
et al., 2010). It is also a widespread symptom among children with 
hearing loss (Coelho et al., 2007) and many causes of hearing loss 
and tinnitus are thought to be the same (Crummer and Hassan, 
2004). 
Recent neuroimaging and animal model studies suggest that 
tinnitus-related neural activity may involve complex interactions 
between several sensory modalities, sensorimotor, somatomotor, 
and visual-motor systems, neuro-cognitive, and neuronal- 
emotional networks (Cacace, 2003; Sanchez and Rocha, 2011a,c; 
Ostermann et al., 2016). Signs of interactions between the 
auditory system and the somatosensory system include gaze- 
evoked tinnitus (Cacace et al., 1994; Pinchoff et al., 1998; 
Lockwood et al., 2001), cutaneous-evoked tinnitus (Cacace et al., 
1999a,b), motor manipulation or forceful muscle contractions  
of head, neck and limbs that induce or suppress tinnitus, or 
affect tinnitus loudness (Sanchez et al., 2002, 2007; Simmons  
et al., 2008). Pressure on myofascial trigger points (Travell, 1960; 
Wyant, 1979; Fricton et al., 1985; Bjorne, 1993; Rocha et al., 
2006, 2008; Rocha and Sanchez, 2007), electrical stimulation of 
the median nerve and hand (Moller and Rollins, 2002), finger 
movements (Cullington, 2001), orofacial movements (Pinchoff 
et al., 1998), and pressure applied to the temporomandibular 
joint (i.e., Bjorne, 1993) are also observed to modulate tinnitus 
in some people. Such “somatosensory tinnitus” is supposed to be 
a prevalent tinnitus subtype (for review see Ralli et al., 2016) and 
prevalence may even be under-estimated because it relies on self- 
report that tinnitus is modulated by touch or movement (Ward  
et al., 2015). For example, the prevalence of somatic modulation 
is higher when the patients are questioned specifically about it 
rather than spontaneous reports (Sanchez et al., 2002). 
For clarity we will use the following definitions: Tinnitus 
Modulation is the human capability of changing the tinnitus 
perception (frequency or intensity) by means of performing a 
certain manouver or movement of the head or neck or jaw or 
limbs or the eyes. Triggers is the phenomenon that acivates 
tinnitus modulation, examples: gaze movement, some tactile 
stimulous, performing a certain manouver or movement of the 
head or neck or jaw or limbs or the eyes. So the peripheral 
activity or stimulation are the primary single sources of a precise 
modulation of the tinnitus sound and it is described as trigger 
activity and the term modulation is reserved solely for describing 
the central neural activity that affect changes in tinnitus percept. 
In the most comprehensive literature review to date on 
somatosensory tinnitus, Sanchez and Rocha (2011a,b) spoke of 
the need to establish evaluation protocols and specific treatments 
for somatosensory tinnitus that focus on both the auditory 
pathway and the musculoskeletal system. Yet there has never 
been a scoping review or systematic review on the topic. In 
this review, we scope the primary research literature on the 
pathophysiology, diagnosis, and treatment of somatosensory 
tinnitus. The aims of the review  are  to  account the breadth 
and current state of knowledge on somatosensory tinnitus, to 
consider priority directions for research, and to identify whether 
any systematic reviews would be informative to the field. 
 
 
MATERIALS AND METHODS 
Literature searches were conducted in November 2016 in 
Google Scholar, PubMed, and EMBASE databases using the 
∗  
search  terms  somato AND   tinnitus   (see   Appendix   1  in 
Supplementary Material for an example search). Search results 
were screened to identify original  articles  and  case  reports  
for review. For Google Scholar, results  were  screened  until 
five consecutive results pages yielded no new potentially 
relevant results. Additional hand  searches  of  publications  
were conducted in the same databases using the additional  
broad search terms etiology, diagnose,  treatment.  Records  
were independently reviewed by  at  least  two  authors.  In  
cases of  disagreement,  opinion  of  a  third  reviewer  was 
taken as consensus. Inclusion criteria were: somatosensory 
tinnitus as main  or  secondary  study  objective,  inclusion  of  
at least one group with patients or case study suffering from 
somatosensory tinnitus, definition of somatosensory tinnitus, 
description of somatosensory tinnitus diagnostic approach or 
treatment. If the focus of the study was somatosensory tinnitus 
pathophysiology, diagnosis, or management, and at least one   
of the study groups or case study consisted of somatosensory 
tinnitus patients, the study was included; otherwise it was 
excluded. Exclusion criteria were articles written in languages 
other than English, and records relating solely to objective 
tinnitus. 
Initial screening was based on abstract reading. Where there 
was uncertainty whether or not a record was relevant the full text 
record was screened. Records were grouped into three categories: 
pathophysiology, diagnosis, and treatment. One record could be 
relevant to more than one category. All records included patients 
with somatosensory tinnitus (P). Interventions (I) and their 
effects were recorded. Outcome measures were also identified 
(O), and comparisons (C) were described either between patients 
and controls, groups of patients divided by tinnitus type or 
intervention, as well between groups of patients before and after 
intervention for somatosensory tinnitus (see Figure 1).   
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RESULTS 
The initial searches for somat ∗  
 
 
AND tinnitus yielded 1,630 
Shore, 2013) whereby somatic modulations of tinnitus results 
from abnormal auditory neural interactions—distortion of the 
normal synaptic activity—within the central nervous system, 
records of which 100 were suitable for inclusion in the review. 
Records are subdivided for review according to pathophysiology, 
diagnosis, and management. 
 
Pathophysiology and Etiology 
Records describing studies on the pathophysiology and etiology 
of somatosensory tinnitus were included and are reviewed here. 
A table compiling the case controlled studies and cross-sectional 
studies were summarized in Appendix 2 in Supplementary 
Material (case reports, reviews and book chapters were excluded). 
A number of authors suggest the somatosensory stimuli 
inducing tinnitus are deeply related to abnormal cross-modal 
plasticity of somatic-auditory interactions (Cacace, 2003; Levine 
et al., 2007; Herraiz, 2008; Rocha et al., 2008; Koehler and 
as Sanchez et al. (2007) describes, “The information triggered 
by muscle contractions is carried by the somatosensory system 
and, upon reaching the cuneiform nucleus, may influence 
tinnitus through its projection over the auditory pathway due   
to an overactivitiy in the cochlear nucleus.” In particular, 
modulation of hyperactivity of neurons in the dorsal cochlear   
is triggered by the stimulation of specific ipsilateral cranial 
nerves, i.e., branch of the trigeminal nerve, explaining how 
ipsilateral tinnitus may be modulated by head and neck’s 
manipulation (see a review, Kaltenbach,  2006).  In  guinea  
pigs, it was demonstrated that DCN bimodal plasticity is 
stimulus timing-dependant and implicated as an underlying 
mechanism in tinnitus (Shore et al., 2007; Koehler and Shore, 
2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1 | Flow chart of study records. 
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Levine et al. (2003) found somatic modulation in patients with 
tinnitus and deafness patients,  identifying  neural  interactions 
in the central nervous  system  as  the  main  protagonists  in  
this process. Levine et al. (2008) also suggest that pulsatile 
tinnitus is modulated by the somatosensory  system  of  the  
head or upper lateral neck, presenting two mechanisms; (1) 
cardiac synchronous somatosensory activation of the central 
auditory pathway, or (2) distortion of the normal synaptic activity 
between the somatosensory and auditory central nervous system. 
Simmons et al. (2008), studying patients who could modulate 
tinnitus with jaw clench found that an alteration in tinnitus 
loudness related to a variation in neural activity in the auditory 
cortex, concluding that tinnitus originates in the central auditory 
pathway. The same effect has been observed in patients who 
can modulate their tinnitus  with  eye  movements  (Lockwood 
et al., 2001; Sanchez and Akemi, 2008), and in patients whose 
tinnitus is modulated by intravenous administration of lidocaine 
(Reyes et al., 2002). Modulation of tinnitus with oral-facial 
movements suggest that the classical auditory system is not 
implicated in tinnitus because limbic structures respond to 
sound stimulation in patients with tinnitus (through hypoactivity 
localized in the hippocampus), further indicating the central 
auditory system and not the cochlea as the origin of tinnitus 
(Lockwood et al., 1998; Cacace, 2003; Schaette and McAlpine, 
2011). In his studies, Levine found that patients could better 
detect changes in their tinnitus when using isometric maneuvers 
of the extremities, compared to head/neck maneuvers, suggestive 
of a major role of the central neural pathway as opposed to the 
auditory periphery (Cacace, 2003). In fact, a higher prevalence of 
somatoform disorders in individuals with tinnitus may also relate 
to certain craniocervical pathological features (e.g., herniated 
discs or temporomandibular joint syndrome; Chole and Parker, 
1992; Rubinstein, 1993; Gelb et al., 1997; Levine, 1999b) and 
dental and jaw diseases (Han et al., 2009). For example, there is a 
higher than general incidence of tinnitus in patients and normal 
hearing who have temporomandibular disorder (TMD) (Levine, 
1999b), suggesting that it may be associated with other symptoms 
of TMD (Chole and Parker, 1992; Bernhardt et al., 2011). The 
temporomandibular joint (TMJ) is thought to be commonly 
involved in the ability to modulate tinnitus, particularly its 
loudness (Ralli et al., 2016). Recently the risk of tinnitus was 
established as 8.37 times higher for patients with TMD (Bürgers 
et al., 2013), and unilateral tinnitus is even reported to be on the 
same side as unilateral TMD (Bürgers et al., 2013). These patients 
are also reportedly able to regulate their tinnitus through certain 
jaw or neck movements (Wright and Bifano, 1997a; Vielsmeier 
et al., 2011, 2012; Bürgers et al., 2013). Since tinnitus is normally 
related to the opposite risk factors (i.e., older males with hearing 
loss), such findings postulate that TMJ may be the cause and 
maintenance of tinnitus (Vielsmeier et al., 2011). It is proposed 
that TMD can cause tinnitus through the disruption of the 
trigeminal input (Vielsmeier et al., 2012; Ostermann et al., 2016). 
Another indication supporting the role of TMD in tinnitus is that 
the two conditions occur simultaneously. Evidence also shows 
that worsening of tinnitus coincides with aggravation of TMD 
(Wright and Bifano, 1997b). 
Diagnosis 
Records describing studies on diagnosis or rate of diagnosis of 
somatosensory tinnitus were included and are reviewed here. A 
table compiling the case controlled studies and cross-sectional 
studies were summarized in Appendixes 3, 4 in Supplementary 
Material (reviews, thesis, and book chapters were excluded), 
concerning both epidemiology and diagnosis fields, respectively. 
Common attributed risk factors for any subtype of tinnitus 
are male gender, older in age and hearing problems (i.e., Hazell, 
1991; Abel and Levine, 2004; Eggermont and Roberts, 2004; 
Hoffman and Reed, 2004; Oostendorp et al., 2016), except for 
TMD-tinnitus patients (Chole and Parker, 1992; Wright and 
Bifano, 1997b; Vielsmeier et al., 2011; Bürgers et al., 2013). Recent 
evidence in a British cohort  study  shows that somatic tinnitus 
is more common among younger people and it is unrelated to 
hearing loss or tinnitus severity (Ward et al., 2015). Some of these 
audiological and demographic traits, may be indeed useful in 
informing therapy (Won et al., 2013) through the identification 
of “clinical criteria for useful subtyping of tinnitus patients” 
(Vielsmeier et al., 2012). 
Signs of somatosensory tinnitus include head or neck 
problems (i.e., temporomandibular joint syndrome, osteophits, 
arthorosis, spondylosis, myofascial trigger points, etc.), dental 
or jaw diseases, frequent pain in head, neck, or shoulder girdle, 
aggravation of events of simultaneous pain and tinnitus, incorrect 
body postures, and severe bruxism (Sanchez and Rocha, 2011b,c). 
Such complexity demands a multidisciplinary team (i.e., dentist, 
physiotherapist) to diagnose. 
Somatosensory tinnitus is strongly evidenced when the patient 
can modulate the loudness or intensity of their tinnitus (Abel and 
Levine, 2004; Latifpour et al., 2009; Sanchez and Rocha, 2011b,c; 
Oostendorp et al., 2016). Hence somatic testing may identify 
patients who could be treated with somatosensory system-related 
therapies. However, this type of testing receives little attention 
(Won et al., 2013). 
There are various presentations of somatosensory tinnitus to 
be aware of. Typical cases include gaze-evoked or modulated 
tinnitus, cutaneous-evoked tinnitus, and tinnitus modulated by 
movement of corporal elements (i.e., head, fingers, jaw). Gaze- 
evoked/modulated tinnitus, the modulation of tinnitus by eye 
movement, provides clues on the potential cortical role in 
tinnitus (Lockwood et al., 2001). Simmons et al. (2008) found   
a large sample of patients who were capable of  modulating 
their tinnitus by eye movement, half of whom had developed 
this ability after undergoing surgery for removal of an acoustic 
neuroma; these patients were able to change the tinnitus loudness 
and pitch through eye movement. 
Studies of cutaneous-evoked tinnitus (using 
magnetoencephalographic signals and tactile discrimination 
tests) have found that cutaneous stimulation of skin on the hand 
region (specifically palm and fingers) activates the somatosensory 
system along with the auditory cortical areas in congenitally deaf 
individuals (Cacace et al., 1999a,b; Cacace, 2003). 
In respect to modulation of tinnitus through of head and 
neck, Levine (1999a) reported that 68% of 70 patients could 
modulate tinnitus through maneuvers of the head, neck, or   
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less intensely, maneuvers of limb. Similarly, Sanchez et al. 
(2002) found both patients with tinnitus (65.3% of 121 persons) 
and healthy subjects (14% of 100) could modulate or develop, 
respectively, tinnitus through 16 different maneuvers, and later 
found 57.9% of a study population could modulate tinnitus using 
nine different maneuvers (Sanchez et al., 2007). Simmons et al. 
(2008) found that, in 93 subjects able to modulate tinnitus by 
jaw clench, 90% could increase the loudness of their tinnitus, 
and 50% could alter the pitch. In a different assessment, the 
same authors found that 78% of their sample of 45 subjects 
could modulate their tinnitus with movement of the head or 
neck, mainly using the cranial and cervical nerves and using 
forceful maneuvers. In another study, Won et al. (2013) found 
that in 57% of tested ears in a population sample of 163 patients, 
tinnitus (especially unilateral tinnitus) was modulated through 
neck maneuvers or jaw maneuvers, decreasing and increasing 
tinnitus loudness respectively. The authors also reported that    
in their sample bilateral and low-pitch tonal tinnitus was rarely 
modulated by movement and may even be aggravated by somatic 
therapy. More distal movement is also observed to modulate 
tinnitus. Cullington (2001) reported the case of a 78-year-old 
man with severe hearing loss implanted with a cochlear implant 
in his right ear was able to modulate his tinnitus by moving    
his finger. Fascinatingly, this patient reported that the quicker 
the movement, the more intense was tinnitus loudness; passive 
or isometric movement did not modulate the tinnitus (Sanchez 
and Akemi, 2008). See Table 1 for a summary of somatic 
maneuvers. 
Even when the patient cannot  self-modulate  tinnitus,  it  
may be altered by other kinds of stimuli, using maneuvers to 
increase activity of the trigeminal nerve such as passive muscular 
palpation to find myofascial trigger points (MFT), relaxation, and 
massage (Simmons et al., 2008; Sanchez and Rocha, 2011b; Shore, 
2011; Won et al., 2013). 
 
Treatment 
Records describing studies on the treatment of somatosensory 
tinnitus were included and are reviewed here by treatment 
category. Case controlled studies and cross-sectional studies were 
summarized in Appendix 5 in Supplementary Material. 
 
Physiotherapeutic Treatment 
Studies have accounted the benefits for tinnitus of treating 
(temporomandibular disorder) TMD. Wright and Bifano (1997a) 
studied tinnitus in TMD patients and reported that 56% had been 
cured and 30% had a significant improvement with cognitive 
therapy and modulation through maneuvers. However, it has 
also been found that that severe tinnitus is less likely to improve 
with TMD therapy (Wright and Bifano, 1997a). Another similar 
study has shown that younger patients with moderate tinnitus 
were more likely to experience relief of their tinnitus through 
TMD therapy (Wright and Bifano, 1997b). Tinnitus severity as 
a predictor of the effectiveness of TMD therapy has already been 
proposed by others including Erlandsson et al. (1991) and Bush 
(1987). 
The presence of fluctuating tinnitus is another factor that may 
associate with TMD treatment effectiveness (e.g., Tullberg and 
Ernberg, 2006). 
One form of TMD treatment is occlusal splint therapy 
(Attanasio et al., 2015). In their study involving this treatment  
in patients presenting with chronic subjective tinnitus Attanasio 
et al. (2015) divided patients into three groups according to 
whether TMD was absent, present, or the patient was considered 
predisposed to TMD. Patients were subjected to treatment with 
 
 
TABLE 1 | Summary of somatic manouvers. 
Authors Body part Maneuvres (examples) 
 
Cullington, 2001 Finger Moving up and down the middle finger of left hand**# 
Levine, 1999a; Sanchez et al., 2002, 2007; Abel and Levine, 2004; Levine et al., 
2007 
Extremities Locking the fingers of the two hands together and pulling as 
hard as possible, or resisting maximal pressure to. Shoulder 
abduction. Flexion or abduction of the hip. Resisting or not an 
applied force. 
Lockwood et al., 2001; Sanchez and Akemi, 2008; Simmons et al., 2008 Eye Moving in the vertical or horizontal axis** 
Cacace et al., 1999a,b; Cacace, 2003; Sanchez and Akemi, 2008 Cutaneous Stimulation of a well-defined region—various regions of the hand 
and fingers (e. g., palm, dorsal web regions, and fingertips)**& 
Pinchoff et al., 1998; Sanchez et al., 2002, 2007; Abel and Levine, 2004; Levine 
et al., 2007; Simmons et al., 2008; Latifpour et al., 2009; Won et al., 2013 
Levine, 1999a; Sanchez et al., 2002, 2007; Abel and Levine, 2004; Simmons 
et al., 2008; Latifpour et al., 2009; Won et al., 2013 
Jaw Clench the teeth, open and close mouth, protrude jaw, slide jaw. 
Resisting or not an applied force. 
Head and neck Moving the head back and in front and laterally, resisting or not 
an applied force (against the head in a neutral position or turned 
to one of the sides). 
Applying pressure on muscle insertions–esternocleidomastoid, 
splenius capitis, and posterior auricular. 
 
 
All the different voluntary muscle contraction manouvers should be sustained during 5–10 s and performed using a moderate degree of force in a silent environment (Levine, 1999a). 
The idiopathic somotosensorial tinnitus will present more relevant modulation with jaw and head-neck manouvers. 
**Very specific to certain cases of patients subjected to brain neurosurgery or cochlear implantation only rarely is it spontaneous. 
# The patient reported that the quicker the movement, the more intense the tinnitus loudness, passive or isometric movement did not modulate the tinnitus. 
& Studies of cutaneous-evoked tinnitus, (using magnetoencephalographic signals and tactile discrimination tests) have found that electrical stimulation of the median nerve and hand 
region or cutaneous stimulation of skin on various regions of the hand including dorsal web regions and fingertips activate the somatosensory system along with the auditory cortical 
areas in congenitally deaf individuals (Cacace et al., 1999a,b; Cacace, 2003).   
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a neuromuscular occlusal splint for 6 months (using the splint  
at night time) and rated for the severity of tinnitus using 10- 
point visual analog scale and Tinnitus Handicap Inventory (THI; 
Newman et al., 2004) questionnaire. Post-treatment THI scores 
were reduced in all groups but was most pronounced in the TMD 
(experience or predisposed) groups. The authors concluded that, 
once otologic disorders and neurological diseases are excluded, 
that clinicians should refer patients for an evaluation of the 
temporomandibular joint and subsequently to treat patients with 
TMD or a predisposition to it. 
Wright (2000) suggested oro-myofunctional therapy as an 
effective alternative to occlusal splints therapy. Their study 
involved patients from the  US  air  force  seeking  treatment  
for tinnitus, dizziness, and/or nonotologic otalgia without an 
identifiable cause and presenting with TMD symptoms in the 
temple, jaw, or preauricular area. Patients were provided a 
dental orthotic and TMD self-care instructions. After 3 months 
of orthotic wear, the percentages of patients reporting at least 
moderate symptom improvement of their tinnitus, dizziness, 
otalgia, and/or TMD were 64, 91, 87, and 92%, respectively. 
Follow-up telephone calls 6 months after completion of TMD 
therapy revealed that all patients maintained their symptom 
improvements. These findings imply that TMD was affecting the 
patients’ otologic symptoms. 
 
Stomatognathic Therapy 
Usually it includes splints therapy, therapeutic  exercises  for 
the lower jaw and occlusal adjustment in combination with 
counseling. 
For a long time, scientists have investigated the effects of 
dental and stomatognathic therapies in tinnitus (Junemann, 
1941; Gelb and Arnold, 1959; Dolowitz et al., 1964; Kelly and 
Goodfriend, 1964; Gelb et al., 1967; Koskinen et al., 1980; 
Ioannides and Hoogland, 1983; Cooper et al., 1986; Bush,  
1987; Rubinstein and Erlandsson, 1991). According to the 
findings of Rubinstein (1993), almost one-third of patients 
report improvement in their tinnitus after mandibula movements 
and/or pressure on their TMJs. More recently, Bürgers et al. 
(2013) found that stomatognathic therapy had a positive effect 
on tinnitus symptoms in 44% of their TMD-tinnitus patients    
(n = 25), up to 3–5 months after the first intervention; while 
promising it is  noted  that  there  was  no  control  group  in  
this study. Using dental functional therapy, the authors found  
an improvement on acute or  subacute  tinnitus  in  100%  of  
the patients but little improvement in patients with chronic 
tinnitus. It is  important  to  note  that  the  authors  discussed  
an individual therapeutic strategy with each patient before the 
start of treatment. The authors suggested long term studies are 
conducted to assess the outcome and advised caution when 
interpreting current epidemiological data. 
 
Chiropractic Therapy 
Chiropractic therapy is a correction  therapeutic  treatment  of 
an  abnormal  movement  pattern  through   the   manipulation 
of the vertebral column and extremities. Only three studies 
related to chiropractic treatment of tinnitus were identified and 
all three were case studies. Alcantara et al. (2002) described 
the chiropractic therapy in a 41-year-old woman with history   
of ear pain, tinnitus, vertigo, altered hearing,  ear  infections, 
and headaches, and who was diagnosed TMD and cervical 
subluxation. The authors reported a complete relief from the 
TMD symptoms, including tinnitus,  after  only  9  treatments  
(2 months). The treatment involved the application of high- 
velocity low amplitude adjustments. Kessinger and Boneva 
(2000) also reported progress in a 75-year-old patient who 
received upper cervical specific chiropractic care which resulted 
in improvements in vertigo, tinnitus, and hearing loss. These 
authors concluded that the success of chiropractic therapy was 
due to improvement in cervical spine function. 
DeVocht et al. (2003) also describes the chiropractic 
management of a 30-year-old woman with TMJ pain. The patient 
suffered daily from unremitting jaw pain for 7 years accompanied 
by headache, tinnitus, decreased hearing, and a feeling of 
congestion in her right ear. Twenty months of chiropractic 
treatment resulted in total resolution of all symptoms except 
fullness of the right cheek. 
 
Muscle Relaxation 
Combined with chiropractic care, muscular relaxation (through 
massage and stretching exercises) is used in clinical practice. For 
instance, evidence suggests that palpation of masseter, pterygoid, 
and sternocleidomastoid muscles or myofascial trigger points 
can modulate tinnitus (Rocha et al., 2008; Teachey et  al.,  
2012). Björne (2007) reported on the effectiveness of stretching 
exercises targeting the suboccipital muscles, along with rotation 
movements in the atlanto-occipital joint and relaxing exercises, 
on a TMD patient population (no control group). Bjorne notes 
that patients with Ménière’s were more likely to present with TMJ 
and cervical spine disorder’s symptoms (including tinnitus), than 
people who do not have Ménière and using a coordinated therapy 
of TMJ and cervical spine disorder (relaxation and posture) 
found improvements in self-reported tinnitus severity that were 
retained up to 3 year follow up. 
Latifpour et al. (2009) evaluated 24 subjects from an original 
pool of 41 subjects (non-randomized), divided into two groups: 
treatment and control group. The authors compared self-training 
of stretching, posture training, and acupuncture, targeting 
muscle symmetry and balance in the jaw and neck, and later 
reported an improvement of tinnitus in the treatment group. In 
this blinded study they observed immediate and long term (3 
months) improvements in the treatment group. 
Another therapy worth noting here; in a pilot study with      
11 patients, Kaute (1998) reported improvement in vestibular 
disturbances through the method of Arlen’s Atlas Therapy, 
normally applied to whiplash-injured patients, concluding it to be 
indicated where tinnitus may be caused by neck muscle tension. 
This study suggest that muscular relaxation may play a significant 
role in the treatment of tinnitus but high quality explanatory 
studies (i.e., comparison with a control, blinded, randomized 
allocation), are needed. 
 
Somatic Modulation Therapy 
Somatic modulation therapy (treatment aiming to modulate the 
intensity of a given symptom, by movement) has rarely been   
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studied beyond case studies. Sanchez et al. (2007) were the first to 
investigate the effect of repetitive training maneuvers with head 
and neck muscle contractions, focusing on its value as a tinnitus 
retraining therapy. The authors found it to have a significant 
effect on the modulation patterns but not in the daily perception 
of tinnitus. 
In the case of a 39-year-old woman who developed gaze- 
evoked tinnitus after surgery to remove a left vestibular 
Schwannoma, therapy consisted of a repetitive gaze training and 
tinnitus was resolved after 14 weeks (Sanchez and Akemi, 2008). 
Interestingly, there was both a “horizontal” and “vertical” gaze 
effect on tinnitus and the vertical component responded more 
quickly to treatment suggesting more than one neural network 
or process was involved in this case. 
In another case, a 54-year-old man with severe tinnitus 
noticed an improvement through tactile stimuli to the ipsilateral 
postauricular area, head rotation, opening of the mouth, and 
clenching teeth and mandible lateralization (Sanchez and Akemi, 
2008). In another case of tinnitus improvement through tactile 
stimulation was reported in a single patient by Emmert et al. 
(2014); the patient reported a decrease in tinnitus intensity in the 
left ear when a tactile stimulus was applied (block-design using 
EPI sequence—the patients touched on the right cheek on seven 
blocks of 25 s, intercalating with 25 vs rest). 
 
Electrical Stimulation 
Recent evidence reported a significant improvement in tinnitus 
using transcutaneous electrical nerve stimulation (Herraiz et al., 
2007; Vanneste et al., 2010). Trans-electrical nerve stimulation 
(TENS) of areas of skin close to the ear increases the activation of 
the dorsal cochlear nucleus through the somatosensory pathway 
and may augment the inhibitory role of this nucleus on the CNS 
and thereby ameliorate tinnitus (Herraiz et al., 2007). 
Vanneste et al. (2010) applied transcutaneous nerve 
stimulation in the upper cervical nerve  in  240  patients  with 
the ability to modulate tinnitus and found a significant 
suppression of tinnitus. Although only 18% of the patients 
responded to the treatment, 43% declared an improvement and 
six patients reported a total suppression of tinnitus (Vanneste    
et al., 2010). Herraiz et al. (2007) showed that trans-electrical 
nerve stimulation led to improvements in 46% of somatic 
tinnitus patients (reduced VAS tinnitus severity scores) after 
2 weeks of treatment. Intermittent “typewriter”—sound like 
tinnitus was the most responsiveness. Herraiz et al. (2007) also 
noted that tinnitus caused by a somatosensory injury had a better 
response than somatic tinnitus with an otologic disease. 
Standardizing the indications and method could increase the 
efficacy of electrical stimulation in somatic tinnitus according to 
most authors. These results are promising so further controlled 
trials are warranted. 
 
Pharmaceutical Treatment 
Only one relevant record describing a pharmaceutical treatment 
was included. In this case study McCormick and Walega  
(2015) reported the successful treatment of refractory somatic 
tinnitus with cervical epidural injection of 80 mg triamcinolone 
acetonide. The patient was 61-year-old male with previous 
history of bacterial otitis media. 
Surgical Treatment 
No surgical treatment studies specific to somatosensory tinnitus 
were identified. One case study worth mentioning however was 
that of a 65 years old patient with left sided tinnitus and with left 
sided cervical neck pain who experienced a complete resolution 
of somatic tinnitus for over 1 year through radiofrequency 
ablation of the left C2–C3 medial branches of the dorsal ramus 
ipsilateral to tinnitus symptoms (Gritsenko et al., 2014). 
 
 
DISCUSSION 
Tinnitus is complex in nature and so ideally, and to achieve    
the best results, diagnosis  and  treatment  should  be  specific  
to an individual patients experience. Further research on the 
physiological processes that lead to somatosensory tinnitus 
would facilitate the development of a specific protocol and 
therapy targeting the auditory pathways and musculoskeletal 
disorders (Sanchez and Rocha, 2011c). Indeed, any holistic view 
of tinnitus needs to take into consideration the auditory system 
as a dynamic and active structure, integrating systems of reaction, 
stimulation, and emotion and tinnitus itself as a symptom with 
complex causes that indicate hyperactive neural activity (Møller, 
2011a) and activation of neural plasticity (Moller and Rollins, 
2002; Møller, 2011b; Smith et al., 2013), without the participation 
of the ear (Møller, 2016). 
Evidence points to a high prevalence of somatosensory 
tinnitus, but that it  is  under-investigated  by  clinicians  and  
the processes underlying are still poorly studied. For instance, 
only very recently have the first steps been made toward 
understanding the genetic underpinnings of subjective tinnitus 
(Lopez-Escamez et al., 2016) or the social context and 
environment which  may  influence  tinnitus,  following  the 
new Social-Neurophysiological Model of Tinnitus. This model 
proposes the integration of the neurophysiological system 
(Jastreboff, 1990; Jastreboff and Jastreboff, 2000) the relation 
between psychophysiological and behavioral systems) and the 
social information system, associated with the emotional 
experience of tinnitus (Li et al., 2015). These avenues may help 
develop clinical strategies that adapt to patient’s understanding 
and attitudes toward tinnitus, through social learning. What 
these will mean for somatosensory tinnitus is an open question. 
It is important to note that an early and precise diagnosis, 
presents the best outcomes for the patient treatment (Herraiz, 
2008). Recent research on the treatment of somatosensory 
tinnitus has focused on bone and muscular disorders, on each 
structure independently or using multimodal approach including 
manual therapy and exercise (Michiels et al.,  2014,  2016).  
This demands different practitioners (dentists, neurologists, 
audiologists, physiatrist etc.) to be involved in treatment. 
Although such strategies do not target tinnitus directly, such 
therapies are shown to ameliorate its side effects. 
It is not possible  to  cure  tinnitus  through  dental  and  
TMD therapies. But these same therapies may contribute to a 
multidisciplinary methodology of tinnitus treatment (Herraiz, 
2008; Bürgers et al., 2011). It is a priority to establish how TMD 
and somatosensory tinnitus are related and what criteria should 
be used to select tinnitus patients for different TMD therapies.   
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Further research is needed to attest the efficacy of TMD therapy 
on tinnitus and to access the placebo effect (Rubinstein, 1993; 
Tullberg and Ernberg, 2006). 
A multidisciplinary approach to managing somatosensory 
tinnitus may result in different strategies being used by  
different teams of clinicians if there is poor interdisciplinary 
communication and the lack of large-scale controlled trials to 
inform evidence-based clinical guidelines (Møller, 2007). In 
addition, standardization of core measures hinders the process 
of any potential meta-analysis on the large datasets, which 
would aid the development of clinical interventions for tinnitus. 
However, it will need to be tested whether these standardized 
outcomes are sensitive to treatment related changes in groups of 
patients or trail participants who have somatosensory tinnitus. 
 
CONCLUSION 
Because somatosensory tinnitus is not judged a disease per se, but 
instead it is considered a symptom, its diagnosis and treatment 
were related to other disorders. Connection to hearing loss and 
bone and muscular disorders are evident. 
With this scoping review, we intended to give the reader a 
broad overview of findings to date concerning somatosensory 
tinnitus, and encourage new systematic and integrative analyses 
which will hopefully bring the much-needed order to the field of 
tinnitus research. 
We propose several outstanding studies on somatosensory 
tinnitus: 
1. There is some discrepancy over the prevalence of 
somatosensory tinnitus; a systematic review is needed. 
2. The etiology of somatosensory tinnitus needs continued 
investigation. Particularly, and considering the involvement 
of neural plasticity, it is necessary to determine the exact 
processes that initiate the abnormal cross-modal plasticity   
of somatic-auditory interactions. Moreover,  it  is important 
to determine the exact relation between the head/neck 
maneuvers in the central neural system. 
3. There is a lack of objective diagnostic methodology, which 
may misguide clinical management. Clinical guidelines that 
consider or are specific to somatosensory tinnitus are needed. 
4. There are many and different strategies for managing tinnitus, 
originating in different clinical fields (audiology, neurology, 
psychology, etc.), and not all strategies have been trialed     
in somatosensory tinnitus. Integrating such strategies, and 
having in mind that each patient is a singular case, may 
increase the success of clinical management practices for 
tinnitus. 
5. To support further trials and data synthesis in somatosensory 
tinnitus there needs to be standard research methodologies. 
Theses should be developed through consensus. 
6. A therapeutic intervention combining simultaneously several 
types of treatment approaches may bring the best results for 
tinnitus relief, but such combinations may also be individual 
specific. 
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Abstract 
Since somatic or somatosensory tinnitus (ST) was first described as a subtype of subjective tinnitus, where altered som- 
atosensory afference from the cervical spine or temporomandibular area causes or changes a patient’s tinnitus perception, 
several studies in humans and animals have provided a neurophysiological explanation for this type of tinnitus. Due to a lack 
of unambiguous clinical tests, many authors and clinicians use their own criteria for diagnosing ST. This resulted in large 
differences in prevalence figures in different studies and limits the comparison of clinical trials on ST treatment. This study 
aimed to reach an international consensus on diagnostic criteria for ST among experts, scientists and clinicians using a Delphi 
survey and face-to-face consensus meeting strategy. Following recommended procedures to gain expert consensus, a two- 
round Delphi survey was delivered online, followed by an in-person consensus meeting. Experts agreed upon a set of criteria 
that strongly suggest ST. These criteria comprise items on somatosensory modulation, specific tinnitus characteristics, and 
symptoms that can accompany the tinnitus. None of these criteria have to be present in every single patient with ST, but in 
case they are present, they strongly suggest the presence of ST. Because of the international nature of the survey, we expect 
these criteria to gain wide acceptance in the research field and to serve as a guideline for clinicians across all disciplines. 
Criteria developed in this consensus paper should now allow further investigation of the extent of somatosensory influence 
in individual tinnitus patients and tinnitus populations. 
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Introduction 
Tinnitus is the phantom sensation of sound in the absence 
of  overt  acoustic  stimulation   (Landgrebe et  al.,  2012). 
It occurs in  approximately  10%  to  15%  of  adults  and 
is experienced as severely annoying by 1.6% (Baguley, 
McFerran, & Hall,  2013).  Reported prevalence  ranges 
can vary, depending on  the  way  tinnitus  is  diagnosed 
and the age and gender of the assessed population 
(McCormack, Edmondson-Jones, Somerset, & Hall, 2016). 
Tinnitus is mostly subjective, as only the patient 
experiences it, and it is generally described as whistling, 
hissing, sizzling, or ringing (Baguley et al., 2013). 
Typically, tinnitus is related to hearing loss or a noise 
trauma, where cochlear abnormalities are the initial 
source, and neural changes in the central auditory 
system maintain the tinnitus (Baguley et al., 2013). 
In the 1990s, the first researchers (Hiller, Janca, & 
Burke, 1997; Pinchoff, Burkard, Salvi, Coad, & 
Lockwood, 1998) started to mention a possible influence 
of the somatosensory system on tinnitus complaints, but 
it was only in 1999 that Levine (1999) first described a 
hypothesis for this tinnitus subtype, which he named 
somatic tinnitus (ST). 
ST (also called somatosensory) is a subtype of sub- 
jective tinnitus, where altered somatosensory afference 
from the cervical spine or temporomandibular area 
causes or changes a patient’s tinnitus perception. 
Since Levine’s first publication (1999), several animal 
and human studies have found connections between the 
somatosensory system of the cervical or temporoman- 
dibular  area  and  the  cochlear  nuclei  (CN),   offering  
a physiological explanation for ST (Lanting, de Kleine, 
Eppinga, & van Dijk, 2010; S. E. Shore, 2011; Zhan, 
2006). According to these studies, cervical or temporo- 
mandibular  somatosensory  information  is   conveyed  
to the brain by afferent fibers, the cell bodies of which 
are located in the dorsal root ganglia or the trigeminal 
ganglion. Some of these fibers also project to the central 
auditory system. This enables the somatosensory system 
to influence the auditory system by altering spontaneous 
rates or synchrony of firing among neurons in the CN, 
inferior colliculus or auditory cortex. In this way, the 
somatosensory system is able to alter the pitch or loud- 
ness of the tinnitus (S. Shore, Zhou, & Koehler, 2007). 
Sanchez and Rocha (2011) proposed a set of diagnos- 
tic criteria to help recognizing patients with ST in clinical 
practice. According to these criteria, ST is suspected 
when the medical history shows at least one of the fol- 
lowing: (a) evident history of head or neck trauma; (b) 
tinnitus association with some manipulation of the teeth, 
jaw, or cervical spine; (c) recurrent pain episodes in head, 
neck, or shoulder girdle; (d) temporal coincidence of 
appearance or increase of both pain and tinnitus; (e) 
increase in tinnitus during inadequate postures during 
rest, walking, working, or sleeping; and (f) intense brux- 
ism periods during the day or night (Sanchez & Rocha, 
2011). In addition, Sanchez and Rocha (2011) mention 
that ST often changes its loudness, pitch, or localization 
during stimulation in the head or neck region. Others 
(Biesinger, Groth, Hoing, & Holzl, 2015; Ward, Vella, 
Hoare, & Hall, 2015) state that the presence of this som- 
atic modulation, through voluntary movements or spe- 
cific resistance tests, is very important, if not the most 
important criterion, in diagnosing ST. These differences 
in diagnostic criteria might, at least partially, explain the 
large differences in prevalence of ST, which vary from 
16% to 83% in different studies (Abel & Levine, 2004; 
Levine, Abel, & Cheng, 2003; Michiels, De Hertogh, 
Truijen, & Van de Heyning, 2015; Ralli et al., 2017; 
Simmons, Dambra, Lobarinas, Stocking, & Salvi, 2008; 
Ward et al., 2015; Won et al., 2013). 
The lack of any agreed standards for clinical assess- 
ment make it unclear how to diagnose ST. Therefore, we 
aimed to reach a consensus on  diagnostic  criteria  for 
ST among professional experts with current experience 
in assessing and managing ST. To reach this goal, we 
conducted a systematic review of the literature, followed 
by a modified two-round Delphi survey and a face-to- 
face meeting. 
 
Methods 
We  used a Delphi  process to  gain consensus on a  set  
of diagnostic criteria for ST among a panel of experts 
(scientists and clinicians). The Delphi technique, origin- 
ally developed by the RAND Corporation, is a struc- 
tured process that uses a series of questionnaires or 
rounds to gather and to provide information on a certain 
topic (Keeney, Hasson, & McKenna, 2001). 
 
Systematic Review 
A modified Delphi technique (Fackrell  et  al.,  2017)  
was used, asking participants to review a long list of 
potential diagnostic criteria for ST rather than asking 
 
Tinnitus, biomarkers and quality of life in an older population 
153 
   
 
Michiels et al. 3 
 
 
participants to nominate criteria from scratch. This long 
list was created using data collected by a systematic 
review of the relevant literature. A search of the online 
search engine PubMed was performed up until October 
2017. PubMed searches biomedical literature from 
MEDLINE,  life  science  journals,  and  online  books.  
A lenient search strategy was  performed  to  identify  
the following terms appearing in all fields— 
(‘‘Tinnitus’’[Mesh])AND (Somatosensory OR somatic). 
Studies were eligible if they contained information on 
specific clinical features or diagnostic criteria of ST or 
inclusion criteria relating to ST. Screening and selection 
of eligible articles and data extraction were conducted by 
the first author. Data extraction was limited to assess-  
ment information only, which was then used to create a 
long list of potential diagnostic criteria for ST (Table 1). 
 
Modified Delphi Survey 
Panel selection. Experts in ST were identified if they were a 
senior (i.e., first or last) author of an included publication 
that had been identified in the systematic review and were 
able to understand written English. Responsibility for 
conducting and managing the Delphi  process was  not 
an exclusion criterion for panel membership. In addition, 
those experts were each asked to recommend other ST 
experts from academic or clinical fields. This process iden- 
tified 18 individual experts from 10 countries (Belgium, 
Brazil, France, Germany, Israel, Italy, Portugal, United 
Kingdom, South Korea, and United States) and 16 uni- 
versities or hospitals. Of those, 15 agreed to participate in 
the Delphi panel. Two answered they did not feel confi- 
dent enough with the subject to be part of the survey and 
one did not respond to the invitation. 
 
The Delphi survey. The two-round Delphi survey was man- 
aged  using  Qualtrics®  Survey  Software  to  support 
the international reach of the study. Academic and clin- 
ical experts were pooled to create a single professional 
stakeholder group. To promote retention of panel mem- 
bers, each round was open for a short time (4 weeks) and 
the  time  between  rounds  was  kept  to  a  minimum   
(2 weeks). Response rates were regularly monitored, 
email reminders were sent to target  individuals  who  
had yet to complete the round. 
In Round 1, 15 panelists were asked to evaluate the 
level of importance of each potential diagnostic criterion 
for ST from the long list. The order of items was fixed 
across rounds. Participants scored each outcome domain 
inspired by the GRADE scale of 1 to 9 (Guyatt et al., 
2011). Scoring used a Likert-type scale with additional 
interpretation categories; 1 to 3 indicated that the item 
was not essential for diagnosing ST, 4 to 6 indicated it 
may be present, but not essential, and 7 to 9 indicated that 
it was essential. Unable to score was always an option. 
Participants were also able to suggest additional diagnos- 
tic criteria in a free-text comment. 
In Round 2, those panelists who completed at least  
80% of the Round 1 survey received the same long list, 
plus the additional items suggested by at least one pane- 
list. Participants were presented with graphical feedback 
(a bar chart) to summarize the panel results from Round 
1. The purpose of Round 2 was to enable the participants 
to reflect on their answers, taking into account the opin- 
ion of their peers, and to score the different items again. 
From Round 2, a recommendation for inclusion as a 
diagnostic criterion for ST was predefined as at least 
70% of the panelists scored 7 to  9,  and  fewer  than  
15% scored 1 to 3. Conversely, a recommendation for 
exclusion was at least 70% of the panelists who scored 1 
to 3 and fewer than 15% scored 7 to 9. 
 
Consensus Meeting 
The 14 panelists who completed Round 2 of the Delphi 
survey were invited to participate in a face-to-face con- 
sensus meeting that took place on March 13, 2018, prior 
to the Tinnitus Research Initiative Conference 2018 in 
Regensburg, Germany. A group of six clinicians or aca- 
demic professionals with expertise on ST attended the 
meeting. The panel included three clinicians (one audi- 
ologist and two ear, nose, and throat [ENTs]) and three 
scientists (one neurologist, one ENT, and one physical 
therapist). Authors 1 to 5 served on this panel. The meet- 
ing lasted 3 h, and the discussion was semistructured 
according to the nominal group technique (Harvey & 
Holmes, 2012). Participants were encouraged to voice 
their opinions. All strongly dissenting opinions were 
considered. 
The  starting  point  for  the  consensus  discussion 
was guided by the recommendations from the Delphi 
survey. First, participants were asked to consider those 
items where, after Round 2 of the survey, the recommen- 
dation was for exclusion as a diagnostic criterion for ST. 
The remaining items were individually discussed and 
voted for, with voting options being include or exclude. 
Again the predefined definition of consensus was for at 
least 70% of the participants to agree. 
 
Results 
Systematic Review 
The search strategy identified 167 articles, of which 18 
were eligible for inclusion. A detailed overview of the 
selection process is shown in Figure 1. Synthesis of the 
data extracted from those 18 articles related to patient 
assessment for ST yielded 34 potential diagnostic cri- 
teria. A list of these can be found  in  Table  1, along 
with references to the source of that information. 
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Table 1. Overview of the ‘‘Long List’’ of 41 Potential Diagnostic Criteria. 
 
 
References Potential diagnostic criterion 
Voting results 
consensus meeting 
Biesinger et al. (2015), Haider et al. (2017), Ward 
et al. (2015), Vielsmeier et al. (2012), Sanchez 
and Rocha (2011), Levine and Oron (2015), 
and Bechter, Wieland, and Hamann (2016) 
Biesinger et al. (2015), Ward et al. (2015), and 
Sanchez and Rocha (2011) 
Ward et al. (2015) and Kapoula, Yang, Vernet, 
Bonfils, and Londero (2010) 
The patient is able to modulate the tinnitus by 
voluntary movements of the head or neck. 
 
 
The patient is able to modulate the tinnitus by 
voluntary movements of the jaw 
The patient is able to modulate the tinnitus by eye 
movements 
100% inclusion 
 
 
 
100% inclusion 
 
100% inclusion 
Biesinger et al. (2015) and Ward et  al. (2015) The patient is able to modulate the tinnitus by 
clenching the teeth 
Biesinger et al. (2015) and Haider et  al. (2017) Tinnitus is modulated by pressure on myofascial 
trigger points 
100% inclusion 
 
100% inclusion 
Biesinger et al. (2015), Ward et al. (2015), Ralli 
et al. (2016), and Ostermann et al. (2016) 
Biesinger et al. (2015), Ward et al. (2015), Ralli 
et al. (2016), and Ostermann et al. (2016) 
Tinnitus is modulated by resistance tests of the 
cervical spine (somatic maneuvers) 
Tinnitus is modulated by resistance tests of the jaw 
(somatic maneuvers) 
100% inclusion 
 
100% inclusion 
Haider et al. (2017) Tinnitus is modulated by resistance tests of the arm 
(somatic maneuvers) 
100% ‘‘can be present 
occasionally’’ 
Bechter et al. (2016), Ralli et al. (2016, 2017), 
Sanchez and Rocha (2011), and Erlandsson, 
Rubinstein, and Carlsson (1991) 
Tinnitus is accompanied by frequent pain in the 
cervical spine, head or shoulder girdle 
100% inclusion 
Bechter et al. (2016) Tinnitus is accompanied by muscular tension of the 
upper posterior cervical muscles of the head-neck 
transition 
100% inclusion 
Haider et al. (2017), Ward et al. (2015), Ralli et al. 
(2016) , Vielsmeier et al. (2012), Erlandsson  
et al. (1991), Tullberg and Ernberg (2006), and 
Buergers, Kleinjung, Behr, and Vielsmeier 
(2014) 
Tinnitus is accompanied by temporomandibular dis- 
orders (pain in the jaw or masticatory muscles) 
100% inclusion 
Haider et al. (2017) Tinnitus is accompanied by signs of osteophytes or 
spondylosis on radiography 
Haider et al. (2017) Tinnitus is accompanied by the presence of pressure 
tender myofascial trigger points 
100% exclusion 
 
100% inclusion 
Haider et al. (2017) Tinnitus is accompanied by dental diseases 75% inclusion 
25% exclusion 
Haider et al. (2017), Ralli et al. (2017), and 
Michiels, Van de Heyning, Truijen, Hallemans, 
and De Hertogh (2017) 
Tinnitus and pain symptoms aggravate simultaneously 100% inclusion 
Haider et al. (2017) Tinnitus is accompanied by poor body posture 100% exclusion 
Haider et al. (2017), Ralli et al. (2017), and Bosel, 
Mazurek, Haupt, and Peroz (2008) 
Tinnitus is accompanied by bruxism 100% inclusion 
Ralli et al. (2017) Tinnitus is accompanied by teeth clenching 100% inclusion 
Ward et al. (2015) Presence of a pulsatile tinnitus, not synchronous with 
the heartbeat 
100% ‘‘can be present 
occasionally’’ 
Ward et al. (2015) Tinnitus loudness is reported to vary from day to day 100% inclusion 
Ralli et al. (2017) and Sanchez and  Rocha (2011) Tinnitus is preceded by a head or  neck trauma 100% inclusion 
Ralli et al. (2017), Sanchez and Rocha (2011), and 
Michiels et al. (2017) 
Tinnitus increases during bad postures (while resting, 
walking, working or sleeping) 
100% inclusion 
Vielsmeier et al. (2012) Tinnitus is maskable by music or sounds 100% exclusion 
Sanchez and Rocha (2011) and 
Michiels et al. (2017) 
Tinnitus and pain complaints appeared 
simultaneously 
100% inclusion 
 
(continued) 
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Table 1. Continued 
 
 
References Potential diagnostic criterion 
 
Voting results 
consensus meeting 
Tullberg and Ernberg (2006) and 
Bosel et al. (2008) 
Tinnitus is accompanied by malocclusion of the teeth 100% ‘‘can be present 
occasionally’’ 
Bosel et al. (2008) Tinnitus is accompanied by oral parafunctions (such 
as: bruxism, teeth clenching, biting nails, . . . ) 
 
Peroz (2003) Tinnitus is accompanied by muscular dysfunction of 
the masticatory area 
 
 
Bosel et al. (2008) Tinnitus is accompanied by noises of the temporo- 
mandibular joint 
 
 
Bosel et al. (2008) Tinnitus is accompanied by palpation pain in the 
masticatory muscles 
 
 
Ostermann et al. (2016) Tinnitus is accompanied by fascial dysesthesia (such 
as a tingling or numb feeling in the face) 
Kapoula et al. (2010) Tinnitus is accompanied by deficits in eye fixation, 
smooth pursuit tests or optokinetic nystagmus 
Item is covered by 
including bruxism 
and teeth clenching 
Item is covered by 
including temporo- 
mandibular 
disorders 
Item is covered by 
including temporo- 
mandibular 
disorders 
Item is covered by 
including temporo- 
mandibular 
disorders 
100% ‘‘can be present 
occasionally’’ 
100% exclusion 
Michiels et al. (2017) Tinnitus is low pitched (<1000 Hz) 100% exclusion 
Levine, Nam, and Melcher (2008) Constant pulsatile tinnitus, synchronous with the 
heartbeat, that can momentarily be abolished by a 
strong muscle contraction of the head or neck or 
a strong pressure applied to the same muscles 
Levine et al. (2008) In case of a unilateral tinnitus, the audiogram does 
not account for unilateral tinnitus (e.g.,: normal 
audiogram, symmetric hearing loss or hearing loss 
greater in the contralateral ear) 
Suggested by panel Patient indicates a relationship between the sleep 
quality at night and the tinnitus during the day 
40% inclusion and 60% 
exclusion 
 
 
100% inclusion 
 
 
 
100% ‘‘can be present 
occasionally’’ 
Suggested by panel Taking a nap during the day affects  the tinnitus 60% inclusion and 40% 
exclusion 
Suggested by panel Tinnitus is accompanied by increased muscle tension 
in the suboccipital muscles 
Suggested by panel Tinnitus appearance is preceded by orthodontic 
procedures 
Suggested by panel Tinnitus is intermittent or has large fluctuations in 
loudness 
Suggested by panel Soft unilateral tinnitus or loud tinnitus throughout 
the head 
100% inclusion 
 
60% inclusion and 40% 
exclusion 
100% inclusion 
 
100% ‘‘can be present 
occasionally’’ 
Suggested by panel Tinnitus is accompanied by lack of molar support 100% exclusion 
 
 
Delphi Survey 
Each round of the Delphi survey was open for 4 weeks, 
with 2 weeks in between both rounds. 
Seven additional items were suggested by at least one 
panelist in Round 1 (see Table 1). These were added to 
Round 2 of the Delphi survey. 
 
At the end of Round 2, scores for the expert panel 
indicated support for the inclusion of two diagnostic 
criteria since more than 70% of the Delphi panel mem- 
bers scored them 7 to 9 and fewer than 15% scored them 
1 to 3 (see Table 1). Conversely, scores indicated the 
exclusion of six diagnostic criteria since more than 
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Figure 1. Overview of the inclusion process of articles in the systematic review. 
 
70% of the Delphi panel members scored them 1 to 3  
and fewer than 15% scored them 7 to 9 (see Table 1). 
 
Consensus Meeting 
The intended goal of the meeting was to agree on a list of 
assessment criteria that should be present in every single 
patient receiving a clinical diagnosis of ST. At the start 
of the consensus meeting, participants urged caution that 
this goal would not be possible. The reasoning for this 
caution was that, according to their extensive clinical 
experience, individual patients with ST  can  present  
with a large set of different symptoms. As an alternative 
goal, the group instead agreed to provide a list of items 
that, if present, would strongly suggest an influence of 
the somatosensory system on the patient’s tinnitus. 
The panel was first asked to consider those 2 items  
that had been identified as essential by the Delphi survey 
participants in Round 2 and 5 items that had been iden- 
tified as not essential in Round 2. They agreed to, 
respectively, include the 2 and exclude the 5 presented 
items (100% agree). The remaining 34/41 items were 
then discussed and voted for (see Table 1 for details).    
In cases where at least four of  the  six  participants 
voted for inclusion, a diagnostic criterion was added to 
the final assessment list. 
The items that were agreed upon for inclusion are 
presented in Tables 2 to 4, according to features of tin- 
nitus modulation, tinnitus characteristics, and accom- 
panying symptoms, respectively. The first set of items   
to be discussed was the patient’s  ability  to  modulate 
his or her tinnitus by voluntary movements, somatic 
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Table 2. Items on Tinnitus Modulation That, If Present, Strongly 
Suggest Somatosensory Influence of Tinnitus. 
 
 
Criteria on tinnitus modulation 
and pain symptoms in the neck or jaw area, potentially 
preceded by a head or neck trauma. In addition, the 
increase in tinnitus during certain postures (such as 
   bad posture during computer work or sleep) and the 
The patient is able to modulate the tinnitus by voluntary move- 
ment of the head, neck, jaw or eyes 
The patient is able to modulate the tinnitus by somatic maneuvers 
Tinnitus is modulated by pressure on myofascial trigger points 
 
 
 
 
Table 3. Tinnitus Characteristics That, If Present, Strongly 
Suggest Somatosensory Influence of Tinnitus. 
 
 
Tinnitus characteristics 
 
 
Tinnitus and neck or jaw pain complaints appeared simultaneously 
Tinnitus and neck/jaw pain symptoms aggravate simultaneously 
Tinnitus is preceded by a head or neck trauma 
Tinnitus increases during bad postures 
Tinnitus pitch, loudness and/or location are reported to vary 
In case of unilateral tinnitus, the audiogram does not account for 
unilateral tinnitus 
 
 
 
 
Table 4. Accompanying Symptoms That, If Present, Strongly 
Suggest Somatosensory Influence of Tinnitus. 
presence of variations in pitch,  loudness,  and location 
of the tinnitus were pointed out as items that strongly 
suggest ST. Another typical tinnitus characteristic is that, 
in case of a unilateral tinnitus, the audiogram does not 
account  for a unilateral tinnitus. One item on this list      
a specific type of constant pulsatile tinnitus, synchronous 
with the heartbeat, that can momentarily be abolished by 
a strong muscle contraction of the head or neck muscles 
or by a strong pressure applied to the same muscles 
(Levine et al., 2008) caused a  prolonged discussion.  
Due to dissenting views on this topic, there was no 
consensus (after voting) to either definitively include or 
exclude the item. 
The third set of items (15/34 items) to be discussed 
were those symptoms that can accompany the patient’s 
tinnitus. Items that were considered important to include 
were frequent pain in head, neck, or shoulder girdle; 
temporomandibular disorders; pressure-tender myofas- 
cial trigger points in the head–neck region; increase in 
muscle tension in the neck extensor muscles; bruxism or 
teeth clenching; and dental diseases. The group agreed 
   that whenever one or more of these symptoms are pre- 
Accompanying symptoms 
 
 
Tinnitus is accompanied by frequent pain in the cervical spine, head 
or shoulder girdle 
Tinnitus is accompanied by the presence of pressure tender 
myofascial trigger points 
Tinnitus is accompanied by increased muscle tension in the sub- 
occipital muscles 
Tinnitus is accompanied by increased muscle tension in the 
extensor muscles of the cervical spine 
Tinnitus is accompanied by temporomandibular disorders 
Tinnitus is accompanied by teeth clenching or bruxism 
Tinnitus is accompanied by dental diseases 
 
 
 
maneuvers, or pressure on myofascial trigger points 
(8/34 items). Seven criteria reached consensus for inclu- 
sion. The ability to modulate the tinnitus by resistance 
tests of the arm was not included. This item was labeled 
as can be present occasionally, but not systematically 
enough to be on the list. All six participants agreed that 
a patient’s ability to modulate his or her tinnitus strongly 
suggests an ST, but that ST can also exist without this 
ability to modulate the tinnitus. Some participants 
strongly cautioned that the  use  of somatic maneuvers 
as a single criterion can potentially lead to overdiagnosis. 
The second set of items (11/34 items) to be discussed 
were tinnitus characteristics that often exist in patients 
with ST. Items that were considered important to include 
were the simultaneous onset and aggravation of tinnitus 
sent, this strongly suggests an influence of the somato- 
sensory system on the patient’s tinnitus. 
In total, six items were identified as can be present in a 
single patient, but not systematically enough to be on the 
list of diagnostic criteria. 
 
Discussion 
This study aimed to reach an international consensus on 
diagnostic criteria for ST. Up until now, academics and 
clinicians have often used their own criteria to include 
patients in trials on ST. For the first time, experts in ST 
were gathered together to create a consensus statement 
about the diagnostic assessment of ST. 
This consensus recommends aspects of tinnitus modu- 
lation, tinnitus characteristics (such as varying pitch and 
loudness), and accompanying symptoms that are  
strongly suggestive of ST in an individual patient while 
acknowledging that the individual presentation of the 
condition can vary from patient to patient. 
In agreement with the diagnostic criteria given by 
Sanchez and Rocha (2011), the experts in  ST  agreed 
that rather than a definitive set of diagnostic features, 
clinical assessment should instead look for evidence of 
certain features that, if present, would strongly suggest 
an influence of the somatosensory system on the patient’s 
tinnitus. The list proposed in this consensus study con- 
firms many of the same diagnostic criteria provided by 
Sanchez and Rocha (2011) but also adds some new items. 
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Implications of Our Findings for the Tinnitus 
Community 
From the literature, many authors have diagnosed a 
patient with ST according to whether the patient could 
modulate the tinnitus by either voluntary movements or 
somatic maneuvers (Biesinger et al., 2015; Haider et al., 
2017; Ward et al., 2015). Our consensus meeting panel 
recognized the importance of somatic modulation, espe- 
cially by voluntary movements, for the  ST  diagnosis 
but added that the absence of this ability does not rule 
out ST. Hence, somatic modulation should  not be used 
as a simple yes or no criterion for diagnosing ST. 
Although the use of somatic maneuvers to assess tinnitus 
modulation was voted in, some participants believed that 
the use of these maneuvers as a single criterion can 
potentially lead to overdiagnosis. For example, a study  
of Abel and Levine (2004) showed that not only were 
83% of patients with tinnitus able to modulate their tin- 
nitus through somatic maneuvers, but in addition,  65% 
of nonclinical healthy participants perceived a tinnitus- 
like sound during somatic maneuvers. 
It must be noted that certain items, such as Tinnitus 
accompanied by frequent pain in the head, neck or 
shoulder girdle or Tinnitus accompanied by temporoman- 
dibular disorders, should be used with a  certain  pru-  
dence if they are the only criterion present in a patient.  
This is because tinnitus and neck or  jaw  problems  can  
also co-occur without a causal relation (Michiels et al., 
2015). On the other hand, when these  items  are  com- 
bined with another criterion,  such  as  Tinnitus  and  neck 
or  jaw  pain  complaints  appeared  simultaneously  or   
The patient is able to modulate the tinnitus by voluntary 
movement of the head, neck, jaw or  eyes,  the  ST  
diagnosis gets stronger. 
 
Strengths and Limitations of the Study 
Our Delphi survey was completed by a relatively small 
number of experts, which might have influenced the deci- 
sion-making. On the other hand, we were able to identify 
only 18 potential ST experts in our literature search, of 
which 14 (78%) completed both rounds. We would have 
liked to have all of them in our consensus meeting, but 
unfortunately only six were able to attend the meeting. 
Because there was no financing for this study, we decided 
to host the consensus meeting prior to the tinnitus 
research initiative conference to enable as many of our 
experts as possible to attend this meeting without extra 
travel costs. Several panelists, however, had other engage- 
ments at the time of the meeting. Although a larger 
sample of consensus meeting panelists would have been 
preferred, a representative sample of ST experts, from 
four different countries and six different institutions, was 
present at the meeting. This is far more than in most 
consensus meetings in larger scientific fields. 
 
The multifactorial causes of tinnitus in most patients 
can probably explain the  differences  in  experience.  
The panel members agree that cases where the somato- 
sensory system is the main cause of the tinnitus exists 
but are rare. On the other hand, a large  group  of  
patients have secondary somatosensory influence on  
their tinnitus to a certain degree. This somatosensory 
influence can be combined with other influences such   
as increased stress levels, anxiety, or depression. All 
these influences can also increase a tinnitus that is 
strongly associated by auditory deafferentation, such as 
noise exposure. 
 
Future Research Directions 
Although the item concerning presence of a constant 
pulsatile tinnitus, synchronous with the heartbeat, 
reached no consensus for either in- or exclusion, the 
group advised that the examiner should keep in mind  
that in some cases such a pulsatile tinnitus can be 
affected by somatic maneuvers. Further research is, how- 
ever, needed to describe the characteristics and treatment 
opportunities for these patients. 
Now that a  set  of  criteria  to  recognize  ST  is 
agreed  upon  by  an  international  panel   of   ST 
experts, clinicians can use these criteria  to  determine 
the extent to which the somatosensory system influences 
an individual patient’s tinnitus. ST should not be seen  
as a specific category of tinnitus, but more as a factor  
that can influence a patient’s tinnitus in a larger or 
smaller degree. 
The next step should be to find the most effective 
treatment for patients with ST. It must  be  noted  that 
this most effective treatment might not be the same for  
all patients with ST. As in all musculoskeletal conditions, 
the most appropriate treatment is often a combination of 
treatment modalities tailored to the individual patient’s 
needs. Since psychological factors, such as stress, anx- 
iety, and depression, influence both  tinnitus  and  neck 
or jaw problems, it might also be interesting to investi- 
gate the effect of a combined treatment comprising phys- 
ical therapy modalities and psychological techniques on 
tinnitus severity in future studies. 
 
Conclusion 
This study used an international Delphi survey and con- 
sensus meeting to agree upon a set of criteria that 
strongly suggest ST. Because of  the  international  
nature of the survey, we expect these criteria to gain a 
wide acceptance in the research field and to serve as a 
guideline for clinicians. The criteria developed in this 
consensus paper now allow to further investigate the 
extent of somatosensory influence in individual tinnitus 
patients and tinnitus populations. 
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5.3. Biomarkers of tinnitus 
5.3.1. Evidence for biological markers of tinnitus: A systematic review 
Submitted in Trends in Hearing 
Haúla  Haider, Diogo Ribeiro, Helena Caria, Nuno Trigueiros, Luís Miguel Borrego, 
Agnieska J Szczepek, Ana Luisa Papoila, Asma Elarbed, Sandra Smith, João Paço, Derek J 
Hoare 
Abstract 
Subjective tinnitus is a phantom sound heard only by the affected person and 
may be a symptom of various diseases. Currently, diagnosis and monitoring of tinnitus 
are based on subjective audiometric and psychometric measurements, there are no 
objective methods. The aim of this review was to synthesize the evidence for the 
existence and clinical usefulness of biomarkers of the development or severity of 
tinnitus. 
 We conducted a systematic search of several databases. The initial searches 
were complemented by scanning reference lists from relevant systematic reviews and 
the included primary studies; citation searching of the included primary studies using 
Web of Science, and hand searching the last 6 months of key otology journals. All 
systematic review stages were carried out by at least two authors.  Forty-six records 
were included in the review and were categorized according to the biological variable 
measured. There was no evidence for an association between tinnitus and thyroid 
function, glucose blood level, sedimentation velocity, C-reactive Protein, or unspecific 
serum Immunoglobulins. The results showed conflicting evidence for the association 
between tinnitus and full blood count, lipid profile, oxidative stress, vitamins, 
neurotrophic factors and inorganic ions. However, there was a negative correlation 
between steroid levels and tinnitus. Neurotransmitters as tinnitus biomarkers are a 
promising line of investigation.  Biological markers may provide an easier means for 
determining the diagnosis and prognosis of tinnitus, as well as a measure of treatment 
effectiveness. However, larger studies, with stricter exclusion criteria and powerful 
harmonized methodological design are needed.  
Protocol published on PROSPERO (CRD42017070998). 
Key words: Tinnitus, biomarker, genetic, oxidative stress, inflammation. 
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Introduction 
Tinnitus is defined as the perception of sound in the absence of external noise, 
commonly described as a phantom sound perception. Subjective tinnitus is perceived 
only by the patient and can manifest as ringing, buzzing or hissing (Kraus et al, 2011; 
Salvinelli et al, 2003). This type of tinnitus affects 5-15% of adults, having a negative 
impact on quality of life. In may induce stress, depressive symptoms, anxiety, sleep 
disturbance or work impairment (Kraus et al, 2011). Tinnitus can be triggered by various 
causes and is associated with multiple comorbidities, which confounds a precise 
phenotype and hampers research (Vona et al, 2017). It is very often associated with 
hearing loss due to the inner, middle or outer ear pathology and neuronal plasticity 
induced by the lesion (Kraus et al, 2011; Henry et al, 2005; Yüksel and Karatas, 2016). 
Additional factors, including ageing, head and neck diseases, noise exposure, systemic 
diseases, infectious diseases, autoimmune diseases, ear diseases, stress and 
temporomandibular joint disorders (TMD) have been associated to tinnitus (Yüksel and 
Karatas, 2016).  
To date, the diagnosis of tinnitus and measurement of therapeutic success  relies 
on the patient self-report. Although very meaningful, these subjective measures must 
be strengthened by the development of objective, unbiased tests using biomarkers. 
There are several definitions of biomarker. The “Biomarkers Definitions” Working 
Group of the National Institute of Health (2001) defines a biomarker as “a characteristic 
that is objectively measured and evaluated as an indicator of normal biological 
processes, pathogenic processes, or pharmacologic responses to a therapeutic 
intervention”. The International Programme on Chemical Safety, led by the World 
Health Organization (WHO, 1995) in coordination with the United Nations and the 
International Labor Organization, has defined a biomarker as “any substance, structure, 
or process that can be measured in the body or its products and influence or predict the 
incidence of outcome or disease”. The WHO (1995) has stated that a true definition of 
biomarkers includes “almost any measurement reflecting an interaction between a 
biological system and a potential hazard, which may be chemical, physical, or biological”. 
Studies using animal models provided important insight on tinnitus biological markers 
(Hu et al, 2014; Kraus et al, 2011). 
 Identification of tinnitus-specific biological factors and their potential 
relationship with various disorders and tinnitus could provide the identification of 
specific markers for tinnitus. These biomarkers would strengthen the existing diagnostic 
methods and could contribute to the development of successful therapeutic 
approaches. 
Aims and objectives 
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The aim of this systematic review was to synthesise the evidence for the 
existence and clinical usefulness of biomarkers of the development or severity of 
tinnitus.  
 
Methods 
This systematic review is reported according to the PRISMA guidelines (Liberati 
et al., 2009). The protocol was published on PROSPERO (Hoare et al., 2017, registration 
ID: CRD42017070998).  
Eligibility criteria. Eligible information sources were assays, investigational 
studies, exploratory studies, and basic science studies. We included studies about 
subjective tinnitus and the association between biological factors and the presence or 
severity of tinnitus. We excluded studies involving populations with Ménière’s disease, 
otosclerosis, vestibular schwannoma, chronic otitis media, history of tumour and 
chemotherapy, ototoxic drugs intake, autoimmune diseases, neurodegenerative or 
demyelinating disease. Study reports not available in English, relating solely to objective 
tinnitus, and animal studies were also excluded. 
Information sources. Initial literature searches were conducted in July 2017 in 
CINAHL, PsychINFO, EMBASE, ASSIA, PubMed, Web of Science, Science Direct, and 
EBSCO Host. The search terms were tinnitus* AND gene* OR protein OR hormone OR 
immunoglobulin OR enzyme OR cytokine OR interleukin OR lipid OR vitamin OR marker. 
The initial search was complemented by scanning the reference lists of related reviews 
and of the included studies. Citation searching of the included studies was conducted 
using Web of Science.  
An update search was conducted in January 2018 (searching key journals and 
Google Scholar) and using the same search terms as in the initial search. We also 
conducted a manual search of the Table of Contents from the last two issues of key 
journals from which these eligible records had been sourced (i.e., Frontiers, The 
Laryngoscope, Hearing Research Journal and International Journal of Audiology).  
Study selection. Eligibility of records was independently reviewed by at least two 
authors at each key step (i.e. abstract screening, full-text screening, and data 
extraction). Where disagreement emerged, consultation with a third reviewer was taken 
to reach consensus.  
Initial screening was based on abstracts analysis. Full text record was screened 
whenever either reviewer was uncertain about exclusion. Records were grouped into 
eleven categories: protein markers, vitamin markers, hormone markers, inorganic ions 
markers, lipid markers, interleukin markers, immunoglobulin markers, enzyme markers, 
general markers, and genetic markers. 
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Data extraction. A data extraction form (Excel) and guidance notes (word 
document) were developed for the review, independently piloted on two included 
records, and revised for clarity before formal data extraction. Data extraction of all 
included records was performed independently by two reviewers. A third reviewer was 
recruited in case of disagreements between the two initial reviewers. Extracted data 
items included: study title, corresponding author details, country where study was 
performed, date of publication, date of study start, study design, aim, type and duration 
of intervention (if applicable), sample characteristics (population, age, sample size, 
sample size calculation, gender, education), duration of tinnitus, intermittent or 
constant tinnitus, tinnitus severity, presence of hearing loss, inclusion/exclusion criteria 
(subtypes of tinnitus, co-morbidities), biological variable measured (gene, protein, 
hormone, immunoglobulin, enzyme, interleukin, lipid, mineral salt, vitamin, other), 
measurement tools, tinnitus assessment, timing of measurements, main findings 
(associations between biological factors and tinnitus), and any further notes.       
Risk of bias in individual studies. Risk of bias was assessed for five key categories 
of medical test performance as reported by Santaguida et al. (2012). Each study was 
assessed for (1) Population bias (Spectrum effects, context or selection bias), (2) Test 
protocol (variations in test execution or test technology), (3) Reference standard and 
verification (inappropriate reference standard, differential or partial verification bias, (4) 
Interpretation (review or incorporation bias, observer variability), and (5) Analysis 
(handling of indeterminate results, arbitrary choice of threshold values). For each 
category a quality judgement was made, scored as either ‘Yes’ (low risk of bias), ‘No’ 
(high risk of bias), or ‘Unclear’ (insufficient information in the record to make a 
judgement). When rating a study ‘No’ on any domain reviewers noted reasons why. At 
least two reviewers independently assessed risk of bias in each record. A third reviewer 
was nominated to arbitrate any disagreements in judgements that were not resolved 
through discussion between the two reviewers.   
Summary measures. Data from individual studies are reported descriptively 
(mean values from individual measures, and correlations between biological factors and 
presence or severity of tinnitus within studies, as reported).   
Synthesis of results. Included records were categorised according to whether 
they reported data on the same biological variable. Sixteen categories (Table 1) were 
identified and records were coded as ‘Category_record number’ (e.g. Proteins_3). Some 
categories include only one study (e. g. Angiotensin converting enzyme, Alpha- Adducin, 
Genome Wide association) and some studies were included in several categories.  
There was insufficient consistency in study design or population to perform a 
meaningful quantitative synthesis of results.  We therefore included all studies in a 
narrative synthesis. Common areas of bias across studies were also described in a 
narrative synthesis. 
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Results 
Study selection. The initial search retrieved 3801 records. After removal of 
duplicates, 3770 records remained for abstract screening. Of the 3770 records, 3689 
were excluded as not related to review question or not meeting the inclusion criteria. 
Seventy-eight full-text records were screened and 44 of them were included. A further 
two included records were identified in update searches.  Reasons for exclusion at the 
full text screening stage are presented in the record flow chart (Figure 5.3-1). Thus, 46 
records were included in the review.  
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Figure 5.3-1 - Flow diagram of study records. 
Study characteristics. Forty-six studies from authors in 17 countries were 
included (Figure 5.3-2). Most studies were conducted in Turkey or Germany (10 in each) 
followed by Italy (four included records). Thirty-one included studies were 
investigational, five were exploratory, five were assays, two were case-controlled 
studies, one was a prospective randomized single-blinded sham-controlled cross over 
study, and one was a genome wide association study. 
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Figure 5.3-2 - World Map with the countries of origin of the included records in our review. 
Legend: Turkey (10), Germany (10), Italy (4), Japan (2), Israel (2), India (2), Canada (2), Iran (2), 
Brazil (2), Czech Republic (2), USA (2), China (1), Nigeria (1), Korea (1), Bulgaria (1), Poland (1) 
and Portugal (1).  
  
 
Narrative description 
For brevity here we describe only the results from studies with statistical relevant 
results (Table 5.3-1). Conclusions however are based on a synthesis of all included 
studies, including those not findings any significant associations.  
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Table 5.3-1 - Categories of included records. 
 
Category of 
biomarker 
Biological variable measured Record code 
Studies with statistical 
relevant results 
Full blood 
count 
Neutrophil-to-lymphocyte ratio General_3, 13 General_13 
Platelet Indices 
General_3, 16; 
Lipid_3 
General_16; Lipid_3 
Lipid profile 
Cholesterol 
Lipid_1, 2, 6; 
General_8 
Lipid_1, 6; General_8 
Low-density lipoprotein 
Lipid_2, 3, 4, 6; 
General_13 
Lipid_4, 6;  
High-density lipoprotein 
Lipid_2, 3, 4, 6; 
General_13 
Lipid_4, 6; 
Triglycerides Lipid_1, 2, 6 Lipid_1, 6 
Glucose Blood glucose level General_13; Lipid_1 Lipid_1 
Thyroid 
function 
Thyroid function 
General_13, Lipids_1, 
3 
- 
Cortisol and 
products 
Cortisol Hormone_2, 3, 4 Hormone_2, 3 
Stress Hormone Hormone_4 - 
Neurosteroids and bioactive 
substances 
General_4 General_4 
Other 
hormones 
Melatonin Vitamins_3 Vitamins_3 
Inorganic ions 
Serum zinc Inorganic_ions_1, 3 Inorganic_ions_1, 3 
Copper, zinc, chromium, 
magnesium 
Inorganic_ions_3 
Inorganic_ions_3 
Oxidative 
stress 
Reactive oxygen metabolites General_8, 9, 10, 11 General_10, 11 
N-Acetyltransferase 2 (NAT2) Genetic_28 - 
Vitamins 
Vitamin B1 Vitamins_1 Vitamins_1 
Vitamin C Vitamins_3 - 
Vitamin B12 Vitamins_2, 3, 4 and 5 Vitamins_3, 4, 5 
Interleukins 
Interleukin-6 
Interleukins_1, 2; 
General_18 
Interleukins_1 
Interleukin-1b Interleukins_2 Interleukins_2 
Interleukin-10 General_18 - 
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Full blood count 
Three investigational studies reporting full blood count were included (Table 5.3-
2). In those studies a total of 569 participants were included. 
‘General_13’ (Ozbay, et al., 2015) compared the Neutrophil-to-Lymphocyte Ratio 
(NLR) in patients with severe tinnitus to healthy participants. Tinnitus severity was 
measured using the Tinnitus Handicap Inventory (THI; Newman et al, 1996). They found 
that mean NLR was significantly higher in patients with severe tinnitus than in control 
participants (p<0.05). 
Tumor necrosis factor alpha ( TNF-
α) 
General_18 
Sedimentation 
Velocity, C - 
reactive 
Protein and 
unspecific 
Immunoglobuli
ns; 
Erythrocyte sedimentation, C-
reactive protein, B2 Glycoprotein 
antibodies, Prothrombin 
antibodies, Anticardiolipin 
antibodies, Annexin antibodies, 
Antinuclear antibodies and 
Antineutrophil cytoplasmic 
antibodies 
Protein_3 - 
Neurotransmis
sors 
Gamma aminobutyric acid (GABA) 
General_5, 
Genetics_19, 20 
Genetics_19, 20 
Serotonine 
General_14, 
Genetic_3, 11 
General_14, Genetics_3 
Glutamate 
General_25, 
Genetics_ 28 
General_25, 
Genetics_28 
Choline, n-ac-Aspartate General_25 - 
Neurotrophic/
protective 
factors 
Brain-derived neurotrophic factor 
(DBNF) 
Protein_1, 4; 
Interleukines_2, 
Genetics_2, 23 
Protein_1, 4, Genetics_2 
Glial cell-derived neurotrophic 
factor (GDNF)  
Genetics_11, 23, 17 Genetics_23, 17 
Heat Shock Protein 70 (HSP70) Protein_3 Protein_3 
Ion channels 
ClC-Kb Genetics_5 - 
Potassium voltage-gated channel 
(KCNE1) 
Genetics_18, 21, 24 Genetics_18 
Single studies: 
Angiotensin 
converting 
enzyme and 
Alpha- Adducin 
Allele frequencies of ACE I/D and 
ADD1 Gene polymorphisms. 
Genetics_27 Genetics_27 
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‘General_16’ (Yüksel & Karatas, 2016) investigated whether there was a 
relationship between platelet indices and subjective tinnitus. Assessments included 
magnetic resonance, biochemical and haematological analyses and auditory evaluation. 
The THI was used to measure tinnitus severity. Mean Platelet Volume (MPV), platelet 
distribution width (PDW), and platelet count (PC) were measured in venous blood 
samples. They found that MPV levels were significantly lower in patients with subjective 
tinnitus than the control group and negative correlations were observed between MPV, 
PDW, and PC levels. PDW and PC levels were significantly higher in tinnitus participants 
than in controls. Authors conclude that tinnitus may be characterized by autoimmune 
and/or inflammatory events, and that measurement of platelet indices may be ca useful 
guide in assessing the aetiology and severity of subjective tinnitus. 
 
‘Lipid_3’ (Sarıkaya et al., 2016) compared MPV and platelet levels in patients with 
idiopathic subjective tinnitus to healthy controls. Complete blood count (CBC) and  lipid 
profile were also evaluated. The authors found that there was no difference in platelet 
levels between groups, but MPV was significantly higher in the patient group.  
 
In the Full Blood Count category, demographics were comparable in terms of age 
and gender, but MPV differed significantly. In ‘General_16’ MPV was significantly lower 
in the tinnitus group, whereas in ‘Lipids_3’ authors found MPV values to be significantly 
higher in the tinnitus group. In ‘General_markers_13’ (Ozbay et al., 2015)  did not find 
statistical differences for MPV values (that were higher for tinnitus group) among 
tinnitus and non-tinnitus groups. Demographics did not differ between ‘General 16’ and 
‘Lipid 3’, whereas ‘General markers 3’ included a younger population and excluded 
participants with moderate to severe hearing loss (Ozbay et al., 2015). There is therefore 
no indication what relationship, if any, exists between MPV and /or hearing loss. 
Differences across the three studies which may explain the varied findings included 
differences in sample size and inclusion criteria (hearing loss, tinnitus severity), and so 
further more consistent studies are needed. 
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Table 5.3-2 - Descriptive Analyses of Full Blood Count 
Note. TP – Tinnitus Patients; C – Control Group; W – Women; M – Men; THI – Tinnitus Handicap Inventory; NLR - neutrophil-to-lymphocyte ratio; MPV - mean platelet volume; 
PDW – platelet distribution width; PC – Platelet Count; PL - platelet levels; CBC – Complete blood count. 
 
 
Record code: Title of the 
study 
Study Design 
(setting) 
Sample Size Age Gender 
Tinnitus severity (tinnitus 
duration - weeks) 
Biological variables (Measure) 
General_13: Neutrophil-
to-lymphocyte ratio in 
patients with severe 
tinnitus: prospective, 
controlled clinical study 
Investigational 
studies 
(University 
hospital) 
107 TP, 107 C. 
TP= age 
38.7±12.7; 
C=35.8±13.9. 
TP=72 W and 35 
M; C= 83 W and 
24 M 
THI - Only patients with 
moderate, severe or 
catastrophic tinnitus 
symptoms (at least two 
weeks) 
NLR: TP=2.067±1.4; (hemogram 
and full biochemistry profile 
analyses) 
General_16: Can Platelet 
Indices Be New 
Biomarkers for Subjective 
Tinnitus? 
Investigational 
study (Hospital) 
100 TP, 100 C 
TP= 
50,95±14.6C=44.
3±8.9 
TP=43 M and 57 
W; C= 39 M and 
61 W 
The average of THI was 
41.62± 14.65. Grade I: 2 
patients, II: 37 patients, III: 
43 patients, IV: 18 patients. 
There was no patient in the 
grade V (NS) 
MPV: 
TP=8.27±0.6fl PDW: 
TP=19.21±2.2fl PC: 
TP=271.75±54.62/u (Venous 
blood samples) 
Lipid_3: “Increased mean 
platelet volume in 
patients with idiopathic 
subjective tinnitus” 
Investigational 
studies 
(University 
Hospital) 
101 TP, 54 C 
TP= 40.87 ± 
14.13; C= 42.35 ± 
8.94 
TP= 54 W and 47 
M; C= 36 W and 
18 M 
NS (average 135.44 weeks 
months, range 12–960 
weeks) 
MPV: TP= 9.69 ± 1.30 (fl) PL: 
TP=260.970 ± 59.700 (103/mm3) 
(CBC) 
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Lipid Profile 
Four studies reporting lipid profiles were included (Table 5.5-3).  These studies 
reported a total of 351 participants (193 participants with tinnitus and 158 controls). All 
studies were investigational, and one additionally presented a matched case-control.  
‘Lipid_1’ (Almeida et al., 2009) compared tinnitus severity (using the Brazilian 
Portuguese version of the THI) pre and post a 7-month nutritional intervention program 
for Tinnitus (NIPT), in subjects with metabolic disorders. Laboratory tests included 
cholesterol levels and fractions, and triglyceride tests. They found that 56.9% of patients 
with tinnitus had hypercholesterolemia, and 17.5% had hyperglycemia; both rates were 
higher than are found in a general population. 
‘Lipid_4’ (Sutbas et al., 2007) investigated the prevalence of hyperlipidemia in 
patients who had high-frequency hearing loss and tinnitus due to chronic noise exposure 
and evaluated the risk of developing sensory hearing loss in those patients compared to 
control subjects. The intervention consisted of a low-cholesterol diet and anti-
hyperlipidemic therapy. Lipid profiles were established through a CBC. According to the 
response to therapy the participants were divided into the “responsive” group and the 
“unresponsive” group. The main findings in the “responsive” group were (1) a reduced 
mean tinnitus score associated with a reduction in triglyceride levels from high to 
normal, and (2) a statistically significant change in self-reported tinnitus severity after 
therapy.   
‘Lipid_6’ (Rajesh, 2016) estimated prevalence of hyperlipidemia in patients with 
tinnitus, and assessed improvements in tinnitus after hyperlipidemia treatment in those 
positively identified. Treatment consisted of oral atorvastatin, 10 mg daily. They 
measured changes in tinnitus symptomatology but did not provide details about the 
tinnitus severity measurement tool used. A fasting lipid profile was evaluated in all the 
patients. Data showed that diabetes and hyperlipidemia were statistically significantly 
associated with tinnitus. Among the patients with an altered lipid profile, after 2 months 
of treatment an improvement in lipid profile was seen in 51 (94.5%) patients and a 
symptomatic improvement in tinnitus was reported by 22 (40.8%) patients. 
In ‘General_8’ (Martines et al., 2015) the aim of the study was to determine the 
risk factors for tinnitus, and the effects of their interactions. The THI was used to 
measure tinnitus severity, and peripheral blood samples were collected to analyze 
several variables. The findings indicated an increased risk of tinnitus in those with 
hypercholesterolemia. Risk of tinnitus increased 8-fold when patients were smokers and 
had hypercholesterolemia, and 3.5-fold in patients with diabetes and 
hypercholesterolemia. 
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Table 5.3-3 - Descriptive Analyses of Lipid Profile. 
Note. TP – Tinnitus Patients; C – Control Group; P – Participants; W – Women; M – Men; UG – Unresponsive Group; RG – Responsive Group; THI – Tinnitus Handicap Inventory; NS – 
Not Stated; HyperCho – hypercholesterolemia; HyperTri – hypertriglyceridemia; A= Pre intervention; B= Pre intervention II; Pt= Post intervention; HDL – high-density lipoprotein; LDL 
– low-density lipoprotein; VLDL – very-low-density lipoprotein; HyperLip – Hyperlipidemia.  
Record code: Title of the 
study 
Study Design 
(setting) 
Sample 
Size 
Age Gender 
Tinnitus severity (tinnitus 
duration - weeks) 
Biological variables (measure) 
Lipid_1: “Tinnitus 
sensation pre and post 
nutritional intervention in 
metabolic disorders” 
Investigational 
studies (University 
Hospital) 
21 TP 60 years old (SD = 10,8). 7 M and 14 W 
THI - Brazilian Portuguese 
version.  Slight:2; Mild: 6; 
Moderate: 7; 
Severe/catastrophic: 6 (NS) 
HyperCho (>200 mg/dl): A= 
66,7%; B= 68,75% Pt= 62,5%, 
HyperTri (>170 mg/dl): – A= 
28,6%; B=25%; Pt= 12,5% (CBC) 
Lipid_4: “Low-Cholesterol 
Diet and Antilipid Therapy 
in Managing Tinnitus and 
Hearing Loss in Patients 
with Noise-Induced 
Hearing Loss and 
Hyperlipidemia” 
Investigational 
studies (Military 
personnel) 
42 TP: - 
UG: 22; 
RG: 20 
TP= age range, 19– 60 
years; mean 45. UG= 
mean age 39; RG= mean 
age 42 
All males. 
NS (8 weeks to 576 weeks, 
mean 264 weeks) 
UG (mean): 
HDL (mg/dl): A=44.5; Pt=48.9; 
LDL (mg/dl): A=144; Pt=153; 
VLDL (mg/dl): A=39; Pt=37; 
RG (mean): 
HDL (mg/dl): A=43.5; Pt=43.1; 
LDL (mg/dl): A=144; Pt=128; 
VLDL (mg/dl): A=38.7; Pt=35.5 
(CBC) 
Lipid_6: “A study on the 
relationship of 
hyperlipidaemia with 
tinnitus among patients in 
a tertiary care centre” 
Investigational 
studies (Tertiary care 
centre) 
84 TP, 84 C 
TP= 8, 16, 20, 18, 14, 
and 8 people belonged 
to the age groups 21-
30, 31-40, 41-50, 51-60, 
61- 70, and 71-80 years; 
C= 6, 10, 23, 19, 20, and 
6 people belonged to 
these age groups. 
TP= 39 (46.42%) 
M and 45 
(53.58%) W; C= 51 
(60.71%) M and 
33 (39.29%) W. 
NS (NS) 
HyperLip: TP=64.29%; 
Diabetes: TP=15.48%; 
P: improvement in lipid profile= 
94.45%; improvement in 
tinnitus=40.75% (Fasting  lipid 
profile – serum samples) 
General_8: “Clinical 
observations and risk 
factors for tinnitus in a 
Sicilian cohort” 
matched case–
control study;  
Investigational 
studies (University 
Hospital) 
120 P - 46 
TP, 74 C 
TP= age range 14 to 85, 
with a mean age of 57.6 
years ± 13.15. The 79.16 
% of subjects were 50 
years old. 
TP= 31M and 15 
W (M/W ratio 
2.06). 74C= 46 M 
and 28 W (M/W 
ratio 1.64). 
THI score: mean value of 
41.04 ± 21.12); Slight: 15.22 % 
(7/ 46), mild: 32.6 % (15/46); 
moderate: 21.73 % (10/46), 
severe 26.08 % (12/ 46) and 
catastrophic 4.35 % (2/46) 
(NS) 
HyperCho (mg/dl): 
TP= 47.82%; 
Serum cholesterol (mg/dl): 
TP=199.24 ± 48.45; (blood 
samples) 
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There is good evidence therefore for an association between the presence or 
severity of tinnitus and hyperlipidaemia. Despite methodological differences across 
studies there is a consistent finding that hyperlipidaemia is associated with the presence 
or severity of tinnitus, and that treatment of hyperlipidaemia is associated with 
improvements in tinnitus.    
Glucose and Thyroid function 
There were no statistically significant relevant results in this category.  
Cortisol and products 
Three studies of cortisol (two investigational studies and one assay) involving a 
total of 104 participants (66 tinnitus patients and 38 controls) were included (Table 5.3-
4). 
‘Hormone_2’ (Hébert & Lupien, 2007) and ‘Hormone_3’ (Hébert & Lupien, 2009) 
assessed reactivity of hypothalamic-pituitary-adrenal (HPA) axis by measuring salivary 
cortisol level in tinnitus patients and age-matched controls after exposure to stressors. 
In ‘Hormone 2’ they used the Trier Social Stress Test (TSST) as a stressor, and in the 
‘Hormone 3’ participants were exposed to noise for 20 minutes with salivary cortisol 
samples taken at baseline and after 10, 20, 30, 40, and 60 minutes. In both studies, 
salivary cortisol analysis was measured by radioimmunoassay. Participants also 
completed the Tinnitus Reaction Questionnaire (TRQ), and a question about subjective 
feelings of stress. In ’Hormone 3’, a self-devised tinnitus intensity scale was used. 
In ‘Hormone_2’, salivary cortisol increased significantly 20 minutes after 
exposure to the TSST in the control group and returned to baseline at 40 minutes. The 
tinnitus group demonstrated a delayed and blunted cortisol response with no increase 
in cortisol level at 20 min after exposure to TSST. In ‘Hormone_3’ tinnitus patients had 
a lower salivary cortisol level than controls. Cortisol at 30 minutes (10 minutes after the 
end of noise) was significantly higher than at 10, 40, or 60 minutes but not higher than 
20 minutes or baseline. The main findings of this study highlighted the effect of noise 
exposure on cortisol secretion in both tinnitus and non-tinnitus participants. Noise 
increased cortisol secretion in both groups, increase subjective stress levels, and tinnitus 
intensity, especially in tinnitus patients who are already distressed by tinnitus. 
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Table 5.3-4 - Descriptive Analyses of Cortisol and Products. 
Note. TP – Tinnitus Patients; C – Control Group; W – Women; M – Men; GP – General Population; SHG – Self Help Group; NS=Not Stated; TRQ – Tinnitus reaction questionnaire; 
DHEA – dehydroepiandrosterone; CBC – complete blood count. 
Record code: Title of the 
study 
Study Design 
(Setting) 
Sample Size Age Gender 
Tinnitus Severity 
(Tinnitus Duration 
- Months) 
Biological variable (measure) 
Hormone_2: “The 
sound of stress: Blunted 
cortisol reactivity to 
psychosocial stress in 
tinnitus sufferers” 
Investigational 
studies (GP and 
SHG) 
18 TP, 18 C 
TP= 68.8 (5.7); 
C= 68.9 (5.5) 
TP= 10 M and 
8 W; C=  8 M 
and 10 W. 
TRQ:  Mean of 
20.2 (17.7) (Mean 
176 months                                                             
range 18 - 420 
months) 
Cortisol levels (µg/dl): Group×Time interaction, F 
(5,170) = 5.92 (saliva samples – specific 
radioimmunoassay) 
Hormone_3: “Salivary 
cortisol levels, 
subjective stress, and 
tinnitus intensity in 
tinnitus sufferers during 
noise exposure in the 
laboratory” 
Assays (NS) 20 TP, 20 C 
TP= 56-78, 
mean 67.9 SD 
6; C= 61-77, 
mean 68.8 SD 
5.5 
TP=10 W and 
10 M; C=9 W 
and 11 M. 
Mean 19.9 (10.3) 
from the Tinnitus 
related distress 
using the TRQ 
Validated French 
version (18 to 420 
months, mean 
14.5 SD 9.7, range 
1.5 – 35) 
Cortisol levels (µg/dl): 
TP= 0.079; effect of group: F(1,38)=4.4; effect time: 
F(5,190)=8.81 (saliva samples – specific 
radioimmunoassay) 
General_4: “Circulating 
steroids negatively 
correlate with tinnitus” 
Investigational 
studies (NS) 
28 TP 
M=52.5 ± 
19.2; W=5.2 ± 
16.5 
12 W, 16 M NS (NS) 
Pregnenolone (nmol/L) =1.4 (0.77, 1,7) and its sulfate 
(nmol/L)= 140 (85, 240), DHEA (nmol/L)=1600 (920, 
2700), 7α Hydroxy-DHEA (nmol/L)= 0.49 (0.35, 0.79) 
Androstenediol (nmol/L)= 1.2 (0.74, 1.9), 
Progesterone (nmol/L)= 1.8 (1, 2.8), Cortisol 
(nmol/L)= 480 (380, 610), 20α-Dihydroprogesterone 
(nmol/L)= 1.1 (0.71, 1.8), Androstenedione (nmol/L)= 
3.4 (2.8, 4.4), Allopregnanolone sulfate (nmol/L)= 7.3 
(4.6, 14), Isopregnanolone (nmol/L)= 0.19 (0.1, 0.29), 
its sulfate (nmol/L)= 11 (7.1, 16), Androsterone 
(nmol/L)= 0.37 (0.23, 0.68), Epiandrosterone 
(nmol/L)= 0-6 (0.34, 0.94) (CBC) 
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In ‘General_4’ (Chrbolka et al., 2017) a wide spectrum of circulating steroids in 
middle-aged tinnitus patients with hearing loss not greater than 40 dB were quantified. 
The study involved tinnitus patients with depression. Using chromatography and 
immunoassay, pregnenolone and its sulfate, dehydroepiandrosterone (DHEA), 7α-
hydroxyl-DHEA, androstenediol, progesterone, cortisol, 20α-dihydroprogesterone, 
androstenedione, allopregnanolone sulfate, isopregnanolone, its sulfate, aldosterone, 
and epiandrosterone were quantified. All variables exhibited a significant relationship 
to tinnitus intensity, mostly at significance levels of p<0.01. Steroid levels negatively 
correlated with both tinnitus intensity (dB) and frequency (kHz). They reported that 
22.2% of the variability in tinnitus intensity and frequency was explained by the levels 
of circulating steroids.  
From this category we highlight that steroid levels negatively correlate with 
tinnitus, i. e. the three included studies in this category consistently show that tinnitus 
patients have lowers cortisol saliva and blood levels compared to healthy controls or 
normative values.  
Melatonin  
One investigational study of melatonin, involving 139 participants (81 tinnitus 
patients and 58 controls) was identified (Table 5.3-5). 
Table 5.3-5 - Descriptive Analyses of other hormones (melatonin). 
Note. TP – Tinnitus Patients; C – Control Group; P – Participants; W – Women; M – Men; NS – Not 
Stated; 
‘Vitamins_3’ (Lasisi, Fehintola & Lasisi, 2012) was a pilot investigational study 
which found a correlation between low plasma melatonin and self-reported tinnitus 
among the elderly.  
 
 
Record code: 
Title of the 
study 
Study Design 
(setting) 
Sample 
Size 
Age Gender 
Tinnitus 
Severity 
(Tinnitus 
duration) 
Biological variable 
(measure) 
Vitamin_3: 
“The role of 
plasma 
melatonin and 
Vitamins C and 
B12 in the 
development of 
idiopathic 
tinnitus in the 
elderly” 
Investigational 
studies 
(Community 
Programme) 
139P - 
81TP 
58C 
Mean 
age=66,9 
(0,77) 
ranging 
from 60 
to 98 
years 
78 W 
and 61 
M 
NS (NS) 
Melatonin 
(pg/mL): TP= 
11.1+3.4;(Plasma 
levels) 
Tinnitus, biomarkers and quality of life in an older population 
177 
 
  
Inorganic ions 
Two investigational studies of inorganic ions and tinnitus, involving 213 
participants (123 tinnitus patients and 85 controls) were included (Table 5.3-6).  
Table 5.3-6 - Descriptive Analyses of inorganic ions. 
Record code: 
Title of the 
Study 
Study Design 
(setting) 
Sample 
Size 
Age Gender 
Tinnitus 
Severity 
(Tinnitus 
Duration) 
Biological variable 
(measure) 
Inorganic_io
ns_1: “Zinc 
deficiency 
and tinnitus” 
Investigation
al studies 
(University 
Hospital) 
73 TP, 
38 C 
TP= 42.7 
(S.D., 11.0); 
C= 42.4 (S.D., 
9.7); 
Inclusion 
criterion: 
(20-59 
years). 
TP= 50 
W 
(68.5%); 
23 M 
(31.5%); 
C= 26 
W; 12 
M 
NS (NS) 
Zn (µg/dl): TP= 
88.19±12.4; (blood 
sample) 
Inorganic_io
ns_3: “Serum 
iron, copper, 
zinc, 
chromium, 
manganese 
levels in 
idiopathic 
tinnitus 
patients in 
comparison 
with healthy 
individuals” 
Investigation
al studies 
(Hospital) 
55 TP, 
47 C 
TP= 47.34 
years 
(range:22 - 
75 years); 
TP= 
53.1% 
W and 
46.9% 
M 
NS (NS) 
Zn (µg/dl): 
TP=100/87±19/00; 
Cu (µg/dl): 
TP=112/48±27/59; 
Fe (µg/dl): 
TP=95/68±35/97; 
(flame atomic 
absorption 
spectrometry. 
Mn (µg/dl): 
TP=12/52±3/35; 
Cr (µg/dl): 
TP=26/71±5/39; 
(Serum Samples – 
Flameless Atomic 
Absorption 
Spectrophotometer) 
Note. TP – Tinnitus Patients; C – Control Group; W – Women; M – Men; NS – Not Stated; Zn – 
Zinc; Cu – Copper; Fe – Iron; Mn – Manganese; Cr – Chromium.  
‘Inorganic_ions_1’ (Ochi et al., 2003) examined the correlation between serum 
zinc (Zn) levels and audiometric performance, measuring serum Zn levels in patients 
suffering from tinnitus. The frequency and loudness of tinnitus were measured using an 
audiometer, and several characteristics of tinnitus including ear side, continuity, and 
duration were assessed. Serum Zn levels were measured from peripheral blood samples. 
Patients were divided into two groups depending on their serum Zn levels: hypozincemia 
(n=24) and normal serum Zn (n=49). Authors did not describe the measurement tool. 
They found no statistically significant differences between their two groups on any 
variables except for tinnitus loudness which was higher in patients with hypozincemia. 
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In ‘Inorganic_ions_3’ (Yazdkhasti, Abtahi & Mozafarinia 2016) the serum 
concentration of chromium (Cr), copper (Cu), iron (Fe), manganese (Mn), and Zn in 
patients with idiopathic tinnitus were measured and compared with those of healthy 
subjects. Tinnitus evaluation was not described. The concentration of Fe, Cu and Zn were 
measured by flame atomic absorption spectrometry and concentration of Cr and Mn 
were measured by Flameless Atomic Absorption Spectrophotometer. Mean serum iron 
and manganese did not differ between groups. However, mean serum Zn concentrations 
were significantly higher in patients with tinnitus than in controls, and mean serum 
copper and chromium levels were significantly lower in tinnitus patients than in the 
control group.  
Only Zn was measured in both studies, and despite differences in study design 
there is evidence for an association between this inorganic ion and the presence or 
severity of tinnitus. Further studies of this and other inorganic ions are indicated. 
Oxidative stress 
Two investigational studies of oxidative stress, with a total of 64 tinnitus patients 
and 47 control participants, were included (Table 5.3-7).   
Table 5.3-7 - Descriptive Analyses of Oxidative Stress. 
Record code: 
Title of study 
Study 
Design 
(setting) 
Sample 
Size 
Age Gender Tinnitus 
Severity 
(Tinnitus 
Duration – 
days) 
Biological variable 
(measure) 
General_10: 
“Tinnitus and 
oxidative 
stress in 
selected 
series of 
elderly 
patients” 
Investiga
tional 
studies 
(NS) 
20 TP, 
22 C 
TP= 67+-
3; 
C=66+-3. 
All 
males. 
NS (Less 
than 180 
days) 
MDA (µmole/dl): TP: 
B=1.97±0.15; J=2.60±0.04; 
4-HNE (µmole/dl): TP: 
B=1.44±0.02; J=2.42±0.01; 
MPO (µmole/dl): TP: 
B=0.30±0.05; J=0.73±0.04;  
(All above by HPLC) GSH-
PX (IU/ml): TP: B=5.36± 
0.03; J=2.22±0.04; (blood 
samples – calorimetric 
method) 
General_11: 
“Oxidative 
stress, nitric 
oxide, 
endothelial 
dysfunction 
and tinnitus” 
Investiga
tional 
studies 
(Universi
ty 
Hospital) 
44 TP, 
25 C 
TP= age 
range 
36–52; 
C= age 
range 
34–50. 
TP= 21 
M and 
23 W; C= 
15 M 
and 23 
W 
NS (not 
more that 
10 days, 
mean 7±2 
days) 
NOx (µmol/dl): TP: B= 
55±1.7; J= 48.17±1.57; L-
arginina (µmol/dl): TP: 
B=30.5±0.9; J=38.05±1.61; 
L-citrulina (µmol/dl): TP: 
B=40±2.9; J=25.73±2.26; 
vWF:A (IU/ml): TP: 
B=82±11; J=116±5.2; TM 
(IU/ml): TP: B=40.2±1.4; 
J=54±2.1 (Plasma 
concentrations) 
Note. TP – Tinnitus Patients; C – Control Group; W – Women; M – Men; NS – Not Stated; MDA – plasma 
malonaldehyde;4-HNE – 4-hydroxynonenal; MPO – mieloperoxydase; GSH -PX – Plasma glutatione 
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peroxidase; NOx – nitrite plus nitrate; vWF:Ag – von Willebrand factor antigen; TM – trombomodulin; B – 
Brachial vein; J – Jugular vein; HPLC – high performance liquid chromatography.  
‘General_10’ (Neri et al., 2002) investigated whether reactive oxygen species 
(ROS) are involved in the pathogenesis of tinnitus. Methodology included an interview 
and audiological examination. Blood levels (from brachial and internal jugular vein) of 
some oxidative markers were determined including plasma malonaldehyde (MDA), 4-
hydroxynonenal (4-HNE), mieloperoxydase (MPO), and plasma glutathione peroxidase 
(GSH-PX). There was a significant difference in the concentration of oxidative markers 
(MDA, 4-HNE, MPO) and antioxidant GSH-PX between brachial and jugular vein in 
tinnitus patients. Namely, the jugular vein values of oxidative markers were all higher, 
while the antioxidant GSH-Px was lower than in the brachial vein within the same group. 
At the same time, in the group without tinnitus, there was no significant difference 
between the brachial and jugular blood concentrations on the other parameters 
measured. However, there was little between group differences, with the exception of 
GSH-Px which was higher in those without tinnitus. The study results indicate that a state 
of oxidative stress is present in reflux blood of cerebral region jugular vein in patients 
affected by tinnitus.   
‘General_11’ (Neri et al., 2006) asked whether pathogenic endothelial 
dysfunction is involved in idiopathic tinnitus. All participants had recent onset tinnitus 
(less than 10 days). Assessments included plasma concentrations (blood from the 
internal jugular vein and brachial vein) of nitrite plus nitrate (NOx), L-arginine and L-
citrulline, and von Willebrand factor antigen (vWF:Ag) to determine endothelial cell 
activation, thrombomodulin plasma concentrations of MDA, 4-HNE and MPO to 
determine oxide-reductive status as stable lipoperoxidation products in vivo, and GSH-
Px to determine oxygen radical scavenging enzyme activity. NOx was measured using a 
photometric method and L-citrulline was measured using high performance liquid 
chromatography (HPLC). Patients with idiopathic tinnitus were found to have 
significantly (p<0.005) higher levels of oxidative damage maker (MDA, 4-HNE, and MPO) 
concentrations and plasma scavenger activity in jugular compared to brachial blood, 
accompanied by increased free radical (FR) concentrations and reduced plasma 
glutathione peroxidase activity. They also displayed a significant reduction in peripheral 
and jugular concentrations of NOx, L-arginine, and L-citrulline and increased L-arginine 
in jugular vein reflux blood compared with peripheral blood (p <0.05 in all cases). 
Regarding the oxidant/antioxidant profile markers, no significant differences between 
tinnitus patients and control group in the asymptomatic period were observed in 
brachial blood whereas mean values of oxidant/ antioxidant profile markers were 
significantly higher in tinnitus patients compared to controls and subjects in the 
symptomatic period. 
Both studies favor oxidative stress as a potential tinnitus biomarker, especially 
for recent onset tinnitus. However, the study populations were not general;  
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‘General_10’ only included male participants and ‘General_11’ included those with 
acute tinnitus (less than 10 days). Neither study included audiological nor tinnitus 
severity measures so, those results have to be interpreted with caution.  Replication 
studies with a general tinnitus population are needed.  
 
Vitamins 
Two investigational studies and two assays, involving a total of 2520 participants 
(532 tinnitus patients and 1988 controls) of vitamins were included (Table 5.3-8). 
‘Vitamin_1’ (Attias et al., 2002) measured Vitamin B1 and Vitamin B12, in 
peripheral blood samples. The main finding in the study was a sudden significant, 
stepwise increase in tinnitus after 10 years of service, as opposed to an almost linear 
increase in the noise-induced hearing loss with age. The study population included only 
male soldiers exposed to noise. They concluded that the low levels of vitamins B1 and 
B12 in the studied population favored tinnitus being of central origin. 
‘Vitamin_2’ (Berkiten et al., 2013) aimed to determine vitamin B12 levels in 
patients with non-pulsatile tinnitus and to assess the efficacy of replacement treatment 
on tinnitus and hearing in patients with vitamin B12 deficiency. Vitamin B12 was 
measured in blood . Patients with vitamin B12 deficiency started vitamin B replacement 
therapy. The results showed no significant relationship between tinnitus and vitamin 
B12, and vitamin B12 replacement treatment was not found to affect tinnitus. The 
authors concluded that vitamin B12 therapy for tinnitus remains controversial. 
‘Vitamin_4’ (Shemesh et al., 1993) aimed to determine the incidence of vitamin 
B12 deficiency in patients with chronic tinnitus and noise-induced hearing loss (NIHL), 
NIHL only, and those without tinnitus or NIHL. Differences in severity of tinnitus and 
hearing sensitivity were compared across participants with and without vitamin B12 
deficiency. In addition, the effects of vitamin B12 replacement therapy on tinnitus in a 
subgroup of cobalamin deficient tinnitus sufferers was evaluated. Levels of vitamin B12 
were evaluated through serum cobalamin levels. The results suggested a relationship 
between vitamin B12 deficiency and dysfunction of the auditory pathway. Some 
improvement in tinnitus and associated complaints were observed in 12 patients 
following vitamin B12 replacement therapy (p = 0.023). These results indicate a high 
prevalence, with more severity of serum Cobalamin deficiency among tinnitus patients. 
There was a tendency toward more severe tinnitus complaints from patients with 
vitamin B12 deficiency than from patients with normal cobalamin levels. 
In ‘Vitamin_5’ (Singh et al., 2016) the objective was to assess the prevalence of 
Vitamin B12 deficiency in chronic subjective tinnitus patients in an Indian population, 
and the therapeutic effect of parenteral vitamin B12 on tinnitus. Vitamin B12 levels were 
evaluated using a chemiluminescence method. Patients were followed for a period of 1 
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month after 6 weeks of interventional therapy. Of the patients with tinnitus, 17 (50%) 
were vitamin B12 deficient. In the control group 35% were vitamin B12 deficient. 
Patients with vitamin B12 deficiency showed a significant improvement in tinnitus 
severity score after vitamin B12 therapy (p = 0.016). However, there was no significant 
improvement in severity scores of patients without B12 deficiency. The results favour 
Vitamin B12 therapy in vitamin deficient subjects. Though tinnitus severity was highest 
in the treatment group with normal cobalamin levels, the improvement in tinnitus 
severity levels was significant in the cobalamin-deficient group. In view of the findings 
of this study, cobalamin deficiency could also be present with tinnitus only in the 
absence of other manifestations and the authors suggest serum cobalamin 
determination in chronic tinnitus patients. There is mixed evidence therefore that 
vitamin B12 levels are a biomarker for tinnitus, and that vitamin B12 supplementation 
in cases of deficiency will lead to improvements in tinnitus severity.
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Table 5.3-8 - Descriptive Analyses of Vitamins. 
Note. TP – Tinnitus Patients; C – Control Group; NTP – Non-Tinnitus Patients; NIHL – noise-induced    hearing   loss; W – Women; M – Men; NS – Not Stated; Vit – Vitamin; TQ – tinnitus 
questionnaire; TSIQ - tinnitus severity index questionnaire; Pret – Pretherapy; Postt – Posttherapy; N – Normal; MD – mild deficiency;  SD – severe deficiency. 
Record code: Title 
of the study 
Study Design (setting) Sample Size Age Gender 
Tinnitus Severity (Tinnitus Duration 
- Months) 
Biological variable (measure) 
Vitamin_1: 
“Support for the 
central theory of 
tinnitus 
generation: a 
military 
epidemiological 
study” 
 
Investigational 
studies 
(soldiers/randomly 
selected) 
TP= 355, 
NTP=1892 
Range from 18-
50 years (random 
group 18-60) 
All males NS (NS) 
Vit B1 TP: N=44.6%; MD=30.5%; 
SD=24.8%; 
Vit B12 TP: N=64%; MD=14%; 
SD=22%; (Blood samples) 
Vitamin_2: 
“Vitamin B12 levels 
in patients with 
tinnitus and 
effectiveness of 
vitamin B12 
treatment on 
hearing threshold 
and tinnitus” 
 
Assays (NS) TP=100, C= 20 
TP=17 to 66, 
mean 43.87± 
10.12); C=19-59, 
mean 33.85± 
11.16 
TP= 38 M 
and 62 W; 
C= 9 M and 
11 W 
NS (3 months to 120 months) 
Vit B12 (pg/mL): TP= 63 low levels, 
and 37 normal levels.  (Blood 
samples) 
Vitamin_4: 
“Vitamin B12* 
Deficiency in 
Patients With 
Chronic-Tinnitus 
and Noise-Induced 
Hearing Loss” 
 
Investigational 
studies (army 
personnel) 
57 TP, C: 29 
subjects with 
NIHL and 27 
normal 
audiograms 
mean age of 
39.4± 10.5 years) 
NS TQ (lasting more than 6 months) 
Vit B12 deficiency (pg/mL) TP and 
NIHL=47% (Serum cobalamin levels) 
Vitamin_5:  
“Therapeutic role 
of Vitamin B12 in 
patients of chronic 
tinnitus: A pilot 
study” 
Assays (Medical 
College) 
20 TP, 20 C 
TP= 38.37 
(±12.40) 
M/W ratio 
2:3. 
TSIQ: B12 deficiency 
(Pret:36.50±7.6 Postt:28.30±6.2 
Without B12 deficiency 
(Pret:38.16±12.0 Postt:37.23±11.2) 
(lasting more than 6 months 
duration, 16.32 (±15.6) months) 
17TP were Vit B12 (pg/ml) deficient 
that is 42.5% showed deficiency. 
Prevalence of Vit B12 deficiency 
TP=50% (serum cobalamin deficiency 
levels – chemiluminescence method) 
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Interleukins 
Three studies of interleukins were included, one cross-sectional, one 
exploratory, and one investigational study (Table 5.3-9). In total, 266 participants, with 
116 tinnitus patients, 13 non-tinnitus patients and 137 healthy control participants were 
included. 
‘Interleukin_1’ (Doi et al., 2015) evaluated the association between the 
polymorphism of the Interleukin-6 (IL-6) gene in the region 174G/C and the presence of 
tinnitus in elderly participants with a history of occupational noise exposure. The study 
included 179 participants, 33.5% of who reported noise exposure history, with 42.5% 
having tinnitus. Of the 66.5% without noise exposure history, 28.5% had tinnitus. The 
findings showed a significant association between the genotype and allele frequencies 
of the IL6–174 gene and tinnitus among those with a history of exposure to noise. 
Participants with tinnitus with the C allele were less likely to have tinnitus associated 
with the history of exposure to occupational noise (OR = 0.167, CI 95% 0.167-0.749) 
compared to those carrying the G allele. No association was found between the 
genotypic frequency of the IL6 -174 gene (rs1800795) and tinnitus among participants 
without exposure to occupational noise. 
‘Interleukin_2’ (Szczepek et al., 2014) explored whether the profile and 
concentrations of circulating cytokines and neurokines could reflect tinnitus-related 
distress. Interleukin-1b (IL-1b) and IL-6 levels in blood were measured. IL-1b was found 
to correlate with tinnitus-related distress, whereas IL-6 concentrations were below the 
detection threshold. A positive correlation between the concentration of IL-1b and a 
visual analogue scale measure of tinnitus awareness was also reported. 
‘General 18’ (Weber et al., 2002) asked whether improving stress management 
would influence psychological and stress-related immunological parameters – IL-6, 
interleukin-10 (IL-10) and Tumor necrosis factor alpha (TNF-α) – in chronic tinnitus 
patients. The tinnitus patients (n = 26) and non-tinnitus participants (n = 13) took part 
in a standardized 10-week relaxation program. An additional group of tinnitus patients 
(n= 18), randomly assigned, served as a further control (C). The hypothesized baseline 
differences between tinnitus and non-tinnitus participants were not verified on most 
parameters. The relaxation program resulted in positive changes in psychometric 
measures, notably a reduction of tinnitus-related distress. It was concluded that 
decreased type 1 (Th1)-derived cytokine TNF-α may be characterized as a biomarker for 
improving stress-management in tinnitus.  There were no differences in IL-6 levels 
between tinnitus patients and and controls. In summary, across three studies only IL-6 
was studied in all with inconsistent results. This may be because the measurement tools 
differed between studies. Any role of Interleukine-6 as a biomarker for tinnitus is 
therefore still unclear and further studies are advised.
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Table 5.3-9 - Descriptive Analyses of Interleukins. 
Note. TP – Tinnitus Patients; C – Control Group; NTP – Non-tinnitus Patients; W – Women; M – Men; NE – Noise Exposure; NS – Not Stated; IL-1b – Interleukin-1b; IL-6 – 
Interleukin-6; IL-10 – Interleukin-10; TNF-α – Tumor necrosis factor alpha; T1 – Time 1; T2 – Time 2; T3 - Time3.  
Record code: Title of the 
study 
Study Design 
(setting) 
Sample Size Age Gender 
Tinnitus Severity 
(Tinnitus Duration 
– Months) 
Biological variable (measure) 
Interleukines_1: 
“Association between 
polymorphism of interleukin-
6 in the region 174G/C and 
tinnitus in the elderly with a 
history of occupational noise 
exposure” 
cross-sectional 
study (public) 
179P= 
33.5% (60P) 
with NE 
(26TP, 34C); 
66.5% 
(119P) 
without NE 
(34TP, 85C) 
68.9 ± 5.25 
years 
65.4% of 
female elderly 
NS (NS) 
Genotype frequency ( ng/μL): 
No NE: TP: GG=2(06.5); CC=15(48.4); 
GC=14(45.2). 
With NE: TP: GG=13(86.7); CC=00(0.0); 
GC=02(13.3); Allelic frequency: No NE TP: 
G=18(29.0); C=44(71.0);. With NE: TP: 
G=28(93.3); C=02(06.7); (Allele 
presence/absence, and genotypic frequency) 
Interleukines_2: “Biological 
correlates of tinnitus-related 
distress: An exploratory 
study” 
 
Exploratory 
studies (tinnitus 
center) 
30 TP 
age 
between 18 
and 67 
years - 
mean age 
47 years, 
14 W and 16 
M 
German version of 
TQ: pure tone (17) 
or a narrow-band 
noise (13) (mean 
60 months, ranging 
from 9 months to 
336 months) 
IL-1b (pg/ml)= 4.00 ± 0.43; 
IL-6 (pg/ml) = 0.38 ± 0.06; (Blood collection and 
serum processing) 
General_18: “Impact of a 
relaxation training on 
psychometric and 
immunologic” 
Investigational 
studies and 
assays 
(relaxation 
programme) 
26 TP; 13 
NTP and 18 
C 
TP=43.2 ± 
9.7; NTP= 
32 ± 6.7; C= 
42.0 ± 11.3 
T= 16 M+10 
W; NTP= , 8 
M+5 W; C= 8 
M+10 W 
NS (NS) 
TNF-α (pg/ml)= significantly decreased in TP 
(p=.001), IL-6 (pg/ml)= higher IL-6 levels than 
NTPs at T1 (P=.002) and T2 (P=.015), but not at 
T3 (P=.092) in TP; IL-10 (pg/ml)- NS (Serum level 
evaluation) 
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Sedimentation Velocity (SV), C - reactive Protein (cRP) and unspecific 
Immunoglobulins 
There was one study in this category with no statistically significant results.  
Neurotransmitters 
Six studies of neurotransmitters were included. Four were investigational 
studies, one was an exploratory study, and one was a prospective randomized controlled 
trial. Those studies include a total of 741 participants (334 tinnitus patients, 35 non-
tinnitus patients and 372 healthy controls) (Table 5.3-10). 
‘Genetic_19’ (Rottenberg et al., 2014) explored the association between tinnitus 
and gamma-aminobutyric acid type A (GABA(A) receptors.  The polymorphism in 
GABA(A) Beta-4 subunit gene was measured by PCR products. Findings suggested two 
main regulatory mechanisms of tinnitus generation. First, a brainstem mechanism that 
depends on severity of hearing loss. And second, a cortical mechanism dependent on 
the genotype of (CA)n tandem repeat in GABA(A) beta-3 subunit gene. However, 
regulation of GABA signaling as well as the role of GABA(A_ receptors in chronic tinnitus 
remains unclear. 
‘Genetic_20’ (Sand et al., 2012) also evaluated the GABA receptor, aiming to 
determine whether there was an association between the gene KCTD12 and tinnitus. 
The GABA-B receptor subunit gene was measured by Sanger sequencing of PCR 
products. A positive family history of tinnitus in first-degree relatives did not predict 
rs34544607 genotype. When allele frequencies were compared to data from a large 
reference population of European ancestry, rs34544607 was associated with tinnitus 
(p=0.04). However, KCTD12 genotype did not predict tinnitus severity (p=0.52) and the 
association with rs34544607 was weakened and no longer significant after screening 50 
additional cases (p=0.07). The results imply genetic variation in a GABA-B receptor 
auxiliary subunit may be a risk modifier in chronic tinnitus. 
In ‘General_5’ (Daftary et al., 2004) authors evaluated the cortical 
benzodiazepine receptor distribution (BZR) in patients with tinnitus, using venous blood 
samples after radiolabeling with 123I-iomazenil, single-photon emission computed 
tomography (SPECT) and magnetic resonance. Comparison of homotypic brain regions 
showed statistically significant asymmetry in the distribution volumes (V3) data in the 
superior temporal cortex (p = 0.03 for both). Comparison of tinnitus patients to healthy 
controls showed a trend toward reduced BZR density in the frontal lobes bilaterally (p < 
.001) and a reduction in the cerebellum (p = 0.045). This preliminary study of BZR 
distribution in a cohort experiencing severe, chronic tinnitus supports temporal, frontal 
lobe, and cerebellar involvement in the disorder. The results of the voxel-based 
statistical parametric mapping (SPM) analysis also suggest changes in BZR distribution 
in the frontal lobes and, to a lesser extent, in the cerebellum. The frontal lobe showed 
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the least asymmetry; for the volume of interest assessment, however, this analysis does 
not account for the symmetrical relative reduction in frontal lobe receptor 
concentration. They also saw an insignificant decrease in receptor concentration in the 
cerebellum.  
Two investigational studies evaluated the serotonin receptor. ‘General_14’ 
(Sachanska, 1999) included patients with vestibular disturbances, healthy controls, and 
patients with tinnitus. The purpose was to evaluate the concentration of serotonin levels 
through blood samples by the Snyder method. The findings showed that patients with 
tinnitus have significantly higher blood serotonin than reference values. Seven patients 
(29.17%) had a mean serotonin value of 1.111 nmol liter; 9 (37.50%) had a value of 660 
nmol liter; and 8 (32. 80%) had standard serotonin values (459 nmol-liter). 
‘Genetic_3’ (Deniz et al., 2010) assessed the association between tinnitus and 
the serotonin transporter gene (SLC6A4 polymorphism) as measured by the SLC6A4 
polymorphism – variable number tandem repeats (VNTR) and the promoter region (5-
HTTLPR), in blood samples, measured by PCR products. There was no difference 
between genotypes of patients and controls regarding VNTR (W 2= 0.012 and p = 0.994) 
or 5-HTTLPR (W 2 = 0.262, p = 0.877) polymorphisms. There was no association between 
the visual analog scale ratings of tinnitus of the patients and VNTR polymorphism (p > 
0.05) but there was an association between the visual analog scale scores of the patients 
and 5-HTTLPR polymorphism. For the first visual analog scale parameter (severity), the 
scores of patients with “ll” genotype were significantly higher than the scores of patients 
with “ls” genotype (p = 0.004). For the third visual analog scale parameter (tinnitus 
discomfort level), the scores of patients with “ll” genotype were significantly higher than 
the scores of patients with “ls” genotype and “ss” genotypes (p = 0.002 and p = 0.03, 
respectively). For the fourth (attention-deficit) and the fifth parameters (sleep disorder), 
the scores of patients with “ll” genotype were significantly higher than the scores of 
patients with “ls” and “ss” genotypes (p=0.04 and p=0.03, respectively). This finding 
suggests that SLC6A4 polymorphism, especially “ll” variant of the 5-HTTLPR 
polymorphism, is associated with the limbic and autonomic system symptoms such as 
tinnitus discomfort, attention-deficit, and sleep disorder. SLC6A4 polymorphism may be 
a marker of tinnitus distress. 
‘General_25’ (Cacace et al., 2017) assessed the efficacy of low frequency (1-Hz) 
repetitive transcranial magnetic stimulation (rTMS) over auditory cortex of the left 
temporal lobe as an experimental treatment modality for noise-induced tinnitus. The 
study measured glutamate, choline, and n-acetylaspartate using the magnetic 
resonance spectroscopy. A significant reduction in tinnitus handicap was observed 
following active rTMS stimulation (p < 0.005). There was a significant pair-wise 
correlation between the metabolite loudness variables; noteworthy was the reduction 
in tinnitus loudness level that correlated positively with down regulation of glutamate. 
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The importance of this finding was that it only occurred in the active rTMS condition and 
that it was specific to the hemisphere that was stimulated (r = 0.77, p < 0.05). 
For the last in this category, the record ‘Genetic_28’ (Haider et al., 2017) 
metabotropic glutamate receptor subtype 7 (GRM7) analyses was performed by qPCR 
in a sample of 78 older adults with age-related hearing loss and with or without tinnitus.  
Findings suggest that individuals with a T/T genotype have 33% lower risk of 
tinnitus compared to individuals with A/A or A/T genotype. There was a statistically 
significant association between the presence of the allele A/T of GRM7 and severe 
tinnitus. The likelihood of severe tinnitus (scoring ≥ 56 on the THI) was 14.2 higher for 
those carrying the allele A/T compared to T/T. The study concluded that allele A/T of 
GRM7 is associated with greater severity of tinnitus. 
Taken altogether the three studies concerning GABA are not consistent. 
‘Genetic_19’ examined GABA-A, ‘Genetic_20’ focuses on GABA-B and replication studies 
are needed. As for serotonin, the two included studies suggest relevance, namely the 
variant “ll” of the SLC6A4 polymorphism seems to  relate to tinnitus distress.  Both 
studies involving glutamate suggest an important role of this neurotransmitter in 
tinnitus, namely a correlation between glutamate down-regulation and symptoms 
improvement, and that GRM7 allele A/T is predictive of tinnitus severity.
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Table 5.3-10 - Descriptive Analyses of Neurotransmissors. 
Record code: Title of the 
study 
Study Design 
(setting) 
Sample Size Age Gender 
Tinnitus Severity 
(Tinnitus Duration - 
Months) 
Biological variable (measure) 
Genetic_19: “The Significante 
of (CA)n Tandem Repeat in 
GABA (A) Beta-3 Subunit 
Gene in Tinnitus 
Manifestation” 
Exploratory studies 
(NS) 
131 TP 
52 ± 13.8 
years 
61 M and 
70 W 
TS (NS) 
polymorphism in GAB(A) Beta-3 subunit 
gene – TP: allele A1 frequency of 0.41 
(Blood samples – PCR and sequencing PRC 
product) 
Genetic_20: “Resequencing 
of the auxiliary GABAB 
receptor subunit gene 
KCTD12 in chronic tinnitus” 
Investigational 
studies (NS) 
95 C, 50 TP 
C= 50.6± 
12.1; TP= 
49.3±11.3 
C= 67 M 
and 28 W; 
TP= 40 M 
and 10 W 
TQ: averaged 
37.1±16.3 (mean±SD) 
out of 84 points (N 
=144) (NS) 
KCTD12: F87F (rs73237446) and T178T 
(rs34544607) variants- rs34544607 was 
associated with TP (p=0.04); minor allele for 
T178T (0.0494 vs. 0.0263, p=0.04); (GABAB 
receptor) (blood samples – sanger 
sequencing of PCR products) 
General_14: “Changes in 
Blood Serotonin in Patients 
with Tinnitus and Other 
Vestibular Disturbances” 
Investigational 
studies (NS) 
134 P – 35 
patients 
with 
vestibular 
disturbance
s; 75 C; 24 
TP 
NS NS NS (NS) 
Serotonin levels (nmol/liter): TP: 12% 
increase/ 23%decrease; Seven of the 
patients (29.17%) had a mean serotonin 
value of 1,111 nmol liter; 9 (37.50%) had a 
value of 660 nmol liter; and 8 (32. 80%) had 
standard serotonin values (Blood samples) 
Genetic_3: “Significance of 
Serotonin Transporter Gene 
Polymorphism in Tinnitus” 
Investigational 
studies (NS) 
54 TP, 174 C 
TP= 
between 20 
and 51 
TP= 33 W 
(61%) and 
21 M (39%) 
THI: 38.8 + 24 
VAS1: VNTR – TP: 
10/10=7.5±2.6; 
10/12=5±2.3; 
12/12=4.6±2.1; 
SLC6A4 polymorphism – VNTR (mmol/L): 
TP: 12/12= 55.6%; 12/10= 37%; 10/10= 
7.4%; 
5-HTTLPR (mmol/L): TP: II= 22.2%; Is= 
48.1%; ss= 29.6%; (Blood samples) 
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5-HTTLPR – TP: 
ll=6.9±1.7; Ls=4.3±2.2; 
ss=5±2.2 (34.7(53.7); 
(1-340months) 
General_25: “Glutamate is 
down-regulated and tinnitus 
loudness-levels decreased 
following rTMS over auditory 
cortex of the left hemisphere: 
A prospective randomized 
single-blinded sham-
controlled cross-over study” 
Prospective 
randomized single-
blinded sham-
controlled cross-
over design (NS) 
25 TP 
ranging in 
age from 24 
to 80 years 
(mean age: 
54.2 ± 14.2 
years) 
All males 
THI (score 38) and TQ 
(NS) 
Glutamate (rTMS)= main effect of 
hemisphere (F=2.01, p > 0.15), there was a 
significant main effect of condition (F=10.4, 
p=.002), choline (rTMS)= main effect of 
hemisphere (F=0.062, p > 0.78) or condition 
(F=0.713, p=0.4) and n-acetyl aspartate 
(rTMS)= main effect of hemisphere 
(F=0.286, p=0.594) or condition (F=0.010, 
p=0.922) (Magnetic resonance 
spectroscopy) 
Genetic_28: “Biomarkers of 
Presbycusis and Tinnitus in a 
Portuguese Older Population” 
Investigational 
studies (Hospital) 
78 P – 50TP, 
28C 
age 55 to 75 
and mean 
64.6± 5.58) 
years 
33 M and 
45 W 
THI: Slight:10; Mild: 
15; Moderate:13; 
Severe: 10; 
Catastrophic: 2 (NS) 
TP: GMR7 (SNPs)= A/A= 5P; A/T= 26P; T/T= 
47P; (PCR amplification followed by Sanger 
sequencing (Blood samples – PCR) 
Note. TP – Tinnitus Patients; C – Control Group; P – Participants; W – Women; M – Men; NS – Not Stated; TS – Tinnitus score; TQ –  Tinnitus questionnaire; THI –  tinnitus 
handicap inventory; VAS1- Visual Analogue Scale for rating tinnitus severity; GABA – gamma-aminobutyric acid; KCTD12 – potassium channel tetramerization domain-
containing protein; SLC6A4 – serotonin transporter gene; 5-HTTLPR – 44-bp insertion deletion in the promoter region; VNTR – 17-bp variable number tandem repeats; GRM7 
- metabotropic glutamate receptor subtype 7;  
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Neurotrophic/protective factors (BDNF, GDNF, HSP70) 
Five investigational studies and one exploratory study including a 684 
participants (518 tinnitus patients and 166 controls) were included (Table 5.3-11).  
In ‘Protein_1’ (Goto et al., 2012) the objective was to investigate the peripheral 
plasma levels of Brain-Derived Neurotrophic Factor (BDNF) in patients with tinnitus, and 
to evaluate  possible correlations between plasma BDNF levels and tinnitus severity and 
comorbid conditions. Patients with mild tinnitus (THI score <36)  had significantly higher 
concentration of BDNF in plasma (1,321.9 ± 1266.1 pg/mL) than  patients with severe 
tinnitus  (385.1 ± 524.9 pg/mL; p < 0.01)  or the controls (p < 0.01). Plasma BDNF levels 
ranged from 48.6 to 4045.4 pg/mL (average, 768.7 ± 961.4 pg/mL) in tinnitus patients 
and from 44.8 to 1289.9 pg/mL (average, 338.5 ± 287.7 pg/mL) in controls. In that study, 
comorbid depressive symptoms were measured using the Hospital Anxiety and 
Depression Scale (HADS). No significant differences were found in BDNF levels, HADS 
scores, or THI scores between the three groups  Interestingly, those patients who had 
few or no depressive symptoms (HADS scores  ≤14) also had significantly lower THI 
scores (p < 0.05) and higher BDNF levels (p < 0.01). After adjusting for possible effects 
of HADS scores, partial correlation coefficients for BDNF levels and THI scores indicated 
that there was no relationship between BDNF levels and THI scores. The results showed 
that plasma BDNF levels may reflect the comorbid depressive symptoms occurring in 
tinnitus patients and therefore may be a useful tool for objective evaluation of the 
health status of tinnitus patients.  
The authors of ‘Protein_4’ (Xiong et al., 2016) evaluated the correlation between 
BDNF levels and tinnitus severity.  In addition, alteration  in plasma levels of BDNF  
before and after Tinnitus Retraining Therapy (TRT) in patients with severe tinnitus was  
analyzed.  The plasma concentration of BDNF in patients with severe tinnitus decreased 
significantly after effective TRT. However, the BDNF concentration did not correlated 
with tinnitus loudness or severity.  
‘Genetic_2’ (Coskunoglu et al., 2017) was designed to detect a possible 
contribution of BDNF mutations to tinnitus pathophysiology by examining the 
relationship between BDNF polymorphisms, mutations, and BDNF serum levels. The 
average serum BDNF level in tinnitus patients was significantly lower than in the  control 
group (p < 0.0001). No statistically significant relationships were found between tinnitus 
handicap and BDNF gene polymorphisms or serum levels (p = 0.30).  
‘Genetic_23’ (Sand et al., 2012) examined the role of genetic variants of glial cell-
derived neurotrophic factor (GDNF) and BDNF in tinnitus. The allele frequencies were 
determined for three GDNF and two BDNF markers measured by restriction fragment 
polymorphisms analyses of PCR amplicons . The authors concluded no main effect of 
individual BDNF or GDNF variants on the susceptibility to the phenotype.  However, 
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multiple regression analysis identified genotypes that predicted tinnitus severity in 
women (but not in men). There was no significant difference in mean tinnitus severity 
scores between carriers and non-carriers of the minor alleles (p>0.19), nor did a positive 
family history of tinnitus in first-degree relatives predict minor allele carrier status 
(p=0.08). Minor allele carrier status explained 19.1% of the variance in tinnitus severity 
of the female subgroup. The investigation provides original information  regarding the 
contribution  of neurotrophic factor genes to the intensity of tinnitus.    
‘Genetic_17’ (Orenay-Boyacioglu et al., 2016) examined the relationship 
between GDNF polymorphisms and tinnitus. Although no correlation was found, 
heterozygosity was significantly lower for GDNF rs1110149 polymorphism in tinnitus 
group than in the controls group (p<0.05). 
’Protein_3’ (Savastano et al., 2006) was an exploratory study that analyzed the 
presence of auto-antibodies against Heat Shock Protein-70 (HSP-70) and circulating 
immune complexes using  Western blot immunoassay  The mean concentration of 
circulating immune complexes in tinnitus patients (4.2 µg/ml)  was significantly higher 
(p = 0.012)  than in the control group (0.9 µg/mlp). Thirteen of 36 tinnitus patients (36%) 
and none (0%) in the control group had circulating anti-HSP-70 antibodies.  In 10 of  13 
HSP70-auto-antibody positive patients, the concentration of circulating immune 
complex  was  significantly elevated. In the tinnitus group, the mean concentration of 
circulating immune complex was 6.9 µg/ml, in the HSP-70- auto-antibody positive 
subgroup and 2.6 µg/ml in the HSP-70-negative subgroup (p =0.024). Thus, the presence 
of circulating complexes and anti-HSP70 antibodies could be a biomarker of tinnitus.  
Four studies involved BDNF and two involved GDNF, with contradictory  results. 
One possible explanation in the case of BDNF is that some studies used serum 
(Coskunoglu A et al., 2017) while others used plasma. Further research is necessary to 
clarify.
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Table 5.3-11 - Descriptive Analyses of Neurotrophic and Protective Factors. 
Record code: Title of 
study 
Study Design 
(setting) 
Sample Size Age Gender Tinnitus Severity (Tinnitus 
Duration - Days) 
Biological variable (measure) 
Protein_1: “Various 
levels of plasma brain-
derived neurotrophic 
factor in patients with 
tinnitus” 
Investigational 
studies 
(hospital) 
43 TP, 30 C TP= 57.1 ± 
15.2; C= 50.7 
± 10.1 
TP= 14 M and 
29 W; C= 15 
M and 15 W 
THI: ranged from 2 to 90 
(average: 38.2± 23.4). 25 
patients with mild tinnitus (THI 
scores of less than 36) and 18 
with severe tinnitus (THI score 
was more than 38) (ranged 
from 2 days to 9360 days 
(average duration: 765±1788 
days) 
BDNF concentration (pg/ml): TP: ranged 
from 48.6 to 4045.4 (average, 768.7 ± 
961.4); (plasma levels) 
Protein_4: “Plasma 
brain-derived 
neurotrophic factor 
levels are increased in 
patients with tinnitus 
and correlated with 
therapeutic effects” 
 
Investigational 
studies 
(hospital) 
82 TP, 32 C TP= 42.7 ± 
14.2; C= 40.1 
± 11.9 
TP= 36 M and 
46 W; C= 17 
M and 15 W 
THI 32.4 ± 16.8 
VAS 
Awareness 6.7 ± 1.5; 
Annoyance 6.3 ± 1.0; Loudness 
6.3 ± 1.2 (mean 1800 days, 
range from 540 to 5400 days) 
Plasma BDNF (pg/ml): TP= 1076.1 ± 495.9 
ranged from 96–2475)  was significantly 
higher than those in C (plasma levels) 
Genetic_2: “Evidence 
of associations 
between brain-derived 
neurotrophic factor 
(BDNF) serum levels 
and gene 
polymorphisms with 
tinnitus” 
Investigational 
studies 
(university 
hospital) 
65 TP, 42 C TP= 22 to 55 - 
43.6 ± 10.7; 
C= 23 to 55, 
39.3 ± 9.8 
TP= 30 W and 
35 M; C=  13 
W and 29 M 
THI - 37.4 ± 20.0; 
VAS 
VAS-1 6.1 ± 2.3, VAS-2  
7.9 ± 2.7, VAS-3 5.8 ± 2.8, VAS-
4 3.2 ± 1.7, and VAS-5 3.7 ± 1.9 
(for at least 90 days) 
BDNF level (pg/ml): TP= 1374 ± 326; 
 BDNF gene polymorphisms (μl): TP= 
84.6% GA and 15.4% AA for rs6265;  
TP= 32.7% CC, 49.9% CT, 17.4% TT for 
rs1491850 (T AF TP= 42.3%; C AF 
TP=57.7%; for rs1491850). 
TP= 23.4% CC, 42.0% CT, and 34.6% TT for 
rs203024; (TP=AF was 55.6%) (serum 
levels, enzyme-linked immunosorbent 
assay and PCR) 
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Genetic_23: “GDNF and 
BDNF gene interplay in 
chronic tinnitus” 
Investigational 
studies (NS) 
240 TP age 50.3 
±12.9 
171 M and 69 
W 
German version of TQ: scores 
averaged 41.0 ± 1.2 out of 84 
points (N=236); mild in 73 
subjects (30.9%), moderate in 
73 (30.9%), severe in 45 
(19.1%), and extreme in 45 
(19.1%) (More than 180 days) 
AF: GDNF – rs1110149 (MAF - 0.490; 
MMA - G:C), rs884344 (MAF - 0.269; MMA 
- T:G) and rs3812047 (MAF - 0.143; MMA 
– G:A). Two BDNF markers - rs2049046 
(MAF - 0.494; MMA - A:T) and rs6265 
(MAF - 0.196; MMA - G:A) (Restriction 
enzyme analses of PCR amplicones -  DNA  
was  extracted  from  lymphocytes) 
Genetic_17: 
“Relationship Between 
Chronic Tinnitus and 
Glial Cell Line-Derived 
Neurotrophic Factor 
Gene rs3812047, 
rs1110149, and 
rs884344 
Polymorphisms in a 
Turkish Population” 
 
Investigational 
studies 
(University 
Hospital) 
TP=52; 
C=42 
TP= 43.6 ± 
10.7; C= 39.3 
± 9.8 
TP= 19 W and 
33M; C= 13W 
and 29M 
THI: 37.4 ± 20.0 
VAS 
VAS-1 6.1 ± 2.3; VAS-2 7.9 ± 
2.7; VAS-3 5.8 ± 2.8; VAS-4 3.2 
± 1.7; VAS-5 3.7 ± 1.9 (at least 
90 days) 
GDNF gene polymorphisms (µmol/µl): 
rs884344: TP=5.8 % T:T, 92.3 % T:G, 1,9 % 
G:G;.  rs3812047: TP= 67.3 % G:G, 28.8 % 
G:A, 3.9 % A:A; rs1110149: TP= 32.7 % C:C, 
55.8 % C:G, 11.5 % G:G. AF: TP=51.9 % T, 
48.1 % G; for rs884344; TP=81.7 % G, 18.3 
% A; for rs3812047; TP=60.6 % C, 39.4 % 
G; for rs1110149 (blood samples, PCR-
based restriction fragment length 
polymorphism) 
Protein_3: “Western 
Blot Immunoassay for 
HSP-70 Antibodies in 
Idiopathic Tinnitus: A 
Preliminary Report” 
Exploratory 
studies 
(University/ 
blood donors) 
36 TP, 20 C TP= 20 and 65 
mean age 
41.0; C= 20 
and 65 mean 
age 43.9 
TP= 17 W and 
19 M; C= 9 W 
and 11 M 
NS (NS) HSP-70 (ug/ml): 13 of the 36 TP: HSP-70-
positive/ none of the C HSP-70-positive. 
Ten of the 13 HSP70-positive patients had 
CIC values higher than normal values. CIC= 
6.9 ug/ml, in the HSP-70-positive subgroup 
and 2.6 ug/ml. in the HSP-70-negative 
subgroup (p =.024). (Serologic tests – 
serum and blood samples) 
Note. TP – Tinnitus Patients; C – Control Group; W – Women; M – Men; NS – Not Stated; ; THI –  tinnitus handicap inventory; VAS – Visual Analog Scale; VAS-1 – 
severity of tinnitus; VAS-2 – frequency and duration of tinnitus;VAS-3 – discomfort level; VAS-4 – attention deficit; VAS-5 – sleep disorders; TQ – Tinnitus Questionnaire; BDNF 
– brain-derived neurotrophic factor; GDNF – Glial Cell Line-Derived Neurotrophic factor; HSP-70 – heat shock protein 70; MAF – minor allele frequency; MMA - major:minor 
allele; AF – Allele frequency; CIC - circulating immune complex 
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Ion channels (K+ and Cl-)  
One exploratory study of potassium and chloride channels had statistically 
significant results (Table 5.3-12).  
The authors of ‘Genetics_18’ (Pawełczyk et al., 2012) tested the hypothesis that 
genetic variability in genes of the potassium-recycling pathway is associated with 
increased susceptibility to tinnitus in male subjects. The study analysed the occurrence 
of Single Nucleotide Polymorphism (SNP) in ten genes encoding potassium-recycling 
proteins. The selected genes were five connexin genes (Cx26 (GJB2), Cx30 (GJB6), Cx30.3 
(GJB4), Cx31 (GJB3), Cx32 (GJB1)), four potassium channels or channel subunits genes 
(KCNJ10 – potassium inwardly-rectifying channel, subfamily J, member 10, KCNQ4, 
KCNE1, KCNQ1 – potassium voltage-gated channel, potassium voltage-gated channels, 
KQT-like family and Na+/2Cl–/K+ cotransporter gene (SLC12A2 – solute carrier family 12, 
member 2). The SNP analyses demonstrated that in subjects with tinnitus, 
polymorphisms in KCNE1 (rs915539, p = 0.005) were associated with the resistance to 
developing noise-related hearing loss whereas polymorphism in Slc12A2 (rs10089, p = 
0.016) were associated with susceptibility to developing noise-related hearing loss. 
Table 5.3-12 - Descriptive Analyses of Ion Channels. 
Record 
code: Title of 
the study 
Study 
Design 
 
Sample 
Size 
 
Age 
Gender 
Tinnitus 
Severity 
(Tinnitus 
Duration) 
Biological variable 
(measure) 
Genetic_18: 
“Analysis of 
inner ear 
potassium  
recycling 
genes as 
potential 
factors  
associated 
with 
tinnitus” 
Explorat
ory 
studies 
(previou
s 
associati
on 
analysis/ 
databas
e) 
128 TP, 
498 C 
TP= mean 
age: 42; 
C=41 
Only males NS (NS) 
KCNE1 OR(95% CI): 
TP= 1.1230 
(0.7890–1.5982); 
Slc12A2 OR(95% 
CI): TP= 1.6899 
(0.9991–2.8582); 
(analysis of Single 
Nucleotide 
Polymorphisms) 
Note. TP – Tinnitus Patients; C – Control Group; NS – Not Stated; 
 
Single studies: Angiotensin converting enzyme and Alpha- Adducin  
‘Genetics_27’ (Yüce et al., 2016) considered whether the polymorphism in genes 
encoding Angiotensin-Converting Enzyme (ACE) and α-adducin (ADD1) could contribute 
to the development of tinnitus, in a sample of 89 tinnitus patients and 104 controls 
(Table 5.3-13). The authors found no differences in the distribution of ACE genotypes 
between tinnitus patients and control subjects. However, the ADD1 GW genotype was 
found to be significantly more frequent in tinnitus patients than in controls (p>0.009). 
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In addition, the results demonstrated that persons carrying ADD1 G460W polymorphism 
had a 2.5-fold increased risk of developing tinnitus than the persons not carrying that 
polymorphism. 
Table 5.3-13 - Descriptive Analyses of Single studies: Angiotensin converting enzyme 
and Alpha- Adducin. 
Record code: Title 
of the Study 
Study 
Design 
(setting) 
Sampl
e Size 
Age Gender 
Tinnitus 
Severity 
(Tinnitus 
Duration - 
Months) 
Biological variable 
(measure) 
Genetic_27: 
“Angiotensin-
Converting 
Enzyme (ACE) I/D 
and Alpha-
Adducin (ADD1) 
G460W Gene 
Polymorphisms in 
Turkish Patients 
with Severe 
Chronic Tinnitus” 
Investigatio
nal studies 
(Hospital) 
193 – 
89 TP, 
104 C 
TP= 
48.1±1
3.5; C= 
45.0±1
6.0 
TP= 48 
W 
(53.9%) 
and 41 
M 
(46.1%); 
C= 50 W 
(48.1%) 
and 54 
M 
(51.9%) 
THI (for 
more 
than 6 
months) 
Genotype 
distribution and 
allele frequencies 
ACE I/D II: TP=18 
(20.2%); ID: TP=41 
(46.1%); DD: TP=30 
(33.7%); Alleles: I: 
TP=77 (43.25%); D: 
TP=101 (56.75%); 
ADD1 Gene 
polymorphisms: GG: 
TP=47 (52.8%), GW: 
TP=41 (46.1%), WW: 
TP=1 (1.1%), Alleles: 
G: TP=135 (75.8%), 
W: TP=43 (24.2%), 
(Blood samples – PCR 
and RFLP) 
Note. TP – Tinnitus Patients; C – Control Group; W – Women; M – Men; THI – Tinnitus Handicap Inventory; 
RFLP – restriction fragment length polymorphism. 
 
Single studies: Genome Wide Association Study 
The record ‘Genetic_8’ (Gilles et al., 2017) involved a genome-wide association 
study (GWAS) but found no statistically significant genome-wide association with 
tinnitus.  
Risk of bias across studies  
Risk of bias according to our five key categories of medical test performance are 
In general, population bias was judged to be low, i.e. studies were judged to include a 
‘homogenous’ tinnitus patient population that would not lead to spectrum effects, 
context or selection bias. For some studies however, population bias was rated unclear, 
e.g. where sample size was small (as in ‘General_3’, ‘General_4’), or where the selection 
of the control group was unclear (as in ‘Inorganic_ions_1’, ‘Inorganic_ions_3’).  Risk of 
bias due to test protocol (variations in test execution or test technology) was also rated 
low for most studies. Risk of bias was rated as unclear for some studies however, e.g. 
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where there was insufficient description of the tinnitus assessment procedure for it to 
be reproduced (as in ‘Lipid_6’). Reference standard and verification bias was rated as 
low for most studies, i.e. the reference standard used was judged appropriate, with no 
evidence of differential or partial verification bias. Nevertheless, for some studies there 
was insufficient information to make a judgement (rated unclear) or evidence of bias 
(rated no). For example, in ‘Inorganic_ions_3’ there was no reference to normative 
values, and in ‘Lipid_4’ they used a tinnitus questionnaire without a reference standard. 
Risk of bias in interpretation was low in most studies and unclear or high in a small 
number. For example, in ‘Inorganic_ions_1’ effects were interpreted from statistical 
difference only without use of a reference standard. Bias due to analysis was low for 
most studies but unclear or high for a small number of studies. For example, ‘Genetic_9’ 
was judged unclear as different definitions of tinnitus were used that could have 
explained some of their findings, and in ‘Genetic_29’ it was judged that a lot of 
confounding factors were not considered in analysis.  For others, reasons or rationale 
for the thresholds chosen unclear (e.g. ‘Inorganic_ions_1’).    
Discussion 
In this systematic review we collated evidence for biological markers of tinnitus 
and provided a narrative synthesis of the results.  A number of strong and 
complementary findings were observed, as were many unanswered conflicts, so there 
are opportunities for replication of studies and further research on this exciting topic.   
Candidate tinnitus biomarkers 
1. Vitamins 
It was observed that low concentration of vitamin B12 correlates with the 
development of subjective idiopathic tinnitus among the elderly and with impaired 
hearing function. Correction of vitamin B12 deficiency also appears to improve tinnitus. 
These findings suggest tinnitus could be an early neurologic feature of vitamin B12-
deficiency, especially in the elderly for whom vitamin B12 screening is advised. However, 
vitamin B12-deficiency can also emerge because of nutritional habits. The choice of 
method to measure vitamin B12 is an important issue. Elevated B12 in serum can 
accompany B12-deficiency resulting from the defects in tissue uptake. A more sensitive 
method of diagnosis would be to evaluate one of the metabolites that accumulate 
because of vitamin B12 cellular deficiency. Vitamin B12 is required for enzymatic 
conversion of methylmalonic acid (MMA) to succinyl-CoA, and in combination with folic 
acid, for homocysteine (HC) to be converted to methionine. Although elevated MMA is 
more specific indicator of vitamin B12 deficiency, elevated MMA and HC levels together 
have been found to be 99.8% sensitive for diagnosing functional vitamin B12 deficiency 
(Vashi et al. 2016). Future studies addressing vitamin B12 as a possible biomarker for 
tinnitus should include larger populations, with stricter exclusion criteria regarding co-
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morbidities, with methodological design that allows better control of possible 
confounding variables namely noise exposure or associated hearing loss. Issues 
regarding the need for more standardized operational cut-off limits to set for the 
definition of Vitamin B12 deficiency in future studies might overcome some of the 
apparent diverging results between studies addressing the role of Vitamin B12 in the 
aetiology and pathophysiologic mechanisms for tinnitus. So, the role of vitamins as 
potential tinnitus biomarkers is still a matter of debate.   
2. Lipid profile 
Studies involving treatment for hyperlipidaemia consistently found an 
improvement in tinnitus severity in line with improvements in lipid levels (Sutbas, A. et 
al, 2007; Rajesh, R. 2016). Evidence therefore favours an association between the two 
variables.  
3. Cortisol and products, and Interleukins 
Every included study of cortisol showed lower level for tinnitus participants 
regardless of  the biological product being saliva or blood. So far, studies suggest a role 
of cortisol in the response of those with tinnitus to acute stress (Herbert & Lupien, 2007, 
2009). The long term cortisol profile in tinnitus patients is yet to be studied. Hormones_2 
and 3 (Herbert & Lupien, 2007, 2009) evaluate cortisol levels at baseline and several 
time-points after stress exposure, but in General_4 (Chrbolka et al., 2017) is not 
recorded the timing of single blood sample measurement so is not possible to anticipate 
the influence of circadian rhythm in this last study. One of the main finding with respect 
to cortisol was a significant and consistent correlation with tinnitus frequency and 
intensity, indicating a significant link between suppressed adrenal steroidogenesis and 
tinnitus supporting the probability that tinnitus can be a stress-related disorder. The 
topic of tinnitus and stress (dually intervening as causal and consequence) related to the 
activation of HPA axis, has been studied by several authors (for a review see Szczepek et 
al., 2017). Cortisol may influence the immune system, the gut microbiome-brain axis, 
the autonomic nervous system, the renin-angiotensin-aldosterone system (RAAS), and 
the energy metabolism (Dallman 2010). On the cellular level, cortisol induces two types 
of responses: rapid (non-genomic, dependent on activation of cell signaling pathways) 
and slow (genomic, in which cortisol acts as transcription factor). Stress interferes with 
the production of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), 
interleukin-1beta (IL-1beta), and interleukin-6 (IL-6) (Szczepek et al. 2014; Weber et al. 
2002) possibly implicating the involvement of inflammatory mechanisms in tinnitus 
pathogenesis. The literature refers to the possibility of a pathogenic connection with 
nonspecific laboratory indicators of immune disease and the neuro-sensorial hearing 
loss, referring to the role of these indicators in the inner ear (Matsuoka & Harris, 2013; 
Mijovic et al, 2013). This relationship between immunologic and auditory systems is a 
starting point for new studies that consider the possibility of this biomarker in the 
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diagnosis of tinnitus. In this review concentrations of Il-1b, Il-6 and TNF-α differed 
significantly between tinnitus patients and controls, implicating these biological 
variables as possible tinnitus biomarkers. However, the measurement tools differed 
between studies and the role of Interleukine-6 is still unclear. These limitations dictate 
the need for large-scale studies, better confounding factors control and consistent 
methodology. 
4. Neurotransmitters 
Neurotransmitters also appear a fruitful line of enquiry, particularly as markers 
of tinnitus severity or distress level.  Concerning serotonin, tinnitus patients have 
significantly higher levels (Sachanska, 1999) and the SLC6A4 polymorphism, especially 
the “ll” variant of the 5-HTTLPR polymorphism, are associated with tinnitus severity 
(Deniz et al., 2009). Serotoninergic activity, particularly 5-HTTLPR activity, is associated 
with a variety of physiological diseases such as anxiety and depression (Yilmaz et al., 
2001; Lesch et al., 1996). Serotonin therefore may be involved in depression and 
tinnitus. Studies involving glutamate also showed interesting results (Cacace et al., 2017; 
Haider et al., 2017).  
5. Angiotensin converting enzyme and Alpha-Adducin 
In this category most relevant finding is that ADD1 G460W polymorphism 
carriers had 2.5 fold increased risk of developing tinnitus compared to those not carrying 
that polymorphism. 
6. Oxidative stress  
One potential cause of tinnitus is oxidative stress, resulting from an imbalance 
between the production of reactive oxygen species (ROS) and the detoxification of their 
reactive intermediates. Under physiological conditions, ROS are neutralized by 
antioxidant enzymatic scavengers including superoxide dismutase (SOD), catalases, 
glutathione S-transferase (GST), and glutathione peroxidase (GPX). With age, the 
production of ROS increases and so does oxidative damage. Consequently, the increase 
of oxidative stress contributes to aging and age-related diseases including tinnitus 
(Fujimoto and Yamasoba, 2014). Our findings confirm oxidative stress as a candidate 
tinnitus biomarker albeit in subpopulation studies of acute tinnitus and an all-male 
population (Neri, S. et al 2002, 2006). Another interesting finding is that, assuming 
effluent blood from the inner ear represents a small proportion of the whole brain flux 
then those results favor the involvement of peripheral and central auditory pathways, 
and certainly central non-auditory related areas in tinnitus etiology. All studies 
considered, there is some evidence that oxidative stress plays a role in acute or sub-
acute tinnitus, but there is a need for studies replication in chronic tinnitus.  Studies 
associated with cell cultures are indicated to establish more conclusive translational 
findings about the role of oxidative stress in tinnitus. 
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7. Other hormones 
Data from one study of elderly patients suggest a correlation between tinnitus 
presence and lower melatonin plasma levels (Lasisi et al, 2012). Moreover, some studies 
have showed great improvement, after melatonin treatment, in patients with severe 
tinnitus and insomnia (Pirodda et al., 2010), as well as another study in tinnitus patients 
with sleep disturbances (Megwalu et al., 2005), but the latter lacked randomization, 
blinding, or placebo control. For this reason further studies with stronger 
methodological design are advised. 
Less likely candidates as tinnitus biomarkers 
1. Neurotrophic/Protective factors 
A number of studies evaluated neurotrophic factors reporting varying findings.  
One possible explanation for this is the fact that in the different included studies the 
biological sample collection differed, for example (Coskunoglu A et al., 2017) used serum 
in their evaluation instead of plasma (Xiong, H. et al 2016; Goto, F. et al, 2012).  
2. Full blood count 
Two included studies found significantly lower and higher MPV in  tinnitus 
participants, with a third study fining no significant difference.   There is therefore no 
indication what relationship, if any, exists between MPV and tinnitus. Differences across 
the three studies which may explain the varied findings included differences in sample 
size and inclusion criteria (hearing loss, tinnitus severity), and so further more consistent 
studies are needed if this factor is to be tested further. 
3. Thyroid function, Glucose blood level, Sedimentation velocity, C – reactive 
Protein, Mineral-salts and unspecific Immunoglobulins 
There was no evidence for an association between thyroid function, glucose 
blood level, sedimentation velocity, C - reactive Protein and unspecific 
Immunoglobulins, and tinnitus. In terms of inorganic ions, the two included studies 
provided contradictory findings concerning Zn concentration in blood. They used 
different tools for Zn measurement, this precludes direct comparison between the 
studies and indicates the need for larger scale studies and stronger methodological 
design. 
4. Ion channels 
The polymorphism of KCNE1 did not correlate with tinnitus severity. The 
potassium channel subunit KCNE3 and chloride channel ClC-Kb gene were not confirmed 
as biomarkers of risk or severity of tinnitus. 
Limitations  
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Heterogeneity of included studies with regards to methodologies, measurement 
tools, and study populations precluded quantitative syntheses. The exclusion of studies 
not reported in English from this review introduces a geographical bias. Nevertheless, 
we assume that the wide use of English in the scientific community minimises the effect 
of this bias (Figure 5.3-2). 
Conclusions 
We conclude that metabolic or endocrine disorders such as hyperlipidemia and 
hypertension are factors contributing to the etiology of tinnitus, probably by means of 
microvascular alterations. Inflammation, oxidative stress and chronic stress are probably 
cellular mechanisms involved in tinnitus pathogenesis.  Subjective chronic tinnitus is not 
a single gene disorder but rather a complex trait, controlled by complex interactions 
between multiple genes, environmental risk factors and personality traits. 
Future studies should include larger populations, with stricter exclusion criteria 
regarding co-morbidities and methodological design that allows better control of 
possible confounding variables, namely noise exposure or associated hearing loss. 
Working definitions, e.g. of values taken as Vitamin B12 deficiency, also need to be 
strictly applied and consistent across studies.   
Biological markers are an emerging field in the area of Otology. Once identified, 
they may provide a means of determining the time-course or most effective treatment 
for an individual with tinnitus, presbycusis or any other otologic disease or impairment. 
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5.4. Tinnitus in an older Portuguese population 
In this subchapter are presented the four original articles originated from the 
PhD studied population in older adults to explore the contribution of audiological, 
inflammatory, genetic factors and psychologic or quality of life factors to tinnitus 
etiology. 
5.4.1. Characteristics, psychological problems, quality of life, and tinnitus in a 
Portuguese Older Population 
Submitted to Plos One 
Haúla Faruk Haider, Sara F. Ribeiro, Vasco Oliveira, Nuno Trigueiros, Derek J 
Hoare, Luis Borrego, João Paço.  
Abstract 
Subjective tinnitus is a symptom involving the perception of a sound without an 
external source, which is only heard by the affected person. It is associated with negative 
psychological and emotional effects leading to impaired quality of life. Explore these 
variables with clinical populations is essential to ensure assessment and management is 
adequately targeted. The aim of this study was to explore psychological symptoms and 
quality of life in a sample of older Portuguese with and without tinnitus. We performed 
a clinical evaluation including audiological, tinnitus assessment, a structured interview 
and ENT observation. The Brief Symptom Inventory (BSI) was used to evaluate 
psychological distress. The Portuguese version of the Medical Outcomes Study Short 
Form Health Survey (MOS-SF36) was used to assess quality of life. Our population 
included 114 participants, 92 of whom had tinnitus. Participants were aged from 55 to 
75 years. In our analysis higher self-reported quality of life (as measured by the General 
Health Perceptions subscale of the MOS-SF36) was associated with lesser tinnitus (i.e. a 
protective effect), while psychological complaint (as measured by the General Severity 
Scale of the BSI) and hearing loss, were both significant risk factors for tinnitus. Tinnitus 
and hearing loss disorders can have a high negative impact on quality of life. With our 
aging population, it is likely that the problems identified here will be increasingly 
prevalent and add to the frailty of older adults. An adequate tinnitus treatment demands 
a multidisciplinary professional team to ensure coverage of all dimensions of the patient. 
 
Keywords: Tinnitus; Quality of life; Psychological distress; Eldery 
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Introduction 
Tinnitus is a symptom involving the subjective perception of sound deprived of 
an external source. It is common, affecting in general 10% to 15% of the population, and 
around 33% of people older than 65 (Nondahl et al., 2002; Tyler & Baker, 1983). 
Prevalence is also higher in patients with hypochondriacal disorder (27%) or with 
somatization disorders (42%)  (Hiller, Janca, & Burke, 1997)(Scott & Lindberg, 2000). For 
about 10 to 15% of people, tinnitus results in  significant handicap and psychological 
distress (Bartels, Middel, van der Laan, Staal, & Albers, 2008; Kennedy, Wilson, & 
Stephens, 2004)  impairing everyday life, sleep, mood, concentration, and ability to 
work, ultimately impairing quality of life (Gopinath, McMahon, Rochtchina, Karpa, & 
Mitchell, 2010; Kennedy et al., 2004).  
The World Health Organization (Group, 1993) defines quality of  life as ‘an 
individual's perception of their position in life in the context of the culture and value 
system in which they live and in relation to their goals, expectations, standards, and 
concerns. It is a broad ranging concept affected in a complex way by the person's 
physical health, psychological state, level of independence, social relationships, and 
their relationship to the salient features of their environment'. The concept of quality of 
life included the perception of the physical restrictions in relation to a condition, the 
ability of the individual to continue within a social and work environment, and the 
mental and physical capacity of the person to be able to handle all the difficulties 
inherent to a condition. Awareness of the impact and severity of a condition may not 
relate with the patient's perception. Accordingly it is important to consider the 
individual's perception of the condition and its effect on the treatment and 
rehabilitation of the disease (Grimby & Wiklund, 1994). Several studies have 
documented symptoms related to stress that have a strong association with severity of 
tinnitus and reduced quality of life (Carpenter-Thompson, McAuley, & Husain, 2015; 
Erlandsson & Hallberg, 2000; Nondahl et al., 2007). Associations have also been 
reported between severity of tinnitus and the occurrence of sleep disorders (Alster, 
Shemesh, Ornan, & Attias, 1993; Crönlein, Langguth, Geisler, & Hajak, 2007; Fioretti, 
Fusetti, & Eibenstein, 2013) and  emotional exhaustion  (Hebert, Canlon, & Hasson, 
2012), bodily pain, vitality and mental health are associated with increased tinnitus 
severity (Nondahl et al., 2007).  
Tinnitus is widely understood to be associated with psychological problems. 
Reynolds and colleagues (2004) found anxiety to be the principal psychological symptom 
in 28% of tinnitus patients. The same study found that although there was a reduction 
of the psychological symptoms after treatment, moderate to severe anxiety and 
depression remained significant. Anxiety has also been identified as a disorder with  a 
higher predictive value for the development tinnitus related psychological distress 
(Andersson & Vretblad, 2000; Erlandsson & Hallberg, 2000; Langenbach, Olderog, 
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Michel, Albus, & Köhle, 2005; Reynolds, Gardner, & Lee, 2004). Depression has also been 
significantly associated with tinnitus. For example, in a longitudinal study of a Swedish 
working population Hebert et al., 2012 found a long-term co-variation between the 
severity or prevalence of tinnitus and depressive symptoms. The relationship was also 
evidenced in a cross-sectional correlation study, with 1274 patients from Tinnitus 
Research Initiative database(Zeman, Koller, Langguth, & Landgrebe, 2014).  
Negative thinking has been a factor influenced by experiencing tinnitus and has 
been associated with more problematic tinnitus. On the other hand, positive thinking 
has an important role in reducing negative thinking about tinnitus and in focusing about 
the positive thinking, and this reflets that positive thinking is not related to 
unproblematic tinnitus. (Handscomb, Hall, Shorter, & Hoare, 2017). Negative thinking is 
central to the cognitive model of tinnitus distress (McKenna, Handscomb, Hoare, & Hall, 
2014). This model suggests that when the patient engages in negative thoughts about 
their tinnitus and its meaning, this triggers a cycle of emotional distress, selective 
attention and avoidance behaviors, which guarantees that tinnitus remains a distressing 
and negative experience. Catastrophic thinking also appears to be associated with 
tinnitus distress in clinical populations (Cima, Crombez, & Vlaeyen, 2011; Conrad et al., 
2015; Weise et al., 2013).  
A common approach to tinnitus management is therefore Cognitive behavior 
therapy (CBT). Several studies have shown CBT to be beneficial in reducing tinnitus 
distress, improving mood, and reducing stress (Hesser, Weise, Westin, & Andersson, 
2011; Hoare, Kowalkowski, Kang, & Hall, 2011). Some studies have however questioned 
the efficacy of the CBT in reducing the severity of tinnitus, mainly because studies using 
visual analogue scale (VAS) did not demonstrate improvements (Langguth et al., 2007; 
Martinez‐Devesa, Perera, Theodoulou, & Waddell, 2010). In any case, treatment needs 
to be individualized to address the problem set of the individual patient.  
To date, only one study has explored quality of life and psychological problems 
in a Portuguese tinnitus patient population; Oliveira and Meneses (2009) found that 
social function, general health, mental health, and vitality were the dimensions of the 
SF-36 most affected. According to a recent survey Portugal as other Southern European 
countries usually do not have specialised tinnitus clinics or multidisciplinary health 
professionals organised for tinnitus care and many people seem to refer to themselves 
for their tinnitus complaints. Generally ENT’s and audiologists are responsible for the 
management of tinnitus patients but there is a demand for the enrolment of other 
health professionals namely for mental health care. 
The purpose of this study was to explore our patient population and consider 
whether their needs are currently met by the standard of care. We evaluated hearing, 
tinnitus, psychological symptoms, and quality of life, in a sample of older Portuguese 
patients presenting with and without tinnitus. 
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Methods 
Participants 
This study included a sample with 114 participants (n=60 women, n=54 men). 
Inclusion criteria were: individuals aged from 55 to 75 years, any gender recruited from 
a Portuguese population. In this study, the sample was divided into two groups, 
according to presence or absence of tinnitus. The first group consisted in a control group 
with 22 participants, while the second group is composed by 92 participants with 
tinnitus. 
Our exclusion criteria, consisted of participants incapacity to comprehend and 
sign the informed consent owing to cognitive impairment. Also, an uncompensated 
medical disorder or a serious psychiatric disorder are considerate as exclusion criteria. 
Patients with tinnitus from disease of the outer ear (occlusive exostosis, outer otitis), 
Ménière's disease, chronic otitis media, otosclerosis; history of ototoxic drugs use; 
exposure to massive noise; history of previous malignancy with chemotherapy; history 
of autoimmune disorders; neurodegenerative or demyelinating disease are excluded for 
this study.  
The present study was approved by the Ethical Committees from Hospital Cuf 
Infante Santo (in 26th November, 2014), by the Nova Medical School 
(nº65/2014/CEFCM) and the National Department of Personal Data Protection 
(authorization number:1637/2016). The study was conducted in accordance with the 
Declaration of Helsinki. 
Clinical Evaluation 
Data were collected from all participants concerning their personal past and 
present and family history, and audiological assessment as part of the clinical evaluation. 
All participants signed written informed consent. 
Epidemiologic data (demographic, previous and present diseases, toxicological 
habits, and exposure to noise) was collected using a structured interview. 
All participants were submitted to immittance to rule out middle ear pathology 
(Model: Madsen Zodiac 901, Serial No.:389122). 
Audiological assessment: 
Pure tone audiometry (air and bone) to evaluate the hearing thresholds 
according to ISO 8253 and 389. The exam was accomplished in a soundproof booth 
employing an Interacoustics®, Assens, Denmark audiometer (Model: AC40, Serial No.: 
98 019 046) and TDH39/HDA300 headphones fitted with noise-excluding headset ME70 
and bone conductor B-71. Audiometry was performed at frequencies from 0.25 kHz to 
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16 kHz (standard tonal audiometry and extended high frequency). The category of 
Hearing Loss (HL) was defined according to the recommendations of Bureau 
International d’Audiophonologie (BIAP): normal or subnormal hearing (below 20 dB), 
mild hearing loss (21-40), moderate hearing loss (41-70), severe hearing loss (71-90), 
very severe hearing loss (91-119) or total hearing loss – cophosis (over 120). Puretone 
average hearing loss was calculated as the average of thresholds at 500 Hz, 1000 Hz, 
2000 Hz and 4000 Hz. Frequencies not heard were given a value of 120 dB. Retrieved 
May 15, 2018 from:http://www.biap.org/en/recommandations/recommendations/tc-
02-classification/213-rec-02-1-en-audiometric-classification-of-hearing-
impairments/file.  
Speech audiometry was conducted with headphones (using mp3 player), or open 
field, where the evaluator was hiding his lips to prevent lip-reading. The number of 
disyllables that patient repeated correctly was recorded. This intelligibility threshold for 
two-syllable words intends to measure hearing sensitivity threshold through the 
intensity level identification in which the patient can correctly identify 50% or more of a 
disyllables list. Moreover, the speech discrimination evaluates the lowest intensity level 
at which a listener can understand speech. 
Tinnitus assessment: 
Psychoacoustic assessment in tinnitus collects information about loudness 
match, pitch match, minimum masking level (MML) or Feldmann masking curves, 
residual inhibition, and loudness discomfort levels (LDL). Through the Portuguese 
validated version of Tinnitus Handicap Inventory (THI; Newman, Jacobson, & Spitzer, 
1996; Oliveira & Meneses, 2008) was evaluated the tinnitus severity. This inventory 
consistes of 25 questions related to tinnitus, with “Yes”, “Sometimes” and “No” as 
possible responses, corresponding to scores of 4, 2 and 0 respectively. In a total, it’s 
obtained a punctuation between 0 and 100 that reflects the severity of tinnitus.  This 
questionnaire consists of three different sub-scales: Functional scales (11 items - 
contributing 0-44 for the finalresult), Emotional scale (9 items - contributing 0-36 for the 
final result) and Catastrophic scale (5 items - contributing 0-20 for the final result). These 
scales allow us to understand the most affected aspects of tinnitus in daily life, in order 
to delineate a more adequate intervention. Depending on the final result, it is possible 
to establish a classification of tinnitus according to severity or daily impact: - 0-16: Slight 
or no handicap (Grade 1), 18-36: Mild handicap (Grade 2), 38-56: Moderate handicap 
(Grade 3), 58-76: Severe handicap (Grade 4), 78-100: Catastrophic handicap (Grade 5). 
In addition, , THI is a self-administered instrument, with good psychometrics properties 
and easy to complete and to interpret (McCombe et al., 2001). 
Medical Outcomes Study Short Form Health Survey: 
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Medical Outcomes Study Short Form Health Survey (MOS SF-36), Portuguese 
validated version,  evaluates health-related quality of life (Ferreira, 2000), administered 
as an interview. The MOS SF-36 questions allows to evaluate the physical and mental 
health through the assessment of aspects related to function, well-being, disability, and 
personal evaluation. The questions are classified in order to group into eight domains to 
measure the health constructs:  Physical Functioning, Role-Physical, Bodily Pain, General 
Health Perceptions, Vitality, Social Functioning, Role-Emotional, and Mental Health. 
These domain can be classified with a punctuation between 0 and 100, being that a 
higher score is more predictive of better quality of life. A combination of the eight 
domains results in a two summary scales: Physical Component Summary scale (PCS) and 
Mental Component Summary scale (MCS).  
Brief Symptom Inventory: 
Psychological symptoms were evaluated using the Portuguese version of Brief 
Symptom Inventory (BSI) (CANAVARRO, 1999). The BSI is a self-reported inventory, 
composed by 53 items,  with punctuation from 0 (not at all) to 4 (extremely), with higher 
scores indicating more severe psychopathology or psychological distress. Participants' 
responses correspond to the psychological symptoms experienced in the last seven 
days. The BSI involves  nine subscales: somatization (SOM), obsessive–compulsive (O-C), 
interpersonal sensitivity (I-S), depression (DEP), anxiety (ANX), hostility (HOS), phobic 
anxiety (PHOB), paranoid ideation (PAR) and psychoticism (PSY). In addition, BSI 
inventory provides three global indices of distress:  the General Severity Scale (GSI), the 
Positive Symptom Distress Index (PSDI), and the Positive Symptom Total (PST). The GSI 
scales allows asses the level of present distress. The PSDI scales indicates if the way a 
person responds increases their level of suffering. The PST scale corresponds to the set 
of all symptoms that the participant reports, even if it is at low levels (Derogatis & 
Melisaratos, 1983). The BSI includes four additional items, which do not belong to any 
subscale, but are considered in the three indices. These items assess the presence of 
sleep disturbances, thoughts of death, feelings of guilt and loss of appetite.  
Statistical analysis 
Descriptive analyses were performed for the sample in study and for the results 
of psychological evaluation and quality of life. Subsequently, association analyses were 
performed between the presence of tinnitus and the parameters evaluated for health-
related quality of life and psychological symptoms. These analyzes were performed with 
non-parametric tests because the variables did not present a standard distribution and 
homogeneity in the variances Fisher Exact Test was used for the general association 
between two variables. Mann-Whitney or Kruskal-Wallis (for more than two groups) 
tests were employed to compare the presence and severity of tinnitus. Taking into 
account that non-parametric tests were used in this study, and these evaluate the 
associations between the variables through the medians and the quartiles, the 
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descriptive results are presented as median and quartiles. The level of significance 
considered was p=0.05.  All the results were analyzed through logistic regression model, 
where age and gender where considered as control variables. In the cases where we had 
missing data we have considered n= total of entries. 
Results 
Sample Distribution:  
Our study population is composed by 114 people aged 64.0 ± 5.6 years old 
(range= 55-75). Most participants were female (n=60, 52.6%) and 54 were men 
(47.4%).The mean age for the subgroup without tinnitus was 64.6  ± 3.8 years old, while 
the mean age for tinnitus group was 64.0 ± 5.6 years old. Interestingly, a high number 
of participants belonged to the sector ‘specialists of scientific and intellectual activities’, 
followed in number by ‘technicians and professionals of intermediate level’ and 
‘administrative staff’. The majority of participants with previous history of psychiatric 
medication and current psychiatric medication belong to the group of participants with 
tinnitus. Table 5.4-1 presents the characteristics of participants in each subgroup (i.e. 
without and with tinnitus).  
Table 5.4-1 - Participant characteristics. 
 
Subgroup 
Total 
Without Tinnitus With Tinnitus 
Gender 
Male 8 46 54 
Female 14 46 60 
N 22 (19.3%) 92 (80.7%) 114 
Age Mean and  Std. Deviation 64.6  ± 3.8 64.0 ± 5.6 64.0 ± 5.6 
Marital status (n=98) 
Single 1 0 
98 
Married 18 62 
Divorced 2 7 
Widower 0 8 
Professions (N=112) 
A 0 0 0 
B 2 3 5 
C 15 43 58 
D 2 14 16 
E 2 13 15 
F 0 2 2 
G 0 2 2 
H 0 5 5 
I 0 0 0 
J 1 8 9 
Total 24 88 112 
Previous medication 
Without medication 19 73 
114 Antidepressants only 1 10 
Anxiolytic only 2 7 
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Legend: A – Military professional; B – Representant of executive bodies or legislative power, leaders, 
directors and executive managers; C – Specialists of scientific and intellectual activities; D – Technicians 
and professionals of intermediate level; E – Administrative staff; F – Workers of personal, safety and 
security services and sellers; G – Farmers and qualified agriculture, fisheries and forestry workers; H – 
Qualified industry, construction and e artwork workers; I – Installation operators and machinery and 
assembly workers; J – Non qualified workers. According to Portuguese classification of professions (2010). 
 
Audiological assessment: 
Average hearing thresholds by group are shown in Figure 5.4-1 (tonal 
audiometry) and Figure 5.4-2 (speech audiometry). Tinnitus participants had higher 
hearing thresholds above 1.5 kHz. 
Figure 5.4-1 - Tonal Audiometry in the subgroups with and without tinnitus. 
 
 
 
Antidepressants + 
Anxiolytic 
0 1 
Other 0 1 
Current medication 
Without medication 21 73 
114 
Antidepressants only 0 2 
Anxiolytic only 0 12 
Antidepressants + 
Anxiolytic 
0 4 
Other 1 1 
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Figure 5.4-2 - Speech Audiometry in the subgroups with and without tinnitus. 
Tinnitus Evaluation: 
The mean tinnitus duration was 7.8 ± 8.6 years, with the mean tinnitus intensity 
of 3.3 ± 1.6, on a visual analogue scale (VAS) of 1-10 (Table 5.4-2). For most participants 
tinnitus was central (i.e. perceived in the head) (47.8%) and tonal (53.2%).In the majority 
of participants tinnitus was constant (87%). Tinnitus onset was gradual for 49% of them 
and abrupt for 19.5% of participants. Dizziness, often associated with tinnitus, was 
reported by 38% of participants with tinnitus, while 54.4% reported not having dizziness 
symptoms. In most participants, tinnitus worsened in situations in which they are 
nervous (58.7%). Finally, 48.9% of the participants reported reduced sound tolerance, 
33.7% of the participants with tinnitus had unprotected exposure to noise, while only 
four participants used protection when exposed to noise. 
Table 5.4-2 - Clinical characterization of tinnitus sample. 
Clinical variables Participants with tinnitus (n=92) 
Tinnitus Duration (mean in years) 7.8 ± 8.6 
Intensity of tinnitus (scale 1-10) 3.3 ± 1.6 
Manifestation of tinnitus  
Constant 80 (87%) 
Intermittent 7 (7.6%) 
Pulsatile 4 (4.3%) 
Omitted 1 (1.1%) 
How did tinnitus begin?  
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Gradual 45 (49%) 
Abrupt 18 (19.5%) 
Omitted 29 (31.5%) 
Dizziness  
Yes 35 (38%) 
No 50 (54.4%) 
Omitted 7 (7.6%) 
Does tinnitus gets worse when you're nervous?  
Yes 54 (58.7%) 
No 37 (40.2%) 
Omitted 1 (1.1.%) 
Lower noise tolerance  
Yes 45 (48.9%) 
No 47 (51.1%) 
Noise exposure  
Yes, with protection 4 (4.3%) 
Yes, without protection 31 (33.7%) 
No 57 (62%) 
 
Tinnitus severity was determined according THI scores (Figure 5.4-3). In our 
tinnitus subgroup, 17 had a slight or no handicap 38 had a mild handicap, 22 had a 
moderate handicap, 14 had a severe handicap, and just one participant scored as having 
catastrophic tinnitus.  
 
 
 
 
 
 
 
 
 
Figure 5.4-3 - THI scores for participants in the tinnitus subgroup. 
Table 5.4-3 shows the psychoacoustic characteristics of tinnitus in the tinnitus 
subgroup (n = 92). In terms of Feldmann’s curve, the most frequent types were 
convergent (43.4%) or distant (27.1%). Most participants experienced no (39.1%) or 
partial (32.6%) residual inhibition, although some (14.1%) also experienced complete 
residual inhibition.  
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Table 5.4-3 - Psychoacoustic tinnitus assessment. 
Audiological measurements  Participants with tinnitus (n=92)  
Pitch (n=83) 4000Hz (2000Hz; 8000Hz) 
Loudness (n=83) 0 dB (0 dB; 5.0 dB) 
Laterality  
Central 44 (47.8%) 
Right 15 (16.3%) 
Left 25 (27.2%) 
Omitted 8 (8.7%) 
Type  
Pure Tone  49 (53.2%) 
Narrow Band Noise  34 (37%) 
Omitted 9 (9.7%) 
Feldmann's Curve  
Congruent 17 (18.4%) 
Convergent 40 (43.4%) 
Divergent 1 (1.1%) 
Distant 25 (27.1%) 
Persistent 1 (1.1%) 
Omitted 8 (8.7%) 
Residual inhibition  
Negative 36 (39.1%) 
Partial 30 (32.6%) 
Complete 13 (14.1%) 
Rebound Effect 3 (3.3%) 
Omitted 10 (10.9%) 
 
Psychological symptoms 
Table 5.4-4 presents the subgroup medians and quartiles of the nine scales and 
three indices of BSI. The results were very similar for each subgroup. Nevertheless, in 
the subgroup without tinnitus the median was higher for the Interpersonal Sensitivity 
and Paranoid Ideation subscales, while in the group with tinnitus the subscales with the 
highest scores were the Somatization and Paranoid Ideation. There was a significant 
difference between the groups without and with tinnitus in the Obsessive-compulsive 
scale, Interpersonal sensitivity scale, General severity scale and Positive symptom total 
scales. 
The median of the nine sub-scales and for the three indices were not above the 
criterion of significance (≥ 63) in the two groups. This means that, through median 
analysis, none of the scales and indexes are clinically significant in characterizing the 
psychological symptoms of the two subgroups.  
Concerning scores obtained at clinical significance level (≥63) at the 3 BSI 
Indexes, for General Severity Scale, 18 tinnitus participants have a significant level score 
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while 4 participants without tinnitus also have this level. In the tinnitus subgroup (18 
participants), 3 have irrelevant THI score, 5 mild, 4 moderate and 6 severe or 
catastrophic THI score. Concerning Positive Symptom Distress Index we found 5 
participants with tinnitus and 4 participants without tinnitus reaching the clinical 
significance level. Among the 5 tinnitus participants their THI score is: 2 irrelevant, 2 
severe or catastrophic and 1 moderate. In the third index, Positive Symptom a total of 
18 tinnitus participants and 6 participants without tinnitus reach scores ≥63. Tinnitus 
severity in the 18 participants is such: 7 severe or catastrophic, while 3 have irrelevant 
THI score, 4 mild and 4 moderate.  
Table 5.4-4 - Brief Symptoms Inventory:  Median and quartiles distributed by the 
population with and without tinnitus. 
BSI 
Scales 
Subgroup 
Without Tinnitus With Tinnitus 
P25 P50 P75 P25 P50 P75 
SOM 34.5 53.0 62.0 41.0 49.5 56.0 
OC 48.0 53.0 64.0 40.0 46.0 59.5 
p-
value 
0.009* 
I-S 41.5 62.0 64.0 37.0 45.0 59.0 
p-
value 
0.026* 
DEP 0.0 43.0 60.0 33.0 42.0 57.0 
ANX 37.8 51.0 59.0 35.0 43.5 59.0 
HOS 0.0 49.0 55.0 38.5 44.0 57.3 
PHOB 0.0 48.5 59.0 0.0 45.0 58.3 
PAR 32.3 56.0 62.0 40.0 48.0 58.0 
PSY 0.0 40.0 61.0 0.0 19.0 56.0 
GSI 45.0 50.0 61.3 35.0 43.5 59.8 
p-
value 
0.020* 
PSDI 42.0 49.5 56.5 34.0 42.0 55.5 
PST 46.8 51.0 63.3 37.0 46.5 60.8 
p-
value 
0.023* 
Legend: * p-value<0.05; SOM – Somatization: OC – Obsessive-compulsive; I-S – Interpersonal sensitivity; DEP 
– Depression; ANX – Anxiety; HOS – Hostility; PHOB – Phobic Anxiety; PAR – Paranoide Ideation; PST – 
Psychoticism; GSI – General Severity Scale; PSDI – Positive Symptom Distress Index; PST – Positive Symptom 
Total. 
Quality of Life: 
Descriptive of MOS scores for each subgroup are presented in Table 5.4-5. 
Compared to the group without tinnitus, patients with tinnitus had lower median scores 
on the scales of Physical Functioning, Bodily Pain, General Health Perception, Vitality 
and Mental Health. Although, only the General Health Perception scale have significant 
difference between the two groups. The tinnitus subgroup also had lower summary 
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scores on the Physical Component Summary scale, Mental Component Summary scale 
and Final mean. Scores on these scales indicating a lower quality of life for those with 
tinnitus. 
Table 5.4-5 -Medical Outcomes Study:  Median and quartiles distributed by the 
population with and without tinnitus. 
MOS Scales 
Subgroup 
Without Tinnitus With Tinnitus 
P25 P50 P75 P25 P50 P75 
PF (%) 68.9 90.0 95.0 71.3 85.0 95.0 
RP (%) 50.0 100.0 100.0 50.0 100.0 100.0 
BP (%) 51.8 74.0 100.0 51.0 72.0 84.0 
GHP (%) 52.0 69.5 83.3 45.0 62.0 72.0 
p-value 0.042* 
VIT (%) 50.0 72.5 90.0 50.05 65.0 78.8 
SF (%) 75.0 87.5 100.0 75.0 87.5 100.0 
RE (%) 58.4 100.0 100.0 66.7 100.0 100.0 
MH (%) 68.0 78.0 89.0 57.0 72.0 84.8 
HC 3.0 3.0 3.0 3.0 3.0 4.0 
PCS (%) 61.6 79.9 89.3 60.2 75.7 85.3 
MCS (%) 61.2 85.7 92.3 60.2 81.2 89.2 
Final Mean (%) 60.2 81.2 89.2 61.8 78.2 83.9 
Legend: * p-value<0.05; PF – Physical Functioning; RP – Role-Physical; BP – Bodily Pain; GHP – General 
Health Perceptions; VIT – Vitally; SF – Social Functioning; RE – Role-Emotional; MH – Mental Health; HC – 
Health Change; PCS – Physical Component Summary scale; MCS – Mental Component Summary scale. 
BSI additional Items and Tinnitus: 
In order to enable statistical analysis of BSI additional items we grouped the 
answers such that the responses ‘nothing’  ‘little’ or ‘moderately’ scored 1 and ‘very’ 
and ‘extremely’ scored 2. 
In our tinnitus subgroup, 79 participants reported little, moderate or no sleep 
difficulty, while 13 participants had very and extreme disturbances at sleep level. On the 
item ‘thoughts of death’, 90 participants had no, little or moderate thoughts, and two 
of participants mentioned having many thoughts of death. Eighty-nine participants 
reported no, little or moderately frequent feelings of guilt, while 3 reported very or 
extreme frequency of such feelings. Finally, on the item ‘loss of appetite’, all participants 
with tinnitus report having not appetite loss, or having low to moderate levels of this 
complaint (Table 5.4-6). 
The Fisher's exact test revealed significant statistical differences when 
comparing the loss of appetite between the two subgroups with or without tinnitus (p= 
0.001). 
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Table 5.4-6 - Analysis of BSI Additional Items - Sleep disturbance, Thoughts of death, 
Feelings of guilt and Lack of appetite - for the population with and without tinnitus. 
Legend: * p-value<0.05 
 
Quality of life and Tinnitus: 
 Only scores on General Health Perceptions scale were significantly different 
between subgroups (Table 5.4-6, U= 721.5, p= 0.042). 
Modelling the data – BSI and MOS 
In a logistic regression modelling quality of life and psychological complaint, age, 
gender and hearing loss where considered as confounding variables. The independent 
variable in the model was presence of tinnitus. The results for the MOS scales and 
hearing loss are presented in Table 5.4-7.  
Table 5.4-7 - Logistic regression model of quality of life and hearing loss applied to 
severe tinnitus. 
Legend: * p-value<0.05 
 For the MOS score the Odds Ratio (OR) was below 1 and significant so is 
considered a ‘protector variable’ for developing tinnitus. On the other hand, for hearing 
BSI Additional Items 
Subgroup 
Total n Without Tinnitus – 
total score 
With Tinnitus –
total score 
Sleep 
Disturbance 
Nothing, little and 
moderately 
19 79 98 
Very and extremely 3 13 16 
p-value Fisher's Exact Test 0.629 
 
 
Thoughts of 
death 
Nothing, little and 
moderately 
21 90 111 
Very and extremely 1 2 3 
p-value Fisher's Exact Test 0.478 
 
 
Feelings of Guilt 
Nothing, little and 
moderately 
21 68 110 
Very and extremely 1 3 4 
p-value Fisher's Exact Test 0.581 
 
 
Loss of appetite 
Nothing, little and 
moderately 
18 92 110 
 Very and extremely 4 0 4 
p-value Fisher's Exact Test    0,001*  
Variable* OR p- value (Wald test) (95% IC) 
General Health Perceptions – 
MOS 
0.956 0.007* (0.926, 0.988) 
Hearing Loss 1.111 0.010* (1.026, 1.203) 
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loss OR is above 1 and significant, so ‘hearing loss’ is a risk variable and the odds to have 
tinnitus is 1.1 higher for those with hearing loss. 
Regarding tinnitus severity, we applied the logistic regression model with the aim 
of verifying which variables are statistically significant at higher levels of tinnitus 
severity, controlling for gender, age and noise exposure. The independent variable in 
the model was severe tinnitus (n=15), (the assemble of severe and catastrophic grades 
from THI, see F Figure 5.4-3). Results for BSI and MOS scales are presented in Table 5.4-
8.  
Table 5.4-8 - Logistic regression model in the BSI and MOS applied to severe tinnitus. 
Legend: * p-value<0.05 
It was found that quality of life and psychological complaint were statistically 
significant relative to the severity of tinnitus. Because the OR of MOS was below 1, the 
variable General Health Perceptions is considered as a "protector factor" for the risk of 
developing severe tinnitus. Thus, if the general health perceptions (MOS) scale 
increases, which means that the quality of life increases on that scale, it decreases the 
risk of developing severe tinnitus. On the other hand, the variable General Severity 
Scales was above 1, so is considered as a “risk factor”. i.e. the odds of developing severe 
tinnitus in the presence of psychological complaint was 1.049 higher.  
Table 5.4-9 - Logistic regression model in the BSI and MOS applied to tinnitus presence. 
 * p-value<0.05 
 We explore which variables are statistically significant to the presence of 
tinnitus, through the logistic regression model (Table 5.4-9). The results showed that 
General Health Perceptions has a statistical significant level and because OR is below 1 
it is considered “protector factor” for developing tinnitus. Thus, in the presence of a 
higher score in general health perceptions (MOS) that means more quality of life, and 
decreases the risk of developing tinnitus. Also presenting statistical significant level the 
variables hearing loss and the variable BSI scales equally or above 63 (the criterion of 
clinical significance) are considered as “risk factors” because OR is above 1. This means 
that the odds of developing tinnitus is higher in the presence of BSI scales above the 
criterion of significance or in the presence of hearing loss.  
Variable* OR p- value (Wald test) (95% IC) 
General Severity Scale - BSI 1.049 0.037* (1.003, 1.097) 
General Health Perceptions – 
MOS 
0.962 0.037* (0.928, 0.998) 
Variable OR p- value (Wald test) (95% IC) 
BSI T≥ 63 16.528 0.035* (1.215, 224.831) 
General Health Perceptions – MOS 0.946 0.004* (0.911, 0.982) 
Hearing Loss 1.118 0.012* (1.024, 1.221) 
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Discussion  
Here we explored presenting characteristics, psychological symptoms, and 
quality of life in a sample of participants aged between 55 and 75 years. We aimed to 
identify aspects that can contribute to the diagnosis and guide therapeutic 
interventions.  
We found higher scores in tinnitus patients on the psychological complaint scales 
of somatization and paranoia. Overall, it seems that patients with tinnitus suffer for  
more distress arising from awareness of bodily representations and present paranoid 
behavior related to a disordered mode of thinking (Derogatis & Spencer, 1982). The 
somatization scale focuses on cardiovascular, gastrointestinal and respiratory 
complaints, pain and discomfort of the gross musculature, and anxiety symptoms 
derived from somatic complaints. Our results are congruent with other studies that 
found higher prevalence of somatization symptoms in tinnitus patients (Hiller et al., 
1997; Scott & Lindberg, 2000).  
Although it was expected to find more psychological symptomatology in the 
group with tinnitus, particularly depressive and anxious symptomatology (Holgers, 
Zöger, & Svedlund, 2005; Krog, Engdahl, & Tambs, 2010; Shargorodsky, Curhan, & 
Farwell, 2010), this was not observed; there were no statistically significant difference 
on any psychological complaint scale. This may have been because there was no 
psychological symptomatology control related to conditions other than tinnitus and also 
because the questionnaire used (the BSI) only assesses psychological complaints 
experienced in the week before its completion. Of note, 22 of our participants have a 
previous history of psychiatric medication, while 20 participants currently take 
psychiatric medication. Concerning psychiatric medication, 20.7% of tinnitus patients 
had a history of psychiatric medication in the whole sample of tinnitus participants, 
those corresponding to 86.3% of the 22 participants who have a previous history of 
medication. Regarding current psychiatric medication, 20.6% of tinnitus sample are 
currently medicated, which corresponds to 95% of the 20 participants that currently 
take psychiatric medication (Table 5.4-1). Those results strongly suggest that the most 
severely affected tinnitus patients will benefit from the care of mental health 
professionals. 
Considering tinnitus severity, only 15 participants had severe or catastrophic 
tinnitus. Since the majority of our tinnitus participants weren´t severely affected (they 
have a mild handicap) it is likely that our BSI scores did not reach clinical significance at 
the group level. The diagnosis of depressive and anxious symptoms is more frequent in 
tinnitus patients with severity and catastrophic handicap (Holgers et al., 2005). 
Significant differences were found in the Obsessive-compulsive and 
Interpersonal sensitivity scales concerning the presence of tinnitus. These findings 
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reveal that these scales differ in the tinnitus and non-tinnitus groups. The interpersonal 
sensitivity dimensions focuses on inferiority and inadequacy feelings when compared 
with others, and with depreciation and restlessness during interpersonal interactions. 
In turn, the Obsessive-Compulsive scale focuses on the thoughts, impulses and actions 
of the individual that are considerate as irresistible, but are of undesired nature 
(Derrogatis & Spencer, 1982). This supports the use of CBT for tinnitus to address 
negative automatic thoughts, safety behaviors, inaccurate beliefs (McKenna et al., 
2014). Those results strongly proposes including psychologists to the multidisciplinary 
approach with different professionals involved at tinnitus treatment. 
Concerning to MOS scales, only the General Health Perceptions scales showed 
significant results between subgroups with and without tinnitus. This scale measures the 
concept of holistic health perception, including not only current health but also disease 
resistance and healthy appearance (Ferreira, 2000). Although it was verified that the 
MOS scales are generally lower in the population with tinnitus, on both physical and 
emotional dimensions suggesting a lower quality of life in this population. Our results 
showed that the physical component of MOS was lower than the emotional component, 
which indicates physical limitations, more impact of the intensity and discomfort caused 
by the pain, and the person's own perception of his overall health. On the other hand, 
the vitality scale referring to energy and fatigue levels, and that qualifies the differences 
in well-being, is the lowest scale referring to the emotional component. 
Interestingly, significant differences in psychological complaint and quality of life 
were found when comparing the more severe grades of tinnitus participants (severe and 
catastrophic from THI) with the other grades. Most BSI scale scores were increased 
(showing a clinically relevant score ≥63) revealing the psychological impact of the 
participants that were severely affected by tinnitus. Higher grades on the scales such as 
somatization, depression and anxiety were related to the severity of tinnitus. This 
finding is in accordance with other published studies showing that depressive and 
anxiety symptoms are more prevalent in patients with higher scores of tinnitus severity 
(Erlandsson & Hallberg, 2000; Holgers et al., 2005).   
Frailty refers to a condition in the elderly where several accelerated inter-related 
diminishment in physiological systems occur, causing high vulnerability to the individual 
(Clegg, Young, Iliffe, Rikkert, & Rockwood, 2013). In this disorder small insults (e. g. new 
medication or a minor infection) can have a disproportionate effect in the person’s 
health status (e. g. to become dependent on others). 
 
Using regression statistical models, we have proven that the scales with more 
relevant statistical association to tinnitus are the General Severity Index (the more 
sensitive BSI scale to distress symptoms) and the General Health Perception. These 
findings bring to discussion the issue of frailty, particularly relevant for the age range 
Tinnitus, biomarkers and quality of life in an older population 
218 
 
  
focused in our study. Clearly, an individual will be more prone to have tinnitus if he has 
high General Severity Index (t≥63) and low values at General Health Perception. 
Study limitations 
We have to recognize that the sample size of population is a limitation of this 
study, a larger sample size would permit more statistic power. Participants in this study 
did not have a psychologist evaluation so we relied entirely on self-report to categorize 
participants as having psychological complaint or not. Furthermore, the questionnaire 
used, the BSI, evaluates the emotional status of the previous seven days only so does 
not capture general longer term psychological complaints which may fluctuate in the 
same way that tinnitus is known to (Hallam et al., 1984; Gopinath et al., 2010).  
Conclusions 
With an increasingly ageing population worldwide raises concerns about quality 
of life with augmented years lived with disability. Taken together, tinnitus and hearing 
loss disorders have a high negative impact on the quality of life of the affected persons 
especially if the grade of tinnitus severity is high. On the other hand, elevated stress 
levels may not only damage an auditory system that is inefficiently protected to 
undesirable stress reactions, but also, prolong a state of emotional distress that by itself 
may exacerbate the tinnitus perception (Mazurek, Haupt, Olze, & Szczepek, 2012; 
Szczepek & Mazurek, 2017). Epidemiologic data confirmed that hearing loss is a tinnitus 
major risk factor. Nevertheless, tinnitus is not always present in every case of hearing 
loss, and often occurs later in time, such as during psychological stress (Han, Lee, Kim, 
Lim, & Shin, 2009).  
Our study brings and reinforces new insights concerning the importance of the 
holistic assessment and management of the individual relevant to tinnitus as a 
multidimensional symptom (Hall et al., 2018). To our knowledge this is the first study to 
use the BSI General Severity Index and identify scoring that represents a risk factor for 
tinnitus and impaired quality of life, and what scoring on the General Health Perception 
scale of MOS represents a protector factor for tinnitus. 
Accordingly, the assessment of the individual with tinnitus and therapy strategies 
should be multidisciplinary to ensure coverage of all dimensions of the patient. 
Moreover, therapeutic strategies should be tailored to the individual, after proper 
information and with respect for patient choice and individual needs. 
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5.4.2. Audiological markers of tinnitus in an older Portuguese population 
Submitted to Trends in Hearing  
Haúla F. Haider, Diogo Ribeiro, Sara F. Ribeiro, Nuno Trigueiros, Helena Caria, 
Luís Borrego, Iola Pinto, Ana L. Papoila, Derek J Hoare, João Paço 
 
Abstract 
Tinnitus is a phantom sound perceived in the absence of external acoustic 
stimulation. It is described in a variety of ways (e.g., buzzing, ringing, roaring) and can 
be a single sound or combination of different sounds. Our study aims to evaluate 
associations between audiological parameters and the presence or severity of tinnitus 
in order to allow us to improve tinnitus diagnosis, treatment and prognosis. Our sample 
included 114 older individuals (60 women and 54 men), aged between 55 to 75 years 
from the Portuguese population, with or without sensory presbycusis and/or tinnitus. 
All participants were subjected to a clinical evaluation through a structured interview, 
complete ENT observation, audiological evaluation (standard and extended audiometry, 
psychoacoustic tinnitus evaluation, ABR and DPOEs) and tinnitus scoring through 
Tinnitus Handicap Inventory (THI). Our data confirm that the odds of developing tinnitus 
was significantly higher in the presence of noise exposure and hearing loss. Participants 
with abrupt tinnitus onset were 5.13 times more likely to develop severe or catastrophic 
tinnitus (p=0.024). Participants who present a negative or rebound effect at residual 
inhibition have 82.2% lower odds of developing a severe or catastrophic tinnitus as 
compared to those having a complete or partial effect. Higher values of 
ABR_mean_RE_LE_Ratio are associated with higher odds for developing severe or 
catastrophic tinnitus (p=0.046). We also found reduction of the amplitude in the ABR 
wave I in patients with tinnitus. Advancing knowledge concerning specific tinnitus 
subtypes origin and maintenance mechanisms is of paramount importance for adequate 
treatment. 
Keywords: Tinnitus; Audiological markers; Pure Tone Average; Auditory 
Brainstem Response; Distortion Product Otoacoustic Emissions.   
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Introduction 
Tinnitus is a phantom sound perceived in the absence of external acoustic 
stimulation being described in a variety of ways (e.g., buzzing, ringing, roaring) and can 
be a single sound or combination of different sounds (Coles, Vernon, & Moller, 1995; 
Stouffer & Tyler, 1990). It can also be perceived in one ear, both ears, or in the head, as 
a constant sound or fluctuating in intensity (loudness) or pitch. Tinnitus is frequently 
perceived as extremely loud, but when matched with calibrated acoustic signals, is 
typically within 10 dB of audiometric threshold (Hall III & Haynes, 2001). Tinnitus is 
categorized as objective or subjective, being the objective tinnitus described as a real 
sound produced by the body that can be heard by an examiner. In contrast, an examiner 
cannot hear subjective tinnitus. Subjective tinnitus is thought to be caused by abnormal 
neural activity in the peripheral or central auditory system (Aage R. Møller, 2006).  
Tinnitus has a variety of etiological factors and may be associated with other 
diseases. Often accompanies hearing loss or hyperacusis, but neither is necessary for its 
presence (Eggermont, 2013, 2015; Eggermont & Roberts, 2004). Most studies have 
found that patients with high-pitched tinnitus have hearing loss in high frequencies and 
the patients with low-pitched tinnitus (below 1,500 Hz) more frequently have low 
frequency hearing loss  (König, Schaette, Kempter, & Gross, 2006; Moore, Vinay, & 
Sandhya, 2010; Sereda et al., 2011).  In a recent study involving patients with 
presbyacusis, the authors found an average pitch in men of 4781,3Hz and women of 
3869,8Hz, considering individuals with a mean age of 69,75 (+-6,53) (Seimetz et al., 
2016).  
The causes and pathogenesis of tinnitus remains unclear and there are no 
objective audiological or non-audiological tests for the diagnosis of tinnitus. Currently, 
the presence and impact of tinnitus is established using subjective measures such as 
questionnaires (e.g., Tinnitus Handicap Inventory – THI (C. W. Newman, Jacobson, & 
Spitzer, 1996); or the Tinnitus Reaction Questionnaire – TRQ (Wilson, Henry, Bowen, & 
Haralambous, 1991) (Henry et al., 2013; Szczepek, Haupt, Klapp, Olze, & Mazurek, 2014). 
Psychoacoustic assessment of tinnitus can also be performed. Although, patients with 
similar psychoacoustic measurements can report it has very different impacts on their 
lives, it may be useful to interpret neurophysiological mechanisms of tinnitus 
perception. It is observed, that when tinnitus is accompanied by hearing loss, 
particularly sloping configurations, the tinnitus pitch is either localized in the “edge” 
frequencies or within the lowest regions of the hearing loss (Langers, de Kleine, & van 
Dijk, 2012). Diminished peripheral input caused by hearing loss is thought to lead to 
reorganizations of the tonotopic framework of the Auditory Cortex (AC) (Eggermont, 
2003; Pinkl, Wilson, Billingsly, & Munguia-Vazquez, 2017). Theoretically, when the 
neural activity within a selected region of the cortical tonotopic map is diminished, if the 
tinnitus pitch corresponds to a region of hearing loss, synaptic connections of the 
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affected regions merge with stronger neighboring neural areas which lead to this over-
representation of “edge” frequencies (Rajan & Irvine, 1998). The over-representation of 
cortical activity within a specific region of the tonotopic map naturally promotes neural 
synchronization potentially causing a phantom perception. Furthermore, it is suspected 
that adaptive changes in the AC can alter its connections with the Inferior Colliculus 
making it more susceptible to incoming afferent spontaneous signals, enhancing tinnitus 
perception (Wang et al., 2013). On the other hand, if the tinnitus percept exists at the 
“edge” frequency, alterations of the tonotopic map would be implicated as the primary 
source of tinnitus percept, possibly supplemented by affected IC tuning curves (Langers 
et al., 2012).  
Abnormal synchronous neural activity can be detected by specialized clinical 
tests, namely auditory-evoked potentials (AEPs). Previous studies have used AEPs 
measures to study the abnormal neuronal activity in tinnitus patients (Gopal, Bishop, & 
Carney, 2004; Gopal, Thomas, Nandy, Mao, & Lu, 2017; Gu, Herrmann, Levine, & 
Melcher, 2012; Hsu et al., 2013; Kehrle et al., 2008). The most widely used AEP is the 
Auditory Brainstem Response (ABR). The ABR is a series of vertex-positive waves that 
occur within 15ms of the onset of a click stimulus in human adults. The most commonly 
evaluated ABR peaks include I, III and V and much is known about the generators of the 
ABR waves. Moller et al. concluded that wave I arises from the distal portion of the 
auditory nerve (within the inner ear), wave III from the cochlear nucleus, and wave V 
from the termination of the lateral lemniscus within the IC of the contralateral side (A R 
Møller, Jho, Yokota, & Jannetta, 1995). This technique is especially important in tinnitus 
evaluation because it is an objective electrophysiological measure of cochlear and 
brainstem auditory pathway functioning. Moreover,  it may allow the differentiation 
between central or peripheral tinnitus (Shulman & Seitz, 1981).  
Differences in the traces of the ABR can be seen depending on the type of 
stimulus used to evoke the response, type of hearing loss, the degree of hearing loss, 
the presence of tinnitus among others. Regarding the degree of hearing loss and the 
type of the stimulus used, elevated hearing thresholds reduce the amplitude of wave V 
using click stimuli, so using tone burst ABR when the tone burst characteristic frequency 
falls within the frequency region of the hearing loss may provide higher sensitivity 
(Lewis, Kopun, Neely, Schmid, & Gorga, 2015). According to Serpanos (2004), listeners 
with sloping configurations of cochlear hearing loss can benefit if more frequency-
specific stimuli are used, such as brief tones, in order to provide more precise 
information on the nature of the relation between loudness growth and ABR wave V 
latency. Considering the models of pathologic enhanced neural synchronization and the 
potential cortical influence on subcortical tuning functions, it is hypothesized that 
unique ABR readings if any, will become more pronounced in tinnitus subjects if the ABR 
parameters are adjusted from click stimuli to tone burst stimuli matched to the tinnitus 
pitch (Pinkl et al., 2017).  
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Although there is a lack of consensus regarding the use of AEPs as diagnostic tool 
of tinnitus, most probably due to the lack of homogeneity in the participant's groups 
and methodologies, AEP measures may contribute to the clarification of the origin of 
tinnitus and provide potentially objective diagnostic indicators (Gopal et al., 2017). 
Furthermore, identifying potential correlations between ABR readings and tinnitus pitch 
can help formalize tinnitus diagnostic procedures (Pinkl et al., 2017). 
Regarding the cochlear function as an important role in the generation of tinnitus 
perception, it is essential the assessment of the inner ear for the evaluation of tinnitus. 
The otoacoustic emissions (OAEs) are sound signals produced by the cochlea and reflects 
some activity of the outer hair cells (OHC). Trough OAEs, the cochlear function can be 
tested in an objective and non-invasive way (Fabijańska et al., 2012; Lapsley Miller & 
Marshall, 2007).  Studies on OAEs in tinnitus patients used distortion product 
otoacoustic emissions (DPOAEs) measure a wide range of primary frequencies (f1 and 
f2) and their levels (L1 and L2) (Fabijańska et al., 2012). There are two cochlear processes 
that explain the generation mechanisms of DPOAS: 1) a nonlinear interaction of the 
primary tones induced by the traveling wave, and mainly at the cochlear site in and 
around the region basal to the f2 location, and 2) a linear coherent reflection of the 
traveling wave from the location corresponding to the distortion product frequency of 
2f1−f2 (Fabijańska et al., 2012; Kalluri & Shera, 2001). In the literature, there are 
controversial results regarding the levels of DPOAEs in tinnitus patients. On the one 
hand, we can see decrease levels in the DPOAEs in tinnitus patients when compared 
with patients without tinnitus (Ozimek, Wicher, Szyfter, & Szymiec, 2006; Shiomi, Tsuji, 
Naito, Fujiki, & Yamamoto, 1997). On the other hand, an increase in the DPOAEs levels 
are seen in tinnitus patients (Gouveris, Maurer, & Mann, 2005; Janssen, Kummer, & 
Arnold, 1998). If we consider hearing loss the results become even more contradictory. 
Ami et al., 2008, found in patients with normal hearing with tinnitus a significantly 
reduction in the mean baseline DPOAEs levels when compared with patients with 
normal hearing without tinnitus, suggesting that reduced outer hair cell activity would 
result in tinnitus even before there is a shift in hearing threshold. On the other hand, in 
patients with reduced hearing loss, they found the opposite, in the group without 
tinnitus there was a markedly reduced mean DPOAEs when compared with the group 
with tinnitus, also postulate that markedly low levels of cochlear hair cell activity may 
actually terminate the source of aberrant peripheral neural activity in tinnitus (Ami, 
Abdullah, Awang, Liyab, & Saim, 2008). Opposite results were found by Sztuka et al., 
2010, patients with normal hearing with tinnitus have a markedly higher DPOAE 
amplitudes when compared with patients with normal hearing and without tinnitus, 
suggest that tinnitus may be caused by increased motility of the OHC induced by 
decreasing efferent fiber activity, and not by OHC failure (Sztuka, Pospiech, Gawron, & 
Dudek, 2010).   
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Depending on where the tonotopic reorganization (cortical plasticity) takes place 
we can speculate on the chronicity of tinnitus, taking into account, as described above, 
that patients with tinnitus can have neural dysfunction at the level of the cochlea, 
auditory nerve and/or brainstem (Sindhusake et al., 2003). 
Biomarker is any substance or biological structure that can be measured in the 
human body and may influence, explain or predict the incidence or outcome of disease 
(Gallo et al., 2011). The identification of these biological markers in individuals with 
tinnitus allows us to improve the diagnosis, treatment and prognostic of tinnitus (Ami et 
al., 2008).  
Our study aims to identify associations between audiological parameters and the 
presence or severity of tinnitus in order to allow us to improve tinnitus diagnosis, 
treatment and prognosis. 
Methods 
The present cross-sectional study was approved by the Ethical Committees from 
Hospital CUF Infante Santo (26th November 2014), Nova Medical School 
(nº65/2014/CEFCM) and the National Department of Personal Data Protection 
(authorization number:1637/2016). The study was conducted in accordance with the 
Declaration of Helsinki.  
Participants 
Our sample included 114 older individuals (60 women and 54 men). Inclusion 
criteria was adults of any gender, aged between 55 to 75 years from the Portuguese 
population. The presence and absence of presbyacusis and the presence of tinnitus were 
recorded. Presbycusis was defined as bilateral sensorineural deafness in down slope 
audiometric pattern, above 1000 Hz with poor speech discrimination (Speech 
Recognition Threshold (SRT) > 40 dB SPL and 100% discrimination to 60 dB or worse). 
Our exclusion criteria were: tinnitus from disease of the outer ear (occlusive 
exostosis, outer otitis), Ménière's disease, chronic otitis media, otosclerosis, history of 
ototoxic drugs use, exposure to massive noise, history of previous malignancy with 
chemotherapy, history of autoimmune disorders, neurodegenerative or demyelinating 
disease, uncompensated medical disorder or a serious psychiatric disorder. Additionally, 
patients unable to comprehend and sign the informed consent or with cognitive 
impairment were also excluded.  
All participants signed a written informed consent and all the data were blind 
coded. 
Clinical Evaluation 
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Data were collected from all participants concerning their personal clinical 
history (past and present), family history, and audiological assessment, including the 
rating of tinnitus intensity in a scale from 0 to 10 (being 10 the loudest possible). As part 
of the clinical evaluation was included a complete ENT observation.  
Epidemiologic data (demographic, previous and present diseases, toxicological 
habits, and exposure to noise) was collected using a structured interview. 
All participants were subjected to immittance to rule out middle ear pathology 
(Model: Madsen Zodiac 901, Serial No.:389122). 
Audiological assessment 
Tonal Audiometry: 
Hearing thresholds were determined by pure tone audiometry (air and bone) 
according to ISO 8253 and 389. The exam was performed in a soundproof booth, (Model: 
IAC), using an Interacoustics®, Assens, Denmark audiometer (Model: AC40, Serial No.: 
98 019 046) and TDH39/HDA300 headphones fitted with noise-excluding headset ME70 
and bone conductor B-71. Audiometry was performed at frequencies from 0.25 kHz to 
16 kHz (standard tonal audiometry and extended high frequency). The category of 
Hearing Loss (HL) was defined according to the recommendations of Bureau 
International d’Audiophonologie (BIAP): normal or subnormal hearing (below 20dB), 
mild hearing loss (21-40), moderate hearing loss (41-70), severe hearing loss (71-90), 
very severe hearing loss (91-119) or total hearing loss – cophosis (over 120). Pure tone 
average (PTA) was taken as the average threshold across 500 Hz, 1000 Hz, 2000 Hz and 
4000 Hz. Frequencies not heard were recorded as 120 dB threshold. Retrieved May 15, 
2018 from: http://www.biap.org/en/recommandations/recommendations/tc-02-
classification/213-rec-02-1-en-audiometric-classification-of-hearing-impairments/file.  
“High frequency” pure-tone average (HF_PTA) was calculated as the average 
thresholds across 2, 4, and 8 kHz (D. L. Newman et al., 2012).  
Tinnitus assessment 
Several tests for measurement and evaluation of tinnitus were performed to all 
the participants. 
Psychoacoustic tinnitus evaluation: 
Tinnitus evaluation was performed after audiometric testing in a soundproof 
booth using an Interacoustics®, Assens, Denmark audiometer (Model: AC40, Serial No.: 
98 019 046) and TDH39/HDA300 headphones fitted with noise-excluding headset ME70. 
First, it was established whether the tinnitus percept was more similar to a pure tone or 
a noise. Both sounds were presented to the participant who was asked which of the two 
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had most resemblance to their tinnitus. Estimation of tinnitus frequency was then 
performed using frequencies from 125 to 16000Hz (pure tones or narrow-band noise 
centered on the same frequencies). The procedure for determining tinnitus pitch was a 
forced choice between two presented stimuli. Stimuli were presented to the participant 
who identified which most closely resembled their tinnitus. The test continued until a 
correspondence between the tinnitus and the presented stimulus was found.  
For the estimation of tinnitus loudness (intensity) the elected frequency (from 
previous step) was offered at an intensity similar to the individuals hearing threshold 
and gradually increased (5dB steps) until is reached the closest matching to participants 
tinnitus percept.  
Loudness discomfort levels (LDL): 
The collection of the discomfort thresholds is performed for each ear individually 
on the frequencies tested in the tonal audiogram as well as for the frequency at which 
the tinnitus was identified using pure tones. The patient is instructed to signal when the 
sound becomes uncomfortable, not only loud but uncomfortable. The method used to 
collect the discomfort thresholds is ascending and three tests should be carried out to 
investigate the thresholds to ensure the reliability of the test (Goldstein & Shulman, 
1996). 
The difference between the auditory threshold and the discomfort thresholds 
gives us the auditory dynamic field (Goldstein & Shulman, 1996). Once this is 
determined, the presence or absence of hyperacusis is evaluated.  
Feldmann masking curves or Minimum Masking Levels (MML): 
This test was performed at the frequencies where tonal audiometry was tested, 
using narrow band noises or pure tones (where tinnitus was not masked by narrow band 
noises). Sound was presented in 5dB steps (1-2 seconds stimulation), from hearing 
thresholds, until the participant reported that they could no longer hear their tinnitus. 
According to the spatial relationship of the resulting curves from hearing thresholds and 
tinnitus masking, MMLs were categorized: 1 - Convergent; 2 – Divergent; 3 – Congruent; 
4 – Distant; 5 – Persistent (Lokenberg R et al, 2000). 
Residual inhibition: 
Residual inhibition (RI) was tested by presenting participants with a narrow band 
noise centered at their tinnitus pitch, at 10 dB above the tinnitus loudness, for 1 minute. 
RI was categorized: 1 – complete (tinnitus is not audible); 2 – partial (tinnitus became 
quiter); 3 – negative (no change at tinnitus percept); and 4 – “rebound” effect (tinnitus 
became louder). At categories 1 and 2 we measured the duration of time that tinnitus 
was abolished or diminished in seconds or minutes, the time that takes for the tinnitus 
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percept to come back to basal characteristics, in terms of loudness (Coles & Hallam, 
1987; Goldstein & Shulman, 1997). 
THI 
Self-reported tinnitus severity was measured using the Portuguese validated 
version of Tinnitus Handicap Inventory (THI (Newman et al., 1996; Oliveira & Menezes, 
2008). This inventory consists of 25 questions related to tinnitus, with “Yes”, 
“Sometimes” and “No” as possible responses, corresponding to scores of 4, 2 and 0 
respectively, giving a total score between 0 and 100.  This questionnaire consists of three 
different sub-scales:  Functional (11 items - contributing 0-44 for the final result), 
Emotional (9 items - contributing 0-36 for the final result) and Catastrophic (5 items - 
contributing 0-20 for the final result). Severity is interpreted according to the total score 
where 0-16 = Slight or no handicap (Grade 1), 18-36 - Mild handicap (Grade 2), 38-56 = 
Moderate handicap (Grade 3), 58-76 = Severe handicap (Grade 4), and 78-100 = 
Catastrophic handicap (Grade 5).  
Auditory Brainstem Response 
ABR examination was performed in a sound proofed electrically insulated room 
Participant were placed in a comfortable position in order to have good relaxation of 
cervical muscles. The Vivosonic audiometer system (Model: IntegrityTM V500, Serial No. 
IP0960) was used to collect ABR and find electrophysiological thresholds. The earphones 
used were the ER-3A, calibrated according to ANSI S3.6-1996, and a 4000 Hz tone burst 
was used to evoke ABR, calibrated in decibel peak-equivalent to the sound pressure level 
(dBpeSPL) (Jiang, 1998). We used an alternating split polarity with a stimulus rate of 27.7 
stimuli/s, high pass filter cutoff frequency at 30 Hz and low pass filter cutoff frequency 
at 1500 Hz, high pass filter rollof at 12dB/Octave and low pass filter rollof at 
24dB/Octave, notch filter off, a Blackman windowing and a Rise-Plateau-Fall of 2-0-2. 
The non-inverting electrode was placed according to the 10-20 system at Frontal Upper 
Forehead (Fz) and the inverting at the mastoid (M1,2) at the examining side (Jasper, 
1958). The neutral electrode is placed at Frontal Lower Forehead (Fzd) region. The 
parameters evaluated monoaural were the absolute latencies for waves I, III and V, 
interwave (interpeak) latency interval (IWI) for waves I-III. III-V, and I-V, V/I amplitude 
ratio. 
Distortion Product Otoacoustic Emissions 
DPOAEs were performed with a Vivosonic audiometer system in a sound proofed 
room. We tested the DPOAEs for the frequencies of 500, 750, 1000, 1500, 2000, 2500, 
3000, 3200, 3500, 4000, 4500, 5000, 5500, 6000, 7000 and 8000 Hz, with a 1.22 F2/F1 
ratio and with an intensity of 65 dB SPL and 55 dB SPL for L1 and L2, respectively. The 
presence of OAEs was considered when the signal-to-noise ratio (SNR) was equal to or 
above 6 dB. 
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Statistical analysis 
All the variables considered were analyzed and when appropriated a data 
modelling phase was performed.  
An exploratory analysis of all registered variables was carried out initially, 
followed by a data modeling phase. Categorical data were presented as frequencies and 
percentages, and continuous variables as median and inter-quartile range (25th 
percentile; 75th percentile), as they presented asymmetric distributions and deviations 
from normality. When appropriate or clinically relevant, some of the variables were 
categorized. 
In the univariable study, to access the association between the presence of 
tinnitus and the demographic and audiological variables, nonparametric tests were 
used. The qualitative variables were analyzed by the chi-square test or Fisher's exact 
test, and the continuous variables by the Mann-Whitney U or Kruskal-Wallis tests.  
Additionally, a univariable logistic regression analysis was used to obtain odds 
ratios estimates (𝑂?̂?) and corresponding 95% confidence intervals (95%CI). Logistic 
regression logit linearity assumption was assessed using the Box-Tidwell test (Box & 
Tidwell, 1962). 
With the purpose of evaluating the discriminative capacity of certain audiological 
parameters the area under the ROC (receiver operating characteristic) curve (AUC), was 
reported. 
The level of significance α=0.05 was considered. Statistical analysis was 
performed using the SPSS software (IBM Corp. Released 2013. IBM SPSS Statistics for 
Windows, Version 22.0. Armonk, NY: IBM Corp.). 
With the purpose of evaluating the discriminative capacity of certain audiological 
parameters the (AUC), area under the ROC (receiver operating characteristic) curve was 
reported. The bilateral statistical tests were considered significant when the respective 
p values were lower than the significance level of 0.05. Statistical analysis was 
performed using the SPSS program Statistics® version 22.0. (IBM Corp. Released 2013. 
IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.).  
Results 
Participant’s demographics and comorbidities  
Participants in our study were 114 elderly with median age of 63.0 (59.8; 68.3) 
years old. Most participants were female (n=60, 52.6%), presenting a median age of 63.5 
(59.0; 68.3) years old. For men (n=54, 47.4%), the median age was 63.0 (60.0; 68.5) years 
old.  
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Concerning to comorbidities, mumps are present in 56% in the tinnitus sample 
and 31.8% for the sample without tinnitus. Also, 53.3% the population with tinnitus and 
22.7% without tinnitus have hearing loss. We have only found statistically significant 
differences between the two subgroups for mumps (p=0.041) and hearing loss 
(p=0,010).  
Audiological assessment 
Two levels of statistical analysis were done. The first considered the sample 
divided in two groups, individuals with tinnitus and individuals without tinnitus. The 
second level of analysis was considered dividing our sample into four subgroups (Table 
5.4-10), the subgroup without hearing loss and without tinnitus considered as control 
group (subgroup 1), subgroup 2 formed by individuals without hearing loss but 
presenting tinnitus, subgroup 3 composed by individuals with hearing loss but without 
tinnitus and the subgroup 4 with individuals with hearing loss and with tinnitus. These 
groups allow the comparison of the presence of tinnitus (subgroup 2 + subgroup 4) with 
its absence (subgroup 1 + subgroup 3).   
Table 5.4-10 - Distribution of the individuals of the sample by 4 subgroups. 
Subgroup Audiological Characteristic 
Gender (n) 
n (%) Median Age (years) 
Male Female 
1 PTA≤20 without Tinnitus 5 12 17 (14.9%) 
63.0 (59.8; 68.3) 
2 PTA≤20 with Tinnitus 15 27 42 (36.8%) 
3 PTA >20 without Tinnitus 3 2 5 (4.4%) 
4 PTA >20 with Tinnitus 31 19 50 (43.9%) 
Total  54 60 114  
Legend: PTA= Pure Tone Average. 
The described subgroups can be distinguished at tonal audiometry (Figure 5.4-4) 
where the best hearing thresholds are in the control group (subgroup 1- individuals with 
no hearing loss and no tinnitus). 
 
 
 
 
 
 
 
Figure 5.4-4 - Tonal Audiometry (average curves) in each of the 4 subgroup. 
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In the comparison of tinnitus patients versus non-tinnitus patients (Figure 5.4-5), 
PTA and HF_PTA were statistically higher in those individuals with tinnitus (Table 5.4-
11).  
Table 5.4-11 - PTA and HF_PTA according tinnitus presence. 
Variables 
All patients 
(n=114) 
With Tinnitus 
(n=92;80.7%) 
Without Tinnitus 
(n=22;19.3%) 
p value 
PTA_mean_RE_LE 20.0 (15.0; 28.3) 21.6 (16.4; 29.4) 15.9 (11.7; 20.3) 0.003 
HF_PTA_mean_LE 36.7 (23.3;48.3) 40 (28.8; 50.0) 22.5 (18.3; 31.7) < 0.001 
HF_PTA_mean_RE 33.3 (23.3;46.7) 36.7 (27.1; 48.3) 22.5 (16.7; 28.3) < 0.001 
HF_PTA_mean_RE 35.4 (23.1; 46.9) 37.9 (28.8; 48.3) 22.8 (17.9; 29.8) < 0.001* 
Legend: Data are summarized as median (25th percentile; 75th percentile); PTA= Pure Tone Average, RE= 
Right Ear, LE= Left Ear, HF_PTA=“High frequency” pure-tone average 
 
 
 
 
 
 
 
 
Figure 5.4-5 - Tonal Audiometry according to the presence of tinnitus. 
Tinnitus Evaluation 
Clinical characteristics of tinnitus in the individuals of the sample presenting it (n 
= 92) are presented in Table 5.4-12. The median duration of tinnitus was 5.0 years (2.0; 
10.0), with a median intensity of 3.0 (2.0; 4.0) on a scale of 1-10. Tinnitus was constant 
in the majority of participants (88.9%), while onset was gradual for 71.4% and abrupt for 
28.6%. In most participants tinnitus worsened in situations where they were nervous 
(59.3%). Finally, 50.6% of the participants with tinnitus reported reduced noise 
tolerance. 
Table 5.4-12 - Clinical characterization of tinnitus sample. 
Clinical variables Participants with tinnitus (n=92) 
Tinnitus Duration (in years) 5.0 (2.0; 10.0) 
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Intensity of tinnitus (scale 1-10) 3.0 (2.0; 4.0) 
Manifestation of tinnitus (n=90)  
Constant 80 (88.9%) 
Intermittent 6 (6.7%) 
Pulsatile 4 (4.4%) 
How did tinnitus begin? (n=63)  
Gradual 45 (71.4%) 
Abrupt 18 (28.6%) 
Does tinnitus gets worse when you're nervous? 
(n=90) 
 
Yes 54 (59.3%) 
No 37 (40.7%) 
Lower noise tolerance (n=89)  
Yes 45 (50.6%) 
No 44 (49.4%) 
Familiar history with Tinnitus  
Yes 25 (29.4%) 
Dizziness   
Yes 35 (41.2%) 
With deafness  
Yes 49 (53.3%) 
Noise exposition n=113   
Non exposed 56 (61.5%) 
Exposed without protection 31 (34.1%) 
Exposed with protection 4 (4.4%) 
 
Psychoacoustic estimates of tinnitus are given in Table 5.4-13. Frequencies 
matched to tinnitus pitch ranged from 2000 Hz to 8000 Hz, with 4000 Hz being the most 
frequently found, while the loudness is 0 dB (with a variation of + or – 5dB considering 
hearing threshold). Our sample is characterized by a majority in central laterality (52.4%) 
and pure tone type (59.0%) of tinnitus. Concerning to Feldmann’s curve, the convergent 
(47.6%) and distant type (29.8%) are the most frequent, while in the residual inhibition, 
the negative (43.9%) and partial (36.6%) characterize a large part of our sample.  
Table 5.4-13 - Psychoacoustic tinnitus assessment.  
Audiological measurements  Participants with tinnitus (n=92)  
Pitch (n=83) 4000Hz (2000Hz; 8000Hz) 
Loudness (n=83) 0 dB (0 dB; 5.0 dB) 
Laterality (n=84)  
Central 44 (52.4%) 
Right 15 (17.9%) 
Left 25 (29.8%) 
Type (n=83)  
Pure Tone  49 (59.0%) 
Narrow Band Noise  34 (41.0%) 
Feldmann's Curve (n=84)  
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Congruent 17 (20.2%) 
Convergent 40 (47.6%) 
Divergent 1 (1.2%) 
Distant 25 (29.8%) 
Persistent 1 (1.2%) 
Residual inhibition (n= 82)  
Negative 36 (43.9%) 
Partial 30 (36.6%) 
Complete 13 (15.9%) 
Rebound Effect 3 (3.7%) 
 
Tinnitus severity was categorized by means of the THI scores. The majority of the 
individuals had a mild handicap (38 participants), followed by moderate handicap (22), 
slight or no handicap (17), severe handicap (14) and finally, one participant had a 
catastrophic handicap score (Figure 5.4-6).  
 
 
 
 
 
 
 
 
 
Figure 5.4-6 - THI scores for the tinnitus individuals of the sample. 
 
Auditory Brainstem Response 
Table 5 gives ABR absolute latencies for waves I, III and V, interwave (interpeak) 
latency interval (IWI) for waves I-III, III-V, and I-V, amplitude wave I and V, and V/I 
amplitude ratio. When comparing the patients with tinnitus and no tinnitus (Table 5.4-
14) we can see a statistically significant difference in the amplitude of wave I (p=0.006) 
(Figure 5.4-7). 
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Table 5.4-14 - Comparison of Auditory Brainstem Response between patients with and 
without tinnitus.  
Legend: Data are summarized as median (25th percentile; 75th percentile); ABR= Auditory Brain Responses; 
RE=Right Ear; LE= Left Ear; Lat_I= Latency of wave I; Lat_III=Latency of wave III; Lat_V=Latency of wave V; 
Amp_I=Amplitude of wave I; Amp_V=Amplitude of wave V; ABR_RE_LE_Ratio=of wave V/I amplitudes.   
 
 
Figure 5.4-7 - Amplitude of wave I and V in patients with tinnitus and no tinnitus. 
 
When comparing the 4 subgroups in relation to ABR variables, statistically 
significant differences were found with respect to the I-III interval (Figure 5.4-8) when 
comparing the subgroup 1 (individuals without hearing loss and with no tinnitus) with 
the subgroup without hearing loss and tinnitus (p=0.050) (Figure 5.4-8).  
 
Auditory Brainstem Response 
All patients 
(n=114) 
With Tinnitus 
(n=92;80.7%) 
Without Tinnitus 
(n=22;19.3%) 
p-value 
ABR_mean_LE_RE_Lat_I 2.0 (1.9; 2.1) 2.0 (1.9; 2.2) 2.0 (1.9; 2.1) 0.191 
ABR_mean_LE_RE_Lat_III 4.2 (4.1; 4.4) 4.2 (4.1; 4.4) 4.2 (4.1; 4.4) 0.928 
ABR_mean_LE_RE_Lat_V 6.2 (6.0; 6.3) 6.2 (6.0; 6.3) 6.1 (6.0; 6.3) 0.974 
ABR_mean_LE_RE_Lat_I-III 2.2 (2.1; 2.3) 2.2 (2.1; 2.3) 2.2 (2.1; 2.4) 0.202 
ABR_mean_LE_RE_Lat_III-V 1.9 (1.8; 1.9) 1.9 (1.8; 2.0) 2.0 (1.9; 2.0) 0.941 
ABR_mean_LE_RE_Lat_I-V 4.1 (4.0; 4.3) 4.1 (4.0; 4.3) 4.2 (4.1; 4.3) 0.255 
ABR_mean_LE_RE_Amp_I 0.7 (0.4; 1.1) 0.7 (0.4; 1.0) 0.9 (0.6; 1.5) 0.006 
ABR_mean_LE_RE_Amp_V 0.2 (0.1; 0.3) 0.2 (0.1; 0.2) 0.2 (0.1; 0.3) 0.180 
ABR_mean_LE_RE_Ratio_V/I 2.9 (1.8; 6.6) 3.2 (1.9; 7.7) 2.2 (1.6; 3.6) 0.118 
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Figure 5.4-8 - Absolute latencies for waves I, III and V, and interpeak latency intervals I-III, III-V 
and I-V for the four subgroups. 
 
Distortion Product Otoacoustic Emissions  
In the evaluation of DPOAEs we found that the subgroup with tinnitus presents 
lower values (Table 5.4-15 and Figure 5.4-9).  
Table 5.4-15 - Comparison of Distortion Product Otoacoustic Emissions in patients with 
and without tinnitus. 
Variables 
All patients 
(n=114) 
With Tinnitus 
(n=92;80.7%) 
Without Tinnitus 
(n=22;19.3%) 
p-value 
Mean_500_8000_ DPOAE 
_RE 
13.7 (11.7; 
16.5) 
13.2 (11.5; 16.2) 14.9 (12.5; 18.5) 0.041 
Mean_500_8000_ DPOAE 
_LE 
13.0 (11.1; 
16.1) 
12.5 (11.1; 15.5) 14.9 (12.1; 17.9) 0.028 
Legend. Data are summarized as median (25th percentile; 75th percentile); DPOAE = Distortion Product 
Otoacoustic Emissions; RE=Right Ear; LE= Left Ear. 
 
 
 
 
 
 
 
 
 
 
Figure 5.4-9 - Distortion Product Otoacoustic Emissions according to the presence of tinnitus. 
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Modelling the data according to presence of tinnitus 
Considering the presence of tinnitus, a model phase was performed in order to 
identify the effects of the presence of tinnitus. Results of logistic regression at 
univariable analysis are shown in Table 5.4-16. 
Table 5.4-16 - Univariable analysis: logistic regression model for the presence of tinnitus. 
Legend:  (1) odds of having tinnitus for each ten units of increase of ABR _RE_Amp_I; (2) odds of having 
tinnitus for each ten units of increase of ABR _LE_Amp_I; 𝑂?̂? odds ratio estimate; CI confidence interval; 
PTA=Pure Tone Average; RE=Right Ear; LE= Left Ear; HF_PTA=“High frequency” pure-tone average; DPOAE 
= Distortion Product Otoacoustic Emissions; ABR= Auditory Brain Responses. 
According to the statistical model developed  (Table 5.4-16) , several variables 
are associated with higher odds for tinnitus: “noise exposure” (p=0.036), “PTA mean for 
both ears” (p=0.009), “Hearing loss” (p=0.014), “Mumps” (p=0.046), “HFPTA_ mean for 
right ear (p=0.001), and for left ear” (p=0.002) and “HFPTA mean for both ears” 
(p=0.001). According to this model some variables are considerate with lower odds for 
developing tinnitus, namely “Mean OEA for left ear” (p=0.043) and “ABR wave 1 
amplitude for right (p=0.004) and left ear” (p=0.048).   
Modelling the data – OAE 
Table 8 presents the results according to noise exposure in patients with tinnitus. 
Two different groups have been identified according whether or not have noise 
exposure. The comparison between this two groups only revealed significant differences 
for left ear (Table 5.4-17). 
Table 5.4-17 - OEA results in patients with tinnitus, according to noise exposure 
condition (n=91). 
Variable 𝑂?̂? p-value (95%CI) 
Noise exposure 3.96 0.036 (1.09, 14.36) 
PTA_mean_RE_LE 1.09 0.009 (1.02, 1.17) 
Hearing Loss 3.87 0.014 (1.32, 11.39) 
Mumps 2.73 0.046 (1.02, 7.34) 
    
HF_PTA_ mean_RE 1.07 0.001 (1.03, 1.11) 
HF_PTA_ mean_LE 1.06 0.002 (1.02, 1.10) 
HF_PTA_mean_RE_LE 1.07 0.001 (1.03, 1.11) 
    
Mean_DPOEA_500_8000_LE 0.88 0.043 (0.77, 1.00) 
    
ABR _RE_Amp_I 0.338(1) 0.004 (0.163, 0.701) 
ABR _LE_Amp_I 0.479(2) 0.048 (0.231, 0.993) 
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Variables n (%) 
Submitted to noise 
exposure 
(n=35;38.5%) 
Non submitted to 
noise exposure 
(n=56;61.5%) 
p-value 
Mean_500_8000_DPOAE_RE 12.1 (11.5; 15.6) 14.7 (11.1; 16.7) 0.094 
Mean_500_8000_DPOAE_LE 11.8 (10.1;13.7) 13.2 (11.2; 16.7) 0.038 
Legend: Data are summarized as median (25th percentile; 75th percentile); DPOAE = Distortion Product 
Otoacoustic Emissions; RE=Right Ear; LE= Left Ear. 
Modelling the data – severity of tinnitus 
Table 5.4-18 presents the statistically significant results according to the severity 
at THI. Two different subgroups are identified, lower THI (slight or no handicap, light 
handicap and moderate handicap) and high THI scores (severe or catastrophic 
handicap). A significant difference concerning tinnitus onset (p=0.026) between slight 
or no handicap, light handicap and moderate handicap compared to patients with 
severe or catastrophic tinnitus. In the hyperacusis group there is a significant difference 
between lower and high tinnitus severity scores (p=0.007) and the same is verified for 
the residual inhibition (p=0.038).  
Table 5.4-18 - Univariable analysis: Patient Characteristics by group (High versus lower 
THI score). 
Variables 
All patients 
(n=92) 
Lower Score 
THI (n=77; 
83.7%) 
High Score THI 
(n=15;16.3%) 
p-value 
Tinnitus appearance (n=63)     
Gradual 45 (71.4%) 41 (77.4%) 4 (40.0%) 
0.026(1) 
Abrupt 18 (28.6%) 12 (22.6%) 6 (60.0%) 
Hyperacusis (n=85)     
Negative 66 (77.6%) 58 (80.6%) 8 (61.5%) 
0.007(2) 
Moderate 5 (5.9%) 4 (5.6%) 1 (7.7%) 
Light 11 (12.9%) 10 (13.9%) 1 (7.7%) 
Severe 3 (3.5%) 0 (0%) 3 (23.1%) 
Residual inhibition     
Negative 36 (43.9%) 34 (48.6%) 2 (16.7%) 
0.038(2) 
Partial 30 (36.6%) 21 (30.0%) 9 (75.0%) 
Complete 13 (15.9%) 12 (17.1%) 1 (8.3%) 
Rebound Effect 3 (3.7%) 3 (4.3%) 0 (0%) 
Legend: (1) Chi-square Test p-value; (2) Fisher Exact Test p-values. 
 
Table 5.4-19 - Univariable analysis logistic regression model: Tinnitus Characteristics by 
group (Higher versus lower THI score). 
Variables 𝑂?̂? (95% CI) p-value 
Tinnitus appearance 5.125 (1.240, 21.188) 
 
p=0.024 
Gradual 
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Abrupt 
Hyperacusis 7.556(1) (1.603, 35.616) 
 
 
p=0.011 Negative + Light 
Moderate +  Severe 
Residual inhibition 
0.178(2) (0.036, 0.874) 
 
p=0.033 Complete + Partial 
Negative + Rebound Effect 
Legend: 𝑂?̂? odds ratio estimate; (1) reference category is light or negative hyperacusis; (2) reference 
category is partial or complete  
 
Considering patient characteristics (Table 5.4-19), individuals with abrupt 
tinnitus onset were 5.13 times more likely to develop severe or catastrophic 
tinnitus(𝑂?̂? = 5.125, 𝑝 = 0.024, 𝐶𝐼 = 1.240 − 21.188). Regarding sound tolerance, 
the participants with moderate or severe sensitivity to sound had 7.56 times greater 
odds of developing severe or catastrophic tinnitus(𝑂?̂? = 7.556, 𝑝 = 0.011, 𝐶𝐼 =
1.603 − 35.616). In respect to the residual inhibition, the presence of a negative or 
rebound effect was associated with lower odds of catastrophic tinnitus (𝑂?̂? =
0.178, 𝑝 = 0.033, 𝐶𝐼 = 0.036 − 0.874). In fact, those patients had an 82.2% lower 
odds of developing a severe or catastrophic tinnitus compared to those who had a 
partial or complete residual inhibition.  In relation to Feldmann masking curves, the 
patients with divergent, distant and persistent curve have 85.6% less chance of having 
severe or catastrophic tinnitus in comparison to participants with congruent or 
convergent curve. However, the association is not statistically significant (p-value = 
0.07). 
Concerning auditory brain response evaluation, the logistic regression model 
showed that the mean ratio of PEAP for both ears the odds are 1.1 times higher for 
developing severe or catastrophic tinnitus(𝑂?̂? = 1.1, 𝑝 = 0.046, 𝐶𝐼 = 1.002 − 1.208).  
Although several variables have been identified in the univariable analysis as 
potential candidates to the multivariable analysis, no multiple model was obtained. 
Discussion 
In this study, we have explored and presented an exhaustive audiological 
evaluation of older patients, presenting with or without hearing loss and/or tinnitus. 
Our data confirm that the odds of developing tinnitus were significantly higher 
in the presence of noise exposure and hearing loss. Our data evidence that participants 
having an abrupt tinnitus onset have more chance to develop severe or catastrophic 
tinnitus. The immediate interpretation of this result is that people having a gradual 
tinnitus onset, develop easily a natural habituation processes (Hallam et al., 1984).  
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We found statistically significant differences for both the mean PTA and HFPTA 
when we compared patients with and without tinnitus, thus there is a possible 
correlation between the development of hearing loss and the appearance of tinnitus. 
These results are in agreement with the literature where has been hypothesized that 
tinnitus is an epiphenomenon of a neuronal process to attempt normalizing impaired 
hearing thresholds (Gollnast et al., 2017). One of the possible causes for tinnitus patients 
to present tonal thresholds at higher frequencies, higher than those without tinnitus, is 
probably due to our population, patients aged between 55 and 75 who present with 
presbycusis (sloping configurations). Studies in individuals with tinnitus on average 
revealed that they suffer from a stronger hearing loss in high frequencies compared with 
individuals with no tinnitus (Gollnast et al., 2017; Moore et al., 2010).  
In the individuals of our sample, the pitch tinnitus frequency ranges from 2000Hz 
to 8000Hz, being 4000Hz the most frequently found. This could be explained by the 
expected localization of the tinnitus pitch in the “edge” frequencies or within the lowest 
regions in individuals presenting both hearing loss and tinnitus (Langers et al., 2012). 
Diminished peripheral input caused by hearing loss, particularly sloping configurations, 
as observed in our sample, can lead to reorganizations of the tonotopic framework of 
the AC (Eggermont, 2003; Pinkl et al., 2017). Such tonotopic reorganizations over-
represent neural activity near tonotopic regions of the “edge” frequency or midpoint of 
the hearing loss slope (Eggermont, 2003; König et al., 2006). 
Residual inhibition, transient modulation in tinnitus loudness (or abolishment) 
after a presentation of a sound, can be achieved in the vast majority of tinnitus patients 
and is thought to suppress tinnitus by temporarily reducing the underlying hyperactivity 
in the ascending auditory pathway (Roberts, Moffat, Baumann, Ward, & Bosnyak, 2008). 
Our data have shown that the presence of a complete (tinnitus abolishment) or rebound 
effect (tinnitus exacerbation) in residual inhibition was found at a statistical regression 
model as a “protector factor”. One possible way of viewing this result is that patients 
with a complete residual inhibition easily mask their tinnitus with environmental 
sounds, so it is expectable that tinnitus will not become very disturbing because is only 
audible in very silent places (e. g. bedroom at sleeping time). 
We also defend that the rebound effect can be correlated with hyperacusis phenomena 
which are easily treatable with desensitization techniques using sound enrichment. In 
our tinnitus population, three participants have a rebound effect on residual inhibition 
and from those 2 have mild hyperacusis and 1 has moderade level. One relevant 
demonstration of hyperacusis treatment comes from Noreña and Chery-Croze (2007) 
who showed that passive exposure to a low-level, complex background sound covering 
the hearing loss region for a few hours a day for 15 weeks rescaled abnormal loudness 
tolerance by as much as 15 dB in hyperacusis patients (Noreña & Chery-Croze, 2007).  
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In analogy with the sensation of pain and phantom limb perception, tinnitus 
emerges from damages in the cochlea (e.g. hair cell loss or synaptic damages) that leads 
to a frequency-specific decrease in electric output towards the brain. Our clinical data 
show that participants with tinnitus have higher hearing thresholds and interestingly 
that participants with moderate, light and severe hyperacusis have more risk to develop 
a severe or catastrophic tinnitus (THI scores). Data from the literature points out that 
there are common pathways for the pathophysiology of tinnitus and hyperacusis 
resulting as a central compensatory gain due to reduced neural activity from a damaged 
cochlea. 
ABR measures in tinnitus patients with normal PTA revealed lower Wave I 
amplitudes pointing out the existence of an auditory nerve damage (Schaette & 
McAlpine, 2011). Lower wave I amplitude correlates with partial synaptic uncoupling (or 
de-afferentation) of the inner hair cells (IHC) and the afferent neurons at specific 
frequency-regions where tinnitus is thought to be perceived (Bauer, Brozoski, & Myers, 
2007; Rüttiger et al., 2013; Singer et al., 2013; Tan, Lecluyse, McFerran, & Meddis, 2013; 
Weisz, Hartmann, Dohrmann, Schlee, & Norena, 2006). 
Regarding the ABR our main findings were in waves I and III, namely in the 
reduction of the amplitude in the wave I in patients with tinnitus, and an increase of the 
interval I-III when compared the group without hearing loss with tinnitus, and the group 
with hearing and tinnitus. The reduction of the wave I amplitude is in accordance to the 
published studies in tinnitus patients (Attias, Urbach, Gold, & Shemesh, 1993; Gu et al., 
2012; Schaette & McAlpine, 2011). As mentioned before, wave I arise from the distal 
portion of the auditory nerve (within the inner ear) (A R Møller et al., 1995). There are 
several possibilities for this reduced amplitude in wave V, particularly changes in the IHC 
and or Auditory Nerve Fibers (ANFs). In relation to IHC, there may be a diffuse loss of 
them compared with patients with no tinnitus that results in a lowered wave I amplitude 
(Gu et al., 2012). In another model the IHC are equally intact in tinnitus patients 
compared to patients without tinnitus but in one of them, there is a diffuse loss of the 
ANFs while in the other the ANFs remains equally intact when the two groups are 
compared (Gu et al., 2012; Le Prell, Halsey, Hughes, Dolan, & Bledsoe, 2005; Le Prell, 
Shore, Hughes, & Bledsoe, 2003). Other possibilities are that ANFs are equally intact, 
and the reduction of the amplitude wave I is due to the reduced excitability of ANFs via 
lateral olivocochlear efferents which terminate on their endings, or there is a diffuse loss 
of ANFs sufficient to manifest a reduction in mean wave I amplitude. 
Another finding regarding the ABR is the statistical difference with respect to the 
interpeak latency I-III when comparing the subgroup without hearing loss and no 
tinnitus, and the subgroup without hearing loss and tinnitus. When we compared both 
subgroups we can see a diminished interval interpeak I-III in the group with normal 
hearing with tinnitus. According to a literature review, we didn’t find similar results. 
However, although we did not find significant differences in absolute latency of wave I 
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latency in our sample when we compared both subgroups, in the subgroup with normal 
hearing and tinnitus, wave I started later when compared to the subgroup with normal 
hearing and without tinnitus. This could be the reason for the difference in the interpeak 
latencies I-III when we compared both groups since the wave I, according to several 
authors, in tinnitus patients had a significant prolongation (Ikner & Hassen, 1990; Kehrle 
et al., 2008; Lemaire & Beutter, 1995; Rosenhall & Axelsson, 1995). This prolongation in 
wave I in tinnitus patients signaling a peripheral lesion in the auditory system (Kehrle et 
al., 2008; Rosenhall & Axelsson, 1995). Lemaire & Beutter, 1995 found a significantly 
lengthened in wave I too in tinnitus patients and suggests that this modification is due 
to a dysfunction of the nucleus tegmenti which is part of the efferent system (Lemaire 
& Beutter, 1995). Future research should be performed in this direction in order to 
clarify this finding. 
Our findings were more relevant for the ABR amplitude wave I as a protective 
factor to the odds to have tinnitus and Ratio RE_LE as a risk factor to the odds of having 
a severe or catastrophic grade of tinnitus. This parameter is also related to the amplitude 
of waves I and V. 
As we can see above, the literature regarding the levels of the DPOAEs in tinnitus 
patients can be controversial. From our data, we have to conclude that DPOAEs results 
are lower when we compared patients with and without tinnitus (Table 6 and Figure 6). 
However, in this case, we don’t consider the presence or not of hearing loss. Our results 
are in agreement with the results reported by Ozimek et al. and Shiomi et al., which 
points us to conclude that these observed changes are specific to the functions of OHC 
instead of nonspecific non-linearity of the basilar membrane system (Ozimek et al., 
2006; Shiomi et al., 1997).  
Distortion product OAEs are statistically significant lower in participants that had 
noise exposure. In fact, this is a protective variable, and when it’s higher the odds to 
have tinnitus diminishes. These results are in accord with the results of the work 
developed by Sindhusake et al (Sindhusake et al., 2003). To conclude, noise exposure is 
a risk factor for tinnitus. 
Conclusions 
Our study confirms that in older people tinnitus is highly correlated with hearing 
loss.  
Current view on tinnitus is that it is a symptom encompassing a distributed 
network of peripheral and central pathways of the nervous system. Due to its complex 
nature, tinnitus should be approached in a multidisciplinary fashion involving different 
health professionals that are specialized to deal with each of the dimensions 
encompassed within this symptom (Hall et al., 2018a). 
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Our study puts in evidence some interesting findings especially concerning 
audiological tinnitus characteristics or its natural history. Our data may contribute to 
defining the odds of a patient to develop severe or catastrophic grade of tinnitus. And 
objectively the ABR Ratio OD_OE as a risk factor for having a severe or catastrophic 
grade of tinnitus, if confirmed in larger populations studies is a potential candidate as 
an audiological marker of tinnitus severity. These are certainly the most original 
contributions of this study since we have documented the relevant audiological tinnitus 
severity markers. 
Important highlights of our findings go to the necessity to have appropriate 
tinnitus subtyping to understand the most probable underlying mechanisms and 
consequently the most appropriate management in terms of diagnosis and treatment 
strategies. 
Future research should be designed to improve the sensitivity of non-invasive 
electrophysiological measures of cochlear synaptopathy in humans and to examine the 
broader neurophysiological impacts of noise exposure. In order also to have a clear 
distinction of mechanisms more specific for tinnitus or for hearing loss. Advancing 
knowledge concerning specific tinnitus subtypes origin and maintenance mechanisms is 
of paramount importance for adequate treatment. 
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5.4.3. Tinnitus, hearing loss and inflammatory processes in an older Portuguese 
population 
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Abstract  
Tinnitus is the perception of sound in the absence of acoustic stimulation and is 
frequently a consequence of hearing loss or activation of the somatosensory system. 
Tinnitus is associated with various conditions such as presbycusis, infectious and 
autoimmune diseases, and many other diseases. 
Our study aims to identify an association between the inflammatory markers and 
the presence of tinnitus or HL. 
Our sample included 60 women and 54 men (55 to 75 years) from the Portuguese 
population, with or without sensory presbycusis and/or tinnitus. All participants were 
subjected to a clinical evaluation through a structured interview, complete ENT 
observation, audiological evaluation, tinnitus scoring through Tinnitus Handicap 
Inventory and an evaluation of inflammatory markers. 
There was a significant difference in IL10 between the group with and without 
tinnitus (p=.025). In the group with tinnitus, we found a significant difference in TGF-β 
(p=,034), in IL1α (p=.033) and in IL2 (p=.019) for the age, type of tinnitus and residual 
inhibition, respectively. Additionally, we observed a negative correlation between 
tinnitus duration and IL10 (r=-.281).  In relation to HSP70 and loudness, the correlation 
coefficient was negative (r=-.377). Concerning the blood sample collection time, we had 
found a significant difference in the inflammatory parameters between the morning and 
afternoon period (p=.012). Lastly, we found significant results for the afternoon 
subgroup and the presence of tinnitus for IL10 (p=.032) and IFN-γ (p=.045). 
The results of our study clearly demonstrate that inflammatory mechanisms are 
involved not only in hearing loss pathogenesis but also in tinnitus. 
Keywords: Tinnitus; Inflammation; ARHL (Age-Related hearing loss); elderly. 
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Introduction 
Tinnitus is the perception of sound in the absence of acoustic stimulation and is 
frequently a consequence of hearing loss (HL) or activation of the somatosensory system 
(Mazurek et al. 2010; Shore 2011). Tinnitus is frequently associated with various 
conditions such as presbycusis, ototoxicity, a number of infectious and autoimmune 
diseases and sleep disturbances, cognitive problems, psychological disorders and many 
other diseases (Seydel et al. 2013; Heller 2003; Hoffmann and Reed 2004).  
Evidence suggests that frailty is due to a low-grade inflammatory response that 
persists for prolonged time, even in the absence of inflammatory stimulus (Hubbard et 
al. 2009; Leng et al. 2007; Qu et al. 2009a; 2009b). Thus, the mechanisms leading to 
frailty involve inflammation affecting the immune and neuroendocrine systems among 
others (Walston et al. 2006; Ferrari and Magri 2008; Poeggeler 2005) with inflammatory 
cytokines such as Interleukin (IL) 6, C-reactive protein and Tumor necrosis factor-α (TNF-
α), playing an important role (Collerton et al. 2012; Leng et al. 2007; Qu et al. 2009a; 
2009b).   
Persistent tinnitus can have a significant negative impact on quality of life and 
frequently causes major psychological distress (Bartels et al. 2007). The relationship 
between tinnitus and distress is complex and manifests itself as the auditory attention 
focused on the tinnitus sound with consequent increased irritability, anxiety, depressive 
mood or somatic complains (Tyler et al. 2014, 2007; Hiller and Goebel 1992). More 
recently, research has focused on the link between stress or other psychosocial factors 
and inflammation markers. In fact, circulating levels of C-reactive protein, IL6 and TNF-
α have been associated with psychological components of many disorders (Steptoe et 
al. 2007).  
Tinnitus can also be regarded as a chronic stressor that interferes with cytokine 
production. The pro-inflammatory cytokines comprise interleukin 1 alfa and beta (IL1 α 
and IL1 β), IL 6 and TNF-α. Besides being associated with inflammatory or infectious 
diseases, changes in circulating levels of IL1 β, IL6 and TNF-α have also been associated 
with the aging process, exposure to stress, and some neurological disorders (Zhang et 
al. 2013). In addition, serum concentrations of IL1 β (Szczepek et al. 2014) and TNF-α are 
biological markers that have been correlated to tinnitus-related distress (Szczepek et al. 
2014; Weber et al. 2002). However, IL 6 doesn’t seem to associate with tinnitus-induced 
distress (Szczepek et al. 2014). Moreover, the neutrophil/lymphocyte ratio is a marker 
of stress and a parameter of systemic inflammation. In tinnitus, which is highly 
correlated with stress, the neutrophil/ lymphocyte ratio can be considered as a potential 
biomarker of tinnitus progression or degree (Ozbay et al. 2015).  
The cochlear resident cells in the organ of Corti have immune competences and 
participate in the cochlear immune response to acoustic overstimulation (Cai Q et al. 
2014). Disruption of gene expression related to pain and inflammation has been 
described as involved in noise-induced tinnitus and spontaneous hyperactivity in the 
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Cochlear Nucleus (CN) (Manohar et al. 2016). Also, the inputs from CN has been 
suggested as a mechanism of tinnitus by leading to the disruption of auditory-
somatosensory pathway. This disruption results from maladaptive auditory-
somatosensory plasticity, which is a form of axonal sprouting that is promoted by 
transforming growth factor (TGF-β) signaling, which can be inhibited by losartan (Mum 
et al. 2018).  
Cochlear and auditory nerve degeneration may elicit a chronic neuroimmune 
response (activation of microglia) and the up-regulation of proinflammatory cytokines 
such as IL1β (Fuentes-Santamaria et al. 2013) through the up-regulation of the 
glutamate transporter Slc17a6. 
Animal studies explored the association between HSP-70 protein and the 
auditory system (Trune et al. 1998; Gong and Yan 2002), being HSP – 70 associated to 
the increase of autoimmune response in the inner ear (Gong and Yan, 2002). 
Controversial results are published in the association of HSP-70 protein with HL, from 
no association (Trune et al.,1998) to its assumption as a prognosis marker of idiopathic 
sudden sensorineural hearing loss (ISSHL) (Düzer et al. 2014).  
A relation between the decrease of TNF-α following a relaxation training 
program applied to patients with chronic tinnitus was described (Weber et al, 2002). 
This training program is described as responsible for a significant decrease in stress, 
anxiety depression, anger and other tinnitus associated disorders. 
Although the association between proinflammatory cytokines and tinnitus has 
been rarely reported some authors have tried to study it and our study aims to identify 
association between the inflammatory markers and the presence or severity of tinnitus 
or HL. We expect that our work will contribute for advancing knowledge about tinnitus 
underlying mechanisms and consequently allow improving tinnitus diagnosis, treatment 
and prognosis. 
 
Methods: 
Participants 
Our sample included 114 elderly individuals (n=60 women, n=54 men). Inclusion 
criteria were adults originating from the Portuguese population persons of both 
genders, aged between 55 to 75 years, presenting or not with sensory presbycusis and 
tinnitus.   
For the purposes of inclusion, presbycusis was defined as bilateral sensorineural 
deafness in downslope audiometric pattern, above 1000 Hz with poor speech 
discrimination (discrimination threshold > 40 dB SPL and 100% discrimination to 60 dB 
or worse).  
Exclusion criteria comprised inability to understand and sign the informed 
consent due to a significant cognitive impairment, an uncompensated medical disorder 
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that requires urgent evaluation or a presence of serious psychiatric disorder. Moreover, 
we have excluded individuals with one of the following conditions: Ménière's disease, 
chronic otitis media, otosclerosis, tinnitus induced by occlusive exostosis, otitis externa, 
or a history of ototoxic drugs use, noise exposure, chemotherapy.  
This study had the approval of the Ethical Committees from Hospital Cuf Infante 
Santo (26 the November, 2014), Nova Medical School (nº65/2014/CEFCM) and the 
National Department of Personal Data Protection (authorization number:1637/2016). 
The study was conducted in accordance with the Declaration of Helsinki. 
Clinical Evaluation 
Data were collected from all participants concerning their personal clinical 
history (past and present), family history, and audiological assessment, including the 
rating of tinnitus intensity in a scale from 0 to 10 (being 10 the loudest possible). As part 
of the clinical evaluation, a complete ENT (Ear Nose and Throat) evaluation was 
performed.  
Epidemiologic data (demographic, previous and present diseases, toxicological 
habits, and exposure to noise) were collected using a structured interview. 
Audiological assessment: 
Pure Tone Audiometry: 
Hearing thresholds were determined by pure tone audiometry (air and bone) 
according to ISO 8253 and 389. The exam was performed in a soundproof booth, (Model: 
IAC), using an Interacoustics®, (Assens, Denmark) audiometer (Model: AC40, Serial No.: 
98 019 046) and TDH39/HDA300 headphones fitted with noise-excluding headset ME70 
and bone conductor B-71. Audiometry was performed at frequencies from 0.25 kHz to 
16 kHz (standard tonal audiometry and extended high frequency). The category of 
hearing loss (HL) was defined according to the recommendations of the Bureau 
International d’Audiophonologie (BIAP): normal or subnormal hearing (below 20dB), 
mild hearing loss (21-40), moderate hearing loss (41-70), severe hearing loss (71-90), 
very severe hearing loss (91-119) or total hearing loss – cophosis (over 120). Pure tone 
average (PTA) was taken as the average threshold across 500 Hz, 1000 Hz, 2000 Hz and 
4000 Hz. Frequencies not heard were recorded as 120 dB threshold. Retrieved May 15, 
2018 from: http://www.biap.org/en/recommandations/recommendations/tc-02-
classification/213-rec-02-1-en-audiometric-classification-of-hearing-impairments/file.  
“High frequency” pure-tone average (HF_PTA) was calculated as the average 
thresholds across 2, 4, and 8 kHz (Newman et al. 2012).  
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All participants were submitted to immittance to rule out middle ear pathology 
(Model: Madsen Zodiac 901, Serial No.:389122). 
Tinnitus assessment 
Psychoacoustic tinnitus evaluation: 
This step was performed after audiometric testing in a soundproof booth using 
an Interacoustics®, Assens, Denmark audiometer (Model: AC40, Serial No.: 98 019 046) 
and TDH39 headphones fitted with noise-excluding headset ME70. At the beginning, we 
checked if the tinnitus percept was more similar to a tone or a noise, and the evaluation 
of tinnitus frequency was performed by offering frequencies from 125 to 16000Hz, two 
stimuli each time, asking the participants to choose, which was the sound more similar 
to its own precept. For the identification of tinnitus loudness (intensity), the elected 
frequency (from the previous step) was offered in an intensity similar to the hearing 
threshold, and loudness was gradually increased (5dB each step) until it reached the 
closest match to tinnitus percept. 
Loudness discomfort levels (LDL): 
This evaluation was performed for each ear individually, using pure tones (those 
from tonal audiometry) in an ascending method. The participant should state when the 
sound was uncomfortable (Goldstein and Shulman 1996).  
Feldmann masking curves or Minimum Masking Levels (MML): 
This test was performed at the frequencies where tonal audiometry was tested, 
using narrow band noises or pure tones (in case tinnitus was not masked by narrow band 
noises), using an ascending method, 5dB each step during 1-2 seconds, from hearing 
thresholds until the participant noticed he/she can’t hear tinnitus. According to the 
spacial relation of the curves from hearing thresholds and tinnitus masking, this one was 
designated as: 1 - Convergent; 2 – Divergent; 3 – Congruent; 4 – Distant; 5 – Persistent, 
(Lokenberg R et al, 2000). 
Residual inhibition: 
Procedure: at the identified tinnitus pitch (frequency), the participant was 
stimulated with a narrow band noise, 10dB above the tinnitus loudness for 1 minute. 
According to participants responses, 4 categories were possible: 1) complete (tinnitus is 
not audible); 2) partial (tinnitus became quitter); 3) negative (no change at tinnitus 
percept); and 4) “rebound” effect (tinnitus became louder). At categories 1 and 2 we 
measured the time that tinnitus was abolished or diminished (Coles and Hallam 1987; 
Goldstein B, et al, 2007). 
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The severity of tinnitus was evaluated using the Tinnitus Handicap Inventory 
(THI; Newman et al. 1996). THI is a self-administered instrument, easy to quote, to 
interpret and has good psychometrics properties (McCombe et al. 2001). THI comprises 
25 questions concerning tinnitus, and the response options were "Yes", "Sometimes" 
and "No", respectively corresponding to 4, 2 and 0, accounting for a total score that may 
vary between 0 and 100. The questionnaire comprehends 3 sub-scales or dimensions: 
Functional (11 items - contributing 0-44 for the final score), Emotional (9 items - 
contributing 0-36 for the final score) and Catastrophic (5 items - contributing 0-20 for 
the final score). This allowed to verify which were the most affected aspects and 
accordingly to choose the therapeutic interventions. The total score of the responses 
allowed tinnitus classification according to its severity or impact in daily life - 0-16: Slight 
or no handicap (Grade 1), 18-36: Mild handicap (Grade 2), 38-56: Moderate handicap 
(Grade 3), 58-76: Severe handicap (Grade 4), 78-100: Catastrophic handicap (Grade 5).  
 
Evaluation of inflammatory markers 
Venous blood samples were collected into tubes without anticoagulant agents.  
Samples were allowed to coagulate for 30 min at room temperature and were 
centrifuged afterwards. After the separation from cells, sera were further divided in 
labeled aliquots of about 500 μL, which were frozen at -80º C until analysis. Each aliquot 
was used only once. 
For the evaluation of IL1α, IL1β, IL2, IL6, IL10, IFN (Interferon)-γ and TNF-α, a BD 
CBA Flex Set (BD Biosciences, San Jose, CA, USA) bead based multiplex assay was used. 
The protocol was performed following strictly the instructions of the manuracturer. In 
brief, after the preparation of standards and other ancillary reagents, serum samples 
were incubated with specific capture beads for 1 hour at room temperature in 
cytometry tubes. The detection reagent was then added to the samples and incubated 
for 2 hours at room temperature in the dark. After a washing step, beads were 
resuspended and analyzed using BD FACS Canto II flow cytometer, previously set up 
according to the BD CBA Flex Set recommendations. A minimum of 300 beads were 
acquired for each cytokine in each sample. The FCAP Array Software (BD Biosciences) 
was used for data analysis. Standard curves covering a 0–2,500 pg/mL concentration 
range were generated after serially diluting reconstituted standards. To be accepted, all 
10-point standard curves should present at least r2 >99.90. Minimum detection levels 
were: 1.0 pg/mL for IL1α; 2.3 pg/mL for IL1β; 11.2 pg/mL for IL2; 1.6 pg/mL for IL6; 0.13 
pg/mL for IL10; 1.8 pg/mL for IFN-gama; and 0.7 pg/mL for TNF-alfa. 
A similar BD CBA Flex Set protocol was performed for TGF-beta, using the Human 
TGF-β1 Single Plex Flex Set (BD Biosciences). The difference between this the the 
previous tests was that it requires activation of the latent TGF-β1 to its immunoreactive 
form. Therefore, Sample Activation Kit 1 (R&D, Minneapolis, MN, USA) was used  with 
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samples being acidified for 10 minutes with 1N HCL and then neutralized using 1.2N 
NaOH/0.5M HEPES, according to the kit’s procedure. After activation, samples were 
incubated with capture beads for 2 hours, washed and incubated with detection 
reagent. Acquisition and analysis were performed as described above. For TGF-beta, 
standard curves covered a 0–10,000 pg/mL concentration range, and minimum 
detection level was 14.9 pg/mL. 
Finally, Heat Shock Protein 70 (HSP70/HSPA4) was assayed using the HSPA4 
(HSP70) Human ELISA Kit (ThermoFisher, Frederick, MD, USA), a classical ELISA plate-
based assay. Samples were assayed in duplicates, following the steps described in the 
manufacturer’s instructions, including sample incubation with capture antibodies 
adsorbed in the plate, Biotinylated Antibody, Streptavidin-HRP Reagent, TMB Substrate 
and finally, Stop solution. After all washing and incubation steps, absorbances were 
assessed at 450nm in an ELISA plate reader (Stat Fax® 2100, Fisher Bioblock Scientific, 
France). Data were analyzed using Logit regression V21042005 free-software, available 
at www.xs4all.nl/~ednieuw. The Range for HSP70/HSPA4 was 2-600 ng/mL, and all 
mean values below the detection limit were evaluated as zero. 
Results 
Sample Distribution  
We include in our sample 114 adults with median age of 63.0 (P25=59.8, P75=68.3) 
years old. Most of the individuals were female (n=60, 52.6%), presenting a median age 
of 63.5 (P25=59.0, P75=68.3) years old. For men (n=54, 47.4%), the median age was 63.0 
(P25=60.0, P75=68.5) years old.  
Participants were grouped primarily as ‘tinnitus’ versus ‘no tinnitus’, and 
secondarily, as ‘with hearing loss’ versus ‘without hearing loss’. For some analyses we 
further subdivided patients’ subgroups (1) without hearing loss and without tinnitus 
(control group), (2) without hearing loss but with tinnitus, (3) with hearing loss but no 
tinnitus, and (4) with hearing loss and tinnitus (Table 5.4-20). As such we could compare 
tinnitus (subgroup 2 + subgroup 4) with no tinnitus (subgroup 1 + subgroup 3). 
Table 5.4-20 - Distribution of the individuals by subgroups. 
Subgroup 
Audiological 
Characteristic 
Gender 
n (%) 
Median Age (years, 
percentile 25 and 75) Male Female 
1 
PTA≤20 without 
Tinnitus 
5 12 17 (14.9%) 
63.0 (59.8, 68.3) 
2 PTA≤20 with Tinnitus 15 27 42 (36.8%) 
3 
PTA >20 without 
Tinnitus 
3 2 5 (4.4%) 
4 PTA >20 with Tinnitus 31 19 50 (43.9%) 
Total 54 60 114  
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Audiological assessment 
The described subgroups can be distinguished at tonal audiometry (Figure 5.4-
10) where the best hearing thresholds are in the control group (subgroup 1- individuals 
with no hearing loss and no tinnitus). 
 
Figure 5.4-10 - Pure Tone Audiometry (average curves) in each of the 4 subgroups. 
PTA and HF_PTA were higher in those individuals with tinnitus than those who 
did not have tinnitus (Figure 5.4-11).  
 
Figure 5.4-11 - Pure tone audiometry profiles based on the presence of tinnitus. 
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Tinnitus characteristics 
The mean tinnitus duration was 7.8 ± 8.6 years. Mean tinnitus intensity was 3.3 
± 1.6, on a visual analogue scale (VAS) of 1-10 (Table 5.4-21). For most participants 
tinnitus was central (i.e. perceived in the head) (47.8%) and tonal (53.2%). In the 
majority of participants tinnitus was constant (87%). Tinnitus onset was gradual for 49% 
and abrupt for 19.5% of participants. Dizziness, often associated with tinnitus, was 
reported by 38% of participants with tinnitus, while 54.4% reported not having dizziness 
symptoms. In most participants, tinnitus worsened in situations where they were 
nervous (58.7%). Reduced sound tolerance was reported by 48.9% of participants. 33.7% 
of participants with tinnitus had unprotected exposure to noise, while only four 
participants used protection when exposed to noise. 
Table 5.4-21 - Clinical characterization of tinnitus sample. 
Clinical variables Participants with tinnitus (n=92) 
Tinnitus Duration (mean in years) 7.8 ± 8.6 
Intensity of tinnitus (scale 1-10) 3.3 ± 1.6 
Manifestation of tinnitus  
Constant 80 (87%) 
Intermittent 7 (7.6%) 
Pulsatile 4 (4.3%) 
Omitted 1 (1.1%) 
How did tinnitus begin?  
Gradual 45 (49%) 
Abrupt 18 (19.5%) 
Omitted 29 (31.5%) 
Dizziness  
Yes 35 (38%) 
No 50 (54.4%) 
Omitted 7 (7.6%) 
Does tinnitus gets worse when you're nervous?  
Yes 54 (58.7%) 
No 37 (40.2%) 
Omitted 1 (1.1.%) 
Reduced sound tolerance  
Yes 45 (48.9%) 
No 47 (51.1%) 
Noise exposure  
Yes, with protection 4 (4.3%) 
Yes, without protection 31 (33.7%) 
No 57 (62%) 
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Psychoacoustic estimates of tinnitus are presented in Table 5.4-22. Frequencies 
matched to tinnitus pitch ranged from 2000 Hz to 8000 Hz, with 4000 Hz being the most 
frequently matched. Loudness was matched to 0 dB (with a variation of + or – 5dB 
according to hearing threshold). Most participants reported central (52.4%) and pure 
tone (59.0%) tinnitus. Convergent (47.6%) and distant (29.8%) Feldmann’s curve types 
were the most frequent. Residual inhibition was negative in 43.9% of participants and 
partial in 36.6%.  
Table 5.4-22 - Psychoacoustic tinnitus assessment. 
Audiological measurements Participants with tinnitus (n=92) 
Pitch (n=83) 4000Hz (2000Hz; 8000Hz) 
Loudness (n=83) 0 dB (0 dB; 5.0 dB) 
Location (n=84)  
Central 44 (52.4%) 
Right 15 (17.9%) 
Left 25 (29.8%) 
Type (n=83)  
Pure Tone 49 (59.0%) 
Narrow Band Noise 34 (41.0%) 
Feldmann's Curve (n=84)  
Congruent 17 (20.2%) 
Convergent 40 (47.6%) 
Divergent 1 (1.2%) 
Distant 25 (29.8%) 
Persistent 1 (1.2%) 
Residual inhibition (n= 82)  
Negative 36 (43.9%) 
Partial 30 (36.6%) 
Complete 13 (15.9%) 
Rebound Effect 3 (3.7%) 
 
Tinnitus severity was categorized by means of the THI scores. The majority of the 
individuals had a mild handicap (38 participants), followed by moderate handicap (22), 
slight or no handicap (17), severe handicap (14) and one participant had catastrophic 
handicap (Figure 5.4-12).  
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Figure 5.4-12 - THI scores of tinnitus participants. 
 
Inflammatory characteristics 
Table 5.4-23 demonstrates the mean values and standard deviation of each 
inflammatory parameter in the groups with and without tinnitus. This study included 
112 participants (two participants were excluded) however, in the analyses of HSP-70 
were included 80 participants. The only significant difference between groups was for 
IL10 (p =.025) and for IL6 and TGFβ we had a marginally significant result (p = .052) and 
(p = .064) respectively.  
Table 5.4-23 - Descriptive analyses of inflammatory parameters for tinnitus. 
Legend: * p ≤ 0,05     
Table 5.4-24 shows mean values and standard deviations with reference to 
presence of deafness in relation to the inflammatory parameters evaluated.   
 
 
Inflammatory parameters With Tinnitus Without Tinnitus p value 
IL1α (pg/mL) 0.698±2.51 0.362±0.68 .300 
IL1β (pg/mL) 1.424±5.40 0.810±1.85 1.000 
IL2 (pg/mL) 0.464±1.62 0.227±0.70 .980 
IL6 (pg/mL) 2.023±3.00 2.164±1.48 .052 
IL10 (pg/mL) 1.175±1.30 1.843±2.51 .025* 
IFN-γ (pg/mL) 3.321±9.88 6.483±16.57 .116 
TNF-α (pg/mL) 2.563±10.24 1.829±4.96 .841 
HSP70 (ng/mL) 0.496±1.24 0.391±0.69 .827 
TGF-β (pg/mL) 1450.609±775.71 1339.357±865.55 .064 
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Table 5.4-24 - Descriptive analyses of inflammatory parameters for hearing loss. 
Legend: * p ≤ 0,05     
Table 5.4-25 shows the mean values and standard deviation of inflammatory 
parameters with reference to the different degrees of deafness - normal, slight and 
moderate. With the exception of IL2 and IFN-γ, the values of the inflammatory 
parameters were lower in the moderately hearing impaired group compared to the 
normal group and mild hearing impairment. It is interesting to note that the mean value 
of several inflammatory parameters (IL1α, IL1β, IL10, IFN-γ, TNFα, and HSP70) decreased 
progressively as the degree of hearing loss increased. However, differences were not 
statistically significant. 
Table 5.4-25 - Descriptive analyses of inflammatory parameters for deafness grade. 
Legend: * p ≤ 0,05     
 
Association tests concerning to inflammatory parameters: 
Tinnitus and comorbidities 
Concerning the comorbidities, the presence of smoking habit was significantly 
associated to levels of IFN-γ (p=.041).  
Inflammatory parameters With hearing loss Without hearing loss p value 
IL1α (pg/mL) 0.736±2.64 2.741±17.22 .433 
IL1β (pg/mL) 1.535±5.68 4.637±28.02 .461 
IL2 (pg/mL) 0.454±1.63 0.311±1.24 .171 
IL6 (pg/mL) 5.339±19.45 1.937±3.49 .582 
IL10 (pg/mL) 1.184±1.18 1.849±4.83 .470 
IFN-γ (pg/mL) 3.985±12.29 7.461±17.60 .181 
TNF-α (pg/mL) 2.573±10.46 5.424±26.93 .691 
HSP70 (ng/mL) 0.396±0.96 0.531±1.24 .544 
TGF-β (pg/mL) 1827.441±1254.80 1807.449±1102.73 .801 
Inflammatory 
parameters 
Hearing impairment grade 
p-value Normal 
<20dB 
Slight 
21-40dB 
Moderate 
41-70dB 
IL1α (pg/mL) 2.693±17.07 0.828±2.88 0.296±0.24 .768 
IL1β (pg/mL) 4.557±27.78 1.772±6.20 0.365±0.31 .539 
IL2 (pg/mL) 0.306±1.23 0.428±1.74 0.657±1.01 .089 
IL6 (pg/mL) 1.904±3.46 6.111±21.21 1.571±1.80 .647 
IL10 (pg/mL) 1.827±4.79 1.273±1.24 0.747±0.66 .239 
IFN-γ (pg/mL) 7.381±17.46 2.738±5.85 11.298±29.57 .302 
TNF-α (pg/mL) 5.331±26.71 3.052±11.40 0.138±0.37 .391 
HSP70 (ng/mL) 0.531±1.24 0.473±1.04 0.000 .333 
TGF-β (pg/mL) 
1819.252±109
6.71 
1861.179±1330.40 1550.385±780.86 .699 
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Clinical characterization and psychoacoustic assessment in tinnitus group:  
We explored the significant results related to the clinical characterization and 
the psychoacoustic assessment in tinnitus group for all inflammatory parameters. 
Concerning the age, we have divided the patients into two groups: 55-64 and 65-75 
years old. The data showed statistically significant differences between these subgroups 
regarding to TGF-β (U= 721.5, p= .034), being significantly lower in the older group (Table 
7). There were also significant differences in IL1α (U= 577.000, p= .033) levels according 
to tinnitus type: IL1α values were statistically higher in patients with tonal tinnitus 
compared to narrow band tinnitus. Concerning residual inhibition, we found statistically 
significant differences for IL2 (H = 9,948, p = .019). Additionally, we observed a negative 
correlation between tinnitus duration and IL10 (r = -.281, p = .007).  
Correlations between loudness and the inflammation factors, are shown in Table 
5.4-26.  
 
Table 5.4-26 - Correlations: inflammatory parameters and tinnitus loudness. 
Inflammatory parameters r- value 
IL1α -.018 
IL1β -.023 
IL2 -.015 
IL6 -.143 
IL10 -.004 
IFN-γ .028 
TNF-α -.026 
HSP70 -.397** 
TGF-β .115 
 
Concerning to the correlation coefficient there was a significant negative weak 
correlation between HSP70 and tinnitus loudness (r = -.397). Since the coefficient is 
negative this means that higher tinnitus loudness values were associated to lower levels 
of HSP70. 
 
Presence of tinnitus and sample collection time 
In a further exploration of the data the study population was divided according 
to the time of collection (morning and afternoon) and the presence of tinnitus and the 
inflammatory parameters. For 36 participants blood samples were collected in the 
morning at 11:30h and  for 78 participants collection was performed in the afternoon at 
16:30h  (Table 5.4-27). For the ‘morning’ period, with the exception ofHSP70, 
inflammatory factors had a higher mean value in the group with tinnitus. In the 
‘afternoon’ group, tinnitus was associated with higher mean levels of IL1α, IL1β, IL2, 
TNF-α, HSP70 and TGF-β, and lower mean levels of IL6, IL10 and IFN-γ. Levels differed 
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significantly between time points (p = .012), which means that there were significant 
differences in the levels of the evaluated parameters according to the time of sample 
collection (morning or afternoon period).  
 
Table 5.4-27 - Mean and standard deviation of the inflammatory markers in the morning 
and afternoon. 
Inflammatory 
marker 
Morning period Afternoon period 
Without tinnitus 
(n=2) 
With tinnitus 
(n=33) 
Without tinnitus 
(n=20) 
With tinnitus 
(n=57) 
IL1α (pg/mL) 0.745±0.96 5.131±22.73 0.307±0.65 0.346±0.54 
IL1β (pg/mL) 3.155±4.02 8.984±37.17 0.560±1.45 0.610±1.37 
IL2 (pg/mL) 0.000 0.556±2.03 0.239±0.72 0.343±1.24 
IL6 (pg/mL) 2.940±2.75 8.064±25.14 2.038±1.37 1.602±2.03 
IL10 (pg/mL) 6.300±8.72 2.186±6.11 1.347±0.60 1.032±0.87 
IFN-γ (pg/mL) 5.090±4.69 7.293±17.30 6.442±16.98 4.645±13.77 
TNF-α (pg/mL) 8.705±12.31 10.227±36.78 1.061±3.54 1.308±4.57 
HSP70 (ng/mL) 1.115±.95 (n=2) 0.682±1.12 (n=14) 0.315±0.65 (n=19) 
0.438±1.28 
(n=45) 
TGF-β  (pg/mL) 694.370±315.22 2095.511±1402.92 1640.260±1349.39 1757.686±940.64 
 
We found significant results for the subgroup who had collection time in the 
afternoon and the presence of tinnitus. The results were significant for IL10 and IFN-γ 
(Table 5.4-28). Hearing loss in high frequency also reached significant results (p = .012). 
 
Table 5.4-28 - Inflammatory parameters for the presence of tinnitus in the afternoon 
time. 
Legend: * p ≤ 0,05     
 
Modelling the data 
 
Presence of tinnitus and inflammatory factors  
Table 5.4-29 presents a logistic regression modelling inflammatory factors, age, 
gender, high frequency, IFN-γ and exposure to noise as confounding variables. This 
analysis was first performed for all participants, and then just for the ‘afternoon’ group. 
The dependent variable in the model was presence of tinnitus. 
 
 
 
Variable p- value 
IL10 .032* 
IFN-γ .045* 
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Table 5.4-29 - Logistic regression model applied to presence of tinnitus. 
Legend:  a whole group, b afternoon group * p ≤ 0,05     
High frequency hearing loss in both ears represented a significant risk of tinnitus 
in all participants and in the ‘afternoon’ group, 1.096 and 1.082 respectively.  
Severity of tinnitus and inflammatory factors  
In a logistic regression modelling inflammatory factors, age, gender, IL2 and 
residual inhibition were considered as confounding variables. The dependent variable in 
the model was severity of tinnitus (Table 5.4-30).  
 
Table 5.4-30 - Logistic regression model applied to severity of tinnitus and residual 
inhibition. 
 B Wald OR Sig. (95% IC) 
 Sex (Female) .813 .693 .535 0.367 (.138, 2.082) 
 Negative/rebound (1) 6.475 .728 6.381 0.011* (1.531,26.599) 
 Age .176 .060 1.026 0.674 (.911, 1.154) 
 IL2 .110 .205 .934 0.740 (.625, 1.397) 
 Constant 1.084 3.889 .017 0.298  
Legend: * p ≤ 0,05     
The logistic regression revealed that the residual inhibition (β = -1.853; χ2 Wald 
(1) = 6.475; p = .011) has a statistically significant effect on the logit of the probability of 
patients having severe or catastrophic tinnitus. Thus, the odds for a patient to have 
severe or catastrophic tinnitus grade is higher in subjects having residual 
negative/rebound residual inhibition when compared to subjects having 
partial/complete residual inhibition. The IL2 mean value is 0.62 pg/mL for individuals 
with Negative or Rebound effect on residual inhibition and is 0.36 pg/mL for those 
Variable* B Wald OR p- value (95% IC) 
Sex .015 .001 1.015 .978 (.345, 2.988) 
Age -.034 .481 .967 .488 (.878, 1.064) 
High_frequency_PTA_OD_OEa .092 6.502 1.096 .011* (1.021, 1.176) 
IFNg .004 .051 1.004 .822 (.972, 1.036) 
Exposure to noise 1.228 3.095 3.414 .079 (.869, 13.405) 
Constant 1.416 .202 4.120 .653  
Sex .109 .032 1.115 .858 (.337, 3.695) 
Age -.030 .310 .971 .577 (.875, 1.077) 
High_frequency_PTA_OD_OEb .079 4.099 1.082 .043* (1.003, 1.168) 
IFNg .001 .002 1.001 .961 (.968, 1.035) 
Exposure to noise 1.242 2.129 3.461 .144 (.653, 18.339) 
Constant 1.080 .103 2.944 .749  
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having a Complete or Partial effect on residual inhibition. Nevertheless the difference is 
not statistically significant (p = .504). 
Discussion  
In this study, we conducted an exhaustive audiological and inflammatory 
evaluation of older persons, with or without hearing loss and/or tinnitus. 
Recent studies have shown that inflammatory responses occur in the inner ear 
under various damaging conditions, including overstimulation with noise (Fujioka et al. 
2006) and cisplatin-induced ototoxicity (Park et al. 2009). Several other studies 
demonstrated possible relationship between inflammation and inflammatory mediators 
in the cochlea and the development of ear diseases such as deafness (Fujioka et al. 
2014). Our results corroborate this evidence, showing that the mean value of several 
systemic inflammatory markers – in detail IL1α, IL1β, IL10, IFN-γ, TNF-α, and HSP70 - 
become progressively lower with the progression of the degree of hearing loss, which 
implies the importance of inflammation during the progress of hearing loss.  Moreover, 
the concentration of evaluated inflammation markers correlated significantly with 
hearing loss, especially with the high frequency hearing loss, which is a statistically 
significant risk factor for tinnitus. Supporting this notion, in a study involving an older 
population, Doi and colleagues found an association between polymorphisms in the IL6 
gene at region – 174G/C and susceptibility to tinnitus (Doi et al. 2015). Our data has 
shown a nearly statistical significant result for IL6 when comparing tinnitus to non-
tinnitus subgroups, but we found a clearly statistical relevant difference for IL10. 
Animal models suggest that the presence of proinflammatory cytokines such as 
IL1β and TNF-α are contributing factors to the prolongation of inflammation processes 
implicated in the development of noise-induced hearing loss (Fujioka et al. 2006, Tan et 
al. 2013; Fuentes-Santamaria et al. 2017) being also described an association between 
TNF-α levels and the susceptibility to tinnitus in elderly individuals with history of 
exposure to occupational noise (Marchiori et al. 2018).  
Circadian rhythms control essential functions such as sleep, renal function, 
hormone secretion, metabolism, inflammation, as well as auditory functions. Only 
recently it was demonstrated that cochlea possesses its own circadian cycle. Studies in 
mice have shown that noise trauma with same duration and intensity (6–12 kHz, 1 h, 
100 dB SPL) had worse consequences if exposure was during night (9pm), causing 
permanent hearing loss (measured by ABR 15 days after noise trauma) while the 
morning (9 am) exposure lead to total recovery (Meltser et al. 2014).  
We have divided our study sample according to the day time period of blood 
collection (morning and afternoon groups) and we have found significant differences (p 
= .012) between the morning and afternoon groups, which means that the time of blood 
sample collection can affect the results of inflammatory factors. In particular, we have 
found statistically relevant results for IL10 in regards to tinnitus presence in the whole 
group. And in the afternoon group for IL10 and INF-
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correlation between tinnitus duration and IL10 levels, since these levels are 
progressively lower according to longer tinnitus duration.  Regarding tinnitus intensity 
(loudness) we found a negative correlation with HSP70, as well as between IL10 and the 
duration of tinnitus. To our best knowledge it is the first time that are stablished those 
correlations of tinnitus characteristics with inflammatory markers.   
Salicylate-induced tinnitus in rats has been a popular animal model for the study 
of human tinnitus (Jastreboff et al. 1988; Paul et al. 2009; Yu et al. 2008; Hwang et al. 
2011a,b; Hu et al. 2014). The mechanism of salicylate-induced tinnitus includes an 
accumulation of arachidonic acid caused by inhibition of cyclooxygenase (COX).  This 
could potentiate the N-methyl D-aspartate receptor (NMDAR) that currents synapses 
between inner hair cells and dendrites of the cochlear spiral ganglion neuron. Some 
studies suggest that tinnitus arises from an increase in excitatory neurotransmission and 
is associated with the NMDAR activity (Ruel et al. 2008; Guitton et al. 2003), previously 
linked to tinnitus in animal models (Guitton et al. 2003; Hwang et al. 2011a).  Recent 
animal studies on tinnitus-related genes expression highlights the role of neural 
inflammation and oxidative metabolism in tinnitus pathophysiology. Studies of 
salicylate-induced tinnitus in mice revealed that the expression levels of NMDA 
receptors type2B (NR2B), TNF-α and IL1β genes increased significantly, whereas 
cyclooxygenase type 2 (COX-2) gene expression decreased in the cochlea and Inferior 
Colliculus (IC) (Hwang et al., 2011a, 2011b).  
Our results open new therapeutic options regarding prevention or retardation of 
the mechanisms involved in age-related hearing loss and tinnitus that, although 
complex, are surely associated to inflammatory mechanisms. Nakamoto and colleagues 
suggested that the suppression of the proinflammatory cytokine HSF-1 in the cochlea by 
the administration of geranylgeranylacetone (GGA) may be an important way of 
protecting the inner ear (Nakamoto et al. 2012). Epidemiologic prospective studies also 
confirm the association between inflammation and hearing loss (long-term serum C-
reactive protein levels) in ARHL (Nash et al. 2013). 
 
Study limitations 
That blood was collected at two different time points reduced the power of the 
sample. Nevertheless, it is interesting to note that the statistically relevant results were 
found for those whose samples were collected in the afternoon, implying that 
inflammatory parameters have a circadian effect. Future studies should consider the 
sample collection time. 
 
Conclusions 
Due to progressive aging of population it is estimated that in 2050 there will be 
2 billion people older than 65. Results from the most recent World Health Organization 
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(WHO) Global Burden of Diseases (2015) reports hearing loss as the fourth leading cause 
of years lived with disability. Given the strong links between hearing loss and tinnitus, 
then tinnitus surely follows this trend. In order to improve quality of life of people with 
those disabilities it is imperative to have investment in studies to clarify the underlying 
causal mechanism in order to enable a more efficient prevention or treatment and avoid 
the progression to frailty and related mental health disabilities. 
The results of our study clearly demonstrate that inflammatory mechanisms are 
involved not only in hearing loss pathogenesis but also in tinnitus. In addition, we have 
shown for the first time that the systemic concentration of IL10 and INF-γ are statistically 
associated with the presence of tinnitus. Another interesting finding is that higher IL1α 
levels are associated with tonal type of tinnitus and HSP70 and HL10 are negatively 
correlated to tinnitus loudness and tinnitus duration respectively. This suggest the need 
for further research, not only for confirmation in larger samples, but also regarding 
pathophysiological mechanisms underlying this phenomenon. Because of the trend for 
negative correlations between the inflammatory markers and tinnitus characteristics it’s 
reasonable to think that inflammatory mechanism are probably involved in the acute 
phase of tinnitus emergence. Future studies should involve higher samples with a 
rigorous methodological design for controlling of confounding factors. 
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5.4.4. Biomarkers of Presbycusis and Tinnitus in a Portuguese Older Population 
The data presented has been published by Haider, H. F., Flook, M., Aparicio, M., 
Ribeiro, D., Antunes, M., Szczepek, A. J., Hoare D. J., Fialho, G., Paço, J.C., & Caria, H. 
(2017) as is possible to see at 
 
Haider, H. F., Flook, M., Aparicio, M., Ribeiro, D., Antunes, M., Szczepek, A. J., ... 
& Caria, H. (2017). Biomarkers of presbycusis and tinnitus in a Portuguese older 
population. Frontiers in aging neuroscience, 9, 346.
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Introduction: Presbycusis or age-related hearing loss (ARHL) is a ubiquitous health 
problem. It is estimated that it will affect up to 1.5 billion people by 2025. In addition, 
tinnitus occurs in a large majority of cases with presbycusis. Glutamate metabotropic 
receptor 7 (GRM7) and N-acetyltransferase 2 (NAT2) are some of the genetic markers 
for presbycusis. 
Objectives: To explore patterns of hearing loss and the role of GRM7 and NAT2 as 
possible markers of presbycusis and tinnitus in a Portuguese population sample. 
Materials and Methods: Tonal and speech audiometry, tinnitus assessment, clinical 
interview, and DNA samples were obtained from patients aged from 55 to 75 with  
or without tinnitus. GRM7 analysis was performed by qPCR. Genotyping of single 
nucleotide polymorphisms (SNPs) in NAT2 was performed by PCR amplification 
followed by Sanger sequencing or by qPCR. 
Results: We screened samples from 78 individuals (33 men and 45 women). T allele 
at GRM7 gene was the most observed (60.3% T/T and 33.3% A/T). Individuals with a 
T/T genotype have a higher risk for ARHL and 33% lower risk for tinnitus, compared 
to individuals with A/A and A/T genotype, respectively. Being a slow acetylator (53%) 
was the most common NAT2 phenotype, more common in men (55.8%). Intermediate 
acetylator was the second most common phenotype (35.9%) also more frequent in 
men (82.6%). Noise exposed individuals and individuals with ‘high frequency’ hearing 
loss seem to have a higher risk for tinnitus. Our data suggests that allele AT of GRM7 
can have a statistically significant influence toward the severity of tinnitus. 
Conclusion: For each increasing year of age the chance of HL increases by 9%. The 
risk for ARHL was not significantly associated with GRM7 neither NAT2. However, we 
cannot conclude from our data whether the presence of T allele at GRM7 increases the 
odds for ARHL or whether the A allele has a protective effect. Genotype A/T at GRM7 
could potentially be considered a biomarker of tinnitus severity. This is the first study 
evaluating the effect of GRM7 and NAT2 gene in tinnitus. 
Keywords: presbycusis, GRM7, NAT2, tinnitus, markers, comorbidities 
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INTRODUCTION 
Presbycusis [age-related hearing loss (ARHL)] is a universal 
feature of mammalian aging  in  which  the  auditory  function  
is compromised, hearing thresholds increase, and frequency 
resolution gets poorer. As a result, in noisy environments speech- 
understanding deteriorates  and  temporal  processing  deficits  
in gap detection measures  increase  (Lee,2013).  In  humans, 
this condition affects tens of millions of people world-wide 
(Yamasoba et al.,2013). Many people with hearing loss also 
experience tinnitus, which is the perception of a sound in one   
or both ears or in the head in the absence of an external sound 
source (Jastreboff and Hazell,1993). 
Presbycusis is complex in that it has repercussions at a 
physical, cognitive, emotional, and social level; quality of life 
can deteriorate, and for  some  people  presbycusis  could  lead 
to depression, social isolation and lower self-esteem (Lee, 
2013;Ciorba  et  al.,2015).  Environmental  factors  such   as 
diet, physical exercise, smoking, and  intake  of  medications  
are some of the extrinsic factors predisposing to presbycusis. 
There are several auditory structures affected by presbycusis, 
such as hair cells, stria vascularis, afferent spiral ganglion 
neurons and the central auditory pathways (Fuentes-Santamaría 
et al.,2013). Based on results  of  audiometric  tests  and 
temporal bone pathology,Schuknecht  and  Gacek(1993)and 
later modified byNelson and Hinojosa(2003), classified 
presbycusis as either sensory (downslope audiometry and 
cochlear degeneration), neural (downslope audiometry  and  
very poor speech discrimination, spiral ganglion and nerve  
fibers degeneration), metabolic (audiometry in a platform and 
strial atrophy), cochlear conductive (downslope audiometry and 
thickening and stiffening of basilar membrane), mixed (mixture 
of the above), or undetermined (none of the above) types. 
Depending on the type and severity of the hearing loss, 
several options are available to reduce the hearing difficulties 
and consequently improve quality of life. When patients are 
appropriately fitted and motivated, hearing aids and cochlear 
implants (CIs) are the most commonly used devices for treating 
mild-severe presbycusis. Electric-acoustic stimulation and active 
middle ear implants may also be suitable solutions for treating 
presbycusis (Sprinzl and Riechelmann,2010). 
Biological markers are widely used in oncology, hematology 
and in other medical disciplines to diagnose or to monitor various 
diseases. In otology, biological markers are not yet widely used, 
but once identified, they could provide a means of determining 
the time-course or most effective treatment for an individual 
with presbycusis or tinnitus. Potential biomarkers include 
mutations in mitochondrial DNA, chromosomal  mutations,  
state of chronic inflammation, presence of certain diseases 
associated with earlier onset or progression of presbycusis (e.g., 
diabetes, hypertension) and metabolic diseases (Van Eyken et al., 
2007;Verschuur et al.,2014). It was recently estimated that 35–
55% of auditory aging could have a genetic background (Ruan 
et al.,2014). Of interest are genes coding for glutamate receptors 
as glutamate is the main excitatory neurotransmitter   in the 
peripheral and central auditory pathways. It has been suggested 
that increased release of glutamate may be involved  in the 
auditory aging and the generation and maintenance of 
tinnitus by causing “excitotoxicity.” There are many types of 
glutamate receptors, such as N-methyl-D-aspartate (NMDA) and 
alfa-amine propionic acid (AMPA), the latter being the most 
relevant receptor in physiological neurotransmission at auditory 
pathways. NMDA receptors are not essential for the auditory 
transmission, but they have been shown  to  be  expressed  in  
the cochlea after induction of tinnitus. Moreover, it has been 
demonstrated that the application of NMDA antagonists directly 
into the cochlear fluid can block salicylate-induced tinnitus in 
animals (Figueiredo et al.,2008). 
GRM7  encodes a metabotropic glutamate receptor subtype   
7 (mGluR7), a G protein-coupled receptor regulating auditory 
nerve excitability. When bound by L-glutamate, mGluR7changes 
the configuration of adenylyl cyclase, which has implications   
in the metabolism of AMPc, control of cellular cycle, and 
normal functioning of central nervous pathways. mGluR7 plays 
a general role in glutamate synaptic transmission (Voytenko and 
Galazyuk,2011). In the auditory periphery, mGluR7 is thought 
to mediate glutamate excitotoxicity (Pujol et al.,1993) and in the 
cochlea mGluR7 maintains the glutamate-dependent equilibrium 
between the inner hair cells and the spiral ganglion neurons 
(Newman et al.,2012). Its role in the higher auditory pathways 
remains unclear (Lu,2014). Single nucleotide polymorphisms 
(SNPs) of GRM7 have been demonstrated to  be  associated  
with auditory aging in European (Friedman et al.,2009) and 
American populations (Newman et al.,2012) but not of a Chinese 
population (Luo et al.,2013). Interestingly,Newman et al.(2012) 
have reported that certain SNP variants of GRM7 associate with 
poorer speech recognition in the elderly. The importance of 
GRM7 in the auditory  system  is  supported  by  the  detection 
of mGluR7 in the inner and outer hair cells and in the spiral 
ganglion nerve (Friedman et al.,2009). 
Highly concentrated glutamate may affect membrane 
permeability  in  the  hair   cells,   causing   an   increase   in   
Cl− influx, and consequently an osmotic imbalance and 
membrane disruption (Puel et al.,1998). In addition, glutamate 
excitotoxicity induces apoptotic cell death and inflammation 
(Sahley et al.,2013). This was demonstrated in an animal model 
to be directly responsible for the loss of inner hair cells in a 
time-, dose- and tonotopy-dependent manner (Hu et al.,2015). 
Interestingly, neonatal exposure to monosodium glutamate has 
been shown to induce neuronal atrophy and dysmorphia in the 
cochlear nucleus and in the superior olivary complex (Foran     
et al.,2017). The physiological effects of glutamate excitotoxicity 
therefore are concluded to include ARHL (Pujol et al.,1993) and 
tinnitus (Brozoski et al.,2012;Sahley et al.,2013;Yu et al.,2016). 
Oxidative stress represents an imbalance between the 
production of reactive oxygen species (ROS) and their 
detoxification and has been  postulated  to  play  a  major  role  
in the overall  aging  process  and  to  significantly  contribute  
to the  ARHL.  Oxidative  stress  in  the  inner  ear,  secondary  
to impairments in defense mechanisms caused by certain 
polymorphisms related to a battery of antioxidant systems, could 
make individuals more susceptible to ARHL (Seidman et al., 
2002;Fujimoto and Yamasoba,2014). 
In the adult inner ear, presence of several detoxification and 
antioxidant enzymes including catalase, superoxide dismutase, 
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glutathione peroxidase, and glutathione S-transferases (GST) has 
been demonstrated. 
One of the sources leading to accumulation of ROS are 
insufficiently  acetylated  drugs  which  accumulate  and  may  
be converted into reactive drug metabolites by oxidative 
enzymes. N-acetyltransferase (NAT) are enzymes  responsible 
for the detoxification of exogenic substrates via N-acetylation  
or O-acetylation. In humans, the catalytic activity by NAT 
isoenzymes NAT1 and NAT2 may be regulate by these substrate 
concentration. Both isoenzymes are highly polymorphic and 
catalyze many aromatic amines and hydrazine substances 
important for the balance of the oxidative status. In addition, 
NATs are known to be involved in the detoxification of harmful 
xenobiotics (Vatsis and Weber,1993;Hein,2002;Ünal et al., 
2005b). 
Variation in NAT2 alleles or haplotypes resulting from 
combination of SNPs is responsible for the N-acetylation 
polymorphism. Regarding the latter, rapid, intermediate, and 
slow acetylator phenotypes have been demonstrated. These 
phenotypes are associated with the rate of catalytic activity and 
accordingly predispose toward drug toxicity (Rajasekaran et al., 
2011). 
Because the individuals with the null genotype for  NAT2 
may be more susceptible to effects of environmental toxins and 
oxidative free radical cellular damage, the presbycusis becomes 
an ideal model for evaluation of gene-environmental interaction 
(Ünal et al.,2005a,b). Although many individuals have been 
exposed to several environmental risk factors, the ARHL develops 
to a different degree in various age groups. This suggests genetic 
host factor(s) contributing to the degenerative mechanisms (Ünal 
et al.,2005b). 
Previous  studies  demonstrated  the  association  between  
the common human NAT2 alleles and ARHL. Independent 
studies have showed a significant association between NAT2 
polymorphisms and presbycusis, namely NAT2∗ 6A in the 
Turkish population (Ünal et al.,2005b) and in the European 
population (Van Eyken et al.,2007) with Caucasian subjects 
carrying a  NAT∗ 6A  mutant  allele  having  an  increased  risk  
to Presbycusis (Bared et al.,2010). Other studies considering 
different NAT2 alleles reported negative associations  with 
ARHL (Dawes et al.,2015) and with the shape of the 
audiograms (Angeli et al.,2012), when considering audiometric 
patterns of presbycusis in older individuals. However, most 
authors suggested that NAT2 gene is a susceptibility factor for 
development of hearing impairment (Ünal et al.,2005b;Dawes  
et al.,2015). 
Here we explore the relationships between presbycusis, 
tinnitus, co-morbidities, and the genotypes of GRM7 and NAT2, 
in a sample of older Portuguese adults. 
 
PATIENTS AND METHODS 
Subjects 
Inclusion criteria was the presence of sensory presbycusis, with 
or without tinnitus, in adults of any gender, aged between 55 and 
75 years, from the Portuguese population. 
n 
Our sample included 78 older individuals (n = 45 women, 
For  the  purposes  of  inclusion  presbycusis  was  defined   
as bilateral sensorineural deafness in downslope audiometric 
pattern, above 1000 Hz with poor speech discrimination 
(discrimination threshold > 40 dB SPL and 100% discrimination 
to  60  dB  or  worse).  Although  all  included   participants  
have presbycusis we will consider a subgroup with normal 
hearing because the adopted classification uses conversational 
frequencies. 
Exclusion criteria were considered: inability to understand 
and sign the informed consent due to a significant cognitive 
impairment, an uncompensated medical disorder that requires 
urgent evaluation or if the individual has a serious psychiatric 
disorder. Also individuals over 55 years who presented possible 
factors that may overlap the variables under study were excluded 
[e.g., Ménière’s disease, chronic otitis media, otosclerosis, tinnitus 
from disease of the outer ear (occlusive exostosis, outer otitis)], 
history of ototoxic drugs use, massive noise exposure, a history of 
previous malignancy with chemotherapy, history of autoimmune 
disorders and neurodegenerative and demyelinating diseases. 
This study had the approval of  the  Ethical  Committees  
from Hospital Cuf Infante Santo  (November  26th,  2014),  
Nova Medical School (n◦65/2014/CEFCM) and the National 
Department of Personal Data Protection (authorization 
number:1637/2016). 
Accordingly we obtained the Institutional Scientific Review 
Board approval of the process for taking informed consent and 
overall study design. The study was conducted in accordance with 
the Declaration of Helsinki. 
Clinical Evaluation 
Written informed consent, clinical and familial history, 
audiological  evaluation  and  a  blood  sample,  using  Whatman§R 
FTA§R    card technology, was obtained from every subject. 
A questionnaire concerning epidemiologic data 
(demographic, previous and present diseases, toxicological 
habits and noise exposure) was completed by the researcher 
through participant interview. 
Audiological Assessment 
Hearing thresholds were determined by pure tone audiometry 
(air and bone) according to ISO 8253 and 389. The exam was 
performed  in  a  soundproof  booth  using  an  Interacoustics§R  , 
Assens, Denmark audiometer (Model: AC40, Serial No.: 98 019 
046) and TDH39 headphones fitted with noise-excluding headset 
ME70 and bone conductor B-71. Audiometry was performed at 
frequencies from 0.25 to 16 kHz (standard tonal audiometry and 
extended high frequency). The category of Hearing Loss (HL) was 
defined according to the average threshold across 500, 1000, 2000, 
and 4000 Hz in the better ear as mild (21–40 dB), moderate (41– 
70 dB), severe (71–95 dB) or profound (>95 dB), from an average 
of thresholds at 500, 1000, 2000, and 4000 Hz in the better ear, 
according to the European Working Group Genetics of Hearing 
Impairment (AfterLiu and Xu,1994;Parving and Newton,1995). 
Speech audiometry evaluation was obtained with headphones 
(using mp3 player), or in open field, where the evaluator was 
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hiding his lips to prevent lip-reading. The number of disyllables 
that patient repeats correctly was recorded. This intelligibility 
threshold for two-syllable words intends to measure hearing 
sensitivity threshold through the  intensity  level  identification 
in which the patient can correctly identify 50% or more of a 
disyllables list. On the other hand, the speech discrimination 
evaluates the lowest intensity level at which a listener can 
understand speech. 
 
Tinnitus Assessment 
Psychoacoustic assessment consisted of loudness match, pitch 
match, minimum masking level (MML) or Feldmann masking 
curves, residual inhibition, and loudness discomfort levels (LDL). 
The severity of tinnitus was evaluated using the Tinnitus 
Handicap Inventory (THI;Newman et al.,1996). THI comprises 
25 questions concerning tinnitus, and the response options are 
“Yes,” “Sometimes,” and “No,”  respectively, corresponds to 4,  
2, and 0, accounting for a total score that may vary between       
0 and 100. The questionnaire comprehends three sub-scales or 
dimensions: Functional (11 items – contributing 0–44 for the 
final score), Emotional (9 items – contributing 0–36 for the final 
score) and Catastrophic (5 items – contributing 0–20 for the final 
score). This allow to verify which are the most affected aspects 
and accordingly choose the therapeutic interventions. The total 
score of the responses allows tinnitus classification according to 
its severity or impact in daily life – 0–16: Slight or no handicap 
(Grade 1), 18–36: Mild handicap (Grade 2), 38–56: Moderate 
handicap (Grade 3), 58–76: Severe handicap (Grade 4), 78–100: 
Catastrophic handicap (Grade 5). 
Additionally THI is  a  self-administered  instrument,  easy  
to quote, to interpret and has good psychometrics properties 
(McCombe et al.,2001). 
 
Genetic Analysis 
Total genomic DNA was extracted from a blood  sample  on 
FTA cards using a commercial NZY  Tissue  gDNA Isolation 
Kit (NZYTech, Lisbon, Portugal), strictly according to the 
manufacturer’s instructions. Molecular analysis of GRM7 gene 
was assessed by qPCR for A/A, A/T, and T/T genotypes, at 
rs11928865 SNP. Concerning NAT2 gene, rs1041983, rs1801280, 
rs1799929, rs1799930, rs108 and s1799931 were assessed by qPCR 
or by bidirectional sequencing of the target region in order to 
identify all the SNPs. 
 
Statistical Analysis 
We conducted a descriptive analysis for variables such as gender 
and age. The audiograms were analyzed considering the best  
ear (estimated based on the lowest average of frequencies of 
0.5–4 kHz). We also evaluated the “high frequency” pure-tone 
 
square Test or Fisher Exact Test for general association between 
two variables were used. Mann–Whitney or Kruskal–Wallis  
(for more than two groups) tests were employed to compare 
hearing thresholds. A Dunn’s test with a Bonferroni correction 
was applied for multiple pairwise comparisons. The level of 
significance considered was p = 0.05. 
All the results were analyzed through logistic regression 
model, where age and gender where considered as control for all 
other variables. 
 
RESULTS 
Participants in our study were 78 older adults aged 
64.6 ± 5.58 years old (range = 55–75 years old). Most 
participants were female (n = 45, 57.7%), presenting an average 
age of 64.1 ± 5.35 years old. For men (n = 33, 42.3%), the mean 
age was 65.3 ± 5.89 years old (Table 1). 
Hearing Thresholds 
The average hearing threshold values (by gender and age) are 
shown in Figure 1. There were significant differences between 
the gender groups regarding average and median values of 
hearing thresholds at the frequencies of 4 kHz (p-value 0.007) 
and 8 kHz (p 0.031) when comparing  male  and  female  
(Figure 1). There were significant differences between age groups 
regarding the average and median values of hearing thresholds 
at frequencies of 4 kHz (p  0.003), 8 kHz (p < 0.001), 10 kHz  
(p < 0.001) and 12 kHz (p < 0.001) when comparing the different 
age groups (Figure 1). 
When comparing hearing thresholds between the different 
age  groups,  we  found  significant  differences  in  females  at  
4  kHz  (p       0.009),  8  kHz  (p      0.011),  10  kHz  (p  0.018) 
and 12 kHz (p 0.002) (Figure 2). For males statistically 
significant differences were observed between age groups at 8 kHz 
(p       0.009),  10  kHz  (p      0.003)  and  12  kHz  (p     0.004) 
(Figure 2). 
According to age and gender grouping and comparing males 
to females we found significant differences for hearing thresholds 
for the age group 55–60 years old for 1 kHz frequency (p 0.022) 
and 4 kHz frequency (p 0.028) (Figure 2). 
Distribution of the individuals according to the hearing loss 
and tinnitus presence  (Table  1)  shows  that  in  subgroup  1,  
18 (23.1%) individuals who had normal hearing thresholds at 
speech frequencies (0.5–4 kHz) but not tinnitus; subgroup 2, 23 
(29.5%) individuals who had normal hearing thresholds at speech 
frequencies and tinnitus; subgroup 3, 10 (12.8%) individuals who 
had hearing loss but not tinnitus; and subgroup 4, 27 (34.6%) 
individuals who had hearing loss and tinnitus (see also Figure 3). 
There are no statistical differences in age or gender between those 
four subgroups. 
 
TABLE 1 | Distribution of the individuals by subgroups according to hearing loss, 
tinnitus presence (PTA = Pure Tone Average) and gender.  
Subgroup Audiological characteristic Gender n 
 
 
1 PTA ≤ 20 without Tinnitus 5 13 18 (28%) 2
  PTA ≤ 20 with Tinnitus 8 15          23 (29.5%) 
3 PTA ≥ 20 without Tinnitus  6  4 10 (12.8%) 
4 PTA ≥ 20 with Tinnitus 14 13          27 (34.6%) 
Total 33 45 78 
average (PTA) at 2, 4, and 8 kHz (Newman et al.,2012). Chi-  Male Female  
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FIGURE 2 | (A) Female and (B) Male hearing thresholds between the different aging groups. 
 
 
 
 
 
 
 
 
 
We found statistically relevant differences between the four 
described groups which corroborates the logical of having chosen 
this subdivision of our study population. (p < 0.001 at the 
majority of frequencies). 
There were significant differences in speech audiograms (PTA, 
speech  recognition  threshold  [SRT],  100%;  p-value <0.001; 
<0.001; <0.001, respectively) between subgroups, either for the 
right ear or for the left ear. The differences were found between 
subgroups 4 or 3 and the subgroups 1 and 2 for PTA (0%), SRT 
(50%) and (100%) (Figure 4). 
Because our study population represents older adult 
individuals with sensory presbycusis we evaluated the “high 
frequency” pure-tone average (PTA) at 2, 4, and 8 kHz. We 
compared the groups of individuals with and without tinnitus 
and the four subgroups (Table 1). In respect to having or not 
tinnitus we found statistical differences between those groups   
(p 0.003) (for more details see Appendix 1). We found 
statistically significant differences (p < 0.001) when comparing 
the four subgroups described in Table 1 (for more details see 
Appendix 2). 
Characterization   of   the   considered   comorbidities   in  
our sample are presented in Table 2. Concerning hearing 
thresholds according to presence or not of the studied 
comorbidities, we found the following relevant significant 
differences: from 0.5 to 4 kHz for cholesterol; at 4 kHz for 
measles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3 | Hearing thresholds between subgroups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1 | Tonal audiogram curves showing differences between: (A) gender and (B) age intervals, for all the frequencies used to estimate HL status. 
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      having hearing loss 9% higher for each increasing year (OˆR = 
 
 
 
 
 
 
When comparing the group of  participants  with  and  
without tinnitus the most statistical relevant results were 
concerning ‘high frequency’ hearing loss and noise exposure.   
In  our  study  population,  50  individuals  (64.1%)  had 
tinnitus. 
We have determined the distribution of studied comorbidities 
in our tinnitus population (Figure 5). The most prevalent were 
measles, hypercholesterolemia, noise exposure, mumps, smoking 
and hypertension, in a descendent order of frequency. 
In our sample, 49 participants (62.8%) reported  to  have  
high blood values of cholesterol. Of those, 27 individuals 
(55.1%) were taking medication (statins) (Appendix 3). There 
was a significant association between tinnitus  and  statins  
intake in  those  individuals  reporting  hypercholesterolemia 
(OR 0.28, p 0.045, CI 0.08 0.99) (Table 3). We found 
no relevant association between statins  intake  and  hearing  
loss. 
Tinnitus Evaluation 
Subgroups 2 and 4 included participants with tinnitus. 
Concerning  tinnitus  laterality,  33  of  them  reported  to  have  
a unilateral tinnitus (12 on the right ear and 21 on the left ear) 
and 17 participants have a bilateral tinnitus. According to THI 
score (Figure 6) for most participants tinnitus was bothersome, 
only 10 subjects had a slight handicap. 
Modeling the data 
All the results were analyzed through a logistic regression model 
age and gender were considered in all the models with the 
objective of controlling eventual confounding since these two 
factors are known to be related to hearing loss. 
The regression logistic model was applied to HL considering 
female as reference (for more details see Appendix 4). The odds 
of developing presbycusis was significantly higher for males than 
for females (OR 2.9, p 0.032). When considering age as a 
covariate, the effect was slight but significant, being the odds of 
 
 
TABLE 2 | Distribution of the most common comorbidities in the individual of the 
sample. 
 
Comorbidities 
 
n 
 
 
Absent 
 
Present 
Cholesterol 29 (37.2%) 
 
49 (62.8%) 
Hypertension 43 (55.1%)  35 (44.9%) 
Cardiovascular disease 73 (93.6%)  5 (6.4%) 
Tinnitus 28 (35.8%)  50 (64.1%) 
Diabetes 65 (83.3%)  13 (16.7%) 
Thyroid problems 70 (89.7%)  8 (10.3%) 
Smoking habits 44 (56.4%)  34 (43.6%) 
Meningitis 77 (98.7%)  1 (1.3%) 
Mumps 44 (56.4%)  34 (43.6%) 
Measles 21 (26.9%)  57 (73.1%) 
Tuberculosis 75 (96.2%)  3 (3.8%) 
Ear diseases 62 (79.5%)  16 (20.5%) 
Ear surgery 76 (97.4%)  2 (2.6%) 
Noise exposure 51 (65.4%)  27 (34.6%) 
Hormonal therapy 55 (70.5%)  23 (29.5%) 
Ototoxic medication 58 (74.4%)  20 (25.6%) 
1.09, p 0.03). 
Using this statistical model for all the comorbidities 
considered and controlled for age the odds of having hearing 
loss was significantly lower for subjects with high cholesterol 
(OR 0.33, p 0.034). 
We found no association between HL and high blood pressure 
or noise exposure. 
In addition, using the regression logistic model for tinnitus 
considering men and the absence of tinnitus as reference, we 
found that noise exposure seems to influence the occurrence     
of tinnitus (OR 3.65, p  0.026, CI  1.2  11.4),  when 
considered isolated. This result is statistically very relevant. 
There were no other statistically significant results concerning 
other comorbidities in this study (for more details  see  
Appendix 5). 
GRM7 and NAT2 genes 
Results for GRM7 gene at rs11928865 SNP refers to A or T 
alleles and contribute for three possible genotypes: A/A, A/T,   
or T/T. GRM7 data are presented comparatively (Table 4) with 
data for Iberian Peninsula and Europe in order to compare our 
population with others. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 5 | Distribution of the most common comorbidities in the individuals 
with tinnitus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 4 | Speech audiograms between subgroups. 
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TABLE 3 | Association between tinnitus and statins intake in individuals reporting 
hypercholesterolemia. 
   
  Statins    Without OˆR p-value (fisher 95% IC  
   
TABLE 5 | Association between THI score (tinnitus severity) and GRM7 gene. 
   
 
Tinnitus 13 17 0.28 p = 0.045 [0.08 – 0.99] 
Without tinnitus 14 5 
   
∗  p-value < 0.05. 
 
 
 
 
 
higher in individuals presenting A/T (29%) or T/T (2%) 
genotype, than in A/A genotype. The same results were 
observed when controlling for age and gender,  however,  in  
this case the odds of HL in A/T genotype individuals  was  
nearly 39% higher than for A/A genotype individuals.  The  
odds of HL in T/T genotype was 15% higher than in A/A 
genotype. 
The relation between tinnitus and GRM7 gene was evaluated 
considering two groups, one defined as “having an A allele” 
(AA  + AT)  other  defined  as  “not  having  an  A  allele” (TT). 
Results  were  not  significant  (OˆR = 0.96) however,  since  the 
estimated  OˆR < 1,  a  decrease  in  the  risk  for  tinnitus  could
 
Some genetic specificity has been reported for different 
populations regarding deafness genes, and, interestingly, 
genotypes representativeness for the individuals of our sample 
were in accordance with values described in the European 
population as well as in the Iberian population. 
Analyzing these results and considering the hearing 
thresholds, no  significant  differences  were  found  in  males  
or females when the three genotypes were compared, however, 
some differences in the pattern of the curves on the audiogram 
can be seen. 
Considering the Tinnitus Handicap Inventory scores (please 
see Figure 6) the variable severe tinnitus (n 12) joins the severe 
and catastrophic grades. We found relevant statistical association 
between the presence of GRM7 and severe tinnitus (individuals 
having scored severe or catastrophic grade in THI). The results 
are present in the Table 5. 
We found no relevant statistical differences considering GRM7 
when comparing the four sub groups already described  in  
Table 1, evidencing no relation with this SNP and the presence 
of presbycusis with or without tinnitus. 
When considering genetic data,  GRM7  genotype  was  
found not to be associated with the risk of developing 
presbycusis (p = 0.889). However, the odds of HL is 
 
 
 
TABLE 4 | Comparative results for rs11928865 SNP on GRM7 gene and 
be thought. The GRM7 genotype was not identified as a risk 
factor for tinnitus, neither when controlling for age (OR = 0.94) 
(OR 0.93). Similar analysis was performed considering also 
two groups but defined as “having a T allele” (TT and AT 
genotypes). However, no significant association with tinnitus was 
found. 
Genetic analysis of NAT2 gene was performed in 65 
individuals, 39 females (60%), and 26 males (40%). Rapid (R) 
phenotype was least common (12.3%, n 8), followed by 
Intermediate (I) phenotype (35.4%, n 23) and Slow (S) 
phenotype (52.3%, n 34) (please see Table 6). 
The genotype 4/4 (considered as wild type) was observed in 
9.1% (n  6) of the individuals being the allele 4 present in   
56.9% (n 37) of the genotypes. The genotype 6A/6A previously 
associated with presbycusis was found in 6.2% (n 4) of the 
individuals being the allele 6A present in 23.1% (n 15) of the 
individuals. The most common genotype is 5B/5B accounting for 
50% (n  11) of all the homozygous genotypes (33.9%, n   22) 
the sample (Kuznetsov et al.,2009). 
We found no statistical differences in NAT2 gene expression 
across our four subgroups described  in  Table  1,  evidencing  
no relation with the presence of presbycusis with or 
 
TABLE 6 | Genotypes observed in the sample and their corresponding 
phenotypes. 
 
 
Genotype Phenotype 
 
comparison with other populations. 
NAT2∗  4/NAT2∗  5U; NAT2∗  6A/NAT2∗  6A; NAT2∗  5B/NAT2∗  5D; S 
 
Genotypes     N     Frequency    Europe    United  Kingdom   Iberian peninsula 
NAT2∗  6J/NAT2∗  13A; NAT2∗  5A/NAT2∗  5B; NAT2∗  6N/NAT2∗  6N;
  
   NAT2∗  6A/NAT2∗  6B; NAT2∗  5D/NAT2∗  5G; NAT2∗  5B/NAT2∗  5B;  
A/A 5 0.064 0.087 0.055 0.065 NAT2
∗  5R/NAT2∗  12A; NAT2∗  4/NAT2∗  5J  
A/T 26 0.333 0.382 0.473 0.393 NAT2
∗  4/NAT2∗  4; NAT2∗  12A/NAT2∗  12C; NAT2∗  4/NAT2∗  12C R 
T/T 47 0.603 0.531 0.473 0.542 NAT2
∗  4/NAT2∗  5B; NAT2∗  4/NAT2∗  6A; NAT2∗  4/NAT2∗  5B; I 
   NAT2∗  4/NAT2∗  5A; NAT2∗  5B/NAT2∗  12A; NAT2∗  4/NAT2∗  13A; 
Total 78 1 1 1 1 NAT2∗  4/NAT2∗  5V; NAT2∗  6A/NAT2∗  13A; NAT2∗  5B/NAT2∗  13A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 6 | Distribution of the individuals according to THI. 
test) Statins intake 
test) Statins intake 
GRM7 Severe tinnitus p-value Fisher test 
A/A 1 
  
A/T 7 0.0233∗  0.0175 
T/T 4   
∗  p-value < 0.05.    
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without tinnitus. No significant association with ARHL was 
found, for  the  in  the  right  and  left  ear  or  best  or  worst  
ear. 
Considering the Tinnitus Handicap Inventory scores, we 
found significant association between severity of tinnitus 
(grades severe and catastrophic  from  THI)  and  the  presence 
of NAT2 gene (please see more details in the next  sub-  
heading). 
 
Modeling the Data – GRM7 and NAT2 
All the results were analyzed through logistic regression model 
(Tables 7, 8) where age, gender and noise exposure were 
considered in the models with the purpose of controlling for 
confounding. The independent variable in the model was severe 
tinnitus (n 12), (the sum of severe and catastrophic grades from 
THI) (Figure 6). 
We have considered the genotype T/T because after crossing 
the GRM7 gene with the tinnitus population, we found that the 
T/T genotype is more frequent and it is the most representative 
so it was chosen as the reference category. 
The odds of developing severe tinnitus was significantly 
higher in the presence of genotype A/T when compared to 
genotype T/T (OR 14.2, p 0.009, CI 2.0 97.8). When 
considering the genotype A/A, no statistically significant 
difference was found (OR  2.9, p   0.443, CI   0.2   42.2).   
The probability of severe tinnitus among individuals with 
genotype A/T is significantly higher when compared with 
individuals with the genotype T/T (for more details see 
Appendix 6). 
When analyzing the presence of severe tinnitus through a 
logistic regression model considering NAT2 as the independent 
variable and controlling for age, gender  and  noise exposure, 
the odds of developing severe tinnitus was significantly higher 
in the presence of slow acetylator phenotype when compared    
to   intermediate  acetylator  (OR 5.7, p 0.095, CI 1.5 
21.9). No statistically significant difference was found with 
respect  to  rapid  acetylator  (OR 2.8, p 0.504, CI 0.4 
20.8) (for more details see Appendix 7). 
 
 
 
TABLE 7 | Logistic regression model in the GRM7 applied to severe tinnitus 
considering the genotype T/T as reference. 
DISCUSSION 
In the present research, we conducted a case history 
questionnaire, hearing evaluation and gene screening analysis 
for GRM7 and NAT2 in a sample of patients aged between 55 and 
75 years, in an attempt to find factors that might contribute to 
the diagnosis of presbycusis and tinnitus, which could be useful 
for diagnosis and future therapeutic interventions. 
Comorbidities Effect 
Although in previous literature was described that individuals 
with thyroid problems present increased hearing thresholds, 
suggesting that thyroid hormones may act as regulators of the 
auditory system (Forrest et al.,1996) our results do not show  
any statistical relevance concerning this, one possible explanation 
is the sample size. Only 10% of our participants report thyroid 
problems which precludes statistical analysis. 
Possibly for a similar reason our data doesn’t show that 
individuals with high blood pressure may be at greater risk of 
presbycusis than the normotensive. Hypertension has previously 
been associated with increasing of the hearing threshold (Agarwal 
et al.,2013, p. 614). Since both presbycusis and hypertension are 
common and widespread disorders, the fact that hypertension 
may influence presbycusis strongly suggests adding cardiologists 
to the multidisciplinary team of professionals screening for 
presbycusis and improving the quality of life of positively 
identified individuals (Agarwal et al.,2013). 
Our results found that hypercholesterolemic individuals had  
a lower risk of HL, probably this is due to the fact that the 
majority of them (67%) were having medication (statins) to 
control cholesterol levels. These results are in accordance with 
previous publications (Gopinath et al.,2011). In individuals with 
hypercholesterolemia the chance of occurring tinnitus is 72% 
lower in those who have statins intake. According to our results 
It seems like the statins have a protector effect. 
Noise exposure and “high frequency” hearing loss seems to 
influence the occurrence of tinnitus, those were two of the most 
statistical relevant findings in our study population, which is in 
accordance with previous literature (Hoffman and Reed,2004). 
Gender and Age Effect 
Significant differences on the HL degree were observed in 
      different frequencies for different age groups (Figure 2). Our 
Variable∗  
 
GRM7 
OˆR p-value (Wald test) (95% IC) results show a significant age-dependent increase of hearing loss 
in about 13% for both genders, although the risk of developing 
 
A/A 2.9 0.443 (0.2, 42.2) 
A/T 14.2 0.009∗  ∗  (2.0, 97.8) 
presbycusis is about three times higher for men. This finding     
is consistent with a previous reports (Pearson et al.,1995) but 
      contradicts another (Homans et al.,2016) where women were 
∗  ∗  p-value < 0.05. 
 
TABLE 8 | Logistic regression model in the NAT2 applied to severe tinnitus 
considering intermediate acetylator as reference. 
found to have more hearing loss. 
According to our data, the risk of presbycusis increases 9% 
per year of life. Considering the increase in life expectancy of 
the population in industrialized countries, our result presents 
Variable∗  OˆR p-value (Wald test) (90% IC) 
obvious consequences and must be considered for future clinical 
management guidelines. 
NAT2    In our sample tinnitus was present in 60.7% of the participants 
Rapid acetylator 2.8 0.504 (0.4, 20.8) and men showed 53% more likelihood of developing tinnitus 
Slow acetylator 5.7 0.095 (1.5, 21.9) than women. This contradicts other results (Vielsmeier et al., 
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2012) who reported higher tinnitus prevalence in women but in a 
much younger population. 
According to our data, and in agreement with previous 
literature (Hoffman and Reed,2004;Shargorodsky et al.,2010) 
age is not associated with the risk of developing tinnitus. 
 
GRM7 and NAT2 Effect 
We did not find a significant relationship between GRM7 
genotype and either presbycusis or tinnitus. Especially for men, 
some differences concerning the pattern in the audiogram curves 
were observed in relation to GRM7 phenotypes. For both 
genders, the T allele in GRM7 gene is the most common allele  
in our sample of older adults with presbycusis and tinnitus, 
where genotypes A/T and T/T present higher level of hearing 
loss compared to A/A genotype. Perhaps in a larger population  
it could be demonstrated that the allele A of GRM7 plays a 
protective role in presbycusis. 
Hence, according to our results, GRM7 genotype does not 
seem to be predictive of presbycusis since the odds to have 
ARHL is not  significant (p 0.78). Corroborating our results, 
Luo et al.(2013)studying  an  all-male  population  found  that 
the T-allele frequency was significantly different from the 
genotype A/A A/T comparing ARHL patients and healthy 
controls and that the GRM7 SNP A > T was significantly 
different between the two groups (Luo et al.,2013).  On  the 
other hand, our findings  differ  fromFriedman  et  al.(2009) 
most likely due to sample size (Luo et al.,2013).  Moreover,    
the impact of the other variables – environmental, lifestyle, 
noise exposure, cholesterol levels and stochastic element – 
perhaps  has  prevailed  over  the  genetic   factor,   declining  
the importance between GRM7 gene and ARHL. Certainly 
multicenter studies with higher sample sizes would overcome 
these aspects. 
Concerning NAT2 gene,  Rapid  (R)  phenotype  was  the  
least common, followed by the Intermediate (I) and Slow (S) 
phenotypes. 
We found relevant statistical association between the presence 
of the allele A/T of GRM7 and severe tinnitus. The chance for 
having a severe grade of tinnitus (severe or catastrophic grades in 
THI) is 14,2 higher for those carrying the allele A/T compared to 
T/T. Probably in larger scale studies could be demonstrated the 
role of allele A/A that is the less frequent in our sample. 
The odds of developing severe tinnitus was relatively higher 
in the presence of slow acetylator phenotype of NAT2 when 
compared to intermediate acetylator. 
Our data suggests that allele A/T of GRM7 can have a 
statistically significant influence toward the severity of tinnitus. 
As well  slow  acetylator  phenotype  of  NAT2  seems  to  have  
a similar influence (not statistically relevant in our results). 
Nevertheless, those results should be interpreted with caution 
and future studies in larger scale are necessary to confirm this 
correlation. 
However, present data shows that genotype A/T and T/T 
present, respectively, a 70 and 33.3% lower risk of developing 
tinnitus, when compared to A/A genotype. No other studies were 
found relating GRM7, NAT2 and tinnitus. 
CONCLUSION 
To the best of our knowledge, this is the first study on the 
association between GRM7 and NAT2 gene and the presbycusis 
and tinnitus in a population of Portuguese older adults. 
Tinnitus was present in the majority of the presbycusis 
individuals. 
Age and gender significantly influence the risk for presbycusis 
but not for tinnitus. Overall hearing thresholds rates increase 
exponentially with age (9% per year), and the increment rate and 
speed were gender-specific, but this increasing rate and velocity 
are different for women and men. 
High blood pressure, thyroid diseases and 
hypercholesterolemia seem to have an effect on the hearing 
thresholds but no significant associations were found. 
Our findings agree with previously observed correlations 
between tinnitus, noise exposure, and “high frequency” hearing 
loss. 
No significant associations between presbycusis, tinnitus, and 
GRM7 or NAT2 were found in our sample. Our results precludes 
a definitive clarification about the role of GRM7 as a possible 
genetic biomarkers for ARHL, although since the  genotypes 
A/T and T/T have higher odds for HL than A/A genotypes,   
thus A allele could be pointed as protective biomarker for HL 
Nevertheless, the current state of knowledge regarding GRM7 
impact in presbycusis is insufficient to make conclusions, and so, 
further large-scale studies are necessary to clarify this relation. 
Considering tinnitus severity (according to THI), our results 
bring-up very innovative conclusions. 
Our data suggests the tracks that can lead to the pathway of a 
tinnitus severity biomarker. Potentially individuals carrying the 
allele A/T of GRM7 and slow acetylator phenotype of NAT2 (the 
later one with smaller statistic relevance) are prone to develop a 
more severe form of tinnitus, that requires specific therapeutic 
interventions and ideally personally tailored. 
The occurrence of presbycusis is thought to be determined  
by genetic factors but can also be influenced by environmental 
or comorbidities effects, with a huge impact on quality of life 
and general health (Huang and Tang,2010;Ciorba et al.,2015). 
However, there is still much research to explore and elucidate 
which risk factors contribute more to presbycusis and tinnitus, 
so this could help on therapeutic or preventive interventions 
(Huang and Tang,2010). 
Information on family history and clinical epidemiological 
data may help the design and development of future clinical 
management plans for an increasing presbycusis population. 
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6. Discussion and Conclusions 
The present study aimed to identify audiological, immunological or genetic 
factors associated to tinnitus, in a way to promote a better understanding of tinnitus 
pathophysiology and improve diagnosis and treatment of tinnitus. Additionally, this 
study allowed us to characterize the most relevant comorbidities associated to tinnitus.   
Characteristics of the population in study: 
We explored different aspects in a sample of participants aged between 55 and 
75 years, with or without hearing loss and/or tinnitus. In the 114 participants aged 64.0 
± 5.6 years old, most of them were female (52.6%). The mean age for the subgroup 
without tinnitus was 64.6 ± 3.8 years old, while the mean age for tinnitus group was 64.0 
± 5.6 years old. Our tinnitus population included a high number of individuals belonging 
to the sector ‘specialists of scientific and intellectual activities’, followed in number by 
‘technicians and professionals of intermediate level’ and ‘administrative staff’. 
Tinnitus and comorbidities 
Using a structured interview, we have explored the following comorbidities in 
our sample: cholesterol, hypertension, cardiovascular disease, diabetes, thyroid 
problems, smoking and alcohol habits, meningitis, mumps, measles, tuberculosis, ear 
diseases, ear surgery, and noise exposure.  
From our sample, 68 participants (59.6%) had high blood values of cholesterol. 
Of those, 27 individuals (55.1%) were taking medication (statins). There was a significant 
association between tinnitus and statins intake in those individuals reporting 
hypercholesterolemia (OR =0.28, p=0.045, CI=0.08-0.99). This finding is in agreement 
with those reported in our systematic review of tinnitus biomarkers. There is good 
evidence therefore for an association between the presence or severity of tinnitus and 
hyperlipidemia.  
We found no relevant association between statins intake and hearing loss. 
Concerning the effect of history of noise exposure and hearing loss, the results 
showed that the odds of developing tinnitus were significantly higher (p=0.036 and 
p=0.009) respectively in the presence of these factors. These results are in agreement 
with the literature where it is hypothesized that tinnitus is an epiphenomenon of a 
neuronal process to attempt normalizing impaired hearing thresholds (Gollnast et al., 
2017). Similarly, some epidemiological studies have confirmed correlations between 
hearing loss, noise exposure, and tinnitus (Chung et al., 1984; Hoffman & Reed,2004; 
Roberts et al., 2010; Sindhusake et al., 2003, 2004; ). 
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High frequency hearing loss in both ears represents a significant risk of tinnitus 
(p=0.001). 
Regarding comorbidities in our sample, mumps are present on 56% of the 
individuals with tinnitus and 31.8% for the individuals without tinnitus. Also, 53.3% the 
individuals with tinnitus and 22.7% without tinnitus had hearing loss. We only found 
statistically significant differences between the two subgroups for mumps (p=0.041) and 
hearing loss (p=0.010). 
According to statistical analysis, the odds of having tinnitus was higher for those 
participants having noise exposure (p=0.036), high frequency hearing loss or 
presbyacusis (p=0.001), hearing loss (p=0.014) and mumps (p=0.046).  
Clinical characterization of tinnitus sample  
Through the Portuguese validated version of Tinnitus Handicap Inventory (THI) 
(Newman et al., 1996; Oliveira & Menezes, 2008), we analyzed the THI scores for 
categorization of tinnitus severity in our sample. A mild handicap score was the most 
frequent grade in our sample being present in 38 participants (41.3%) followed by 
moderate handicap (22 participants, 23.9%), slight or no handicap (17 participants, 
18.5%), severe handicap (14 participants, 15.2%). One participant had a catastrophic 
handicap score (1.1%). We analyzed the possible factors contributing to development of 
tinnitus or different grades of tinnitus severity and found some clinical aspects, 
described ahead, that may contribute more to developing severe or catastrophic 
tinnitus.  
Our results showed that the onset of tinnitus is an important factor contributing 
to the severe or catastrophic tinnitus grade. In our sample, 49% of participants showed 
a gradual tinnitus onset followed by 19.5% of participants that had abrupt onset tinnitus. 
Our results evidence that an abrupt tinnitus onset is 5.13 times more likely to develop a 
severe or catastrophic tinnitus. This indicates that a gradual tinnitus onset permits a 
natural habituation process which is also mentioned in the bibliography (Hall, Rachman 
& Hinchcliffe, 1984).  
Psychoacoustic tinnitus assessment  
We performed several tests to characterize, measure and evaluate tinnitus 
percept in all the participants with this complaint. Tinnitus pitch ranged  from 2000 Hz 
to 8000 Hz, with 4000 Hz being the most frequently found. Mean loudness was 0 dB. We 
have considerate the difference between tinnitus intensity at the frequency identified 
by psychoacoustic measurements and hearing threshold at that frequency as the 
tinnitus sensation.  
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The majority of our sample had a pure tone tinnitus (59%) and central location 
(52.4%). The Feldmann’s curve showed that the convergent (47.6%) and distant type 
(29.8%) are the most frequent. Residual inhibition was generally negative (43.9%) or 
partial (36.6%). Patients with negative or rebound residual inhibition had an 82.2% 
higher odds of developing a severe or catastrophic tinnitus. Complementary, the 
presence of a complete (tinnitus abolishment) or rebound effect (tinnitus exacerbation) 
in residual inhibition was found as a “protector factor”. This result seems to be related 
to the possibility that patients with complete residual inhibition can more easily mask 
their tinnitus with environmental sounds. Hence it is expected that tinnitus will not 
become very disturbing because is only audible in very silent places (e. g. bedroom at 
sleeping time). These results represent novel findings for the importance of residual 
inhibition in the diagnosis.  
Audiological markers of tinnitus 
The exploration of audiological markers in our participants, with or without 
tinnitus, allowed us to identify new relevant insights regarding tinnitus evaluation.  
Hyperacusis (over sensitivity to sound) demonstrates a relationship with tinnitus 
severity. In our sample, participants with moderate or severe hyperacusis were 7.56 
times more likely to develop severe or catastrophic tinnitus (OR=7.556, p=0.011, 
CI=1.603-35.616).This finding favors the central gain theories regarding common 
pathophysiology for tinnitus and hyperacusis. 
Data from the literature suggest common pathways for the pathophysiology of 
tinnitus and hyperacusis resulting as a central compensatory gain due to reduced neural 
activity from a damaged cochlea (Auerbach et al., 2014; Knipper et al., 2013). 
The study of possible Auditory Brainstem Response (ABR) markers in tinnitus 
patients identified a reduction of the amplitude in the wave I in patients with tinnitus, 
and an increase of the I-III interval when compared the group without hearing loss with 
tinnitus, and the group with hearing loss and tinnitus. The reduction of the wave I 
amplitude had already been reported in other studies (Attias, et al., 1993; Gu et al., 
2012; Schaette & McAlpine, 2011). Also, the ABR amplitude wave I was considered as a 
protective factor in relation to developing tinnitus and Ratio RE_LE as a risk factor to the 
odds of having a severe or catastrophic grade of tinnitus. This parameter is also related 
to the amplitude of waves I and V. The reduction of amplitude I may be due to changes 
in the IHC and/or in Auditory Nerve Fibers (ANFs). Changes can be a diffuse loss of the 
IHC compared with patients with no tinnitus that results in a lowered wave I amplitude 
(Gu et al., 2012) or a diffuse loss of the ANFs while the IHC remains intact (Gu et al., 
2012; Le Prell et al., 2003, 2005). Other possibilities are that ANFs are equally intact, and 
the reduction of the amplitude wave I is due to the reduced excitability of ANFs via 
lateral olivocochlear efferents which terminate on their endings, or there is a diffuse loss 
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of ANFs sufficient to manifest a reduction in mean wave I amplitude. The evaluation of 
ABR audiological markers also adds that the mean ratio of PEAP (Potential Evoked 
Auditory Potentials) for both ears are 1.1 times higher for developing severe or 
catastrophic tinnitus((OR) ̂=1.1,p=0.046,CI=1.002-1.208).  
Analysis of DPOAEs showed that are lower in patients with tinnitus (p=0.041 for 
RE and p=0.028 for LE) to those without. However, in this case, we do not consider the 
presence or not of hearing loss. Our results are in agreement with those reported by 
Ozimek et al. and Shiomi et al., which points us to conclude that these observed changes 
are specific to the functions of OHC instead of nonspecific non-linearity of the basilar 
membrane system (Ozimek et al., 2006; Shiomi et al., 1997). In addition, DPOAEs were 
statistically lower (p=0.038 in the LE) in participants that had noise exposure. In fact, this 
is a protective variable, and when it is higher the odds of having tinnitus diminish. These 
data are in accordance with others results (Sindhusake et al., 2003). Thus, noise 
exposure was a risk factor for tinnitus in our sample, which is in agreement to published 
literature. 
In summary, according to the regression statistical model some variables 
represent lower odds for developing tinnitus, namely “Mean OEA for left ear” (p=0.043) 
and “ABR wave 1 amplitude for right (p=0.004) and left ear” (p=0.048).   
Immunological markers of tinnitus 
The majority of the participants (n=112) of the sample were evaluated for IL1α, 
IL1β, IL2, IL6, IL10, IFN-γ, TNF-α and TGF-β and a small group (n=80) for HSP70 in 
peripheral blood samples. 
The comparison between subgroups of individuals with or without tinnitus 
revealed significant difference for the levels of IL10 (p = 0.025) and for IL6 and TGFβ we 
observe a marginally significant result (p =0.052 and p = 0.064, respectively). We had 
two-day timepoint for blood sample collection and our results showed that 
inflammatory markers have a circadian cycle which is accordance with others authors 
(Altara et al., 2015). Interestingly, we observe more statistical relevant results for the 
afternoon group (p =0.012). This finding is in accordance with the recent demonstration 
that the cochlea also has a circadian cycle. In animal studies of hearing loss secondary 
to noise trauma consequences on hearing were significantly worse when noise trauma 
was delivered at 9pm than at 9am (Meltser et al. 2014).  
The IL1α values were statistically higher in patients with tonal tinnitus compared 
to narrow band tinnitus.  Regarding residual inhibition, we found statistically significant 
differences for IL2 (p = 0.019). Additionally, we observed a negative correlation between 
tinnitus duration and the level of IL10 (r = -0.281, p =0.007) and also a significant 
negative weak correlation between HSP70 and tinnitus loudness (r = -0.397). To our best 
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this is the first report of those correlations between tinnitus characteristics and 
psychoacoustic measurements with inflammatory markers. 
The concentration of evaluated inflammation markers correlated significantly 
with hearing loss, especially with the high frequency hearing loss (presbycusis), which is 
a statistically significant risk factor for tinnitus. 
Genetic markers of tinnitus 
Our study of GRM7 and NAT2 found factors that might contribute to the 
diagnosis of presbycusis and tinnitus, eventually lead to future therapeutic 
interventions. 
Results were obtained from 78 individuals from the sample, most participants 
were female (n=45, 57.7%), presenting an average age of 64.1 ± 5.35 years old. Male 
participants (n=33, 42.3%) had a mean age of 65.3 ± 5.89 years. GRM7 gene was studied 
for rs11928865 SNP, which refers to A or T alleles and contribute for three possible 
genotypes: A/A, A/T or T/T. When considering GRM7 genotypes results in the patients 
with tinnitus, we identified the genotype T/T as the most frequent and representative, 
thus it was chosen as the reference category for further statistical analysis. The odds of 
developing severe tinnitus was significantly higher in the presence of genotype A/T 
when compared to genotype T/T (OR=14.2, p=0.009, CI=2.0-97.8). 
Genetic analysis of NAT2 gene was performed in 65 individuals, 39 females 
(60%), and 26 males (40%). Rapid (R) phenotype was least common (12.3%, n=8), 
followed by Intermediate (I) phenotype (35.4%, n=23) and Slow (S) phenotype (52.3%, 
n=34). When analyzing the presence of severe tinnitus through a logistic regression 
model considering NAT2 as the independent variable and controlling for age, gender 
and noise exposure, the odds of developing severe tinnitus was significantly higher in 
the presence of slow acetylator phenotype when compared to intermediate acetylator 
(OR=5.7, p=0.095, CI=1.5-21.9). No statistically significant difference was found with 
respect to rapid acetylator (OR=2.8, p=0.504, CI=0.4-20.8).  
Our data suggests individuals carrying the allele A/T at GRM7 and slow acetylator 
phenotype of NAT2 (the later one with smaller statistic relevance) are prone to develop 
a more severe form of tinnitus that requires specific therapeutic interventions, and 
ideally, personally tailored treatment. 
Quality of life and psychological aspects of tinnitus 
We explored characteristics, psychological symptoms, and quality of life in the 
individuals of the sample. For the whole sample, 22 of the participants had a previous 
history of psychiatric medication, while 20 participants were, at the moment, taking 
psychiatric medication. From the 22 participants with previous history of psychiatric 
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medication, 86.3% participants were patients with tinnitus (n= 19) with a previous 
history of medication. Regarding those having psychiatric medication, 20 patients had 
tinnitus (corresponding to 20.6% of all individuals with tinnitus) were, at the moment of 
inclusion in the study medicated, which corresponds to 95% of the total of the 
participants that were taking psychiatric medication. Those results strongly suggest that 
the most severely affected tinnitus patients will benefit from the care of mental health 
professionals. 
Analysis of the Portuguese validated version of Brief Symptom Inventory (BSI) 
Canavarro, 1999) observe higher scores in tinnitus patients on the psychological 
complaint scales of somatization and paranoia. Overall, is described that patients with 
tinnitus suffer more distress arising from awareness of bodily representations and 
present paranoid behavior related to a disordered mode of thinking (Derogatis & 
Spencer, 1982). Significant differences were found in the Obsessive-compulsive 
(p=0.009) and Interpersonal sensitivity (p=0.026) scales concerning the presence of 
tinnitus. The interpersonal sensitivity dimensions focus on inferiority and inadequacy 
feelings when compared with others, and with depreciation and restlessness during 
interpersonal interactions. In turn, the Obsessive-Compulsive scale focuses on thoughts, 
impulses and actions of the individual that are considered irresistible, but are of an 
undesired nature (Derogatis & Spencer, 1982). This supports the importance of CBT in 
tinnitus treatment, mainly in respect to negative automatic thoughts, safety behaviors 
and inaccurate beliefs in relation to tinnitus (McKenna et al., 2014). Those results 
strongly propose including psychologists to the multidisciplinary approach with different 
professionals involved at tinnitus treatment. 
The Portuguese validated version of the Medical Outcomes Study Short Form 
Health Survey (MOS SF-36), evaluates health-related quality of life (Ferreira, 2000). Here 
the MOS scales were generally lower in the population with tinnitus, on both physical 
and emotional dimensions, suggesting a lower quality of life in this population. Our 
results showed that the physical component of MOS was lower than the emotional 
component, which indicates physical limitations, more impact of the intensity and 
discomfort caused by the pain, and the person's own perception of his overall health. 
Also, the lowest scale concerning emotion was the vitality scale which measures energy 
and fatigue levels, and that qualifies the differences in well-being.  According to another 
study in a Portuguese population using the MOS SF-36 (Oliveira & Meneses, 2008), 
vitally was one of the most affected scales, together with the social function, general 
health, mental health dimensions. 
Regarding the comparison of the more severe grades of tinnitus participants 
(severe and catastrophic according to THI) with other grades, significant differences in 
psychological complaint and quality of life were found. Through the logistic regression 
model, with severe or catastrophic tinnitus as an independent variable, it was found 
Tinnitus, biomarkers and quality of life in an older population 
277 
 
  
significant differences in General Severity Scale (BSI) (p=0.037) and in General Health 
Perceptions (MOS) (p=0.037). For the odds of developing severe tinnitus, the variable 
General Severity Scale was considerated as a risk factor (OR was above 1) and General 
Heath Perceptions was considerated as a protector factor (OR was below 1). Most BSI 
scale scores were increased (showing a clinically relevant score ≥63) revealing the 
psychological impact of the participants that were severely affected by tinnitus. Higher 
grades on the scales such as somatization, depression and anxiety were related to the 
severity of tinnitus, as reported in previous studies (Erlandsson & Hallberg, 2000; 
Holgers et al., 2005) 
Using regression statistical models, we have proven that the scales with more 
relevant statistical association to tinnitus are the General Severity Index (the more 
sensitive BSI scale to distress symptoms according to Derogatis & Spencer, 1982) and 
the General Health Perception (from MOS). These findings bring to discussion the issue 
of frailty, particularly relevant for the age range focused in our study. Clearly, an 
individual will be more prone to have tinnitus if they have higher General Severity Index 
(t≥63) and lower values at General Health Perception scores. 
Our results bring and reinforces new insights concerning the importance of the 
holistic assessment and management of the individual relevant to tinnitus as a 
multidimensional symptom (Hall et al., 2018a). To our knowledge this is the first study 
to use the BSI General Severity Index and identify scoring that represents a risk factor 
for tinnitus and impaired quality of life, and what scoring on the General Health 
Perception scale of MOS represents a protector factor for tinnitus. 
European Research Network  
Towards a global standardization in tinnitus scientific field 
Many people with tinnitus do not seek medical support. Even for those reporting 
tinnitus as a bothersome problem, a large American survey found that only 50% had 
visited a physician for a consultation appointment (Bhatt et al., 2016). Although there 
are multiple management options for tinnitus, the majority lack high quality scientific 
evidence to support strong claims for their benefit. From of all therapeutic options, 
Cognitive Behavioral Therapy (CBT) delivered by a qualified clinical psychologist has the 
most support for its effectiveness in reducing tinnitus symptom severity (Cima et al., 
2012; Hesser et al., 2011; Martinez Devesa et al., 2010). 
Given the heterogeneity of the tinnitus condition, one of the major challenges to 
advancing the field of tinnitus concerns the lack of standardization in approaches to 
research and clinical management. To address this, a European consortium gathered 
together in 2014 under the auspices of a four-year European Cost Action BM1306 
“Tinnitus Research Network” (TINNET) (http://tinnet.tinnitusreserch.net/). The main 
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objective of this Action was the creation of an international network for identifying 
clinically meaningful subtypes of tinnitus and their neurobiological underpinnings in 
order to develop better strategies for diagnosis and management. TINNET comprised 
five working groups (WG) covering clinical, database, neuroimaging, genetics and 
measurement outcomes. These coordinated efforts from basic scientists, technicians 
and clinicians working in different medical disciplines working together in close 
collaboration. TINNET interdisciplinary objectives were to create standards for 
identifying i) meaningful clinical and demographic characteristics for tinnitus subtyping 
(WG1), ii) assessing tinnitus-related changes in brain activity associated with different 
subtypes of tinnitus (WG3), iii) intermediate genetic phenotypes and genetic factors in 
the pathogenesis of tinnitus (WG4), iv) standards for assessing outcomes after clinical 
intervention (WG5). Cross-cutting all of these themes WG2 was aimed at establishing an 
electronic data repository to promote scientific transparency and support data sharing. 
The legacy from TINNET is wide ranging. WG1 planned a roadmap in which a 
systematic review of existing tinnitus guidelines as well as a European survey on tinnitus 
management were the foundations for their final goal (Fuller & Haider et al., 2017) They 
have gathered the opinions of clinical experts using consultation methods to generate 
an evidence-based good practice guideline for the assessment and management of 
people with bothersome tinnitus. This is now in the final stage of dissemination, but was 
launched at the 11th Tinnitus Research initiative and 2nd TINNET conference in 
Regensburg in March 2018.  
WG5 have gathered the opinions of many different stakeholders including 
people with tinnitus as well as professionals using consensus methods to produce 
recommendations for what tinnitus-related complaints are critical and important to 
measure when assessing treatment-related benefit. Of interest, these guidelines 
separately consider sound-based, psychology-based and pharmacology-based 
interventions, since each of these approaches has a different therapeutic rationale and 
therefore aims to address different tinnitus symptoms. For WG5, a series of publications 
has already appeared in various peer-reviewed journals (Hall et al., 2016, 2018a,b; Smith 
et al., 2018) and the main findings are again in the final stage of dissemination. The next 
step is to identify how the different tinnitus-related complaints should be measured. 
This work will continue over the next few years beyond the initial TINNET funding. 
Diagnostic criteria for Somatosensory tinnitus: A Delphi consensus  
From the need on increasing knowledge about subtypes of tinnitus we 
underwent also a scoping review regarding somatosensorial tinnitus pathophysiology, 
diagnostic and treatment. And participated in a study aimed to reach an international 
consensus on diagnostic criteria for somatosensory tinnitus (ST) among experts, 
scientists and clinicians, using a Delphi survey and consensus meeting strategy. The 
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consensus meeting panel recognized that somatic modulation, especially by voluntary 
movements, specific tinnitus characteristics and symptoms that can accompany the 
tinnitus are suggestive of the presence of ST, but added that the absence of somatic 
modulation does not rule out ST. None of these criteria have to be present in every single 
patient with ST, but in case they are present, they strongly suggest the presence of ST. 
It was also considered the possibility of the presence of specific type of constant 
pulsatile tinnitus. Although not an item included there is a strong recommendation for 
attention to keep in mind that in some cases a pulsatile tinnitus, synchronous with the 
heartbeat, can be affected by somatic maneuvers. 
There was an agreement concerning the cases where the somatosensory system 
is the main cause of the tinnitus. This study also report that a large proportion of patients 
has a secondary somatosensory influence on the tinnitus clearly caused by auditory 
deafferentation, such as noise exposure (Michiells et al., 2018). 
Conclusions 
The world’s population is aging and hearing loss is one of the most prevalent 
chronic diseases that causes of disability (Wilson, Tucci, Merson, & O'Donoghue, 2017). 
The consequences of hearing impairment for general health condition of the affected 
people are considerable including reduced physical and mental activity and secondary 
social isolation caused by hearing loss (Arlinger, 2003) increases the risk of cognitive 
decline and dementia (Lin et al., 2011), mental illness (Matthews, 2013), and depression 
(Davis, 2011; Matthews, 2013).  
Given the strong links between hearing loss and tinnitus, then tinnitus surely 
follows this trend. Altogether this symptoms contribute for progression to frailty. 
Our audiological study highlits some interesting findings especially concerning 
audiological tinnitus characteristics. Our data may contribute to foresee the evolution 
of the severity of the tinnitus, namely the odds of a patient develop severe or 
catastrophic grade of tinnitus. ABR Ratio OD_OE as a risk factor for having a severe or 
catastrophic grade of tinnitus, if confirmed in larger populations studies is a potential 
candidate as an audiological marker of tinnitus severity. 
In our study of inflammatory parameters, we have shown for the first time that 
the systemic concentration of IL10 and INF-γ are statistically associated with the 
presence of tinnitus. Another interesting finding is that higher IL1α levels are associated 
with tonal type of tinnitus and HSP70 and HL10 are negatively correlated to tinnitus 
loudness and tinnitus duration respectively. Because of the trend for negative 
correlations between the inflammatory markers and tinnitus characteristics, it is 
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reasonable to think that inflammatory mechanisms are involved in the acute phase of 
tinnitus emergence. 
On the other hand, our data suggests a potential genetic tinnitus severity 
biomarker, since individuals carrying the A/T genotype at rs11928865 SNP of GRM7 gene 
and slow acetylator phenotype of NAT2 gene (the later bordering significance) are prone 
to develop a more severe form of tinnitus. This data allow the identification of tinnitus 
that requires specific therapeutic interventions and is ideally personalized treatment. 
Taken together, tinnitus and hearing loss disorders have a high negative impact 
on the quality of life of the affected persons especially if the grade of tinnitus severity is 
high. 
To our knowledge this is the first study to use the BSI General Severity Index and 
identify scoring that represents a risk factor for tinnitus and impaired quality of life, and 
what scoring on the General Health Perception scale of MOS represents a protector 
factor for tinnitus. 
Our study brings and reinforces new insights concerning the importance of the 
holistic assessment and management of the patient pointing for tinnitus as a 
multidimensional symptom. 
Accordingly, the assessment of the individual with tinnitus and therapy strategies 
should be multidisciplinary to ensure coverage of all dimensions of the patient. 
Moreover, therapeutic strategies should be tailored to the individual, after proper 
information and with respect for patient choice and individual needs. 
Due to the huge diversity of tinnitus etiologies it is highly relevant to 
appropriately identify clinical tinnitus subtyping, thus deal with potential treatable 
causes and obtain the appropriate tinnitus management for each patient. 
Multidisciplinary guidelines are essential.  
The establishment of guidelines for clinical diagnosis, treatment, neuroimaging 
assessments and outcome assessment, through the identification of clinically 
meaningful tinnitus subtypes, provides an important basis for the standardization of 
clinical research and management of tinnitus. 
7. Future Directions 
Worldwide the population is ageing, World Health Organization (WHO) Global 
Burden of Diseases (2015) estimated that in 2050 there will be 2 billion people older 
than 65 and reports hearing loss as the fourth leading cause of years lived with disability. 
Given the strong links between hearing loss and tinnitus, then tinnitus surely follows this 
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trend. Taken together, tinnitus and hearing loss disorders have a high negative impact 
on the quality of life of the affected persons especially if the grade of tinnitus severity is 
high. In order to improve quality of life of people with those conditions it is imperative 
to have investment in studies to clarify the underlying causal mechanism in order to 
enable a more efficient prevention or treatment and avoid the progression to frailty and 
related mental health disabilities. 
 
Tinnitus and hearing loss  
The association between hearing loss and tinnitus is more complex than simply 
having both conditions. When hearing loss is present, the tinnitus frequency usually 
matches the region of greatest threshold losses, especially in the case of down-sloping 
sensorineural hearing loss profiles (Schecklmann et al., 2012).  
In this perspective the procedures to prevent hearing loss will have a reflection 
on tinnitus such as vaccination, especially in infants, against the most frequent agents 
of acute otitis media (Haemophilus influenza type B, Streptococcus pneumoniae and 
Moraxella catarrhalis) and also promote vaccination for measles, mumps and, rubella. 
Other preventive measures concern the avoidance of ototoxic medication and 
environmental risk factors such as noise exposure by means of ear protection (in leisure 
or work activities) and education before adolescence. Other important preventive 
measures regards lifestyle optimization by avoiding high calorie diet, toxic consumption 
(alcohol, tobacco), and a generally harmful lifestyle (Wong & Ryan, 2015). In those 
people already presenting hearing loss hearing rehabilitation is mandatory. 
Future research lines in treatment 
Ahlf and colleagues have proposed, after their work in animal models of noise 
induced tinnitus, that animals who did not develop tinnitus after noise trauma had an 
overall higher neurologic activity. Hence he suggests that an inhibitor of neuronal 
activity (such as GabaA) could prevent tinnitus development (Ahlf, Tziridis, Korn, 
Strohmeyer, & Schulze, 2012). Unfortunately, this remains speculative, and one of the 
limiting factors for interpretation is that noise trauma not only induces tinnitus but also 
hearing loss.  
Future research should be designed to improve the sensitivity of non-invasive 
electrophysiological measures of cochlear synaptopathy in humans and to examine the 
broader neurophysiological impact of noise exposure. Additionally, it is essential to have 
a clear distinction of the specific mechanisms for isolated tinnitus or for isolated hearing 
loss.  
Genetics is one of the most promising research areas regarding hearing loss 
because we can anticipate the cloning of some isolated genes responsible for hearing 
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loss and procedures of gene replacement. Similarly, advances in the immunology and 
pharmacology fields in combination with advanced cochlear drug delivery systems will 
allow the molecular replacement or treatment to prevent the loss of damaged cochlear 
sensorial epithelium (anti-apoptotic, proliferative, nurturing and, anti-inflammatory 
molecules).  
Also, genetics bioengineering will allow us to have cochlear damaged ciliated 
cells replacement and probably rehabilitate or prevent hearing loss and associated 
tinnitus. 
Those genetic research lines in combination with advances in 
neuropharmacology molecules, in turn inspired on animal research finding and cells-
culture research will certainly allow reaching more effective therapies. Recent novel 
findings may open perspectives for new therapeutic approaches on molecular level (e.g. 
intracochlear application of NMDA antagonists, modulation of microtubule associated 
proteins molecular pathway, GABA modulation); on a systemic level (behavioral 
strategies, transcranial magnetic stimulation); “hybrid” solutions that would involve 
synergistic action of pharmacotherapy and Vagal Nerve Stimulation (Bojic et al., 2017) 
and lastly the intracochlear pharmacological interventions supported by a nonspecific, 
mostly anxiolytic pharmacotherapy (Guitton, 2012). Factors that determine the phase 
of tinnitus pathophysiological evolution (initiation or maintenance), the level (molecular 
or systemic), the mechanism (neurotransmission or neuromodulation) (Guitton, 2012) 
will in the future determine the therapeutic approach. 
Our finding regarding audiological, inflammatory, genetic and psychological 
parameters suggest the need for further research, not only for confirmation in larger 
samples, but also regarding pathophysiological mechanisms underlying this 
phenomenon. Ideally future research on this area should include animal research 
combined with cell culture studies in order to establish more conclusive translational 
findings. 
Final Considerations  
Although there are multiple treatment options for tinnitus management most of 
them lack scientific evidence-based confirmation. Cognitive behavioral treatment (CBT) 
is the modality with the highest level of evidence for clinical efficacy (Martinez-Devesa 
et al., 2010; Hesser et al., 2011; Cima et al., 2012). 
Another relevant aspect that should be considered in the development of new 
therapies is the patient’s valorization and acceptance of each treatment option.  When 
developing guidelines for tinnitus diagnosis and treatment, the involvement of the 
patient’s perspective is paramount (Tyler, 2012). 
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Subjective chronic tinnitus’s etiology is still unknown. Current view on tinnitus is 
that it is a symptom encompassing a distributed network of peripheral and central 
pathways of the nervous system. Due to its complex nature tinnitus should be 
approached in a multidisciplinary fashion involving different health professionals that 
are specialized to deal with each of the dimensions encompassed within this symptom 
(Hall et al., 2018a). 
Frequently, scientific results are impaired due to small and heterogenous sample 
sizes and also because of lack of standardization among scientific research methods 
(Vielsmeier et al., 2016). The low rate of therapeutic effectiveness reflects the general 
dissatisfaction of both patients and health professionals (Hall et al., 2011). It also 
supports the urgent need for standardization both for clinical practice and for research. 
Moreover, the real impact of subjective chronic tinnitus in scientific research, clinical 
practice and patient’s life is still undervalued (Hall et al., 2011). 
The most recent arguments point to the benefits of a multidisciplinary approach 
both for tinnitus diagnosis and treatment. The collaboration of professional from 
different fields (audiologist, psychologist, otorhinolaryngologist, maxillo-facial surgeon, 
dentist, phisiatricion etc.) will ultimately improve care and improve patient’s quality of 
life (Cima, et al., 2014).  
Advancing knowledge concerning specific tinnitus subtypes, origins, and 
maintenance mechanisms is of paramount importance for obtaining for adequate 
treatment. 
TINNET has been an important pan-European project in bringing together a range of 
multi-disciplinary experts with an interest in tinnitus. The four years have succeeded in 
generating a tinnitus community. While the guidelines thus created for clinical diagnosis, 
management, neuroimaging assessments and outcome measurements provide an 
important basis for standardization, the future challenge will be in ensuring that these 
recommendations are adopted and implemented on an international scale. In terms of 
tinnitus standardization, the next step is to identify how the different tinnitus-related 
complaints should be measured. Only by working together as a community can we 
ultimately pave the way to help our patients more effectively manage their symptoms 
and ultimately to find a cure for this debilitating condition. 
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